
<html lang="en"     class="pb-page"  data-request-id="1cee9c69-703c-4e81-a30d-b750f495727f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.8b01951;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-7;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors" /></meta><meta name="dc.Creator" content="Suhui  Yang" /></meta><meta name="dc.Creator" content="Andrea  Shergalis" /></meta><meta name="dc.Creator" content="Dan  Lu" /></meta><meta name="dc.Creator" content="Anahita  Kyani" /></meta><meta name="dc.Creator" content="Ziwei  Liu" /></meta><meta name="dc.Creator" content="Mats  Ljungman" /></meta><meta name="dc.Creator" content="Nouri  Neamati" /></meta><meta name="dc.Description" content="Protein disulfide isomerase (PDI) is responsible for nascent protein folding in the endoplasmic reticulum (ER) and is critical for glioblastoma survival. To improve the potency of lead PDI inhibito..." /></meta><meta name="Description" content="Protein disulfide isomerase (PDI) is responsible for nascent protein folding in the endoplasmic reticulum (ER) and is critical for glioblastoma survival. To improve the potency of lead PDI inhibito..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 13, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01951" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01951" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01951" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01951" /></link>
        
    
    

<title>Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01951" /></meta><meta property="og:title" content="Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0022.jpeg" /></meta><meta property="og:description" content="Protein disulfide isomerase (PDI) is responsible for nascent protein folding in the endoplasmic reticulum (ER) and is critical for glioblastoma survival. To improve the potency of lead PDI inhibitor BAP2 ((E)-3-(3-(4-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile), we designed and synthesized 67 analogues. We determined that PDI inhibition relied on the A ring hydroxyl group of the chalcone scaffold and cLogP increase in the sulfonamide chain improved potency. Docking studies revealed that BAP2 and analogues bind to His256 in the b′ domain of PDI, and mutation of His256 to Ala abolishes BAP2 analogue activity. BAP2 and optimized analogue 59 have modest thiol reactivity; however, we propose that PDI inhibition by BAP2 analogues depends on the b′ domain. Importantly, analogues inhibit glioblastoma cell growth, induce ER stress, increase expression of G2M checkpoint proteins, and reduce expression of DNA repair proteins. Cumulatively, our results support inhibition of PDI as a novel strategy to treat glioblastoma." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01951"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01951">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01951&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01951&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01951&amp;href=/doi/10.1021/acs.jmedchem.8b01951" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3447-3474</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01938" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01961" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Suhui Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Suhui Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Suhui++Yang">Suhui Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrea Shergalis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrea Shergalis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Shergalis">Andrea Shergalis</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1155-1583" title="Orcid link">http://orcid.org/0000-0002-1155-1583</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dan Lu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dan Lu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Lu">Dan Lu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anahita Kyani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anahita Kyani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anahita++Kyani">Anahita Kyani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ziwei Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ziwei Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ziwei++Liu">Ziwei Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mats Ljungman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mats Ljungman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiation Oncology Rogel Cancer Center, University of Michigan Medical School and Rogel Cancer Center, School of Public Health, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mats++Ljungman">Mats Ljungman</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Nouri Neamati</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nouri Neamati</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (734)647-2732. E-mail: <a href="/cdn-cgi/l/email-protection#99f7fcf8f4f8edf0d9ecf4f0faf1b7fcfdec"><span class="__cf_email__" data-cfemail="751b10141814011c3500181c161d5b101100">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nouri++Neamati">Nouri Neamati</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3291-7131" title="Orcid link">http://orcid.org/0000-0003-3291-7131</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01951&amp;href=/doi/10.1021%2Facs.jmedchem.8b01951" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3447–3474</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 13, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 December 2018</li><li><span class="item_label"><b>Published</b> online</span>13 February 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 April 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01951" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01951</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3447%26pageCount%3D28%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSuhui%2BYang%252C%2BAndrea%2BShergalis%252C%2BDan%2BLu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D7%26contentID%3Dacs.jmedchem.8b01951%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BNovel%2BAllosteric%2BProtein%2BDisulfide%2BIsomerase%2BInhibitors%26numPages%3D28%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3474%26publicationDate%3DApril%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01951"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2135</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01951" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Suhui&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Shergalis&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Lu&quot;},{&quot;first_name&quot;:&quot;Anahita&quot;,&quot;last_name&quot;:&quot;Kyani&quot;},{&quot;first_name&quot;:&quot;Ziwei&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Mats&quot;,&quot;last_name&quot;:&quot;Ljungman&quot;},{&quot;first_name&quot;:&quot;Nouri&quot;,&quot;last_name&quot;:&quot;Neamati&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;3447-3474&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01951&quot;},&quot;abstract&quot;:&quot;Protein disulfide isomerase (PDI) is responsible for nascent protein folding in the endoplasmic reticulum (ER) and is critical for glioblastoma survival. To improve the potency of lead PDI inhibitor BAP2 ((E)-3-(3-(4-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile), we designed and synthesized 67 analogues. We determined that PDI inhibition relied on the A ring hydroxyl group of the chalcone scaffold and cLogP increase in the sulfonamide chain improved potency. Docking studies revealed that BAP2 and analogues bind to His256 in the b′ domain of PDI, and mutation of His256 to Ala abolishes BAP2 analogue activity. BAP2 and optimized analogue 59 have modest thiol reactivity; however, we propose that PDI inhibition by BAP2 analogues depends on the b′ domain. Importantly, analogues inhibit glioblastoma cell growth, induce ER stress, increase expression of G2M checkpoint proteins, and reduce expression of DNA repair proteins. Cumulatively, our results support inhibition of PDI as a novel strategy to treat glioblasto&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01951&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01951" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01951&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01951" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01951&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01951" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01951&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01951&amp;href=/doi/10.1021/acs.jmedchem.8b01951" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01951" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01951" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (12 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01951%26sid%3Dliteratum%253Aachs%26pmid%3D30759340%26genre%3Darticle%26aulast%3DYang%26date%3D2019%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BBiological%2BEvaluation%2Bof%2BNovel%2BAllosteric%2BProtein%2BDisulfide%2BIsomerase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D7%26spage%3D3447%26epage%3D3474%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (18)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291074" title="Purification">Purification</a>,</li><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291235" title="Column chromatography">Column chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291122" title="Boron">Boron</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/jmcmar.2019.62.issue-7/20190411/jmcmar.2019.62.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Protein disulfide isomerase (PDI) is responsible for nascent protein folding in the endoplasmic reticulum (ER) and is critical for glioblastoma survival. To improve the potency of lead PDI inhibitor <b>BAP2</b> ((<i>E</i>)-3-(3-(4-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile), we designed and synthesized 67 analogues. We determined that PDI inhibition relied on the A ring hydroxyl group of the chalcone scaffold and cLogP increase in the sulfonamide chain improved potency. Docking studies revealed that <b>BAP2</b> and analogues bind to His256 in the b′ domain of PDI, and mutation of His256 to Ala abolishes <b>BAP2</b> analogue activity. <b>BAP2</b> and optimized analogue <b>59</b> have modest thiol reactivity; however, we propose that PDI inhibition by <b>BAP2</b> analogues depends on the b′ domain. Importantly, analogues inhibit glioblastoma cell growth, induce ER stress, increase expression of G2M checkpoint proteins, and reduce expression of DNA repair proteins. Cumulatively, our results support inhibition of PDI as a novel strategy to treat glioblastoma.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35055" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35055" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glioblastoma (GBM) is the most aggressive primary brain tumor in adults. Standard treatment for GBM consists of surgical resection followed by radiotherapy and chemotherapy with the DNA-alkylating agent temozolomide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These treatments are effective at shrinking tumors initially, but they are not curative and the cancer ultimately recurs in almost all patients due to drug resistance and tumor heterogeneity.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> To overcome these limitations, research into new therapies with novel mechanisms and innovative combination modalities is needed.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> Unfortunately, most trials have demonstrated only modest increases in progression-free survival and no improvements in overall survival.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Therefore, there still exists an urgent unmet medical need for more effective therapies for GBM.</div><div class="NLM_p">Cancer cells require increased protein synthesis and respond to endoplasmic reticulum (ER) stress by activating the unfolded protein response (UPR) which is mediated by ER chaperones.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6−8)</a> ER chaperones, such as protein disulfide isomerase (PDI), have emerged as interesting targets for cancer research. PDI is an oxidoreductase chaperone, located in the ER, that assists protein folding by catalyzing disulfide-bond formation (oxidation), breakage (reduction), and rearrangement (isomerization).<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> PDI is composed of four thioredoxin-like domains (a, a′, b, and b′), a linker between the a′ and b′ domains (x), and a C terminal acidic tail. Both the a and a′ domains contain structurally similar active sites, including a CGHC motif, and are responsible for the oxidoreductase activity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The b′ domain possesses a large hydrophobic pocket for substrate binding and recognition. The C-terminal domain functions in chaperone activity.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> All these domains are attached in a U-shaped structure that is open in the oxidized state and closed in the reduced state. In addition to the vital roles in protein folding, PDI is overexpressed in a variety of cancers but more significantly in GBM.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Furthermore, upregulation of PDI is associated with acquired temozolomide resistance in GBM, and inhibition of PDI enhances temozolomide-mediated cell death through apoptosis via the ER stress response pathway.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Selective PDI inhibitors can sensitize several cancer cell lines to chemotherapeutic agents such as etoposide, fenretinide, and velcade.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> PDI inhibition induces acute ER stress in multiple myeloma cells accompanied by apoptosis-inducing calcium release.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In addition, PDI is strongly expressed in invasive glioma cells, in both xenografts and at the invasive front of human GBMs, and PDI inhibition leads to reduced glioma cell migration and invasion by interfering with the integrin outside-in signaling pathway.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> All these findings suggest that PDI is an important target for cancer therapy, especially for brain cancers, thus emphasizing the need for the development of novel and potent PDI inhibitors.</div><div class="NLM_p">Recently, we identified the PDI inhibitor <b>BAP2</b>, a benzylidene acetophenone, with an IC<sub>50</sub> value of 930 ± 90 nM, via a combination of high-throughput screening and experimental analysis (unpublished) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). <b>BAP2</b> shows in vitro and in vivo antiproliferative activities in human brain cancer models as a single agent. A simple chalcone is a 1,3-diaryl-2-propen-1-one in which the two aromatic rings are connected by a three-carbon α,β unsaturated carbonyl bridge. Chalcone is considered a valuable scaffold due to its simple chemistry, ease of synthesis, and wide biological activity, including antioxidant, anti-inflammatory, antibacterial, and antitumor properties.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Several chalcones, such as metochalcone, sofalcone,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> PD-156707, licochalcone A, and elafibranor, have been marketed or clinically tested for various diseases, are well-tolerated and nontoxic to humans, and they have reasonable pharmacokinetic properties (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Herein, we report the synthesis of 67 <b>BAP2</b> derivatives, provide a structure–activity relationship (SAR) analysis, and present an evaluation of PDI inhibitory activity and cytotoxicity against brain cancer cells. The most potent <b>BAP2</b> analogue inhibited GBM migration and cell growth, lowered MMP9 expression, and blocked MMP2 secretion. Furthermore, extensive transcriptomic and proteomic analysis of analogue treatment in a brain cancer cell line demonstrated that <b>BAP2</b> and analogues induced ER stress, increased expression of G2M checkpoint proteins, and reduced expression of ribosomal and DNA replication proteins. While <b>BAP2</b> and <b>59</b> have some thiol reactivity, we provide evidence that PDI inhibition by <b>BAP2</b> analogues is dependent on allosteric binding in the b′ domain.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of chalcones that have been marketed or clinically tested and the hit compound <b>BAP2</b> as a PDI inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31526" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31526" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis of BAP2 Derivatives and Their Structure–Activity Relationship</h3><div class="NLM_p">To investigate the structural aspects of the lead <b>BAP2</b> for ability to inhibit PDI reductase activity, a series of derivatives were designed and synthesized. The most commonly used method for the preparation of chalcones is the base-catalyzed Claisen–Schmidt condensation reaction between a methyl ketone and an aldehyde in the presence of sodium hydroxide (NaOH),<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> potassium hydroxide (KOH),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> or lithium hydroxide (LiOH·H<sub>2</sub>O).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> However, the base-mediated reactions sometimes require longer reaction times (several days), give low chemical yields, and have a high probability of side reactions such as the Cannizzaro reaction of an aldehyde, aldol condensation, or the Michael addition reaction.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> On the other hand, the acid-catalyzed method involves the use of aluminum trichloride (AlCl<sub>3</sub>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> or dry HCl,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and recently boron trifluoride etherate (BF<sub>3</sub>·Et<sub>2</sub>O) has been used as a condensing agent.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> This new BF<sub>3</sub>·Et<sub>2</sub>O-assisted method is advantageous over existing methods because it produces higher yields, requires shorter reaction times, and has minimal side reactions.<a onclick="showRef(event, 'ref30 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref32 ref33">(30,32,33)</a> Therefore, we applied the BF<sub>3</sub>·Et<sub>2</sub>O method for the synthesis of most <b>BAP2</b> derivatives in this study.</div><div class="NLM_p">Several 4-substituted acetophenones (<b>3a</b>–<b>n</b>) and benzaldehydes (<b>4a</b>,<b>b</b>) were prepared via typical methylation (<b>3a</b>),<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> nucleophilic substitution reactions with amines (<b>3b</b>–<b>i</b>, <b>4b</b>), activation of acid with thionyl chloride, and the subsequent substitution reaction with nucleophiles (<b>3j</b>–<b>m</b>), hydroxylation at an aliphatic carbon of 3′-bromo-4′-methyl acetophenone (<b>3n</b>), and esterification of 3-carboxybenzaldehyde (<b>4a</b>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). With the acetophenones (<b>3</b>) and benzaldehydes (<b>4</b>), most <b>BAP2</b> derivatives were prepared by a modified procedure of the BF<sub>3</sub>·Et<sub>2</sub>O-assisted Claisen–Schmidt reaction (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Some <b>BAP2</b> derivatives were synthesized by applying the base-catalyzed condensation reaction (<b>8</b>, <b>9</b>, <b>39</b>),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and pyrazine-containing derivatives were obtained in the presence of diethylamine in pyridine at 80–120 °C (<b>29</b> and <b>56</b>). Microwave-assisted one-pot reaction of a Sonogashira coupling of an aryl halide with an aryl alcohol, and the subsequent base-catalyzed isomerization were carried out to provide the boronate-containing chalcone <b>71</b>,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and further oxidative cleavage of the boronate afforded the boronic acid chalcone <b>72</b>.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Another boronic acid chalcone <b>31</b> was prepared by Miyaura borylation of aryl halide <b>10</b> and subsequent oxidative cleavage. Microwave-assisted Suzuki coupling of aryl halide <b>67</b> afforded chalcones <b>68</b> and <b>69</b>. In addition, methylation of compounds <b>5</b> and <b>25</b>, demethylation of <b>8</b>, esterification of <b>37</b>, and base-promoted hydrolysis of <b>53</b> afforded corresponding <b>BAP2</b> derivatives <b>7</b>, <b>27</b>, <b>6</b>, <b>46</b>, and <b>45</b>, respectively.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-Substituted Acetophenones (<b>3a</b>–<b>n</b>) and Benzaldehydes (<b>4a</b>–<b>b</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <b>3a</b>, K<sub>2</sub>CO<sub>3</sub>, MeI, acetone, reflux. (ii) <b>3b</b>, THF, rt; <b>3c</b>–<b>i</b>, Et<sub>3</sub>N, anhyd THF, rt. (iii) <b>3j</b> (1) pyridine, anhyd DCM, rt; (2) 1 N HCl, <b>3k</b>–<b>m</b>; (1) SOCl<sub>2</sub>, rt; (2) pyridine, DCM. (iv) <b>3n</b> (1) NBS, AIBN, MeCN, reflux; (2) CaCO<sub>3</sub>, dioxane, H<sub>2</sub>O, reflux. (v) (1) Cs<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (10:1), rt; (2) MeI, DMF, rt. (vi) benzimidazole, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>BAP2</b> Analogues <b>5</b>–<b>72</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <b>5</b>, <b>10</b>–<b>26</b>, <b>28</b>, <b>30</b>–<b>38</b>, <b>40</b>–<b>44</b>, <b>47</b>–<b>55</b>, <b>57</b>–<b>67</b>, <b>70</b>: BF<sub>3</sub>·Et<sub>2</sub>O, 1,4-dioxane, 80 °C. <b>8</b>–<b>9</b>, <b>39</b>: 60% NaOH, EtOH, 0 °C → rt. <b>29</b>, <b>56</b>: (1) Et<sub>2</sub>NH, pyridine, 80–120 °C; (2) acetic acid. (ii) <b>71</b>: DBU, PPh<sub>3</sub>, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, THF, MW 120 °C, 40 min. (iii) <b>6</b>: (1) Py·HCl, 210 °C; (2) NaHCO<sub>3</sub>, pH 7–8. (iv) <b>7</b>, <b>27</b>: K<sub>2</sub>CO<sub>3</sub>, MeI, acetone, reflux. (v) <b>31</b>: (1) Bis(pinacolato)diboron, PdCl<sub>2</sub>(dppf), KOAc, dioxane, reflux; (2) NaIO<sub>4</sub>, THF, H<sub>2</sub>O, rt; (3) HCl, H<sub>2</sub>O, rt. (vi) <b>45</b>: (1) NaOH, H<sub>2</sub>O, THF, rt; (2) HCl, H<sub>2</sub>O. (vii) <b>46</b>: cat. H<sub>2</sub>SO<sub>4</sub>, anhyd MeOH, reflux. (viii) <b>68</b>: pyridine-3-boronic acid, 10 mol % Pd(OAc)<sub>2</sub>, KF, PEG/EtOH, MW 110 °C, 30 min. (ix) <b>69</b>: Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, MW 130 °C, 20 min. (x) <b>72</b>: (1) NaIO<sub>4</sub>, H<sub>2</sub>O, THF, rt; (2) HCl, H<sub>2</sub>O, rt.</p></p></figure><div class="NLM_p">A total of 68 synthetic chalcones were prepared and tested for the inhibitory effect against PDI using the PDI reductase assay.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> Their structure–activity relationship (SAR) was analyzed by categorizing the derivatives into three clusters based on the substituent of ring <b>B</b>. In the first series of analogues (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), we maintained the nitrile group of the lead <b>BAP2</b> at R<sup>2</sup> and made modifications at R<sup>1</sup>. Replacement of the hydroxyl group (<b>6</b>, IC<sub>50</sub> of 0.85 μM) with bromine (<b>10</b>) led to a 2-fold decrease in the inhibition of PDI activity. Activity dropped substantially upon replacement of the hydroxyl group (<b>5</b>, IC<sub>50</sub> of 1.87 μM and <b>6</b>) with a methoxy group (<b>7</b> and <b>8</b>), amine (<b>9</b>), or heterocycle (<b>11</b>, <b>12</b>), and upon the introduction of a pyrazine moiety to replace the phenyl ring (<b>29</b>). Similarly, the compounds containing at least one hydroxyl group retained activity or showed stronger activity depending on the additional substituent (<b>21</b>–<b>24</b>, <b>32</b>–<b>36</b>, IC<sub>50</sub> range of 0.21–2.37 μM) regardless of the position of the nitrile at <i>meta</i> or <i>para</i> of R<sup>2</sup>. However, introduction of a methoxy group (<b>25</b>, <b>26</b>) seemed to be unfavorable for activity even with the hydroxyl group maintained (IC<sub>50</sub> of 10.9 and 2.72 μM, respectively). Analogue activity decreased with dimethoxy groups (<b>27</b>) or dihalogen atoms (<b>28</b>) in place of the hydroxyl group, indicating the importance of the hydroxyl group for potency. Interestingly, several <b>BAP2</b> analogues lacking a hydroxyl group retained or even improved PDI inhibitory activity (<b>13</b>–<b>20</b>). These compounds contain a sulfonamide moiety in place of the hydroxyl group and increase in hydrophobic character with increasing alkyl chain. As hydrophobicity increased, the PDI inhibitory activity of the analogues improved (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Figure S1</a>), and the derivatives with 3 < cLogP < 5 were quite potent, with IC<sub>50</sub> values of 0.82–1.23 μM (<b>15</b>, <b>16</b>, <b>19</b>, <b>20</b>). On the other hand, another type of sulfonamide-containing chalcone derivative (e.g., <b>30</b>, IC<sub>50</sub> of 8.51 μM) was not as potent as <b>20</b> (IC<sub>50</sub> of 1.11 μM) although they both have a bulky hydrophobic moiety, suggesting that an electron withdrawing group such as −SO<sub>2</sub>NHR prepared the olefin for nucleophilic attack by the thiol in the active site. Potentially, the hydrophobic region would interact with a pocket near the active site to stabilize binding. These findings suggest that both active site and hydrophobic interactions play important roles in the activity of this series.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. PDI Inhibitory Activity of the Synthesized <b>BAP2</b> Derivatives <b>5</b>–<b>36</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0018.gif" alt="" id="GRAPHIC-d7e1013-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">scaffold</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b> (<b>BAP2</b>)</td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-OH</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">0.85 ± 0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-OH</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">1.87 ± 0.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-OMe</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">8.13 ± 1.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-OMe</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-Br</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">1.66 ± 0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-morpholine</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-piperidine</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-SO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">6.64 ± 0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-SO<sub>2</sub>NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">6.23 ± 0.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-SO<sub>2</sub>NEt<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">1.23 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-SO<sub>2</sub>NPr<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">0.82 ± 0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-SO<sub>2</sub>NBu<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">1.34 ± 0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-SO<sub>2</sub>NPe<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">0.16 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-SO<sub>2</sub>NHCPh</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">1.05 ± 0.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-SO<sub>2</sub>NHPh</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">1.11 ± 0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">2-OH, 4-F</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">2.37 ± 1.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-OH, 4-F</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">1.15 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-F, 4-OH</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">1.14 ± 0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-CF<sub>3</sub>, 4-OH</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">2.00 ± 0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-OH, 4-OMe</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">10.93 ± 0.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-OMe, 4-OH</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">2.72 ± 0.74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3,4-OMe</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-F, 4-Cl</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">>500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"><i>N</i>-methyl-4-nitrobenzenesulfonamide</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">8.51 ± 3.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">B(OH)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">0.83 ± 0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-OH</td><td class="colsep0 rowsep0" align="center">4-CN</td><td class="colsep0 rowsep0" align="center">0.74 ± 0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">2-OH, 4-F</td><td class="colsep0 rowsep0" align="center">4-CN</td><td class="colsep0 rowsep0" align="center">1.80 ± 0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-OH, 4-F</td><td class="colsep0 rowsep0" align="center">4-CN</td><td class="colsep0 rowsep0" align="center">1.83 ± 0.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-F, 4-OH</td><td class="colsep0 rowsep0" align="center">4-CN</td><td class="colsep0 rowsep0" align="center">0.21 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-CF<sub>3</sub>, 4-OH</td><td class="colsep0 rowsep0" align="center">4-CN</td><td class="colsep0 rowsep0" align="center">1.11 ± 0.33</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of PDI was assessed by PDI reductase assay.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values are indicated as the mean ± SD (standard error) of at least three independent experiments.</p></div></div></div><div class="NLM_p">Next, we investigated PDI inhibitory activity of the derivatives containing a carboxylic acid or carboxymethyl ester in place of the nitrile group at the <i>meta</i> position of R<sup>2</sup> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The introduction of carboxylic acid at R<sup>2</sup> (<b>37</b>–<b>45</b>) generally reduced potency regardless of the presence of a hydroxyl group at R<sup>1</sup>. However, a carboxymethyl ester (<b>46</b>, <b>47</b>, <b>49</b>) increased potency with an IC<sub>50</sub> range of 0.12–0.49 μM compared to compounds containing a nitrile group (<b>5</b>, <b>6</b>, <b>24</b>, IC<sub>50</sub> range of 0.85–2.0 μM), and we obtained the most potent analogue <b>46</b> with a carboxymethyl ester (IC<sub>50</sub> = 120 ± 10 nM) at R<sup>2</sup>. These results indicate that the carboxymethyl ester facilitates stronger binding affinity for PDI than chalcones containing other electron-withdrawing groups such as a nitrile group or carboxylic acid. Intriguingly, the activity was lost when the carboxymethyl ester at R<sup>2</sup> was added to the sulfonamide-containing chalcones (<b>51</b>–<b>53</b>), suggesting that the chalcones with a hydroxyl group or a sulfonamide moiety at R<sup>1</sup> may have different binding interactions.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. PDI Inhibitory Activity of the Synthesized <b>BAP2</b> Derivatives <b>37</b>–<b>53</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0019.gif" alt="" id="GRAPHIC-d7e1678-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">scaffold</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6 (BAP2)</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-OH</td><td class="colsep0 rowsep0" align="center">3-CN</td><td class="colsep0 rowsep0" align="center">0.85 ± 0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-OH</td><td class="colsep0 rowsep0" align="center">3-COOH</td><td class="colsep0 rowsep0" align="center">10.19 ± 1.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-COOH</td><td class="colsep0 rowsep0" align="center">40 < IC<sub>50</sub> < 500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-COOH</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-morpholine</td><td class="colsep0 rowsep0" align="center">3-COOH</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-piperidine</td><td class="colsep0 rowsep0" align="center">3-COOH</td><td class="colsep0 rowsep0" align="center">40 < IC<sub>50</sub> < 500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-OH, 4-OMe</td><td class="colsep0 rowsep0" align="center">3-COOH</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-F, 4-OH</td><td class="colsep0 rowsep0" align="center">3-COOH</td><td class="colsep0 rowsep0" align="center">9.10 ± 2.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-CF<sub>3</sub>, 4-OH</td><td class="colsep0 rowsep0" align="center">3-COOH</td><td class="colsep0 rowsep0" align="center">4.09 ± 1.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"><i>N</i>-methyl-4-nitrobenzenesulfonamide</td><td class="colsep0 rowsep0" align="center">3-COOH</td><td class="colsep0 rowsep0" align="center">4.00 ± 0.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-OH</td><td class="colsep0 rowsep0" align="center">3-COOMe</td><td class="colsep0 rowsep0" align="center">0.12 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-OH</td><td class="colsep0 rowsep0" align="center">3-COOMe</td><td class="colsep0 rowsep0" align="center">0.40 ± 0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-OH, 4-OMe</td><td class="colsep0 rowsep0" align="center">3-COOMe</td><td class="colsep0 rowsep0" align="center">47.8 ± 11.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-CF<sub>3</sub>, 4-OH</td><td class="colsep0 rowsep0" align="center">3-COOMe</td><td class="colsep0 rowsep0" align="center">0.49 ± 0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">3-Br, 4-CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="center">3-COOMe</td><td class="colsep0 rowsep0" align="center">0.13 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-SO<sub>2</sub>NPr<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-COOMe</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="center">A</td><td class="colsep0 rowsep0" align="center">C</td><td class="colsep0 rowsep0" align="center">4-SO<sub>2</sub>NBu<sub>2</sub></td><td class="colsep0 rowsep0" align="center">3-COOMe</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="center">B</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"><i>N</i>-methyl-4-nitrobenzenesulfonamide</td><td class="colsep0 rowsep0" align="center">3-COOMe</td><td class="colsep0 rowsep0" align="center">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of PDI was assessed by PDI reductase assay.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values are indicated as the mean ± SD (standard error) of at least three independent experiments.</p></div></div></div><div class="NLM_p">We also examined the potency of <b>BAP2</b> derivatives containing different functional groups such as trifluoromethyl, hydroxy, methoxy, bromo, boronate, or boronic acid moieties at R<sup>2</sup> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Replacing the nitrile in <b>BAP2</b> (<b>6</b>) and <b>32</b> with a trifluoromethyl group reduced the potency about 2–4-fold (<b>55</b>, <b>57</b>), suggesting the electron-withdrawing properties at R<sup>2</sup> are not driving PDI inhibition. But interestingly, replacement with a heterocycle increased analogue activity with IC<sub>50</sub> values of 0.21–0.35 μM (<b>68</b>–<b>70</b>). In a series of carboxamide-, sulfonamide-, or carboxylate-containing analogues (<b>60</b>–<b>65</b>), the compounds with a hydroxyl group at R<sup>2</sup> afforded PDI inhibition with an IC<sub>50</sub> range of 1.7–11 μM (<b>60</b>–<b>62</b>), but the potency was abolished upon replacement with a methoxy group (<b>63</b>–<b>65</b>), suggesting that the analogues with a hydrophobic moiety at R<sup>1</sup> may require the hydroxyl anchor at R<sup>2</sup> to position them for hydrophobic interactions around the binding pocket. In addition, the analogues containing −SO<sub>2</sub>NHR at R<sup>1</sup> and hydroxyl group at R<sup>2</sup> (<b>58</b>, <b>59</b>) tolerated the activity compared to the ones containing nitrile group at R<sup>2</sup> (<b>15</b>, <b>16</b>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. PDI Inhibitory Activity of the Synthesized <b>BAP2</b> Derivatives <b>54</b>–<b>72</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0020.gif" alt="" id="GRAPHIC-d7e2141-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0021.gif" alt="" id="gr18" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Inhibition of PDI was assessed by PDI reductase assay.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values are indicated as the mean ± SD (standard error) of at least three independent experiments.</p></div></div><div></div></div><div class="NLM_p">In addition, 17 analogues were obtained from the National Cancer Institute (NCI) Therapeutics Development Program and tested in the PDI reductase assay, but most of these analogues were inactive (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Table S1</a>). Compounds containing the 6′-OH to stabilize the carbonyl were inactive in the PDI reductase assay (<b>NC587</b>, <b>NC588</b>, and <b>NC589</b>).</div><div class="NLM_p">The SAR of all derivatives are summarized in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, and the results suggest two different series of active chalcone derivatives. The first series contains a hydroxyl group at <i>meta</i> or <i>para</i> position of ring A, and the potency of compounds decreases based on the functional group on ring B as follows: COOMe ≈ Br, pyridine, benzimidazole > CN > CF<sub>3</sub> ≫ COOH. The second series contains a sulfonamide moiety or aromatic ring with linkers such as carboxamide, carboxylate, or sulfonamide at <i>para</i> position on ring A, and the potency of compounds decreased based on the functional group of ring B as follows: CN ≈ OH > OMe ≈ COOMe.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Summarized SAR of synthesized <b>BAP2</b> analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> BAP2 Analogues Selectively Reduce Brain Cancer Cell Viability</h3><div class="NLM_p">We selected 23 <b>BAP2</b> analogues with IC<sub>50</sub> values lower than 1.5 μM against PDI and tested for cytotoxicity in a panel of brain cancer cell lines (U87MG, A172, and NU04) (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Compound <b>19</b> was not soluble in DMSO and therefore not considered further in this study. The <b>BAP2</b> analogues were moderately cytotoxic to U87MG cells, with IC<sub>50</sub> values from 10 to 30 μM for most of the analogues. In general, the NU04 cells were more sensitive than the U87MG cells to treatment. Compounds more potent than <b>BAP2</b> (<b>6</b>) in both A172 and NU04 cells included <b>18</b>, <b>59</b>, <b>68</b>, <b>69</b>, and <b>70</b>. Among the compounds, <b>18</b> was the most potent in both U87MG and A172 cells (IC<sub>50</sub> = 5.6 ± 2.1 and 9.0 ± 3.4 μM, respectively). Compound <b>69</b> was the most potent in the NU04 cell line, with an IC<sub>50</sub> value of 3.8 ± 0.1 μM. These chalcone derivatives also inhibited PDI activity more potently compared to <b>PACMA31</b>,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> a previously reported PDI inhibitor (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A,B). Treatment with <b>BAP2</b> caused lipid vesicles to form around the nucleus of the cell after 48 h (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Figure S2</a>), whereas inactive analogue <b>8</b> did not visibly affect cell morphology. Furthermore, <b>46</b> created a ring of debris around the cell akin to necroptotic cell death, while <b>59</b> exhibited vesicle formation and membrane blebbing. Next, we investigated the effect of five <b>BAP2</b> derivatives on GBM cell proliferation (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). All compounds generally showed a dose-dependent inhibition of colony formation in U87MG cells. <b>BAP2</b> was less potent in the colony formation assay than in the MTT assay as it inhibited less than 40% of cell proliferation at 10 μM, whereas the IC<sub>50</sub> value of <b>BAP2</b> in U87MG cells was 10.7 ± 1.8 μM (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Interestingly, unlike <b>BAP2</b>, all other analogues except <b>59</b> inhibited more than 50% of cell proliferation at a lower dose than their IC<sub>50</sub> values in U87MG cells, indicating that these analogues can inhibit the clonogenic properties of the cells.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Cytotoxicity of the 23 Selected <b>BAP2</b> Analogues in a Panel of Human GBM Cell Lines<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">U87MG</th><th class="colsep0 rowsep0" align="center">A172</th><th class="colsep0 rowsep0" align="center">NU04</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b> (<b>BAP2</b>)</td><td class="colsep0 rowsep0" align="center">10.3 ± 2.3</td><td class="colsep0 rowsep0" align="center">16.8 ± 3.5</td><td class="colsep0 rowsep0" align="center">15.7 ± 3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="center">17.7 ± 4.6</td><td class="colsep0 rowsep0" align="center">26.4 ± 4.1</td><td class="colsep0 rowsep0" align="center">19.9 ± 8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="center">25.6 ± 5.0</td><td class="colsep0 rowsep0" align="center">35.0 ± 13.1</td><td class="colsep0 rowsep0" align="center">26.6 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="center">17.0 ± 3.3</td><td class="colsep0 rowsep0" align="center">67.3 ± 46.8</td><td class="colsep0 rowsep0" align="center">15.5 ± 4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">5.6 ± 2.1</td><td class="colsep0 rowsep0" align="center">9.0 ± 3.4</td><td class="colsep0 rowsep0" align="center">5.0 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="center">NS</td><td class="colsep0 rowsep0" align="center">NS</td><td class="colsep0 rowsep0" align="center">NS</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="center">48.5 ± 37.5</td><td class="colsep0 rowsep0" align="center">28.9 ± 3.0</td><td class="colsep0 rowsep0" align="center">18.7 ± 11.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="center">22.9 ± 8.1</td><td class="colsep0 rowsep0" align="center">16.8 ± 3.3</td><td class="colsep0 rowsep0" align="center">10.6 ± 3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="center">29.1 ± 6.9</td><td class="colsep0 rowsep0" align="center">21.9 ± 7.1</td><td class="colsep0 rowsep0" align="center">9.8 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="center">24.3 ± 11.0</td><td class="colsep0 rowsep0" align="center">20.2 ± 11.0</td><td class="colsep0 rowsep0" align="center">13.0 ± 2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="center">15.1 ± 5.6</td><td class="colsep0 rowsep0" align="center">20.0 ± 8.6</td><td class="colsep0 rowsep0" align="center">12.8 ± 2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="center">29.0 ± 9.3</td><td class="colsep0 rowsep0" align="center">28.4 ± 8.4</td><td class="colsep0 rowsep0" align="center">15.8 ± 10.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="center">26.4 ± 8.2</td><td class="colsep0 rowsep0" align="center">33.7 ± 13.5</td><td class="colsep0 rowsep0" align="center">10.4 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="center">16.5 ± 7.6</td><td class="colsep0 rowsep0" align="center">19.5 ± 6.9</td><td class="colsep0 rowsep0" align="center">22.7 ± 8.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="center">28.8 ± 2.3</td><td class="colsep0 rowsep0" align="center">32.3 ± 1.6</td><td class="colsep0 rowsep0" align="center">30.6 ± 4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="center">11.6 ± 0.6</td><td class="colsep0 rowsep0" align="center">35.0 ± 35.7</td><td class="colsep0 rowsep0" align="center">10.3 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="center">13.6 ± 1.8</td><td class="colsep0 rowsep0" align="center">20.6 ± 10.4</td><td class="colsep0 rowsep0" align="center">17.2 ± 10.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="center">40.7 ± 14.5</td><td class="colsep0 rowsep0" align="center">31.2 ± 8.0</td><td class="colsep0 rowsep0" align="center">19.2 ± 10.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="center">15.0 ± 3.5</td><td class="colsep0 rowsep0" align="center">11.3 ± 0.3</td><td class="colsep0 rowsep0" align="center">7.6 ± 3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="center">76.3 ± 23.8</td><td class="colsep0 rowsep0" align="center">67.8 ± 6.4</td><td class="colsep0 rowsep0" align="center">26.2 ± 8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="center">10.7 ± 0.8</td><td class="colsep0 rowsep0" align="center">11.0 ± 0.8</td><td class="colsep0 rowsep0" align="center">4.9 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="center">24.9 ± 12.1</td><td class="colsep0 rowsep0" align="center">11.3 ± 0.1</td><td class="colsep0 rowsep0" align="center">3.8 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="center">10.8 ± 1.2</td><td class="colsep0 rowsep0" align="center">10.7 ± 0.6</td><td class="colsep0 rowsep0" align="center">9.9 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="center">31.2 ± 2.1</td><td class="colsep0 rowsep0" align="center">32.1 ± 1.1</td><td class="colsep0 rowsep0" align="center">22.9 ± 6.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Cytotoxicity was assessed by MTT assay. IC<sub>50</sub> values are indicated as the mean ± SD (standard error) of at least three independent experiments for active compounds (IC<sub>50</sub> < 20 μM). NS: not soluble in DMSO.</p></div></div></div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Optimized <b>BAP2</b> analogues inhibit colony formation and PDI activity. (a) Chemical structures of five optimized <b>BAP2</b> (<b>6</b>) analogues. (b) PDI reductase inhibition activity of <b>PACMA31</b>, <b>6</b>, <b>18</b>, <b>46</b>, <b>59</b>, <b>68</b>, and <b>69</b>. Recombinant PDI at 400 nM was incubated at 42 °C for 1 h in the presence or absence of indicated compounds. Reduction of insulin was followed by an increase in absorbance at 620 nm for 120 min. IC<sub>50</sub> values were calculated at 80 min. (c) Colony formation ability of U87MG cells was determine in the presence of DMSO or PDI inhibitors. Normalized well intensity from three independent experiments is shown in the right panel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we tested the five <b>BAP2</b> derivatives in HFF-1 normal human fibroblast cells to determine the therapeutic window of this series (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>; Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Figure S3</a>). Interestingly, <b>BAP2</b> had the largest therapeutic window, with a 5.8-fold difference in potency in NU04 (15.7 ± 3.4 μM) versus HFF-1 cells (91.2 ± 13.1 μM). Compounds <b>59</b> and <b>68</b> demonstrated a 3.8-fold and 4.6-fold difference in potency, respectively, between cancer cells and normal cells. In the case of compound <b>18</b>, potency was greater against the HFF-1 cells (3.4 ± 1.1 μM) than the NU04 cells (5.0 ± 1.8 μM). These results suggest that <b>BAP2</b> and analogues may be effective in combination therapy because they may cause less off-target toxicity.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cytotoxicity of Six <b>BAP2</b> Analogues in a Human Fibroblast Cell Line HFF-1 and Comparison to NU04<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">NU04 (μM)</th><th class="colsep0 rowsep0" align="center" char="±">HFF-1 (μM)</th><th class="colsep0 rowsep0" align="center" char=".">fold difference</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>BAP2</b></td><td class="colsep0 rowsep0" align="char" char="±">15.7 ± 3.4</td><td class="colsep0 rowsep0" align="char" char="±">91.2 ± 13.1</td><td class="colsep0 rowsep0" align="char" char=".">5.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="±">3.4 ± 1.1</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char="±">22.7 ± 8.2</td><td class="colsep0 rowsep0" align="char" char="±">17.4 ± 3.5</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="char" char="±">7.6 ± 3.1</td><td class="colsep0 rowsep0" align="char" char="±">29.2 ± 4.5</td><td class="colsep0 rowsep0" align="char" char=".">3.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="char" char="±">4.9 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">22.5 ± 8.0</td><td class="colsep0 rowsep0" align="char" char=".">4.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">31.8 ± 13.2</td><td class="colsep0 rowsep0" align="char" char=".">8.39</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Cytotoxicity was assessed by MTT assay. IC<sub>50</sub> values are indicated as the mean ± SD (standard error) of at least three independent experiments.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> BAP2 Analogues Stabilize PDI to Thermal Degradation</h3><div class="NLM_p">To validate that our compounds interact with PDI and stabilize the protein to thermal denaturation, we further tested the compounds in the biochemical thermal shift assay. Compounds <b>18</b>, <b>46</b>, <b>59</b>, <b>68</b>, and <b>69</b> were tested at 100 μM against recombinant PDI, and an inactive compound <b>8</b> was used as a negative control in addition to DMSO. Typically, compounds that bind to a protein stabilize its secondary structure and increase the melting temperature; however, <b>PACMA31</b>, a validated PDI inhibitor, does not stabilize PDI. This may be explained by the irreversible covalent nature of binding to the reactive site cysteines. Because the bond is irreversibly covalent, it may not require additional interaction to inhibit PDI activity. On the other hand, estradiol, known to bind in the b′ domain of PDI and form critical interactions with His256,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> stabilizes PDI to thermal denaturation.</div><div class="NLM_p">Similar to estradiol and <b>BAP2</b>, the analogues <b>46</b>, <b>59</b>, and <b>68</b> increased the melting temperature by more than 1 °C in a dose-dependent manner, suggesting that these compounds form important stabilizing interactions with PDI (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,B, and Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Figure S4</a>). However, compounds <b>18</b> and <b>69</b> did not stabilize PDI in the thermal shift assay despite being potent inhibitors of PDI activity; these results, suggest that these compounds may interact in the active site of PDI instead of the hydrophobic pocket of the b′ domain. This suggests that <b>BAP2</b> analogues <b>46</b>, <b>59</b>, and <b>68</b> may form critical interactions with PDI that <b>PACMA31</b> does not form. To provide additional evidence to support our hypothesis, we prepared two mutants of PDI: H256A and C53S/C397S. The H256A mutant contains a point mutation from histidine to alanine at the key residue 256 where estradiol normally binds. The C53S/C397S mutant contains serine residues replacing one cysteine from each of the CGHC active sites. In the thermal shift assay, the stabilization by estradiol and <b>BAP2</b> was abolished in the H256A mutant but not the C53S/C397S mutant (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). Interestingly, the shift caused by analogues <b>46</b>, <b>59</b>, and <b>68</b> was not abolished by either mutation. This suggests that the histidine may be crucial for <b>BAP2</b> binding, but other hydrophobic interactions are important for analogue binding and activity. Specifically, <b>46</b>, <b>59</b>, and <b>68</b> may react with the active site thiols. These results ultimately suggest that <b>46</b>, <b>59</b>, and <b>68</b> may be interacting with both the active site and b′ domain of PDI.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Optimized <b>BAP2</b> analogues stabilize PDI. (a) Boltzmann melting temperatures calculated for PDI (0.5 μg/μL) in the presence of 100 μM <b>PACMA31</b>, <b>6</b>, <b>8</b>, <b>18</b>, <b>46</b>, <b>59</b>, <b>68</b>, <b>69</b>, or DMSO. The change in melting temperature compared to DMSO is reported above each bar. (b) Dose–response effects of estradiol, <b>6</b>, <b>46</b>, <b>59</b>, and <b>68</b> in the presence of PDI. Results are reported as the change in the melting temperature of the curve compared to the vehicle control. (c) Change in melting temperature of 0.5 μg/μL wild-type, C53S/C397S, and H256A PDI in the presence of indicated compounds at 100 μM (DMSO used as vehicle control). P, <b>PACMA31</b>; E2, estradiol. Results are reported as mean ± standard deviation of three experiments. *, <i>p</i> < 0.05; **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001, compared to wild-type PDI values. Statistical significance was measured using 2-way analysis of variance (ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The binding affinity of <b>BAP2</b> to wild-type PDI is around 10 μM, tested with the thermal shift assay (<i>K</i><sub>d</sub> = 9.8) and isothermal calorimetry (ITC) (<i>K</i><sub>d</sub> = 9.1 μM) (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Figure S5</a>). Binding affinities of analogues of <b>BAP2</b>, including <b>46</b> and <b>59</b>, were unable to be determined via ITC due to poor solubility, suggesting further optimization of this series will be necessary. However, <b>BAP2</b> binding affinity is similar to quercetin-3-rutinoside, another b′ domain PDI inhibitor (12.3 μM).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> BAP2 Analogues Induce ER Stress in GBM Cells</h3><div class="NLM_p">PDI plays an important role in regulating the ER stress response, a mechanism that triggers the UPR and ultimately balances ER homeostasis.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In this study, we hypothesized that inhibition of PDI by <b>BAP2</b> analogues would exacerbate ER stress mechanisms by disrupting homeostatic balance, ultimately leading to cell death. To monitor whether the <b>BAP2</b> analogues induce ER stress, we first investigated their effect on phosphorylation of eukaryotic translation initiation factor 2α (EIF2α) in U87MG and A172 cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). EIF2α is a translation initiation factor downstream of the PERK arm of the UPR, and phosphorylation of EIF2α in response to ER stress leads to inhibition of protein synthesis.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Like tunicamycin, a protein glycosylation inhibitor, treatment with <b>BAP2</b> analogues increased phosphorylation of EIF2α above basal levels in both GBM cell lines. Unexpectedly, <b>PACMA31</b> did not induce phosphorylation of EIF2α. We also observed an increase in expression of GRP78 in response to <b>PACMA31</b>, <b>BAP2</b>, and analogues (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). These results indicate that treatment of GBM cells with <b>BAP2</b> analogues promotes ER stress, upregulates the UPR, and inhibits protein synthesis. Compound <b>46</b> significantly promotes the ER stress response in GBM cells. PDI expression was also measured and did not change upon treatment with PDI inhibitors.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>BAP2</b> analogues inhibit protein synthesis via EIF2α pathway (a) U87MG cells were treated with tunicamycin (10 μg/mL), 1.0 μM <b>PACMA31</b>, or 20 μM <b>6</b>, <b>46</b>, <b>18</b>, <b>68</b>, <b>69</b>, or <b>59</b> for 2 h, and Western blots were performed as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (b) U87MG cells treated with tunicamycin (10 μg/mL), 1.0 μM <b>PACMA31</b>, or indicated compounds at 20 μM for 24 h. Abbreviations: P, <b>PACMA31</b>; TM, tunicamycin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> BAP2 Analogues Inhibit GBM Cell Migration</h3><div class="NLM_p">PDI is involved in the migratory capabilities of glioma cells via the integrin outside-in pathway.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Therefore, inhibiting PDI may prevent GBM cell invasion and metastasis. To determine whether the <b>BAP2</b> analogues could inhibit cell migration, we performed the wound healing assay in A172 cells. <b>BAP2</b> inhibited wound healing at 10 μM, and all analogues, except <b>69</b>, inhibited cell migration in a dose-dependent manner, similar to <b>PACMA31</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A).</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>BAP2</b> analogues inhibit cell migration in a dose-dependent manner. (a) Compounds tested in the wound healing assay for 24 h. Cells were stained with Giemsa stain, and images were taken at 10× magnification. (b) A172 cells migrated through an 8.0 μm membrane in the transwell migration assay, in the presence of <b>6</b>, <b>18</b>, <b>45</b>, and <b>PACMA31</b>, at indicated concentrations, or DMSO as a vehicle control. Wells without FBS were used as a control. Images are representative of five fields per well. (c) U87 cells were treated for 48 h with 10 μM <b>BAP2</b> analogues (or 0.25 μM <b>PACMA31</b>). The activity of MMP-2 was assessed by gelatin zymography. (d) Western blot was performed on the conditioned media of the chalcone-treated cells to determine the expression of cleaved MMP2. (e) Western blot was performed on the cell lysates of the chalcone-treated U87MG cells to determine expression of MMP2 and MMP9. (f) Western blot was performed on chalcone-treated U87MG cells to assess changes in the phosphorylation of FAK.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">An additional transwell migration assay was performed to validate the migration of A172 cells in the presence of selected compounds, <b>PACMA31</b>, <b>6</b>, <b>18</b>, and <b>59</b> at subtoxic concentrations (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Cells were treated with the compounds for 4 h. All compounds inhibited migration at 30 μM, and <b>18</b> inhibited migration at 10 μM. We further examined the effect of the compounds on the expression level of migration markers including MMP2, MMP9, and p-FAK in U87MG cells at 10 μM for 48 h. Gelatin zymography and Western blot analysis of the conditioned media confirmed that <b>PACMA31</b> and <b>68</b> inhibit MMP2 activity and secretion (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C,D). MMP2 expression in cells did not change upon <b>BAP2</b> analogue treatment; however, MMP9 expression decreased in the presence of <b>PACMA31</b>, <b>18</b>, <b>59</b>, and <b>68</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>E). FAK phosphorylation did not change with <b>BAP2</b> analogue treatment (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>F). These results demonstrate that <b>BAP2</b> analogues inhibit GBM cell migration via downregulation of MMP9 and decreased secretion of MMP2.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <b>BAP2</b> and Analogue <b>46</b> Induce ER Stress and Downregulate DNA Damage Response Genes</h3><div class="NLM_p">Previously, with nascent RNA sequencing (Bru-seq), we demonstrated that <b>BAP2</b> treatment of U87MG cells upregulated ER stress and UPR genes and decreased expression of DNA repair and DNA damage response (DDR) genes (unpublished). We performed Bru-seq on analogues <b>18</b> and <b>46</b> and found they had a similar effect on the cells (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Tables <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>–<named-content content-type="anchor" rid="tbl7" type="simple"></named-content><named-content content-type="anchor" rid="tbl8" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>; Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_002.xls" class="ext-link">Files 1</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_003.xlsx" class="ext-link">2</a>). The transcription of ER stress response genes including <i>DDIT3</i>, <i>CHAC1</i>, <i>ASNS</i>, and <i>XBP1</i> increased upon treatment with both compounds, although <b>18</b> increased transcription to a greater extent (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). Furthermore, both compounds also decreased transcription of <i>RAD51</i> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B) and <i>E2F1</i> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). Additionally, Gene Set Enrichment Analysis (GSEA) was performed on the log 2-fold changes of the abundance ratios of protein expression between DMSO- and compound-treated U87MG cells. GSEA confirmed that both <b>18</b> and <b>46</b> treatment resulted in profiles that positively correlated with UPR and negatively correlated with E2F signaling (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>–<named-content content-type="anchor" rid="fig9" type="simple"></named-content><named-content content-type="anchor" rid="fig10" type="simple"></named-content><a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>; Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Tables S2–S27</a>). We applied Hallmark pathway analysis via GSEA and identified that genes with decreased transcription upon <b>46</b> treatment also correlated with epithelial-to-mesenchymal transition, TNFα signaling, and KRAS signaling (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Table S15</a>).</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>BAP2</b> analogues induce transcription of ER stress genes and downregulate DNA damage response genes <i>RAD51</i> and <i>E2F1</i>. Traces of RNA transcripts derived from (a) ER stress genes, (b) <i>RAD51</i>, or (c) <i>E2F1</i> loci in U87MG cells treated with 10 μM <b>18</b> or 16 μM <b>46</b> for 4 h. Traces represent RNA abundance following treatment. RPKM: reads/kilobase of transcript/million mapped reads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>18</b> treatment (10 μM in U87MG cells) positively correlates with enrichment of (a) HALLMARK_TNFA_SIGNALING_VIA_NFKB, (b) HALLMARK_MTORC1_SIGNALING, (c) HALLMARK_UNFOLDED_PROTEIN_RESPONSE, (d) KEGG_PROTEASOME, (e) TTCNRGNNNNTTC_HSF_Q6, and (f) CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP. NES, normalized enrichment score; FDR q-val, false discovery rate <i>q</i>-value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compound <b>18</b> treatment (10 μM in U87MG cells) negatively correlates with enrichment of (a) HALLMARK_E2F_TARGETS, (b) HALLMARK_G2M_CHECKPOINT, and (c) E2F1_Q6. NES, normalized enrichment score; FDR q-val, false discovery rate <i>q</i>-value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Compound <b>46</b> treatment (16 μM in U87MG cells) positively correlates with enrichment of (a) HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY, (b) HALLMARK_MTORC1_SIGNALING, (c) HALLMARK_XENOBIOTIC_METABOLISM, (d) HALLMARK_UNFOLDED_PROTEIN_RESPONSE, (e) KEGG_PROTEASOME, and (f) TTCNRGNNNNTTC_HSF_Q6. NES, normalized enrichment score; FDR q-val, false discovery rate <i>q</i>-value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compound <b>46</b> treatment (16 μM in U87MG cells) negatively correlates with enrichment of (a) HALLMARK_E2F_TARGETS, (b) HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION, (c) HALLMARK_TNFA_SIGNALING_VIA_NFKB, (d) HALLMARK_KRAS_SIGNALING_UP, (e) KEGG_RIBOSOME, and (f) BMI1_DN.V1_UP. NES: normalized enrichment score; FDR q-val: false discovery rate <i>q</i>-value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Top 25 Protein-Coding Genes with Increased Transcription upon Treatment with 10 μM Compound <b>18</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">gene symbol</th><th class="colsep0 rowsep0" align="center">gene name</th><th class="colsep0 rowsep0" align="center" char=".">fold change</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HSPA6</td><td class="colsep0 rowsep0" align="left">heat shock protein family A (Hsp70) member 6</td><td class="colsep0 rowsep0" align="char" char=".">464.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HSPA1B</td><td class="colsep0 rowsep0" align="left">heat shock protein family A (Hsp70) member 1B</td><td class="colsep0 rowsep0" align="char" char=".">107.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CHAC1</td><td class="colsep0 rowsep0" align="left">ChaC glutathione specific γ-glutamylcyclotransferase</td><td class="colsep0 rowsep0" align="char" char=".">40.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRIB3</td><td class="colsep0 rowsep0" align="left">tribbles pseudokinase 3</td><td class="colsep0 rowsep0" align="char" char=".">34.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP1</td><td class="colsep0 rowsep0" align="left">matrix metallopeptidase 1</td><td class="colsep0 rowsep0" align="char" char=".">32.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HMOX1</td><td class="colsep0 rowsep0" align="left">heme oxygenase 1</td><td class="colsep0 rowsep0" align="char" char=".">27.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">INHBA</td><td class="colsep0 rowsep0" align="left">inhibin beta A subunit</td><td class="colsep0 rowsep0" align="char" char=".">27.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SESN2</td><td class="colsep0 rowsep0" align="left">sestrin 2</td><td class="colsep0 rowsep0" align="char" char=".">26.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SLC7A11</td><td class="colsep0 rowsep0" align="left">solute carrier family 7 member 11</td><td class="colsep0 rowsep0" align="char" char=".">20.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HSPH1</td><td class="colsep0 rowsep0" align="left">heat shock protein family H (Hsp110) member 1</td><td class="colsep0 rowsep0" align="char" char=".">20.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NR4A1</td><td class="colsep0 rowsep0" align="left">nuclear receptor subfamily 4 group A member 1</td><td class="colsep0 rowsep0" align="char" char=".">18.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTH</td><td class="colsep0 rowsep0" align="left">cystathionine γ-lyase</td><td class="colsep0 rowsep0" align="char" char=".">17.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BAG3</td><td class="colsep0 rowsep0" align="left">BCL2 associated athanogene 3</td><td class="colsep0 rowsep0" align="char" char=".">17.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALOXE3</td><td class="colsep0 rowsep0" align="left">arachidonate lipoxygenase 3</td><td class="colsep0 rowsep0" align="char" char=".">17.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DNAJB1</td><td class="colsep0 rowsep0" align="left">DnaJ heat shock protein family (Hsp40) member B1</td><td class="colsep0 rowsep0" align="char" char=".">16.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SLC7A5</td><td class="colsep0 rowsep0" align="left">solute carrier family 7 member 5</td><td class="colsep0 rowsep0" align="char" char=".">16.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATP6 V0D2</td><td class="colsep0 rowsep0" align="left">ATPase H<sup>+</sup> transporting V0 subunit D2</td><td class="colsep0 rowsep0" align="char" char=".">11.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NUPR1</td><td class="colsep0 rowsep0" align="left">nuclear protein 1, transcriptional regulator</td><td class="colsep0 rowsep0" align="char" char=".">11.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PSAT1</td><td class="colsep0 rowsep0" align="left">phosphoserine aminotransferase 1</td><td class="colsep0 rowsep0" align="char" char=".">11.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DEDD2</td><td class="colsep0 rowsep0" align="left">death effector domain containing 2</td><td class="colsep0 rowsep0" align="char" char=".">11.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NGF</td><td class="colsep0 rowsep0" align="left">nerve growth factor</td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GCNT3</td><td class="colsep0 rowsep0" align="left">β-1,3-galactosyl-<i>O</i>-glycosyl-glycoprotein β-1,6-<i>N</i>-acetylglucosaminyltransferase 3</td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADAMTS5</td><td class="colsep0 rowsep0" align="left">ADAM metallopeptidase with thrombospondin type 1 motif 5</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TM4SF19-TCTEX1D2</td><td class="colsep0 rowsep0" align="left">TM4SF19-TCTEX1D2 readthrough (NMD candidate)</td><td class="colsep0 rowsep0" align="char" char=".">8.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HSPA4L</td><td class="colsep0 rowsep0" align="left">heat shock protein family A (Hsp70) member 4 like</td><td class="colsep0 rowsep0" align="char" char=".">8.6</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Top 25 Protein-Coding Genes with Decreased Transcription upon Treatment with 10 μM Compound <b>18</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">gene symbol</th><th class="colsep0 rowsep0" align="center">gene name</th><th class="colsep0 rowsep0" align="center" char=".">fold change</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SLITRK5</td><td class="colsep0 rowsep0">SLIT and NTRK like family member 5</td><td class="colsep0 rowsep0" align="char" char=".">–3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKAP5</td><td class="colsep0 rowsep0">A-kinase anchoring protein 5</td><td class="colsep0 rowsep0" align="char" char=".">–3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ST8SIA4</td><td class="colsep0 rowsep0">ST8 α-<i>N</i>-acetyl-neuraminide α-2,8-sialyltransferase 4</td><td class="colsep0 rowsep0" align="char" char=".">–3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LYPD6</td><td class="colsep0 rowsep0">LY6/PLAUR domain containing 6</td><td class="colsep0 rowsep0" align="char" char=".">–3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLA-DQB1</td><td class="colsep0 rowsep0">major histocompatibility complex, class II, DQ β 1</td><td class="colsep0 rowsep0" align="char" char=".">–2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ANKRD36B</td><td class="colsep0 rowsep0">ankyrin repeat domain 36B</td><td class="colsep0 rowsep0" align="char" char=".">–2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KCTD4</td><td class="colsep0 rowsep0">potassium channel tetramerization domain containing 4</td><td class="colsep0 rowsep0" align="char" char=".">–2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ZNF404</td><td class="colsep0 rowsep0">zinc finger protein 404</td><td class="colsep0 rowsep0" align="char" char=".">–2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FBXO43</td><td class="colsep0 rowsep0">F-box protein 43</td><td class="colsep0 rowsep0" align="char" char=".">–2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MYBL1</td><td class="colsep0 rowsep0">MYB proto-oncogene like 1</td><td class="colsep0 rowsep0" align="char" char=".">–2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CHSY3</td><td class="colsep0 rowsep0">chondroitin sulfate synthase 3</td><td class="colsep0 rowsep0" align="char" char=".">–2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LRRC63</td><td class="colsep0 rowsep0">leucine rich repeat containing 63</td><td class="colsep0 rowsep0" align="char" char=".">–2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTHRC1</td><td class="colsep0 rowsep0">collagen triple helix repeat containing 1</td><td class="colsep0 rowsep0" align="char" char=".">–2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NFIA</td><td class="colsep0 rowsep0">nuclear factor I A</td><td class="colsep0 rowsep0" align="char" char=".">–2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ANKRD36</td><td class="colsep0 rowsep0">ankyrin repeat domain 36</td><td class="colsep0 rowsep0" align="char" char=".">–2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">E2F8</td><td class="colsep0 rowsep0">E2F transcription factor 8</td><td class="colsep0 rowsep0" align="char" char=".">–2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C11orf87</td><td class="colsep0 rowsep0">chromosome 11 open reading frame 87</td><td class="colsep0 rowsep0" align="char" char=".">–2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FKBP7</td><td class="colsep0 rowsep0">FK506 binding protein 7</td><td class="colsep0 rowsep0" align="char" char=".">–2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAD2L1</td><td class="colsep0 rowsep0">mitotic arrest deficient 2 like 1</td><td class="colsep0 rowsep0" align="char" char=".">–2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FPGT</td><td class="colsep0 rowsep0">fucose-1-phosphate guanylyltransferase</td><td class="colsep0 rowsep0" align="char" char=".">–2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DUT</td><td class="colsep0 rowsep0">deoxyuridine triphosphatase</td><td class="colsep0 rowsep0" align="char" char=".">–2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HIST1H2BC</td><td class="colsep0 rowsep0">histone cluster 1 H2B family member C</td><td class="colsep0 rowsep0" align="char" char=".">–2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BARD1</td><td class="colsep0 rowsep0">BRCA1 associated RING domain 1</td><td class="colsep0 rowsep0" align="char" char=".">–2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BBS10</td><td class="colsep0 rowsep0">Bardet–Biedl syndrome 10</td><td class="colsep0 rowsep0" align="char" char=".">–2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CCNA2</td><td class="colsep0 rowsep0">cyclin A2</td><td class="colsep0 rowsep0" align="char" char=".">–2.3</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Top 25 Genes with Increased Transcription upon Treatment with 16 μM Compound <b>46</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">gene symbol</th><th class="colsep0 rowsep0" align="center">gene name</th><th class="colsep0 rowsep0" align="center" char=".">fold change</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HMOX1</td><td class="colsep0 rowsep0" align="left">heme oxygenase 1</td><td class="colsep0 rowsep0" align="char" char=".">21.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SLC7A11</td><td class="colsep0 rowsep0" align="left">solute carrier family 7 member 11</td><td class="colsep0 rowsep0" align="char" char=".">21.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NMRAL2P</td><td class="colsep0 rowsep0" align="left">NmrA like redox sensor 2, pseudogene</td><td class="colsep0 rowsep0" align="char" char=".">15.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HSPA1B</td><td class="colsep0 rowsep0" align="left">heat shock protein family A (Hsp70) member 1B</td><td class="colsep0 rowsep0" align="char" char=".">10.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKR1C1</td><td class="colsep0 rowsep0" align="left">aldo-keto reductase family 1 member C1</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGFD</td><td class="colsep0 rowsep0" align="left">vascular endothelial growth factor D</td><td class="colsep0 rowsep0" align="char" char=".">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OSGIN1</td><td class="colsep0 rowsep0" align="left">oxidative stress induced growth inhibitor 1</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TXNRD1</td><td class="colsep0 rowsep0" align="left">thioredoxin reductase 1</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AC005324.3</td><td class="colsep0 rowsep0" align="left">novel tripartite motif-containing 16 (TRIM16) and CMT1A duplicated region transcript 1 (CDRT1) protein</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KCNE4</td><td class="colsep0 rowsep0" align="left">potassium voltage-gated channel subfamily E regulatory subunit 4</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HSPH1</td><td class="colsep0 rowsep0" align="left">heat shock protein family A (Hsp70) member 4 like</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRIM16L</td><td class="colsep0 rowsep0" align="left">tripartite motif containing 16-like</td><td class="colsep0 rowsep0" align="char" char=".">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EID3</td><td class="colsep0 rowsep0" align="left">EP300 interacting inhibitor of differentiation 3</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PIR</td><td class="colsep0 rowsep0" align="left">pirin</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYYR1-AS1</td><td class="colsep0 rowsep0" align="left">cysteine and tyrosine rich 1 antisense RNA 1</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HSPA4L</td><td class="colsep0 rowsep0" align="left">heat shock protein family A (Hsp70) member 4 like</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AC069257.3</td><td class="colsep0 rowsep0" align="left">ENSG00000272741 (novel transcript)</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AC087672.3</td><td class="colsep0 rowsep0" align="left">ENSG00000254288 (novel transcript)</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKR1C7P</td><td class="colsep0 rowsep0" align="left">aldo-keto reductase family 1 member C7, pseudogene</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NQO1</td><td class="colsep0 rowsep0" align="left">NAD(P)H quinone dehydrogenase 1</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">UGDH</td><td class="colsep0 rowsep0" align="left">UDP-glucose 6-dehydrogenase</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BCO2</td><td class="colsep0 rowsep0" align="left">β-carotene oxygenase 2</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BAG3</td><td class="colsep0 rowsep0" align="left">BCL2 associated athanogene 3</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FTH1</td><td class="colsep0 rowsep0" align="left">ferritin heavy chain 1</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GCLC</td><td class="colsep0 rowsep0" align="left">glutamate–cysteine ligase catalytic subunit</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Top 25 Genes with Decreased Transcription upon Treatment with 16 μM Compound <b>46</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">gene symbol</th><th class="colsep0 rowsep0" align="center">gene name</th><th class="colsep0 rowsep0" align="center" char=".">fold change</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CSF3</td><td class="colsep0 rowsep0" align="left">colony stimulating factor 3</td><td class="colsep0 rowsep0" align="char" char=".">–8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IL1B</td><td class="colsep0 rowsep0" align="left">interleukin 1 β</td><td class="colsep0 rowsep0" align="char" char=".">–5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AC139722.1</td><td class="colsep0 rowsep0" align="left">uncharacterized LOC101928942</td><td class="colsep0 rowsep0" align="char" char=".">–4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C8orf4</td><td class="colsep0 rowsep0" align="left">chromosome 8 open reading frame 4</td><td class="colsep0 rowsep0" align="char" char=".">–4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">STRA6</td><td class="colsep0 rowsep0" align="left">stimulated by retinoic acid 6</td><td class="colsep0 rowsep0" align="char" char=".">–4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AC006206.2</td><td class="colsep0 rowsep0" align="left">ENSG00000256417 (novel transcript)</td><td class="colsep0 rowsep0" align="char" char=".">–3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLA-DQB1</td><td class="colsep0 rowsep0" align="left">major histocompatibility complex, class II, DQ β 1</td><td class="colsep0 rowsep0" align="char" char=".">–3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LRRN3</td><td class="colsep0 rowsep0" align="left">leucine rich repeat neuronal 3</td><td class="colsep0 rowsep0" align="char" char=".">–3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RAET1E</td><td class="colsep0 rowsep0" align="left">retinoic acid early transcript 1E</td><td class="colsep0 rowsep0" align="char" char=".">–3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTHRC1</td><td class="colsep0 rowsep0" align="left">collagen triple helix repeat containing 1</td><td class="colsep0 rowsep0" align="char" char=".">–3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GGT4P</td><td class="colsep0 rowsep0" align="left">gamma-glutamyltransferase 4 pseudogene</td><td class="colsep0 rowsep0" align="char" char=".">–3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIRC3</td><td class="colsep0 rowsep0" align="left">baculoviral IAP repeat containing 3</td><td class="colsep0 rowsep0" align="char" char=".">–3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AC010931.3</td><td class="colsep0 rowsep0" align="left">ENSG00000261543 (novel transcript)</td><td class="colsep0 rowsep0" align="char" char=".">–3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTGF</td><td class="colsep0 rowsep0" align="left">connective tissue growth factor</td><td class="colsep0 rowsep0" align="char" char=".">–3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KCTD4</td><td class="colsep0 rowsep0" align="left">potassium channel tetramerization domain containing 4</td><td class="colsep0 rowsep0" align="char" char=".">–3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AC124276.2</td><td class="colsep0 rowsep0" align="left">ENSG00000254991 (novel transcript)</td><td class="colsep0 rowsep0" align="char" char=".">–2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AC007848.1</td><td class="colsep0 rowsep0" align="left">ENSG00000255983 (novel transcript)</td><td class="colsep0 rowsep0" align="char" char=".">–2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP1B1</td><td class="colsep0 rowsep0" align="left">cytochrome P450 family 1 subfamily B member 1</td><td class="colsep0 rowsep0" align="char" char=".">–2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LIF</td><td class="colsep0 rowsep0" align="left">leukemia inhibitory factor</td><td class="colsep0 rowsep0" align="char" char=".">–2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CD83</td><td class="colsep0 rowsep0" align="left">CD83 antigen</td><td class="colsep0 rowsep0" align="char" char=".">–2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H1F0</td><td class="colsep0 rowsep0" align="left">H1 histone family member 0</td><td class="colsep0 rowsep0" align="char" char=".">–2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AC022601.1</td><td class="colsep0 rowsep0" align="left">ENSG00000268873 (novel transcript)</td><td class="colsep0 rowsep0" align="char" char=".">–2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HIST1H4B</td><td class="colsep0 rowsep0" align="left">histone cluster 1 H4 family member B</td><td class="colsep0 rowsep0" align="char" char=".">–2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KIAA0040</td><td class="colsep0 rowsep0" align="left">uncharacterized protein KIAA0040</td><td class="colsep0 rowsep0" align="char" char=".">–2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PRLR</td><td class="colsep0 rowsep0" align="left">prolactin receptor</td><td class="colsep0 rowsep0" align="char" char=".">–2.6</td></tr></tbody></table></div></div><div class="NLM_p">To further validate the GSEA results, proteomics with tandem mass tag multiplexing was performed in U87MG cells treated for 24 h with DMSO and 20 μM <b>BAP2</b> or <b>18</b> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_004.xlsx" class="ext-link">File 3</a>). GSEA revealed that <b>BAP2</b> treatment was positively correlated with the G2M DNA damage checkpoint and negatively correlated with ribosomes and associated proteins. Furthermore, <b>18</b> treatment was positively correlated with an arsenic trioxide signature and negatively correlated with DNA replication (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_005.xlsx" class="ext-link">File 4</a>). These results suggest the analogues are targeting PDI and promoting a similar transcriptional response in the cells as <b>BAP2</b>. Long, noncoding RNAs (lncRNA) can act as transcriptional regulators<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and impact glioma initiation and progression.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> GSEA of the Bru-seq transcription profiles of <b>18</b> and <b>46</b> also revealed noncoding genes with increased or decreased transcription (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Tables S26–S29</a>). Transcription of <i>NMRAL2P</i>, a transcribed unprocessed pseudogene and target of Nrf2,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> increased upon both <b>18</b> (+2.72 log2 fold change) and <b>46</b> (+4.10 log2 fold change) treatment of U87MG cells.</div><figure id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. GSEA analysis of proteome perturbation by <b>BAP2</b> and <b>18</b> reveals increased expression of G2M checkpoint and arsenic trioxide response and reduced expression of proteins involved in ribosome and DNA replication. Gene set enrichment analysis was used to assess the effect of PDI inhibitors <b>BAP2</b> and <b>18</b> on the proteome of U87MG cells. GSEA plots of (a) upregulated and (b) downregulated pathways upon 20 μM <b>BAP2</b> treatment: G2M checkpoint and ribosome, respectively. GSEA plots of (c) upregulated and (d) downregulated pathways upon 20 μM <b>18</b> treatment: Response to arsenic trioxide and DNA replication, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Additionally, PDI inhibition by <b>18</b> and <b>46</b> induces an immune response. Treatment of U87MG cells with <b>18</b> increases transcription of genes involved in the GO_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I gene set (NES = +2.37; FDR q-val = 0), and treatment with <b>46</b> correlates with the REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION gene set (NES = +1.47; FDR q-val = 0.24). Furthermore, treatment with compound <b>18</b> correlates with both an inflammatory and immune response. PDI has been demonstrated to play a role in the immune response, and PDI is required for the degradation of major histocompatibility complex (MHC) class I, a protein responsible for antigen presentation that is essential for adaptive immunity.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> On the other hand, another study demonstrated that PDI forms a key disulfide bond with the α<sub>2</sub> domain of the MHC class I heavy chain to aid early folding of the complex,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and another PDI family member, ERp57, may also aid stabilization of the MHC class I heavy chain via disulfide bond formation.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Thus, the role of PDI in the immune response is complex and the upregulation of transcription in these pathways in response to PDI inhibition may be a feedback response to pathway inhibition.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> BAP2 Analogues Have Similar Gene Expression Signatures as Brazilin and HSP Inhibitors</h3><div class="NLM_p last">We analyzed the Bru-seq signatures of compound <b>18</b> and <b>46</b> for similarity to gene expression profiles of known drugs using the Connectivity Map (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Tables S30–S33</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The signatures of both compounds were similar to heterotetracyclic brazilin, an anti-inflammatory compound<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> that promotes apoptosis and inhibits cancer cell growth.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> Furthermore, signatures of both compounds demonstrated a high level of correlation with several HSP inhibitors, including luminespib (NVP-AUY922) for compound <b>18</b>, and luminespib (NVP-AUY922), geldanamycin, PU-H71, and BIIB021 for compound <b>46</b>. These results further confirm that <b>BAP2</b> analogues <b>18</b> and <b>46</b> inhibit ER chaperone activity in the cells.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> BAP2 Analogue Treatment Is Synergistic with Arsenic Trioxide</h3><div class="NLM_p last">Previously, we demonstrated that <b>BAP2</b> treatment induces transcription of genes similar to that of arsenite treatment (unpublished). Furthermore, we observed increased expression of proteins involved in the response to arsenic oxide upon treatment with compound <b>18</b>. Arsenic trioxide has been used to treat patients with acute promyelocytic leukemia,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and synergy between tetra-arsenic oxide and paclitaxel in cancer cells has been observed.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a><b>BAP2</b> and derivatives <b>13</b>, <b>14</b>, and <b>15</b> inhibit GBM cell proliferation synergistically with As<sub>2</sub>O<sub>3</sub> (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Figure S6A</a>). Synergistic combinations had a combination index value below 1 using the Chou–Talalay method (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Figures S6B and S6C</a>).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Our results suggest that these <b>BAP2</b> analogues may best function in combination with other drugs.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> BAP2 Analogue Treatment Synergizes with Radiation</h3><div class="NLM_p last">Because PDI inhibition and <b>BAP2</b> treatment cause global downregulation of DNA damage repair genes, we next determined whether <b>BAP2</b> analogues would synergize with radiation to decrease GBM cell viability. PDI inhibition radiosensitizes GBM cells (unpublished). The clonogenic survival assay demonstrated synergy upon combination of PDI inhibitors and ionizing radiation (IR) compared to either modality alone (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">Figure S7</a>). Both <b>BAP2</b> and <b>68</b> treatment synergized with IR; however, <b>PACMA31</b> at 0.05 μM did not. It is likely that the dose of <b>PACMA31</b> was too low to demonstrate synergy because the enzymatic IC<sub>50</sub> value of <b>PACMA31</b> inhibition of PDI is around 10 μM. Therefore, the more potent <b>BAP2</b> analogues likely synergize with IR by inhibiting PDI. These findings provide a strong rationale for the development of PDI inhibitors as agents to combine with DNA damage-inducing therapies such as IR.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> BAP2 Analogue Activity Varies against H256A Mutant PDI</h3><div class="NLM_p">As we previously demonstrated, <b>BAP2</b> requires His256 in the b′ domain for activity, similar to estradiol binding (unpublished). We also tested the <b>BAP2</b> analogues in the PDI reductase assay (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>A). The activity of <b>BAP2</b> analogues, except <b>59</b>, was reduced upon mutation of His256 to Ala as <b>BAP2</b>, suggesting the analogues also bind in the b′ domain of PDI and require His256 for activity. To further confirm their binding, we used the fluorescent dye, 1-anilinonaphthalene-8-sulfonic acid (ANS), which is known to bind and fluoresce selectively in the b′ domain of PDI.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> As expected, <b>BAP2</b> and active analogues hindered the ability of ANS to fluoresce at 370 nm, whereas <b>PACMA31</b>, which binds in the active site of PDI, and inactive <b>BAP2</b> analogues (<b>8</b> and <b>29</b>) did not hinder dye fluorescence (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>B). Compound <b>59</b> is active against the H256A mutant but competes with ANS for the b′ domain, further suggesting a complex binding mode. It is possible that <b>59</b> inhibits PDI by binding in between the a′ and b′ domains or binds in both sites. To address the potential role of thiol-dependent inhibition, we tested the <b>BAP2</b> analogues after competition with <i>N</i>-acetyl cysteine (NAC). As a positive control, the activity of <b>PACMA31</b> was significantly abolished after competition with NAC (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>C). Activity of <b>BAP2</b> and <b>68</b> were unaffected by up to 5 mM NAC. Activity of <b>46</b> and <b>59</b> was abolished by 5 mM NAC but not by lower concentrations, suggesting they may be attacked by the thiol groups on the cysteine active sites. For compound <b>59</b>, this is further confirmed by the fact that activity is not dependent on His256. These results, in combination with the alanine mutation of His256, suggest that analogue <b>68</b> binds in the b′ domain of PDI to inhibit activity.</div><figure id="fig13" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. <b>BAP2</b> analogues interact with the b′ domain of PDI. (a) Activity of PDI inhibitors at 10 μM (<b>PACMA31</b> tested at 30 μM) against wild-type and H256A PDI, measured with the PDI reductase assay. Results are reported as mean ± standard deviation of three independent experiments. (b) ANS spectral scan with 5 μM PDI and 100 μM PDI inhibitors (estradiol, <b>BAP2</b>, <b>PACMA31</b>, <b>46</b>, <b>68</b>, and <b>59</b>) or inactive <b>BAP2</b> analogues (<b>8</b> and <b>29</b>). (c) Activity of PDI inhibitors at 40 μM in the presence of indicated concentrations of <i>N</i>-acetyl cysteine (NAC). P: <b>PACMA31</b>. DMSO used as a negative control. **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001 compared to wild-type PDI result in the same treatment group. Statistical significance was measured using two-way analysis of variance (ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> BAP2 Analogues Interact with Hydrophobic Residues in the b′ Domain</h3><div class="NLM_p">We hypothesized that <b>BAP2</b> derivatives may interact with the b′ domain to enhance binding to PDI. This hypothesis is supported by the observation that the replacement of residue His256 with Ala abolishes the activity of <b>BAP2</b> and its analogues. Using a computational approach, we docked all <b>BAP2</b> analogues into three PDI ligand binding sites, including two catalytic sites as well as the hydrophobic pocket in the b′ domain (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>A). The catalytic sites contain reactive Cys56 and Cys397, where <b>PACMA31</b> binds,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and the b′ domain contains a hydrophobic pocket for substrate recognition. Molecular docking demonstrated that <b>BAP2</b> analogues preferentially interact with the b′ domain of PDI compared to catalytic sites, supporting the mutagenesis results (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>B). Noncovalent docking of active <b>BAP2</b> derivatives into the b′ domain results in binding affinity values of −6.6 and −6.7 kcal/mol for active compounds <b>49</b> and <b>68</b>, respectively (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>).</div><figure id="fig14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. <b>BAP2</b> analogues interact with the b′ domain of PDI. (a) Molecular docking of 68 <b>BAP2</b> derivatives into three binding sites of PDIA1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a>): Cys56 (Top right), His256 (middle), and Cys397 (top left). (b) Heat map plot for binding affinities of <b>BAP2</b> derivatives in three potential binding pockets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig15" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. <b>BAP2</b> analogues docked in the b′ domain. Docking pose and protein–ligand interactions of PDI inhibitors (a) <b>49</b> and (b) <b>68</b> in the b′ domain of PDI (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Hydrogen bonding interaction between <b>BAP2</b> derivatives and His256 of the b′ domain of PDI is critical for their PDI inhibitory activity. Previous studies demonstrated that His256 plays a key role in the binding of estradiol in the b′ domain.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Phe249 stabilizes the interaction with π–π stacking. The other key residues in the binding of <b>BAP2</b> analogues with the b′ domain are Leu320 and Ile318, as demonstrated by the docking pose. π–Alkyl interactions of the benzene rings with these residues stabilize the structures in this binding site and contribute to the potency of <b>BAP2</b> derivatives as PDI inhibitors.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76447" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76447" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, we report a novel target, PDI, for a series of chalcones, perform an extensive SAR study, determine their activity on human glioblastoma cell lines, and propose their mechanism of action as allosteric inhibitors of the b′ domain of PDI. Electron-deficient olefins, such as Michael acceptors, are susceptible to reactions with nucleophiles, resulting in a covalent bond with threonine and cysteine residues of proteins.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> For example, <b>PACMA31</b>, which was previously identified as a PDI inhibitor, irreversibly inhibits PDI through its propynoic acid amide moiety by covalently binding to cysteine residues in the active site,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and this is further supported by the results herein that demonstrate that <b>PACMA31</b> inhibition of PDI is challenged by <i>N</i>-acetyl cysteine. We would expect chalcone analogues would also inhibit PDI via Michael addition reaction with the nucleophilic cysteines in the PDI active site because of their olefin structure. However, the activity of <b>BAP2</b> and its analogues <b>46</b> and <b>68</b> is unaffected by NAC. Instead, their ability to inhibit PDI is abolished upon mutation of the key residue, His256, that is responsible for substrate-binding interactions in the b′ domain.<a onclick="showRef(event, 'ref39 ref59'); return false;" href="javascript:void(0);" class="ref ref39 ref59">(39,59)</a> Furthermore, the stabilizing shift caused by <b>BAP2</b> and analogues in the thermal shift assay is also abolished upon H256A mutation, and <b>BAP2</b> and analogues compete with ANS for the b′ hydrophobic binding pocket of PDI. These results suggest that the b′ domain is at least critical for <b>BAP2</b> analogue binding. It should be noted that the activity of some <b>BAP2</b> analogues, such as <b>59</b>, is not His256-dependent, and the electron-withdrawing sulfonamide may activate the olefin for nucleophilic attack. These findings indicate that <b>BAP2</b> and analogues primarily use the hydrophobic pocket in the b′ domain to inhibit PDI.</div><div class="NLM_p">When the substituent on ring A is an electron-withdrawing group such as a sulfonamide, the carbonyl may be activated for a Michael addition with the thiols in the PDI active sites. Without an electron-withdrawing group on ring A, the carbonyl is a weak electrophile, and other hydrophobic interactions, such as the hydrogen bond with His256, may play a more important role instead. It remains to be determined whether b′ domain-binding analogues such as <b>BAP2</b> and <b>46</b> also interact reversibly with the active site cysteines. As a whole, the mutagenesis evidence suggests that <b>BAP2</b> and analogue <b>46</b> inhibit PDI not by attack on the weak Michael acceptor but by interaction with the hydrophobic binding pocket of PDI. This agrees with the recent findings that chalcones without any substituents on the olefin do not induce Nrf2, possibly because no effective alkylation reaction occurs between the electrophilic chalcone compound and the distinct cysteine residues in Keap1.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Finally, although all the tested chalcones contain the Michael accepting site, only a few are potent PDI inhibitors. Additionally, the SAR profile of the analogues was not flat, demonstrating that these compounds do not all bind the active site cysteines but have a more complex binding mode.</div><div class="NLM_p">Nascent RNA transcription analysis of <b>BAP2</b> analogue treatment provided a blueprint of their effect on GBM cell transcription. Cells treated with <b>BAP2</b> analogues <b>18</b> and <b>46</b> demonstrated increased transcription of genes related to the UPR after 4 h of treatment. The increased transcription of UPR genes suggests the compounds inhibit PDI in the cells, leading to an increase in the unfolded protein load. This result is consistent with the findings of another research group that treatment with 2′-hydroxy-2,3,5′-trimethoxychalcone induces the UPR in MDA-MB-231 breast cancer cells.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Additionally, <b>BAP2</b> analogues <b>18</b> and <b>46</b> decreased transcription of E2F targets. <b>BAP2</b> downregulated protein expression of E2F1 (unpublished), and PDI knockdown was linked to reduced E2F expression (unpublished). These results provide further target engagement validation and suggest <b>BAP2</b> analogues inhibit PDI activity in the cells.</div><div class="NLM_p">In addition to their role in tumor proliferation, PDI family members are involved in tumor immune recognition. Immune response proteins, such as antibodies, are secretory molecules and require maturation through the ER to be prepared for secretion. Tumors evade immune recognition by “shedding” key immune signal proteins from the tumor cell surface. Neutrophil <span class="smallcaps smallerCapital">l</span>-selectin adhesion to lymphocytes is dependent on disulfide bonds. PDI inhibition promotes neutrophil <span class="smallcaps smallerCapital">l</span>-selectin shedding, suggesting that PDI promotes signaling for immune pathways to eliminate tumor cells.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Furthermore, PDI has been shown to promote antibody production and the humoral immune response in GM-CSF-secreting cancer cells.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> However, ERp5 is necessary for shedding of the soluble major histocompatibility complex class-I-related ligand MICA and thus allows the tumor to evade the immune response.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> ERp5, along with ADAM10 (a disintegrin and metalloproteinase 10), were also found to block the antitumor immune response in classic Hodgkin’s lymphoma by shedding NKG2D (natural killer group 2D) receptor ligands.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Thus, the increase in transcription of MHC-related genes that we observe upon treatment with <b>BAP2</b> analogues may be a response to MHC complex degradation. Clearly, thiol-based redox reactions play a key role in regulating the humoral immune response; however, the precise role of PDI in each pathway remains to be defined.</div><div class="NLM_p last">In summary, we explored the structure of <b>BAP2</b> by modifying the substituents around ring <b>A</b> and ring <b>B</b> and identified potent analogues that may be promising treatment strategies for GBM. We identified five compounds that were more potent and cytotoxic than the lead <b>BAP2</b>, as well as compounds that induced ER stress and inhibited GBM cell migration and MMP9 expression. Especially, the analogues <b>18</b> and <b>46</b> induced genes involved in the UPR and decreased expression of E2F target genes, validating PDI inhibition in the cells. Additionally, we demonstrated the therapeutic window afforded with the derivatives and the potential for combination with As<sub>2</sub>O<sub>3</sub>. Furthermore, preliminary results suggest that the interaction between the compounds and PDI may rely on more than a nucleophilic attack with the Michael acceptor region of the compound, and hydrophobic interaction in the b′ domain of PDI may play the most significant role. Further structural studies are needed to confirm the binding pose of the <b>BAP2</b> analogues. Our data demonstrate that PDI inhibitors should be tested in combination with other targeted agents as well as cytotoxic chemotherapy to deliver significant beneficial effects.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Methods</h3><div class="NLM_p last">All commercial chemicals and solvents were reagent grade and used without further purification unless otherwise specified. Analytical thin layer chromatography was performed on Merck precoated plates (Silica Gel 60 F254) to follow the course of reactions. Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectroscopy was performed on a Bruker Ultrashield 300 MHz, a Bruker Ascend 400 MHz, or 500 MHz Varian NMR spectrometer. Chemical shifts (δ) are reported in parts per million (ppm) relative to residual undeuterated solvent. The following abbreviations were used to describe peak splitting patterns when appropriate: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), bs (broad singlet), dd (doublet of doublets), ddd (doublet of doublet of doublets), dt (doublet of triplets), and td (triplet of doublets). Coupling constant (<i>J</i>) is shown in hertz (Hz). Mass spectra were obtained on a Shimadzu LCMS-2020 liquid chromatography mass spectrometer using the electron spray ionization (ESI) method. HPLC was used to determine purity by Shimadzu HPLC Test Kit C18 column (3 μm, 4.6 mm × 50 mm) under the following gradient elution condition: mobile phase A of acetonitrile/water (10–95%) or mobile phase B of methanol/water (10–95%). The purity was established by integration of the areas of major peaks detected at 254 nm, and all tested compounds have ≥95% purity. Flash chromatography was performed using a Biotage Isolera One flash purification system.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Synthesis of Acetophenones <b>3a</b>–<b>n</b> and Benzaldehyde <b>4-b</b></h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 1-(4-Methoxyphenyl)ethan-1-one (<b>3a</b>)</h4><div class="NLM_p last">A mixture of 4′-hydroxyacetophenone (2.0 g, 14.4 mmol), methyl iodide (2.25 g, 15.8 mmol), and potassium carbonate (5.96 g, 43.2 mmol) in acetone (150 mL) was refluxed overnight. The resulting mixture was filtered off to remove potassium salt, and the filtrate was evaporated to dryness. The residue was purified using column chromatography (<i>n</i>-hexane:EtOAc = 3:1) to obtain <b>3a</b> as an off-white solid (2.1 g, 97%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.96 (d, <i>J</i> = 8.8 Hz, 2H), 6.95 (d, <i>J</i> = 8.8 Hz, 2H), 3.89 (s, 3H), 2.58 (s, 3H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4-Acetylbenzenesulfonamide (<b>3b</b>)</h4><div class="NLM_p last">To a solution of 4-acetylbenzenesulfonyl chloride (500 mg, 2.29 mmol) was added 0.5 M ammonia in dioxane (22.9 mL, 11.4 mmol). The resulting suspension was stirred at room temperature. After the reaction was completed, the solvent was removed, and the residue was taken up in EtOAc. The organic phase was washed with satd NH<sub>4</sub>Cl (aq) and then brine, and removal of solvent in vacuo afforded <b>3b</b> as a white solid (312 mg, 68%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.12 (d, <i>J</i> = 8.1 Hz, 2H), 7.95 (d, <i>J</i> = 8.1 Hz, 2H), 7.55 (s, 2H), 2.63 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 198 (M – H)<sup>−</sup>.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-Acetyl-<i>N</i>,<i>N</i>-dimethylbenzenesulfonamide (<b>3c</b>)</h4><div class="NLM_p last">A mixture of 4-acetylbenzenesulfonyl chloride (200 mg, 0.92 mmol), dimethylamine (2 M in THF, 0.5 mL, 1.0 mmol), and triethylamine (185 mg, 1.83 mmol) in anhydrous THF (10 mL) was stirred at room temperature overnight. Brine was added, and the reaction mixture was extracted with EtOAc (3 times). The combined organic layer was washed with brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. Removal of solvent in vacuo gave <b>3c</b> as an off-white solid (152 mg, 73%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.11 (d, <i>J</i> = 8.1 Hz, 2H), 7.88 (d, <i>J</i> = 8.4 Hz, 2H), 2.74 (s, 6H), 2.67 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 228 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-Acetyl-<i>N</i>,<i>N</i>-diethylbenzenesulfonamide (<b>3d</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>3c</b> was used with 4-acetylbenzenesulfonyl chloride (200 mg, 0.92 mmol), diethylamine (73 mg, 1.0 mmol), and triethylamine (185 mg, 1.83 mmol) to obtain <b>3d</b> as an ivory solid (192 mg, 82%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.06 (d, <i>J</i> = 8.1 Hz, 2H), 7.91 (d, <i>J</i> = 8.4 Hz, 2H), 3.27 (q, <i>J</i> = 7.2 Hz, 4H), 2.65 (s, 3H), 1.14 (t, <i>J</i> = 7.2 Hz, 6H). MS (ESI): <i>m</i>/<i>z</i> 256 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 4-Acetyl-<i>N</i>,<i>N</i>-dipropylbenzenesulfonamide (<b>3e</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>3c</b> was used with 4-acetylbenzenesulfonyl chloride (200 mg, 0.92 mmol), dipropylamine (101 mg, 1.0 mmol), and triethylamine (185 mg, 1.83 mmol) to obtain <b>3e</b> as a yellow oil (222 mg, 86%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.06 (dt, <i>J</i> = 8.7, 1.8 Hz, 2H), 7.90 (dt, <i>J</i> = 8.7, 1.8 Hz, 2H), 3.14–3.07 (m, 4H), 2.65 (s, 3H), 1.55 (sextet, <i>J</i> = 7.5 Hz, 4H), 0.87 (t, <i>J</i> = 7.5 Hz, 6H).</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 4-Acetyl-<i>N</i>,<i>N</i>-dibutylbenzenesulfonamide (<b>3f</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>3c</b> was used with 4-acetylbenzenesulfonyl chloride (300 mg, 1.37 mmol), dibutylamine (193 mg, 1.50 mmol), and triethylamine (277 mg, 2.74 mmol) to obtain <b>3f</b> as a yellow oil (363 mg, 85%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.06 (d, <i>J</i> = 8.3 Hz, 2H), 7.90 (d, <i>J</i> = 8.4 Hz, 2H), 3.14 (t, <i>J</i> = 7.5 Hz, 4H), 2.65 (s, 3H), 1.58–1.44 (m, 4H), 1.29 (d, <i>J</i> = 7.5 Hz, 4H), 0.90 (t, <i>J</i> = 7.5 Hz, 6H). MS (ESI): <i>m</i>/<i>z</i> 312 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-Acetyl-<i>N</i>,<i>N</i>-dipentylbenzenesulfonamide (<b>3g</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>3c</b> was used with 4-acetylbenzenesulfonyl chloride (200 mg, 0.92 mmol), diamylamine (157 mg, 1.0 mmol), and triethylamine (185 mg, 1.83 mmol) to obtain <b>3g</b> as a yellow oil (268 mg, 86%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.06 (d, <i>J</i> = 8.1 Hz, 2H), 7.89 (d, <i>J</i> = 8.2 Hz, 2H), 3.18–3.06 (m, 3H), 3.03–2.86 (m, 1H), 2.65 (s, 3H), 1.56–1.36 (m, 4H), 1.31–1.18 (m, 6H), 0.92–0.83 (m, 8H). MS (ESI): <i>m</i>/<i>z</i> 340 (M + H)<sup>+</sup>.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 4-Acetyl-<i>N</i>-cyclopropylbenzenesulfonamide (<b>3h</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>3c</b> was used with 4-acetylbenzenesulfonyl chloride (300 mg, 1.37 mmol), cyclopropylamine (85 mg, 1.50 mmol), and triethylamine (278 mg, 2.74 mmol) to obtain <b>3h</b> as a white solid (245 mg, 75%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.10 (d, <i>J</i> = 7.8 Hz, 2H), 8.01 (d, <i>J</i> = 8.1 Hz, 2H), 4.94 (s, 1H), 2.67 (s, 3H), 2.34–2.23 (m, 1H), 0.63–0.61 (m, 4H). MS (ESI): <i>m</i>/<i>z</i> 238 (M – H)<sup>−</sup>.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 4-Acetyl-<i>N</i>-phenylbenzenesulfonamide (<b>3i</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>3c</b> was used with 4-acetylbenzenesulfonyl chloride (300 mg, 1.37 mmol), aniline (139 mg, 1.50 mmol), and triethylamine (277 mg, 2.74 mmol) to obtain <b>3i</b> as an off-white solid (239 mg, 63%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.99 (d, <i>J</i> = 8.2 Hz, 2H), 7.85 (d, <i>J</i> = 8.3 Hz, 2H), 7.28–7.23 (m, 2H), 7.16–7.06 (m, 3H), 2.61 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 274 (M – H)<sup>−</sup>.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(4-Acetylphenyl)-4-nitrobenzenesulfonamide (<b>3j</b>)</h4><div class="NLM_p last">A solution of 4-nitrobenzenesulfonyl chloride (500 mg, 2.3 mmol) in anhydrous DCM (5 mL) was added dropwise over 10 min to a solution of 4-aminoacetophenone (335 mg, 2.5 mmol) and pyridine (196 mg, 2.5 mmol) in anhydrous DCM (5 mL). The resulting mixture was stirred at room temperature overnight. Then 1 N HCl solution was added until the pH of the aqueous phase became about 2, and the aqueous phase was then extracted with DCM (3 times). The combined organic extracts were washed with brine, then dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude product was recrystallized from MeOH to give <b>3j</b> as a pink solid (557 mg, 77%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.17 (s, 1H), 8.39 (d, <i>J</i> = 8.7 Hz, 2H), 8.08 (d, <i>J</i> = 8.7 Hz, 2H), 7.86 (d, <i>J</i> = 8.6 Hz, 2H), 7.24 (d, <i>J</i> = 8.6 Hz, 2H), 7.16 (dd, <i>J</i> = 4.9, 3.9 Hz, 1H), 2.48 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 319 (M – H)<sup>−</sup>.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-(4-Acetylphenyl)thiophene-2-carboxamide (<b>3k</b>)</h4><div class="NLM_p last">2-Thiophenecarboxylic acid (640 mg, 5.0 mmol) and SOCl<sub>2</sub> (2–3 mL) were reacted overnight at room temperature and evaporated to give the corresponding reactive acyl chloride. The crude acyl chloride was dissolved in DCM (2–3 mL) and treated with 4-aminoacetophenone (675 mg, 5.0 mmol) and pyridine (2 mL) in DCM. The reaction mixture was stirred at 0 °C for 2 h. Then the mixture was evaporated under reduced pressure, and the resulting precipitate was washed with saturated NaHCO<sub>3</sub> (aq). Extraction of the saturated NaHCO<sub>3</sub> layer with ethyl acetate (3 times) yielded <b>3k</b> as a solid (1.1 g, 90%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.00 (d, <i>J</i> = 8.7 Hz, 2H), 7.76 (d, <i>J</i> = 8.7 Hz, 1H), 7.70 (d, <i>J</i> = 3.1 Hz, 1H), 7.61 (d, <i>J</i> = 5.0 Hz, 2H), 7.16 (dd, <i>J</i> = 4.9, 3.9 Hz, 1H), 2.61 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 266 (M – H)<sup>−</sup>.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 4-Acetylphenyl Thiophene-2-carboxylate (<b>3l</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>3k</b> was used with 2-thiophenecarboxylic acid (640 mg, 5.0 mmol) and 4-hydroxyacetophenone (675 mg, 5.0 mmol) to obtain <b>3l</b> as solid (1.1 g, 86%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.06 (d, <i>J</i> = 8.7 Hz, 2H), 8.02 (d, <i>J</i> = 3.8 Hz, 1H), 7.72 (d, <i>J</i> = 5.0 Hz, 1H), 7.36 (d, <i>J</i> = 8.6 Hz, 2H), 7.24–7.18 (m, 1H), 2.64 (s, 3H).</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(4-Acetylphenyl)thiophene-2-sulfonamide (<b>3m</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>3k</b> was used with 2-thiophenesulfonic acid (910 mg, 5.0 mmol) and 4-aminoacetophenone (675 mg, 5.0 mmol) to obtain <b>3m</b> as solid (1.2 g, 87%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.93 (dd, <i>J</i> = 5.0, Hz, 1H), 7.88 (d, <i>J</i> = 8.7 Hz, 2H), 7.66 (dd, <i>J</i> = 3.7, Hz, 1H), 7.27 (d, <i>J</i> = 8.7 Hz, 2H), 7.14 (t, <i>J</i> = 4.8, Hz, 1H), 2.50 (s, 3H).</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(3-Bromo-4-(hydroxymethyl)phenyl)ethan-1-one (<b>3n</b>)</h4><div class="NLM_p last">A solution of 3′-bromo-4′-methyl acetophenone (300 mg, 1.407 mmol), <i>N</i>-bromosuccinimide (275 mg, 1.548 mmol), and AIBN (46 mg, 0.28 mmol) in MeCN (10 mL) was refluxed for 12 h. After cooling to room temperature, the mixture was filtered through a silica pad and washed with DCM. After concentration, CaCO<sub>3</sub> (422 mg, 4.221 mmol) was added to the residue, followed by addition of 1,4-dioxane/water (5 mL/5 mL). The resulting suspension was heated under reflux for 16 h. After cooling to room temperature, the solid was removed by filtration. The filtrate was extracted with EtOAc, and the organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The resulting residue was purified by column chromatography (<i>n</i>-hexane:EtOAc = 5:1) to obtain <b>3n</b> as a white solid (160 mg, 50%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.14 (d, <i>J</i> = 1.7 Hz, 1H), 7.93 (dd, <i>J</i> = 8.0, 1.7 Hz, 1H), 7.65 (d, <i>J</i> = 8.0 Hz, 1H), 4.82 (s, 2H), 2.62 (s, 3H), 2.13 (bs, 1H).</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Methyl 3-Formylbenzoate (<b>4a</b>)</h4><div class="NLM_p last">A solution of 3-carboxybenzaldehyde (500 mg, 3.3 mmol) in MeOH:H<sub>2</sub>O (10:1, 10 mL) was treated with Cs<sub>2</sub>CO<sub>3</sub> (542 mg, 1.7 mmol) and stirred at room temperature. After stirring 18 h, the solvent was evaporated under reduced pressure at 60 °C. The resulting residue was suspended in anhydrous DMF (5 mL) and treated with methyl iodide (0.41 mL, 6.7 mmol). After stirring at room temperature for 2 h, the mixture was poured into water and extracted with EtOAc. The organic extract was combined, washed with water, saturated NaHCO<sub>3</sub> (aq), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified using column chromatography (<i>n</i>-hexane:EtOAc = 3:1) to obtain <b>4a</b> as a white solid (374 mg, 68%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 10.09 (s, 1H), 8.54 (s, 1H), 8.31 (d, <i>J</i> = 7.7 Hz, 1H), 8.09 (d, <i>J</i> = 7.7 Hz, 1H), 7.64 (t, <i>J</i> = 7.7 Hz, 1H), 3.97 (s, 3H).</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 4-(1<i>H</i>-Benzo[<i>d</i>]imidazol-1-yl)benzaldehyde (<b>4b</b>)</h4><div class="NLM_p last">A solution of 4-fluorobenzaldehyde (300 mg, 2.42 mmol), benzimidazole (238 mg, 2.01 mmol), and potassium carbonate (557 mg, 4.03 mmol) in DMF (5 mL) was heated at 100 °C overnight. After cooling to room temperature, water was added and the aqueous layer was extracted with EtOAc. The combined organic phase was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The resulting residue was purified using column chromatography (<i>n</i>-hexane:EtOAc = 1:1) to obtain <b>4b</b> as a white solid (375 mg, 70%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 10.11 (s, 1H), 8.19 (s, 1H), 8.12 (d, <i>J</i> = 7.4 Hz, 2H), 7.91–7.89 (m, 1H), 7.74 (d, <i>J</i> = 7.8 Hz, 2H), 7.63–7.61 (m, 1H), 7.40–7.38 (m, 2H). MS (ESI): <i>m</i>/<i>z</i> 223 (M + H)<sup>+</sup>.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Synthesis of Chalcone Analogues <b>5</b>–<b>72</b></h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>E</i>)-3-(3-(3-Hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>5</b>)</h4><div class="NLM_p last">Boron trifluoride etherate (48% BF<sub>3</sub>, 781 mg, 5.5 mmol) was added to a stirred solution of 3′-hydroxyacetophenone (150 mg, 1.1 mmol) and 3-cyanobenzaldehyde (289 mg, 2.2 mmol) in 1,4-dioxane (10 mL), and the reaction mixture was heated at 80 °C for 14–24 h. After cooling, the resultant solution was partitioned with EtOAc, washed with 10% HCl (aq), distilled water, and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was purified using column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 1:1) to obtain <b>5</b> as an ivory solid (170 mg, 62%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.82 (s, 1H), 8.49 (s, 1H), 8.18 (d, <i>J</i> = 8.0 Hz, 1H), 8.03 (d, <i>J</i> = 16.0 Hz, 1H), 7.89 (d, <i>J</i> = 7.6 Hz, 1H), 7.72 (d, <i>J</i> = 15.6 Hz, 1H), 7.68–7.64 (m, 2H), 7.49 (s, 1H), 7.38 (t, <i>J</i> = 8.0 Hz, 1H), 7.08 (dd, <i>J</i> = 8.0, 2.4 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 248 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 98%.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>E</i>)-3-(3-(4-Hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>6</b>)</h4><div class="NLM_p last"><b>8</b> (200 mg, 0.76 mmol) and pyridine hydrochloride (890 mg, 7.6 mmol) were combined in a reaction vessel and heated at 210 °C. After stirring overnight, the resultant solution was cooled to room temperature and added to ice–water (10 mL). The pH of the aqueous solution was adjusted to 7–8 with satd Na<sub>2</sub>CO<sub>3</sub> (aq). The precipitate formed was removed by filtration. The filtrate was partitioned with DCM, and the organic layer was washed with distilled water, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The resulting residue was purified using column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 1:1, EtOAc) to obtain <b>6</b> as a yellow solid (70 mg, 37%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.46 (s, 1H), 8.48 (s, 1H), 8.16 (d, <i>J</i> = 8.0 Hz, 1H), 8.11 (d, <i>J</i> = 8.4 Hz, 2H), 8.08 (d, <i>J</i> = 15.2 Hz, 1H), 7.87 (d, <i>J</i> = 7.2 Hz, 1H), 7.78 (d, <i>J</i> = 15.6 Hz, 1H), 7.65 (t, <i>J</i> = 8.0 Hz, 1H), 6.91 (d, <i>J</i> = 8.4 Hz, 2H). MS (ESI): <i>m</i>/<i>z</i> 250 (M + H)<sup>+</sup>, 248 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>E</i>)-3-(3-(3-Methoxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>7</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>3a</b> was used with <b>5</b> (50 mg, 0.20 mmol), methyl iodide (31 mg, 0.22 mmol), and potassium carbonate (83 mg, 0.60 mmol) to obtain <b>7</b> as a yellow solid (48 mg, 91%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.51 (s, 1H), 8.20 (d, <i>J</i> = 8.0 Hz, 1H), 8.09 (d, <i>J</i> = 16.0 Hz, 1H), 7.90 (d, <i>J</i> = 7.6 Hz, 1H), 7.81 (d, <i>J</i> = 7.6 Hz, 1H), 7.76 (d, <i>J</i> = 15.6 Hz, 1H), 7.69–7.65 (m, 2H), 7.51 (t, <i>J</i> = 8.4 Hz, 1H), 7.27 (dd, <i>J</i> = 8.4, 2.8 Hz, 1H), 3.86 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 264 (M + H)<sup>+</sup>. HPLC (mobile phase B): purity 95%.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>E</i>)-3-(3-(4-Methoxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>8</b>)</h4><div class="NLM_p last">To a stirred solution of <b>3a</b> (1.0 g, 6.7 mmol) and 3-cyanobenzaldehyde (0.90 g, 6.7 mmol) in anhydrous EtOH (2 mL) was added 60% NaOH (10 mL) dropwise over 20 min on ice. The reaction mixture was stirred at room temperature for 2–3 h and cooled at 4 °C for 1–2 h. The resulting residue was diluted with cold water. The precipitate that formed was filtered, washed with cold water, dried in air, and recrystallized from MeOH to obtain <b>8</b> as a white solid (1.25g, 71%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.34 (s, 1H), 8.13 (d, <i>J</i> = 8.0 Hz, 1H), 8.10 (d, <i>J</i> = 8.8 Hz, 2H), 8.00 (d, <i>J</i> = 15.6 Hz, 1H), 7.79 (d, <i>J</i> = 8.0 Hz, 1H), 7.71 (d, <i>J</i> = 15.6 Hz, 1H), 7.58 (t, <i>J</i> = 7.6 Hz, 1H), 7.03 (d, <i>J</i> = 9.2 Hz, 2H), 3.75 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 264 (M + H)<sup>+</sup>, 296 (M + Na)<sup>+</sup>. HPLC (mobile phase A): purity 95%.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>E</i>)-3-(3-(4-Aminophenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>9</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>8</b> was used with 4′-aminoacetophenone (200 mg, 1.5 mmol) and 3-cyanobenzaldehyde (200 mg, 1.5 mmol) to obtain <b>9</b> as a yellow solid (174 mg, 47%) after neutralization using 10% HCl, filtration, and recrystallization from MeOH. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.45 (s, 1H), 8.13 (d, <i>J</i> = 8.0 Hz, 1H), 8.03 (d, <i>J</i> = 15.6 Hz, 1H), 7.96 (d, <i>J</i> = 8.6 Hz, 2H), 7.85 (d, <i>J</i> = 7.7 Hz, 1H), 7.63(t, <i>J</i> = 7.8 Hz, 1H), 7.62 (d, <i>J</i> = 15.3 Hz, 1H), 6.63 (d, <i>J</i> = 8.6 Hz, 2H), 6.21 (s, 2H). MS (ESI): <i>m</i>/<i>z</i> 249 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>E</i>)-3-(3-(4-Bromophenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>10</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 582 mg, 4.0 mmol), 4′-bromoacetophenone (150 mg, 0.8 mmol), and 3-cyanobenzaldehyde (215 mg, 1.6 mmol) to obtain <b>10</b> as a yellow solid (176 mg, 71%) after filtration and recrystallization from MeOH. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.50 (s, 1H), 8.20 (d, <i>J</i> = 8.0 Hz, 1H), 8.13 (d, <i>J</i> = 8.4 Hz, 2H), 8.10 (d, <i>J</i> = 15.6 Hz, 1H), 7.90 (d, <i>J</i> = 7.6 Hz, 1H), 7.81 (d, <i>J</i> = 8.4 Hz, 2H), 7.78 (d, <i>J</i> = 15.6 Hz, 1H), 7.67 (t, <i>J</i> = 7.6 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 313 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 95%.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>E</i>)-3-(3-(4-Morpholinophenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>11</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 678 mg, 4.8 mmol), 4-morpholinoacetophenone (200 mg, 1.0 mmol), and 3-cyanobenzaldehyde (259 mg, 1.9 mmol) to obtain <b>11</b> as an orange solid (60 mg, 20%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.48 (s, 1H), 8.17 (d, <i>J</i> = 8.0 Hz, 1H), 8.11 (d, <i>J</i> = 11.2 Hz, 2H), 8.09 (d, <i>J</i> = 16.0 Hz, 1H), 7.87 (d, <i>J</i> = 8.0 Hz, 1H), 7.67 (d, <i>J</i> = 16.0, 1H), 7.65 (t, <i>J</i> = 7.6 Hz, 1H), 7.04 (d, <i>J</i> = 11.2 Hz, 2H), 3.75 (t, <i>J</i> = 4.8 Hz, 4H). 3.35 (t, <i>J</i> = 4.8 Hz, 4H). MS (ESI): <i>m</i>/<i>z</i> 319 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>E</i>)-3-(3-Oxo-3-(4-(piperidin-1-yl)phenyl)prop-1-en-1-yl)benzonitrile (<b>12</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 852 mg, 6.0 mmol), piperidinoacetophenone (248 mg, 1.2 mmol), and 3-cyanobenzaldehyde (325 mg, 2.4 mmol) to obtain <b>12</b> as a green solid (253 mg, 67%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.46 (s, 1H), 8.16 (d, <i>J</i> = 7.9 Hz, 1H), 8.17–8.05 (m, 3H), 7.86 (d, <i>J</i> = 7.7 Hz, 1H), 7.68–7.62 (m, 2H), 6.99 (d, <i>J</i> = 8.9 Hz, 2H), 3.42 (s, 4H), 1.60 (s, 6H). MS (ESI): <i>m</i>/<i>z</i> 317 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 98%.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>E</i>)-4-(3-(3-Cyanophenyl)acryloyl)benzenesulfonamide (<b>13</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 463 mg, 3.26 mmol), <b>3b</b> (130 mg, 0.65 mmol), and 3-cyanobenzaldehyde (171 mg, 1.31 mmol) to obtain <b>13</b> as an off-white solid (80 mg, 39%) after extraction and crystallization from EtOH. <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>) δ: 8.34 (s, 1H), 8.33 (d, <i>J</i> = 8.1 Hz, 2H), 8.17 (d, <i>J</i> = 7.9 Hz, 1H), 8.08 (d, <i>J</i> = 15.6 Hz, 1H), 8.07 (d, <i>J</i> = 8.7 Hz, 2H), 7.87 (d, <i>J</i> = 7.8 Hz, 1H), 7.85 (d, <i>J</i> = 15.6 Hz, 1H), 7.71 (t, <i>J</i> = 7.8 Hz, 1H), 6.80 (bs, 2H). MS (ESI): <i>m</i>/<i>z</i> 311 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 98%.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>E</i>)-4-(3-(3-Cyanophenyl)acryloyl)-<i>N</i>,<i>N</i>-dimethylbenzenesulfonamide (<b>14</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 312 mg, 2.2 mmol), <b>3c</b> (100 mg, 0.44 mmol), and 3-cyanobenzaldehyde (115 mg, 0.88 mmol) to obtain <b>14</b> as a light-beige solid (102 mg, 68%) after extraction and crystallization from EtOH. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.16 (d, <i>J</i> = 8.1 Hz, 2H), 7.95 (s, 1H), 7.94 (d, <i>J</i> = 8.4 Hz, 2H), 7.87 (d, <i>J</i> = 8.1 Hz, 1H), 7.81 (d, <i>J</i> = 15.9 Hz, 1H), 7.73 (d, <i>J</i> = 7.8 Hz, 1H), 7.58 (t, <i>J</i> = 8.1 Hz, 1H), 7.55 (d, <i>J</i> = 15.9 Hz, 1H), 2.77 (s, 6H). MS (ESI): <i>m</i>/<i>z</i> 363 (M + Na)<sup>+</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>E</i>)-4-(3-(3-Cyanophenyl)acryloyl)-<i>N</i>,<i>N</i>-diethylbenzenesulfonamide (<b>15</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 278 mg, 2.0 mmol), <b>3d</b> (100 mg, 0.39 mmol), and 3-cyanobenzaldehyde (102 mg, 0.78 mmol) to obtain <b>15</b> as an ivory solid (67 mg, 47%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 5:1, 3:1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 8.12 (d, <i>J</i> = 8.4 Hz, 2H), 7.96 (d, <i>J</i> = 8.8 Hz, 2H), 7.94 (s, 1H), 7.86 (d, <i>J</i> = 8.0 Hz, 1H), 7.80 (d, <i>J</i> = 16.0 Hz, 1H), 7.72 (dt, <i>J</i> = 7.6, 1.2 Hz, 1H), 7.58 (t, <i>J</i> = 7.6 Hz, 1H), 7.54 (d, <i>J</i> = 15.6 Hz, 1H), 3.30 (q, <i>J</i> = 7.2 Hz, 4H), 1.16 (t, <i>J</i> = 6.8 Hz, 6H). MS (ESI): <i>m</i>/<i>z</i> 369 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 99%.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>E</i>)-4-(3-(3-Cyanophenyl)acryloyl)-<i>N</i>,<i>N</i>-dipropylbenzenesulfonamide (<b>16</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 250 mg, 1.8 mmol), <b>3e</b> (100 mg, 0.35 mmol), and 3-cyanobenzaldehyde (93 mg, 0.71 mmol) to obtain <b>16</b> as an ivory solid (67 mg, 47%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 10:1, 5:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.12 (dt, <i>J</i> = 8.7, 1.8 Hz, 2H), 7.99–7.93 (m, 3H), 7.86 (dt, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.80 (d, <i>J</i> = 15.7 Hz, 1H), 7.72 (dt, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.58 (t, <i>J</i> = 7.8 Hz, 1H), 7.55 (d, <i>J</i> = 15.9 Hz, 1H), 3.18–3.08 (m, 4H), 1.57 (d, <i>J</i> = 7.5 Hz, 4H), 0.89 (t, <i>J</i> = 7.5 Hz, 6H). MS (ESI): <i>m</i>/<i>z</i> 397 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 98%.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>E</i>)-<i>N</i>,<i>N</i>-Dibutyl-4-(3-(3-cyanophenyl)acryloyl)benzenesulfonamide (<b>17</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 342 mg, 2.4 mmol), <b>3f</b> (150 mg, 0.48 mmol), and 3-cyanobenzaldehyde (126 mg, 0.96 mmol) to obtain <b>17</b> as an off-white solid (116 mg, 57%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 5:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.12 (d, <i>J</i> = 8.3 Hz, 2H), 7.99–7.92 (m, 3H), 7.86 (d, <i>J</i> = 8.0 Hz, 1H), 7.80 (d, <i>J</i> = 15.7 Hz, 1H), 7.72 (d, <i>J</i> = 7.6 Hz, 1H), 7.58 (t, <i>J</i> = 8.1 Hz, 1H), 7.55 (d, <i>J</i> = 15.9 Hz, 1H), 3.16 (t, <i>J</i> = 7.5 Hz, 4H), 1.56–1.45 (m, 4H), 1.30 (sextet, <i>J</i> = 7.5 Hz, 4H), 0.91 (t, <i>J</i> = 7.3 Hz, 6H). MS (ESI): <i>m</i>/<i>z</i> 425 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>E</i>)-4-(3-(3-Cyanophenyl)acryloyl)-<i>N</i>,<i>N</i>-dipentylbenzenesulfonamide (<b>18</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 209 mg, 1.47 mmol), <b>3g</b> (100 mg, 0.29 mmol), and 3-cyanobenzaldehyde (77 mg, 0.59 mmol) to obtain <b>18</b> as a white solid (44 mg, 33%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 10:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.12 (d, <i>J</i> = 8.1 Hz, 2H), 7.99–7.92 (m, 3H), 7.86 (d, <i>J</i> = 8.0 Hz, 1H), 7.80 (d, <i>J</i> = 15.7 Hz, 1H), 7.72 (d, <i>J</i> = 7.8 Hz, 1H), 7.57 (t, <i>J</i> = 7.8 Hz, 1H), 7.59–7.50 (m, 1H), 3.21–3.09 (m, 3H), 3.06–2.91 (m, 1H), 1.71–1.39 (m, 4H), 1.42–1.06 (m, 6H), 0.92–0.84 (m, 8H). MS (ESI): <i>m</i>/<i>z</i> 453 (M + H)<sup>+</sup>. HPLC (mobile phase B): purity 98%.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>E</i>)-4-(3-(3-Cyanophenyl)acryloyl)-<i>N</i>-cyclopropylbenzenesulfonamide (<b>19</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 296 mg, 2.09 mmol), <b>3h</b> (100 mg, 0.42 mmol), and 3-cyanobenzaldehyde (109 mg, 0.84 mmol) to obtain <b>19</b> as an off-white solid (16 mg, 11%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.52 (s, 1H), 8.38 (d, <i>J</i> = 7.9 Hz, 2H), 8.22 (d, <i>J</i> = 7.8 Hz, 1H), 8.14 (s, 1H), 8.14 (d, <i>J</i> = 15.6 Hz, 1H), 7.99 (d, <i>J</i> = 8.0 Hz, 2H), 7.93 (d, <i>J</i> = 7.1 Hz, 1H), 7.82 (d, <i>J</i> = 15.8 Hz, 1H), 7.69 (t, <i>J</i> = 7.8 Hz, 1H), 2.16 (bs, 1H), 0.55–0.36 (m, 4H). MS (ESI): <i>m</i>/<i>z</i> 351 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 95%.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>E</i>)-4-(3-(3-Cyanophenyl)acryloyl)-<i>N</i>-phenylbenzenesulfonamide (<b>20</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 258 mg, 1.82 mmol), <b>3i</b> (100 mg, 0.36 mmol), and 3-cyanobenzaldehyde (95 mg, 0.73 mmol) to obtain <b>20</b> as a light-yellow solid (35 mg, 25%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 5:1, 3:1). <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>) δ: 9.17 (bs, 1H), 8.34 (s, 1H), 8.28 (d, <i>J</i> = 8.2 Hz, 2H), 8.17 (d, <i>J</i> = 7.9 Hz, 1H), 8.05 (d, <i>J</i> = 15.8 Hz, 1H), 7.97 (d, <i>J</i> = 8.1 Hz, 2H), 7.88–7.81 (m, 2H), 7.71 (t, <i>J</i> = 7.7 Hz, 1H), 7.32–7.24 (m, 4H), 7.13 (t, <i>J</i> = 6.1 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 387 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>E</i>)-3-(3-(4-Fluoro-2-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>21</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 688 mg, 4.9 mmol), 4′-fluoro-2′-hydroxyacetophenone (150 mg, 0.97 mmol), and 3-cyanobenzaldehyde (256 mg, 2.0 mmol) to obtain <b>21</b> as a yellow solid (48 mg, 19%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 5:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 12.99 (s, 1H), 7.95–7.85 (m, 4H), 7.72 (d, <i>J</i> = 7.5 Hz, 1H), 7.64–7.55 (m, 2H), 6.75–6.66 (m, 2H). MS (ESI): <i>m</i>/<i>z</i> 266 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 97%.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>E</i>)-3-(3-(4-Fluoro-3-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>22</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 426 mg, 3.0 mmol), 4′-fluoro-3′-hydroxyacetophenone (94 mg, 0.60 mmol), and 3-cyanobenzaldehyde (162 mg, 1.2 mmol) to obtain <b>22</b> as a yellow solid (42 mg, 25%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.32 (s, 1H), 8.49 (s, 1H), 8.18 (d, <i>J</i> = 7.7 Hz, 1H), 8.05 (d, <i>J</i> = 15.7 Hz, 1H), 7.89 (d, <i>J</i> = 7.6 Hz, 1H), 7.80–7.63 (m, 4H), 7.38–7.32 (m, 1H). MS (ESI): <i>m</i>/<i>z</i> 266 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 98%.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>E</i>)-3-(3-(3-Fluoro-4-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>23</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 852 mg, 6.0 mmol), 3′-fluoro-4′-hydroxyacetophenone (189 mg, 1.2 mmol), and 3-cyanobenzaldehyde (325 mg, 2.4 mmol) to obtain <b>23</b> as a pink solid (228 mg, 71%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 1:1, EtOAc). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.49 (s, 1H), 8.17 (d, <i>J</i> = 7.9 Hz, 1H), 8.08 (d, <i>J</i> = 15.6 Hz, 1H), 8.03 (d, <i>J</i> = 12.3 Hz, 1H), 7.94 (d, <i>J</i> = 8.6 Hz, 1H), 7.88 (d, <i>J</i> = 7.6 Hz, 1H), 7.71 (d, <i>J</i> = 15.8 Hz, 1H), 7.70–7.65 (t, <i>J</i> = 7.8 Hz, 1H), 7.10 (t, <i>J</i> = 8.6 Hz, 1H), 3.56 (s, 1H). MS (ESI): <i>m</i>/<i>z</i> 266 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 95%.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>E</i>)-3-(3-(4-Hydroxy-3-(trifluoromethyl)phenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>24</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 426 mg, 3.0 mmol), 4′-hydroxy-3′-(trifluoromethyl)acetophenone (125 mg, 0.60 mmol), and 3-cyanobenzaldehyde (158 mg, 1.2 mmol) to obtain <b>24</b> as a white solid (54 mg, 32%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.50 (s, 1H), 8.36 (d, <i>J</i> = 8.8 Hz, 1H), 8.33 (s, 1H), 8.20 (d, <i>J</i> = 7.9 Hz, 1H), 8.13 (d, <i>J</i> = 15.6 Hz, 1H), 7.90 (d, <i>J</i> = 7.7 Hz, 1H), 7.76 (d, <i>J</i> = 15.6 Hz, 1H), 7.67 (t, <i>J</i> = 7.8 Hz, 1H), 7.19 (d, <i>J</i> = 8.6 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 316 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 100%.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (<i>E</i>)-3-(3-(3-Hydroxy-4-methoxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>25</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 852 mg, 6.0 mmol), 3′-hydroxy-4′-methoxyacetophenone (200 mg, 1.2 mmol), and 3-cyanobenzaldehyde (315 mg, 2.4 mmol) to obtain <b>25</b> as a yellow solid (233 mg, 70%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.40 (s, 1H), 8.47 (s, 1H), 8.17 (d, <i>J</i> = 8.0 Hz, 1H), 8.05 (d, <i>J</i> = 15.6 Hz, 1H), 7.88 (dd, <i>J</i> = 7.6, 1.2 Hz, 1H), 7.80 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.68 (d, <i>J</i> = 15.6 Hz, 1H), 7.65 (t, <i>J</i> = 7.6 Hz, 1H), 7.55 (d, <i>J</i> = 2.0 Hz, 1H), 7.07 (d, <i>J</i> = 8.4 Hz, 1H), 3.89 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 280 (M + H)<sup>+</sup>, 278 (M – H)<sup>−</sup>. HPLC (mobile phase B): purity 95%.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (<i>E</i>)-3-(3-(4-Hydroxy-3-methoxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>26</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 853 mg, 6.0 mmol), 4′-hydroxy-3′-methoxyacetophenone (200 mg, 1.2 mmol), and 3-cyanobenzaldehyde (315 mg, 2.4 mmol) to obtain <b>26</b> as a yellow solid (240 mg, 72%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.11 (s, 1H), 8.47 (s, 1H), 8.18 (d, <i>J</i> = 7.6 Hz, 1H), 8.08 (d, <i>J</i> = 15.6 Hz, 1H), 7.88–7.83 (m, 2H), 7.69 (d, <i>J</i> = 15.6 Hz, 1H), 7.65–7.63 (m, 2H), 6.92 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 3.88 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 280 (M + H)<sup>+</sup>, 278 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 97%.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (<i>E</i>)-3-(3-(3,4-Dimethoxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>27</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>3a</b> was used with <b>25</b> (60 mg, 0.22 mmol), methyl iodide (33 mg, 0.24 mmol), and potassium carbonate (89 mg, 0.64 mmol) to obtain <b>27</b> as a yellow solid (57 mg, 90%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.48 (s, 1H), 8.19 (d, <i>J</i> = 7.6 Hz, 1H), 8.11 (d, <i>J</i> = 15.6 Hz, 1H), 7.96 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.89 (d, <i>J</i> = 8.0 Hz, 1H), 7.72 (d, <i>J</i> = 15.6 Hz, 1H), 7.66 (t, <i>J</i> = 8.0 Hz, 1H), 7.62 (d, <i>J</i> = 2.0 Hz, 1H), 7.12 (d, <i>J</i> = 8.4 Hz, 1H), 3.88 (s, 3H), 3.86 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 294 (M + H)<sup>+</sup>. HPLC (mobile phase B): purity 98%.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (<i>E</i>)-3-(3-(4-Chloro-3-fluorophenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>28</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 852 mg, 6.0 mmol), 4′-chloro-3′-fluoroacetophenone (214 mg, 1.2 mmol), and 3-cyanobenzaldehyde (325 mg, 2.4 mmol) to obtain <b>28</b> as a yellowish-green solid (145 mg, 42%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 5:1, 4:1, 3:1, EtOAc). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.53 (s, 1H), 8.27–8.21 (m, 2H), 8.12 (d, <i>J</i> = 15.6 Hz, 1H), 8.06 (d, <i>J</i> = 8.7 Hz, 1H), 7.93 (d, <i>J</i> = 7.5 Hz, 1H), 7.94–7.79 (m, 2H), 7.69 (t, <i>J</i> = 7.9 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 284 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 99.7%.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (<i>E</i>)-3-(3-Oxo-3-(pyrazin-2-yl)prop-1-en-1-yl)benzonitrile (<b>29</b>)</h4><div class="NLM_p last">2-Acetyl pyrazine (150 mg, 1.2 mmol) and 3-cyanobenzaldehyde (161 mg, 1.2 mmol) were dissolved in pyridine (1 mL). Diethylamine (0.13 mL, 1.2 mmol) was added into the reaction mixture, and the resulting mixture was heated at 80–120 °C for 2 h. After cooling, the reaction residue was poured into ice–water and acidified to pH 3 using a few drops of acetic acid. The precipitate that formed was filtered off and crystallized from EtOH to obtain <b>29</b> as an ivory solid (107 mg, 37%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.39 (s, 1H), 8.81 (d, <i>J</i> = 2.4 Hz, 1H), 8.72 (bs, 1H), 8.25 (d, <i>J</i> = 16.2 Hz, 1H), 8.01 (s, 1H), 7.94–7.89 (m, 2H), 7.71 (d, <i>J</i> = 7.8 Hz, 1H), 7.57 (t, <i>J</i> = 7.8 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 236 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (<i>E</i>)-<i>N</i>-(4-(3-(3-Cyanophenyl)acryloyl)phenyl)-4-nitrobenzenesulfonamide (<b>30</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with <b>3j</b> (100 mg, 0.31 mmol), boron trifluoride etherate (48% BF<sub>3</sub>, 222 mg, 1.6 mmol), and 3-cyanobenzaldehyde (81 mg, 0.62 mmol) to obtain <b>30</b> as a yellowish solid (46 mg, 34%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1) followed by recrystallization from EtOH. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.24 (s, 1H), 8.46 (s, 1H), 8.40 (d, <i>J</i> = 8.7 Hz, 2H), 8.15 (d, <i>J</i> = 8.6 Hz, 1H), 8.11 (d, <i>J</i> = 8.7 Hz, 2H), 8.10 (d, <i>J</i> = 8.7 Hz, 2H), 8.03 (d, <i>J</i> = 15.7 Hz, 1H), 7.89 (d, <i>J</i> = 7.8 Hz, 1H), 7.69 (d, <i>J</i> = 15.6 Hz, 1H), 7.66 (d, <i>J</i> = 8.1 Hz, 1H), 7.29 (d, <i>J</i> = 8.6 Hz, 2H). MS (ESI): <i>m</i>/<i>z</i> 432 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 95%.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (<i>E</i>)-(4-(3-(3-Cyanophenyl)acryloyl)phenyl)boronic acid (<b>31</b>)</h4><div class="NLM_p last">To a solution of <b>10</b> (150 mg, 0.48 mmol) in 1,4-dioxane (10 mL) were added bis(pinacolato)diboron (243 mg, 0.96 mmol), PdCl<sub>2</sub>(dppf) (35 mg, 0.048 mmol), and potassium acetate (141 mg, 1.44 mmol), and the mixture was heated to reflux under N<sub>2</sub> (<i>g</i>) overnight. After cooling to room temperature, the reaction mixture was filtered through Celite and washed with EtOAc. The filtrate was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The resulting residue was purified by column chromatography (<i>n</i>-hexane:EtOAc = 5:1) to obtain the intermediate as an ivory solid (116 mg, 67%). The intermediate (<b>31a</b>, 100 mg, 0.278 mmol) was immediately added to a solution of THF (1 mL) and H<sub>2</sub>O (1 mL) at room temperature. To the mixture was added NaIO<sub>4</sub> (178 mg, 0.835 mmol), and the reaction mixture was stirred at room temperature for 1 h. To the resulting slurry was added 1 N HCl, and the mixture was allowed to stir for 4 h. Then, the residue was transferred to a separating funnel, and the product was extracted from the aqueous mixture with EtOAc. The combined organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude solid was purified by trituration with hexane followed by crystallization from DCM to obtain <b>31</b> as an ivory solid (24 mg, 31%). <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>) δ: 8.37 (s, 1H), 8.20–8.16 (m, 3H), 8.11 (d, <i>J</i> = 15.7 Hz, 1H), 8.06 (d, <i>J</i> = 8.2 Hz, 2H), 7.88–7.80 (m, 2H), 7.72 (t, <i>J</i> = 7.8 Hz, 1H), 7.47 (s, 1H). HPLC (mobile phase A + FA): purity 95%.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (<i>E</i>)-3-(3-oxo-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)prop-1-en-1-yl)benzonitrile (<b>31a</b>, the intermediate)</h4><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.00 (d, <i>J</i> = 8.2 Hz, 2H), 7.96–7.93 (m, 3H), 7.85 (d, <i>J</i> = 7.9 Hz, 1H), 7.76 (d, <i>J</i> = 15.8 Hz, 1H), 7.69 (d, <i>J</i> = 7.7 Hz, 1H), 7.58 (d, <i>J</i> = 16.2 Hz, 1H), 7.55 (d, <i>J</i> = 7.5 Hz, 1H), 1.37 (s, 12H). MS (ESI): <i>m</i>/<i>z</i> 360 (M + H)<sup>+</sup>.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (<i>E</i>)-4-(3-(4-Hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>32</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 781 mg, 5.5 mmol), 4′-hydroxyacetophenone (150 mg, 1.1 mmol), and 4-cyanobenzaldehyde (288 mg, 2.2 mmol) to obtain <b>32</b> as an ivory solid (115 mg, 42%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, EtOAc). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.51 (bs, 1H), 8.11–8.05 (m, 5H), 7.92 (d, <i>J</i> = 8.1 Hz, 2H), 7.71 (d, <i>J</i> = 15.6 Hz, 1H), 6.91 (d, <i>J</i> = 8.7 Hz, 2H). MS (ESI): <i>m</i>/<i>z</i> 248 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (<i>E</i>)-4-(3-(4-Fluoro-2-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>33</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 688 mg, 4.9 mmol), 4′-fluoro-2′-hydroxyacetophenone (150 mg, 0.97 mmol), and 4-cyanobenzaldehyde (256 mg, 2.0 mmol) to obtain <b>33</b> as a yellow solid (50 mg, 19%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 5:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 12.98 (s, 1H), 7.95–7.86 (m, 2H), 7.74 (bs, 4H), 7.64 (d, <i>J</i> = 15.3 Hz, 1H), 6.75–6.66 (m, 2H). MS (ESI): <i>m</i>/<i>z</i> 266 (M – H)<sup>−</sup>. HPLC (mobile phase B): purity 98%.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (<i>E</i>)-4-(3-(4-Fluoro-3-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>34</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 426 mg, 3.0 mmol), 4′-fluoro-3′-hydroxyacetophenone (94 mg, 0.60 mmol), and 4-cyanobenzaldehyde (120 mg, 0.90 mmol) to obtain <b>34</b> as a yellow solid (106 mg, 66%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.33 (s, 1H), 8.10–8.01 (m, 3H), 7.93 (d, <i>J</i> = 8.1 Hz, 2H), 7.76–7.67 (m, 3H), 7.35 (dd, <i>J</i> = 10.6, 8.8 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 266 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (<i>E</i>)-4-(3-(3-Fluoro-4-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>35</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 426 mg, 6.0 mmol), 3′-acetophenone (248 mg, 1.2 mmol), and 3-cyanobenzaldehyde (325 mg, 2.4 mmol) to obtain <b>35</b> as a pink solid (43 mg, 27%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.51 (d, <i>J</i> = 8.4 Hz, 2H), 8.49 (d, <i>J</i> = 16.0 Hz, 1H), 8.44 (dd, <i>J</i> = 12.4, 2.0 Hz, 1H), 8.35 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 8.34 (d, <i>J</i> = 8.4 Hz, 2H), 8.15 (d, <i>J</i> = 15.6 Hz, 1H), 7.52 (t, <i>J</i> = 8.6 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 266 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 99%.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (<i>E</i>)-4-(3-(4-Hydroxy-3-(trifluoromethyl)phenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>36</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 170 mg, 1.2 mmol), 4′-hydroxy-3′-(trifluoromethyl)acetophenone (50 mg, 0.20 mmol), and 4-cyanobenzaldehyde (65 mg, 0.50 mmol) to obtain <b>36</b> as a light-green solid (70 mg, 92%) after filtration and recrystallization from MeOH. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.35–8.32 (m, 2H), 8.14–8.10 (m, 3H), 7.94–7.92 (m, 2H), 7.76 (d, <i>J</i> = 15.6 Hz, 1H), 7.16 (d, <i>J</i> = 8.4 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 316 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 97%.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> (<i>E</i>)-3-(3-(3-Hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzoic acid (<b>37</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 1.0 g, 7.4 mmol), 3-hydroxyacetophenone (200 mg, 1.5 mmol), and 3-carboxybenzaldehyde (441 mg, 2.9 mmol) to obtain <b>37</b> as a yellow solid (156 mg, 40%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 1:1, EtOAc). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.36 (s, 1H), 8.14 (d, <i>J</i> = 7.6 Hz, 1H), 8.00 (d, <i>J</i> = 8.0 Hz, 1H), 7.92 (d, <i>J</i> = 16.0 Hz, 1H), 7.77 (d, <i>J</i> = 15.6 Hz, 1H), 7.66 (d, <i>J</i> = 8.0 Hz, 1H), 7.59 (t, <i>J</i> = 8.0 Hz, 1H), 7.48 (t, <i>J</i> = 2.0 Hz, 1H), 7.38 (t, <i>J</i> = 8.0 Hz, 1H), 7.06 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 269 (M + H)<sup>+</sup>, 267 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 100%.</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> (<i>E</i>)-3-(3-(4-Nitrophenyl)-3-oxoprop-1-en-1-yl)benzoic Acid (<b>38</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 852 mg, 6.0 mmol), <i>p</i>-nitroacetophenone (198 mg, 1.2 mmol), and 3-carboxybenzaldehyde (360 mg, 2.4 mmol) to obtain <b>38</b> as a yellow solid (203 mg, 57%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.43 (s, 1H), 8.39 (s, 4H), 8.17 (d, <i>J</i> = 8.4 Hz, 1H), 8.05 (d, <i>J</i> = 15.6 Hz, 1H), 8.03 (d, <i>J</i> = 7.5 Hz, 1H), 7.86 (d, <i>J</i> = 15.6 Hz, 1H), 7.62 (t, <i>J</i> = 7.8 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 296 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 99%.</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> (<i>E</i>)-3-(3-(4-Aminophenyl)-3-oxoprop-1-en-1-yl)benzoic Acid (<b>39</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>8</b> was used with 4′-aminoacetophenone (200 mg, 1.5 mmol) and 3-carboxybenzaldehyde (225 mg, 1.5 mmol) to obtain <b>39</b> as an orange solid (233 mg, 70%) after neutralization using 10% HCl and purification by column chromatography (<i>n</i>-hexane:EtOAc = 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.91 (s, 1H), 8.69 (d, <i>J</i> = 7.8 Hz, 1H), 8.59–8.48 (m, 4H), 8.25 (d, <i>J</i> = 15.6 Hz, 1H), 8.16 (t, <i>J</i> = 7.8 Hz, 1H), 7.22 (d, <i>J</i> = 8.7 Hz, 2H), 6.77 (s, 2H). MS (ESI): <i>m</i>/<i>z</i> 268 (M + H)<sup>+</sup>, 266 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 99%.</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> (<i>E</i>)-3-(3-(4-Morpholinophenyl)-3-oxoprop-1-en-1-yl)benzoic Acid (<b>40</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 678 mg, 4.8 mmol), 4-morpholinoacetophenone (200 mg, 1.0 mmol), and 3-carboxybenzaldehyde (287 mg, 1.9 mmol) to obtain <b>40</b> as a yellow solid (112 mg, 33%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 13.14 (s, 1H), 8.35 (d, <i>J</i> = 1.2 Hz, 1H), 8.14 (d, <i>J</i> = 8.0 Hz, 1H), 8.11 (d, <i>J</i> = 8.0 Hz, 2H), 8.02 (dd, <i>J</i> = 10.0, 1.2 Hz, 1H), 8.01 (d, <i>J</i> = 15.6 Hz, 1H), 7.72 (d, <i>J</i> = 15.6, 1H), 7.59 (t, <i>J</i> = 7.6 Hz, 1H), 7.04 (d, <i>J</i> = 8.0 Hz, 2H), 3.75 (t, <i>J</i> = 4.0 Hz, 4H), 3.34 (t, <i>J</i> = 4.0 Hz, 4H). MS (ESI): <i>m</i>/<i>z</i> 338 (M + H)<sup>+</sup>, 336 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 98%.</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (<i>E</i>)-3-(3-Oxo-3-(4-(piperidin-1-yl) phenyl)prop-1-en-1-yl)benzoic Acid (<b>41</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 852 mg, 6.0 mmol), piperidinoacetophenone (248 mg, 1.2 mmol), and 3-carboxybenzaldehyde (360 mg, 2.4 mmol) to obtain <b>41</b> as a yellowish-green solid (142 mg, 35%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.41 (s, 1H), 8.13 (d, <i>J</i> = 7.6 Hz, 1H), 8.01 (d, <i>J</i> = 8.9 Hz, 2H), 7.85 (d, <i>J</i> = 5.7 Hz, 1H), 7.83 (t, <i>J</i> = 15.6 Hz,, 1H), 7.66 (d, <i>J</i> = 15.6 Hz, 1H), 7.54 (s, 1H), 7.26 (s, 1H), 6.91 (d, <i>J</i> = 8.9 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 336 (M + H)<sup>+</sup>, 334 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 98%.</div></div><div id="sec4_3_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> (<i>E</i>)-3-(3-(3-Hydroxy-4-methoxyphenyl)-3-oxoprop-1-en-1-yl)benzoic Acid (<b>42</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 852 mg, 6.0 mmol), 3-hydroxy-4-methoxyacetophenone (200 mg, 1.2 mmol), and 3-carboxybenzaldehyde (360 mg, 2.4 mmol) to obtain <b>42</b> as a white solid (158 mg, 44%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.34 (s, 1H), 8.11 (d, <i>J</i> = 8.0 Hz, 1H), 8.00 (d, <i>J</i> = 7.6 Hz, 1H), 7.94 (d, <i>J</i> = 15.6 Hz, 1H), 7.78 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.72 (d, <i>J</i> = 15.6 Hz, 1H), 7.58 (t, <i>J</i> = 7.6 Hz, 1H), 7.55 (d, <i>J</i> = 2.0 Hz, 1H), 7.06 (d, <i>J</i> = 7.6 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 299 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 99%.</div></div><div id="sec4_3_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> (<i>E</i>)-3-(3-(3-Fluoro-4-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzoic Acid (<b>43</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 426 mg, 3.0 mmol), 3′-fluoro-4′-hydroxyacetophenone (94 mg, 0.60 mmol), and 3-carboxybenzaldehyde (140 mg, 0.90 mmol) to obtain <b>43</b> as a pink solid (42 mg, 25%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.38 (s, 1H), 8.13 (d, <i>J</i> = 7.5 Hz, 1H), 8.04–7.94 (m, 4H), 7.75 (d, <i>J</i> = 15.5 Hz, 1H), 7.58 (t, <i>J</i> = 7.7 Hz, 1H), 7.10 (t, <i>J</i> = 8.5 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 287 (M + H)<sup>+</sup>, 285 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 98%.</div></div><div id="sec4_3_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (<i>E</i>)-3-(3-(4-Hydroxy-3-(trifluoromethyl)phenyl)-3-oxoprop-1-en-1-yl)benzoic Acid (<b>44</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 215 mg, 1.5 mmol), 4′-hydroxy-3′-(trifluoromethyl)acetophenone (60 mg, 0.30 mmol), and 3-carboxybenzaldehyde (70 mg, 0.50 mmol) to obtain <b>44</b> as a light-yellow solid (46 mg, 46%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 2:1, 1:1, EtOAc). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.38–8.31 (m, 3H), 8.16 (d, <i>J</i> = 7.6 Hz, 1H), 8.05 (d, <i>J</i> = 15.9 Hz, 1H), 7.99 (d, <i>J</i> = 8.0 Hz, 1H), 7.79 (d, <i>J</i> = 15.6 Hz, 1H), 7.59 (t, <i>J</i> = 7.5 Hz, 1H), 7.17 (d, <i>J</i> = 8.7 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 387 (M + H)<sup>+</sup>, 385 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 99%.</div></div><div id="sec4_3_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (<i>E</i>)-3-(3-(4-((4-Nitrophenyl)sulfonamido)phenyl)-3-oxoprop-1-en-1-yl)benzoic Acid (<b>45</b>)</h4><div class="NLM_p last">NaOH (6 mg, 0.26 mmol) was added to a solution of <b>53</b> (60 mg, 0.13 mmol) in a mixture of THF:H<sub>2</sub>O (1:1, 10 mL), and the reaction mixture was stirred at room temperature overnight. The solution was acidified with 2 M HCl (aq) and extracted with EtOAc. The organic layer was washed with brine and concentrated. The crude solid was dissolved in saturated NaHCO<sub>3</sub> (aq) and extracted with EtOAc. The water layer was acidified with acetic acid, and the formed precipitate was filtered off to obtain <b>45</b> as a yellow solid (50 mg, 86%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.26–8.19 (m, 3H), 7.99–7.89 (m, 4H), 7.84 (d, <i>J</i> = 16.5 Hz, 1H), 7.82 (d, <i>J</i> = 8.4 Hz, 2H), 7.60 (d, <i>J</i> = 15.5 Hz, 1H), 7.45 (t, <i>J</i> = 7.7 Hz, 1H), 6.88 (d, <i>J</i> = 8.6 Hz, 2H). MS (ESI): <i>m</i>/<i>z</i> 451 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 99%.</div></div><div id="sec4_3_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Methyl-(<i>E</i>)-3-(3-(3-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzoate (<b>46</b>)</h4><div class="NLM_p last"><b>37</b> (50 mg, 0.19 mmol) was dissolved in dry MeOH (4 mL), a catalytic amount of sulfuric acid (3 drops) was added, and the reaction mixture was refluxed overnight. After cooling to room temperature, the residue was neutralized with 2N NaOH, concentrated in vacuo, and dissolved in EtOAc. The organic layer was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give the crude product. The crude product was further crystallized from EtOH to give <b>46</b> as an off-white solid (13 mg, 25%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.82 (s, 1H), 8.39 (s, 1H), 8.19 (d, <i>J</i> = 7.7 Hz, 1H), 8.02 (d, <i>J</i> = 7.8 Hz, 1H), 7.96 (d, <i>J</i> = 15.9 Hz, 1H), 7.78 (d, <i>J</i> = 15.8 Hz, 1H), 7.70–7.58 (m, 2H), 7.49 (s, 1H), 7.39 (t, <i>J</i> = 7.9 Hz, 1H), 7.08 (d, <i>J</i> = 7.8 Hz, 1H), 3.90 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 283 (M + H)<sup>+</sup>, 281 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Methyl-(<i>E</i>)-3-(3-(4-hydroxyphenyl)-3-oxoprop-1-en-1-yl)benzoate (<b>47</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 521 mg, 3.67 mmol), 4-hydroxyacetophenone (100 mg, 0.73 mmol), and <b>4a</b> (241 mg, 1.47 mmol) to obtain <b>47</b> as a light-yellow solid (125 mg, 60%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.34 (s, 1H), 8.07 (d, <i>J</i> = 8.0 Hz, 1H), 8.03 (d, <i>J</i> = 8.5 Hz, 2H), 7.85–7.78 (m, 2H), 7.61 (d, <i>J</i> = 15.7 Hz, 1H), 7.51 (t, <i>J</i> = 7.7 Hz, 1H), 6.95 (d, <i>J</i> = 8.6 Hz, 2H), 5.72 (bs, 1H), 3.97 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 283 (M + H)<sup>+</sup>, 281 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 97%.</div></div><div id="sec4_3_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Methyl-(<i>E</i>)-3-(3-(3-hydroxy-4-methoxyphenyl)-3-oxoprop-1-en-1-yl)benzoate (<b>48</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 427 mg, 3.01 mmol), 3-hydroxy-4-methoxyacetophenone (100 mg, 0.60 mmol), and <b>4a</b> (197 mg, 1.20 mmol) to obtain <b>48</b> as a yellow solid (10 mg, 5%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 1:1) followed by crystallization from DCM. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.46 (bs, 1H), 8.37 (s, 1H), 8.18 (d, <i>J</i> = 7.9 Hz, 1H), 8.01 (dt, <i>J</i> = 7.8, 1.2 Hz, 1H), 7.98 (d, <i>J</i> = 15.6 Hz, 1H), 7.80 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.73 (d, <i>J</i> = 15.6 Hz, 1H), 7.61 (t, <i>J</i> = 7.8 Hz, 1H), 7.54 (d, <i>J</i> = 2.2 Hz, 1H), 7.07 (d, <i>J</i> = 8.5 Hz, 1H), 3.90 (s, 3H), 3.88 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 311 (M – H)<sup>−</sup>. HPLC (mobile phase B): purity 95%.</div></div><div id="sec4_3_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Methyl-(<i>E</i>)-3-(3-(4-hydroxy-3-(trifluoromethyl)phenyl)-3-oxoprop-1-en-1-yl)benzoate (<b>49</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 348 mg, 2.50 mmol), 4′-hydroxy-3′-(trifluoromethyl)acetophenone (100 mg, 0.49 mmol), and <b>4a</b> (160 mg, 0.98 mmol) to obtain <b>49</b> as an off-white solid (17 mg, 10%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1) and further crystallization from EtOAc. <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>) δ: 10.32 (bs, 1H), 8.40 (s, 2H), 8.34 (d, <i>J</i> = 8.9 Hz, 1H), 8.16–7.98 (m, 3H), 7.86 (d, <i>J</i> = 15.5 Hz, 1H), 7.61 (t, <i>J</i> = 7.6 Hz, 1H), 7.25 (d, <i>J</i> = 78.2 Hz, 1H), 3.93 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 349 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 99%.</div></div><div id="sec4_3_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> (<i>E</i>)-3-(3-(3-Bromo-4-(hydroxymethyl)phenyl)-3-oxoprop-1-en-1-yl)benzonitrile (<b>50</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 216 mg, 1.525 mmol), <b>3n</b> (70 mg, 0.305 mmol), and <b>4a</b> (100 mg, 0.61 mmol) to obtain <b>50</b> as a white solid (5 mg, 4%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 5:1, 3:1) followed by crystallization from DCM. <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>) δ: 8.44 (s, 1H), 8.33 (s, 1H), 8.24 (dd, <i>J</i> = 8.1, 1.7 Hz, 1H), 8.15 (d, <i>J</i> = 7.8 Hz, 1H), 8.10–8.03 (m, 2H), 7.89 (d, <i>J</i> = 15.5 Hz, 1H), 7.84 (d, <i>J</i> = 8.1 Hz, 1H), 7.64 (t, <i>J</i> = 7.8 Hz, 1H), 4.77 (s, 2H), 3.94 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 377 (M + H)<sup>+</sup>, 375 (M + H)<sup>+</sup>. HPLC (mobile phase A + FA): purity 98%.</div></div><div id="sec4_3_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Methyl-(<i>E</i>)-3-(3-(4-(<i>N</i>,<i>N</i>-dipropylsulfamoyl)phenyl)-3-oxoprop-1-en-1-yl)benzoate (<b>51</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 250 mg, 1.76 mmol), <b>3e</b> (100 mg, 0.35 mmol), and <b>4a</b> (116 mg, 0.71 mmol) to obtain <b>51</b> as a light-yellow solid (12 mg, 8%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 10:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.35 (s, 1H), 8.16–8.08 (m, 3H), 7.95 (d, <i>J</i> = 8.4 Hz, 2H), 7.86 (d, <i>J</i> = 16.0 Hz, 1H), 7.85–7.79 (m, 1H), 7.57 (d, <i>J</i> = 15.9 Hz, 1H), 7.53 (t, <i>J</i> = 7.8 Hz, 1H), 3.97 (s, 3H), 3.13 (t, <i>J</i> = 7.5 Hz, 4H), 1.57 (sextet, <i>J</i> = 7.5 Hz, 4H), 0.89 (t, <i>J</i> = 7.5 Hz, 6H). MS (ESI): <i>m</i>/<i>z</i> 430 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 98%.</div></div><div id="sec4_3_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Methyl-(<i>E</i>)-3-(3-(4-(<i>N</i>,<i>N</i>-dibutylsulfamoyl)phenyl)-3-oxoprop-1-en-1-yl)benzoate (<b>52</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 228 mg, 1.61 mmol), <b>3f</b> (100 mg, 0.32 mmol), and <b>4a</b> (105 mg, 0.64 mmol) to obtain <b>52</b> as an off-white solid (22 mg, 15%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 10:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.35 (s, 1H), 8.14–8.09 (m, 3H), 7.95 (d, <i>J</i> = 8.1 Hz, 2H), 7.90–7.79 (m, 2H), 7.57 (d, <i>J</i> = 15.9 Hz, 1H), 7.53 (d, <i>J</i> = 7.8 Hz, 1H), 3.97 (s, 3H), 3.16 (t, <i>J</i> = 7.2 Hz, 4H), 1.60–1.45 (m, 4H), 1.32 (sextet, <i>J</i> = 7.2 Hz, 4H), 0.91 (t, <i>J</i> = 7.3 Hz, 6H). MS (ESI): <i>m</i>/<i>z</i> 458 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 98%.</div></div><div id="sec4_3_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> Methyl-(<i>E</i>)-3-(3-(4-((4-nitrophenyl)sulfonamido)phenyl)-3-oxoprop-1-en-1-yl)benzoate (<b>53</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>4</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 443 mg, 3.1 mmol), <b>3j</b> (200 mg, 0.62 mmol), and <b>4a</b> (205 mg, 1.3 mmol) to obtain <b>53</b> as a yellowish solid (159 mg, 55%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 1:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.23 (s, 1H), 8.43–8.37 (m, 3H), 8.17–8.07 (m, 5H), 8.01 (d, <i>J</i> = 8.2 Hz, 1H), 7.95 (d, <i>J</i> = 15.9 Hz, 1H), 7.75 (d, <i>J</i> = 15.6 Hz, 1H), 7.61 (t, <i>J</i> = 7.8 Hz, 1H), 7.29 (d, <i>J</i> = 8.5 Hz, 2H), 3.89 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 465 (M – H)<sup>−</sup>. HPLC (mobile phase B): purity 96%.</div></div><div id="sec4_3_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> (<i>E</i>)-1-(4-Hydroxyphenyl)-3-(2-(trifluoromethyl)phenyl)prop-2-en-1-one (<b>54</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 781 mg, 5.5 mmol), 4′-hydroxyacetophenone (150 mg, 1.1 mmol), and 2-(trifluoromethyl)benzaldehyde (383 mg, 2.2 mmol) to obtain <b>54</b> as an ivory solid (11 mg, 3%) after purification by column chromatography (DCM:EtOAc = 20:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.53 (bs, 1H), 8.30 (d, <i>J</i> = 7.5 Hz, 1H), 8.09 (d, <i>J</i> = 8.1 Hz, 2H), 8.02–7.89 (m, 2H), 7.84–7.75 (m, 2H), 7.67–7.62 (m, 1H), 6.91 (d, <i>J</i> = 8.1 Hz, 2H). MS (ESI): <i>m</i>/<i>z</i> 293 (M + H)<sup>+</sup>, 291 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> (<i>E</i>)-1-(4-Hydroxyphenyl)-3-(3-(trifluoromethyl)phenyl)prop-2-en-1-one (<b>55</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 1.04 g, 7.3 mmol), 4′-hydroxyacetophenone (200 mg, 1.5 mmol), and 3-(trifluoromethyl)benzaldehyde (511 mg, 2.9 mmol) to obtain <b>55</b> as a light-yellow solid (275 mg, 64%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.47 (s, 1H), 8.32 (s, 1H), 8.17–8.07 (m, 4H), 7.78–7.65 (m, 3H), 6.92 (d, <i>J</i> = 8.4 Hz, 2H). MS (ESI): <i>m</i>/<i>z</i> 291 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> (<i>E</i>)-1-(Pyrazin-2-yl)-3-(3-(trifluoromethyl)phenyl)prop-2-en-1-one (<b>56</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>29</b> was used with 2-acetyl pyrazine (150 mg, 1.2 mmol), 3-(trifluoromethyl)benzaldehyde (214 mg, 1.2 mmol), and diethylamine (0.13 mL, 1.2 mmol) to obtain <b>56</b> as a yellow crystal (23 mg, 7%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.40 (s, 1H), 8.81 (d, <i>J</i> = 2.1 Hz, 1H), 8.73 (s, 1H), 8.25 (d, <i>J</i> = 16.2 Hz, 1H), 7.98 (d, <i>J</i> = 15.6 Hz, 1H), 7.97 (s, 1H), 7.88 (d, <i>J</i> = 7.5 Hz, 1H), 7.69 (d, <i>J</i> = 7.8 Hz, 1H), 7.57 (t, <i>J</i> = 7.5 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 266 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 97%.</div></div><div id="sec4_3_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> (<i>E</i>)-1-(4-Hydroxyphenyl)-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-one (<b>57</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 781 mg, 5.5 mmol), 4′-hydroxyacetophenone (150 mg, 1.1 mmol), and 4-(trifluoromethyl)benzaldehyde (383 mg, 2.2 mmol) to obtain <b>57</b> as a yellow solid (93 mg, 29%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.48 (bs, 1H), 8.12–8.03 (m, 5H), 7.82–7.71 (m, 3H), 6.91 (d, <i>J</i> = 8.1 Hz, 2H). MS (ESI): <i>m</i>/<i>z</i> 293 (M + H)<sup>+</sup>, 291 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 97%.</div></div><div id="sec4_3_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> (<i>E</i>)-<i>N</i>,<i>N</i>-Diethyl-4-(3-(3-hydroxyphenyl)acryloyl)benzenesulfonamide (<b>58</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 223 mg, 1.6 mmol), <b>3d</b> (80 mg, 0.31 mmol), and 3-hydroxybenzaldehyde (77 mg, 0.63 mmol) to obtain <b>58</b> as a yellow oil (55 mg, 49%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.09 (d, <i>J</i> = 8.6 Hz, 2H), 7.93 (d, <i>J</i> = 8.6 Hz, 2H), 7.76 (d, <i>J</i> = 15.7 Hz, 1H), 7.46 (d, <i>J</i> = 15.7 Hz, 1H), 7.28 (t, <i>J</i> = 8.4 Hz, 1H), 7.21–7.16 (m, 2H), 6.99–6.96 (m, 1H), 6.73 (bs, 1H), 3.29 (q, <i>J</i> = 7.1 Hz, 4H), 1.15 (t, <i>J</i> = 7.1 Hz, 6H). MS (ESI): <i>m</i>/<i>z</i> 360 (M + H)<sup>+</sup>, 358 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 97%.</div></div><div id="sec4_3_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> (<i>E</i>)-4-(3-(3-Hydroxyphenyl)acryloyl)-<i>N</i>,<i>N</i>-dipentylbenzenesulfonamide (<b>59</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 209 mg, 1.472 mmol), <b>3g</b> (100 mg, 0.294 mmol), and 3-hydroxybenzaldehyde (72 mg, 0.589 mmol) to obtain <b>59</b> as an off-white solid (29 mg, 22%) after purification by column chromatography (<i>n</i>-hexane, <i>n</i>-hexane:EtOAc = 10:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.12 (d, <i>J</i> = 8.0 Hz, 2H), 7.95 (d, <i>J</i> = 8.2 Hz, 2H), 7.79 (d, <i>J</i> = 15.7 Hz, 1H), 7.48 (d, <i>J</i> = 15.7 Hz, 1H), 7.33 (t, <i>J</i> = 7.8 Hz, 1H), 7.24 (d, <i>J</i> = 7.7 Hz, 1H), 7.17 (s, 1H), 6.96 (dd, <i>J</i> = 7.6, 2.5 Hz, 1H), 5.26 (bs, 1H), 3.22–3.09 (m, 3H), 3.07–2.92 (m, 1H), 1.61–1.41 (m, 4H), 1.39–1.21 (m, 6H), 0.94–0.85 (m, 8H). MS (ESI): <i>m</i>/<i>z</i> 442 (M – H)<sup>−</sup>. HPLC (mobile phase B + FA): purity 97%.</div></div><div id="sec4_3_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> (<i>E</i>)-<i>N</i>-(4-(3-(3-Hydroxyphenyl)acryloyl)phenyl)thiophene-2-carboxamide (<b>60</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 568 mg, 4.0 mmol), <b>3k</b> (254 mg, 1.0 mmol), and 3-hydroxybenzaldehyde (134 mg, 1.1 mmol) to obtain <b>60</b> as a solid (80 mg, 23%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 1:1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.63 (s, 1H), 8.27 (dt, <i>J</i> = 8.8, 1.8 Hz, 2H), 8.14 (dd, <i>J</i> = 5.0, 1.3 Hz, 1H), 8.08 (dd, <i>J</i> = 3.8, 1.3 Hz, 1H), 7.88 (d, <i>J</i> = 15.6 Hz, 1H), 7.68 (d, <i>J</i> = 15.6 Hz, 1H), 7.51 (dt, <i>J</i> = 8.8, 2.4 Hz, 2H), 7.38–7.32 (m, 2H), 7.30–7.24 (m, 2H), 6.89 (ddd, <i>J</i> = 7.9, 2.3, 0.8 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 348 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 97%.</div></div><div id="sec4_3_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> (<i>E</i>)-<i>N</i>-(4-(3-(3-Hydroxyphenyl)acryloyl)phenyl)thiophene-2-sulfonamide (<b>61</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 568 mg, 4.0 mmol), <b>3m</b> (281 mg, 1.0 mmol), and 3-hydroxybenzaldehyde (134 mg, 1.1 mmol) to obtain <b>61</b> as a solid (73 mg, 19%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 1:1). <sup>1</sup>H NMR (400 MHz, MeOD) δ: 7.99 (dt, <i>J</i> = 8.8, 2.4 Hz, 2H), 7.72 (dd, <i>J</i> = 5.0, 1.3 Hz, 1H), 7.67 (d, <i>J</i> = 15.6 Hz, 1H), 7.63 (dd, <i>J</i> = 3.7, 1.4 Hz, 1H), 7.62 (d, <i>J</i> = 16.0 Hz, 1H), 7.32 (dt, <i>J</i> = 8.8, 2.4 Hz, 2H), 7.23 (t, <i>J</i> = 7.8 Hz, 1H), 7.18 (d, <i>J</i> = 7.8 Hz, 1H), 7.11 (t, <i>J</i> = 2.0 Hz, 1H), 7.06 (dd, <i>J</i> = 5.0, 3.8 Hz, 1H), 6.86 (ddd, <i>J</i> = 7.9, 2.4, 1.1 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 384 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> (<i>E</i>)-4-(3-(3-Hydroxyphenyl)acryloyl)phenyl thiophene-2-carboxylate (<b>62</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 568 mg, 4.0 mmol), <b>3l</b> (246 mg, 1.0 mmol), and 3-hydroxybenzaldehyde (134 mg, 1.1 mmol) to obtain <b>62</b> as a solid (70 mg, 20%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 1:1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.63 (s, 1H), 8.26 (dt, <i>J</i> = 8.8, 2.4 Hz, 2H), 8.13 (dd, <i>J</i> = 5.0, 1.2 Hz, 1H), 8.08 (dd, <i>J</i> = 3.8, 1.3 Hz, 1H), 7.88 (d, <i>J</i> = 15.6 Hz, 1H), 7.67 (d, <i>J</i> = 15.6 Hz, 1H), 7.50 (dt, <i>J</i> = 7.2, 2.0 Hz, 2H), 7.36–7.31 (m, 2H), 7.28–7.25 (m, 2H), 6.89 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 349 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 97%.</div></div><div id="sec4_3_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> (<i>E</i>)-<i>N</i>-(4-(3-(4-Methoxyphenyl)acryloyl)phenyl)thiophene-2-carboxamide (<b>63</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 568 mg, 4.0 mmol), <b>3k</b> (254 mg, 1 mmol), and 4-anisaldehyde (149.6 mg, 1.1 mmol) to obtain <b>63</b> as a solid (94 mg, 26%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 1:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.08 (d, <i>J</i> = 8.7 Hz, 2H), 7.97 (s, 1H), 7.82 (d, <i>J</i> = 15.6 Hz, 1H), 7.80 (d, <i>J</i> = 8.7 Hz, 2H), 7.71 (d, <i>J</i> = 3.5 Hz, 1H), 7.66–7.61 (m, 3H), 7.46 (d, <i>J</i> = 15.6 Hz, 1H), 7.17 (t, <i>J</i> = 3.9 Hz, 1H), 6.96 (d, <i>J</i> = 8.7 Hz, 1H), 3.88 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 362 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 99%.</div></div><div id="sec4_3_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> (<i>E</i>)-<i>N</i>-(4-(3-(4-Methoxyphenyl)acryloyl)phenyl)thiophene-2-sulfonamide (<b>64</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 568 mg, 4.0 mmol), <b>3m</b> (281 mg, 1.0 mmol), and 4-anisaldehyde (150 mg, 1.1 mmol) to obtain <b>64</b> as a solid (91 mg, 23%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 1:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.97 (d, <i>J</i> = 8.5 Hz, 2H), 7.79 (d, <i>J</i> = 15.6 Hz, 1H), 7.62–7.55 (m, 4H), 7.37 (d, <i>J</i> = 15.6 Hz, 1H), 7.30–7.22 (m, 3H), 7.03 (t, <i>J</i> = 4.5 Hz, 1H), 6.94 (d, <i>J</i> = 8.6 Hz, 2H), 3.86 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 398 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 99%.</div></div><div id="sec4_3_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> (<i>E</i>)-4-(3-(4-Methoxyphenyl)acryloyl)phenyl-thiophene-2-carboxylate (<b>65</b>)</h4><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 568 mg, 4.0 mmol), <b>3l</b> (246 mg, 1.0 mmol), and 4-anisaldehyde (150 mg, 1.1 mmol) to obtain <b>65</b> as a solid (84 mg, 23%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 1:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.10 (d, <i>J</i> = 8.6 Hz, 2H), 8.01 (d, <i>J</i> = 3.7 Hz, 1H), 7.81 (d, <i>J</i> = 15.6 Hz, 1H), 7.70 (d, <i>J</i> = 4.9 Hz, 1H), 7.62 (d, <i>J</i> = 8.7 Hz, 2H), 7.41 (d, <i>J</i> = 15.3 Hz, 1H), 7.37 (d, <i>J</i> = 8.4 Hz, 2H), 7.20 (d, <i>J</i> = 4.2 Hz, 1H), 6.95 (d, <i>J</i> = 8.7 Hz, 2H), 3.86 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 365 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 95%.</div></div></div><div id="sec4_3_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> (<i>E</i>)-1-(4-Hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one (<b>66</b>)</h3><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 568 mg, 4.0 mmol), 4-hydroxyacetophenone (136 mg, 1.0 mmol), and 4-anisaldehyde (150 mg, 1.1 mmol) to obtain <b>66</b> as a solid (58 mg, 23%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 3:1, 1:1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.39 (bs, 1H), 8.07 (d, <i>J</i> = 8.6 Hz, 1H), 7.82 (d, <i>J</i> = 8.7 Hz, 2H), 7.78 (d, <i>J</i> = 15.5 Hz, 1H), 7.66 (d, <i>J</i> = 15.5 Hz, 1H), 7.00 (d, <i>J</i> = 8.7 Hz, 2H), 6.91 (d, <i>J</i> = 8.6 Hz, 2H), 3.81 (s, 3H). MS (ESI): <i>m</i>/<i>z</i> 253 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 97%.</div></div><div id="sec4_3_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> (<i>E</i>)-3-(4-Bromophenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one (<b>67</b>)</h3><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 521 mg, 3.67 mmol), 3-hydroxyacetophenone (100 mg, 0.73 mmol), and 4-bromobenzaldehyde (272 mg, 1.47 mmol) to obtain <b>67</b> as an off-white solid (99 mg, 44%) after purification by column chromatography (<i>n</i>-hexane:EtOAc = 5:1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.75 (d, <i>J</i> = 15.6 Hz, 1H), 7.59–7.51 (m, 6H), 7.47 (d, <i>J</i> = 7.4 Hz, 1H), 7.39 (d, <i>J</i> = 7.9 Hz, 1H), 7.10 (dd, <i>J</i> = 7.9, 1.4 Hz, 1H), 5.57 (bs, 1H). MS (ESI): <i>m</i>/<i>z</i> 303 (M + H)<sup>+</sup>, 305 (M + H)<sup>+</sup>, 301 (M – H)<sup>−</sup>, 303 (M – H)<sup>−</sup>. HPLC (mobile phase A): purity 97%.</div></div><div id="sec4_3_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> (<i>E</i>)-1-(3-Hydroxyphenyl)-3-(4-(pyridin-3-yl)phenyl)prop-2-en-1-one (<b>68</b>)</h3><div class="NLM_p last"><b>67</b> (30 mg, 0.099 mmol), pyridine-3-boronic acid (18.2 mg, 0.15 mmol), Pd(OAc)<sub>2</sub> (2.2 mg, 10 mol %), KF (17.2 mg, 0.30 mmol), PEG-400 (1.5 mL), and EtOH (0.5 mL) were placed in a microwave tube, and the sealed vessel was heated by microwave to 110 °C for 30 min. After cooling to room temperature, the crude product was filtered through a pad of silica gel and washed with EtOAc. The organic phase was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The resulting residue was purified using column chromatography (<i>n</i>-hexane:EtOAc = 3:1), followed by recrystallization from EtOH to obtain <b>68</b> as a fluffy off-white solid (10 mg, 34%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.81 (s, 1H), 8.99 (d, <i>J</i> = 1.8 Hz, 1H), 8.61 (dd, <i>J</i> = 4.7, 1.5 Hz, 1H), 8.18 (dt, <i>J</i> = 8.4, 1.8 Hz, 1H), 8.03 (d, <i>J</i> = 8.4 Hz, 2H), 7.94 (d, <i>J</i> = 15.7 Hz, 1H), 7.86 (d, <i>J</i> = 8.3 Hz, 2H), 7.78 (d, <i>J</i> = 15.6 Hz, 1H), 7.67 (d, <i>J</i> = 7.8 Hz, 1H), 7.54–7.48 (m, 2H), 7.39 (t, <i>J</i> = 7.9 Hz, 1H), 7.07 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 302 (M + H)<sup>+</sup>, 300 (M – H)<sup>−</sup>. HPLC (mobile phase B + FA): purity 96%.</div></div><div id="sec4_3_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> (<i>E</i>)-1-(3-Hydroxyphenyl)-3-(4-(pyridin-4-yl)phenyl)prop-2-en-1-one (<b>69</b>)</h3><div class="NLM_p last">To a solution of <b>67</b> (50 mg, 0.165 mmol) in DMF (1 mL) in a microwave tube were successively added Pd(PPh<sub>3</sub>)<sub>4</sub> (19 mg, 0.0165 mmol), cesium carbonate (107 mg, 0.329 mmol), and pyridine-4-boronic acid pinacol ester (51 mg, 0.247 mmol). The sealed vessel was heated by microwave to 130 °C for 20 min. After cooling to room temperature, the reaction mixture was partitioned between 0.1 N HCl and DCM. The organic phase was extracted with water, and the combined organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The resulting residue was heated in EtOH, and insoluble black solid was removed by filtration using hot EtOH. The crude product was then purified by recrystallization from EtOH to obtain <b>69</b> as an orange crystal (9 mg, 18%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.81 (s, 1H), 8.66–8.64 (m, 2H), 8.02 (d, <i>J</i> = 8.3 Hz, 2H), 7.94 (d, <i>J</i> = 15.6 Hz, 1H), 7.90 (d, <i>J</i> = 8.3 Hz, 2H), 7.78–7.74 (m, 3H), 7.65–7.63 (m, 1H), 7.47 (t, <i>J</i> = 2.1 Hz, 1H), 7.37 (t, <i>J</i> = 7.9 Hz, 1H), 7.06 (dd, <i>J</i> = 8.1, 2.5 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 302 (M + H)<sup>+</sup>, 300 (M – H)<sup>−</sup>. HPLC (mobile phase B): purity 96%.</div></div><div id="sec4_3_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> (<i>E</i>)-3-(4-(1<i>H</i>-Benzo[<i>d</i>]imidazol-1-yl)phenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one (<b>70</b>)</h3><div class="NLM_p last">The procedure applied to the synthesis of <b>5</b> was used with boron trifluoride etherate (48% BF<sub>3</sub>, 261 mg, 1.84 mmol), 3-hydroxyacetophenone (50 mg, 0.37 mmol), and <b>3n</b> (163 mg, 0.73 mmol) to obtain <b>70</b> as a yellow solid (10 mg, 8%) after filtration of solid from EtOAc. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 9.83 (s, 1H), 8.74 (s, 1H), 8.17 (d, <i>J</i> = 8.1 Hz, 2H), 7.98 (d, <i>J</i> = 15.5 Hz, 1H), 7.85–7.80 (m, 4H), 7.73 (d, <i>J</i> = 7.7 Hz, 1H), 7.68 (d, <i>J</i> = 7.5 Hz, 1H), 7.50 (s, 1H), 7.42–7.33 (m, 3H), 7.09 (d, <i>J</i> = 8.2 Hz, 1H). MS (ESI): <i>m</i>/<i>z</i> 341 (M + H)<sup>+</sup>, 339 (M – H)<sup>−</sup>. HPLC (mobile phase B): purity 97%.</div></div><div id="sec4_3_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> (<i>E</i>)-1-Phenyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)prop-2-en-1-one (<b>71</b>)</h3><div class="NLM_p last">To a solution of 1-phenyl-2-propyn-1-ol (200 mg, 1.51 mmol), 4-bromophenyl boronic acid pinacol ester (415 mg, 1.47 mmol), bis(triphenylphosphine)palladium(II) chloride (41 mg, 0.059 mmol), CuI (8 mg, 0.044 mmol), and triphenylphosphine (77 mg, 0.29 mmol) in 3 mL of degassed THF in a microwave vial under N<sub>2</sub> (<i>g</i>) was added 1,8-diazabicyclo(5.4.0)undec-7-ene (237 mg, 1.56 mmol). The sealed vessel was heated by microwave to 120 °C for 40 min. After cooling to room temperature, water was added and the aqueous layer was extracted with EtOAc. The combined organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The resulting residue was purified using column chromatography (<i>n</i>-hexane:EtOAc = 5:1) to obtain <b>71</b> as an off-white solid (162 mg, 33%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.03 (d, <i>J</i> = 7.5 Hz, 2H), 7.85 (d, <i>J</i> = 7.8 Hz, 2H), 7.82 (d, <i>J</i> = 16.0 Hz, 1H), 7.64 (d, <i>J</i> = 7.9 Hz, 2H), 7.61–7.48 (m, 4H), 1.36 (s, 12H). MS (ESI): <i>m</i>/<i>z</i> 335 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_3_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> (<i>E</i>)-(4-(3-Oxo-3-phenylprop-1-en-1-yl)phenyl)boronic Acid (<b>72</b>)</h3><div class="NLM_p last">A 50 mL round-bottom flask was charged with <b>71</b> (100 mg, 0.30 mmol), followed by THF (1 mL) and H<sub>2</sub>O (1 mL) at room temperature. To the mixture was added NaIO<sub>4</sub> (192 mg, 0.90 mmol), and the reaction mixture was stirred at room temperature for 1 h. To the resulting slurry was added 1 N HCl, and the mixture was allowed to stir for 4 h. Then, the residue was transferred to a separating funnel, and the product was extracted from the aqueous mixture with EtOAc. The combined organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude solid was triturated with hexane to obtain <b>72</b> (50 mg, 66%) as a yellow solid. <sup>1</sup>H NMR (300 MHz, acetone-<i>d</i><sub>6</sub>) δ: 8.16 (d, <i>J</i> = 7.4 Hz, 2H), 7.97–7.90 (m, 3H), 7.83–7.77 (m, 3H), 7.68–7.54 (m, 3H), 7.29 (s, 2H). MS (ESI): <i>m</i>/<i>z</i> 253 (M + H)<sup>+</sup>. HPLC (mobile phase A): purity 96%.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> Cell Culture</h3><div class="NLM_p last">The human cell lines, U87MG, A172, and NU04 (ATCC, Manassas, VA), were obtained in 2013 and were maintained in RPMI-1640 or DMEM (Thermo Fisher Scientific, Waltham, MA) with 10% fetal bovine serum (Thermo Fisher Scientific). Cells were grown as monolayer cultures at 37 °C in a humidified atmosphere of 5% CO<sub>2</sub> and tested for <i>Mycoplasma</i> contamination with the <i>Mycoplasma</i> detection kit, PlasmoTest (InvivoGen, San Diego, California). All cell lines were authenticated with STR DNA profiling (University of Michigan, Ann Arbor, MI) and matched to reference profiles from the ATCC database.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> PDI Protein Purification</h3><div class="NLM_p last">The expression vector of recombinant human PDI protein with N-terminal His tag was a gift from Dr. Lloyd W. Ruddock (University of Oulu, Oulu, Finland). PDI wild-type, C53S/C397S, and H256A expression and purification were performed as previously described with slight modifications (unpublished).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In brief, protein production was carried out in <i>Escherichia coli</i> strain BL21 (DE3) pLysS grown in LB medium with 200 μg/mL ampicillin (EMD Biosciences, La Jolla, CA) at 37 °C and incubated at an <i>A</i><sub>600</sub> of 0.5 at 37 °C for 4 h with 1 mM isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside (GoldBio, St. Louis, MO). Cells were harvested by centrifugation (4000<i>g</i> for 15 min) and were resuspended in one-tenth volume buffer A (20 mM sodium phosphate, pH 7.3). Cells were lysed by sonication, and the cell debris was removed by centrifugation (16000<i>g</i> for 30 min). The supernatant was applied to a bed of Ni-nitrilotriacetic acid in a histidine-binding column (Qiagen, Hilden, Germany), equilibrated with 10 mL of buffer A and incubated at 4 °C, overnight. After incubation, the column was washed in buffer A and then in buffer B (20 mM sodium phosphate, 0.5 M sodium chloride, and 50 mM imidazole, pH 7.3). His-tagged proteins were eluted using 20 mM sodium phosphate buffer containing 50 mM EDTA (pH 7.3), and eluent was dialyzed in 100 mM sodium phosphate buffer (pH 7.0) with 2 mM EDTA.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> Measurement of PDI Activity and Competition With <i>N</i>-Acetyl Cysteine</h3><div class="NLM_p">PDI activity was assessed by measuring the PDI-catalyzed reduction of insulin as previously described.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In brief, recombinant PDI protein (0.4 μM) was incubated with indicated compounds at 37 °C for 1 h in sodium phosphate buffer (100 mM sodium phosphate, 2 mM EDTA, 8 μM DTT, pH 7.0). For the PDI reductase assay containing H256A PDI, the compounds were tested at 10 μM. A mixture of sodium phosphate buffer, DTT (500 μM) and bovine insulin (130 μM; Gemini BioProducts, West Sacramento, CA) was added to the incubated PDI protein. The reduction reaction was catalyzed by PDI at room temperature, and the resulting aggregation of reduced insulin B chains was measured at 620 nm. PDI activity was calculated with the formula, PDI activity (%) = [(OD<sub>T80[PDI+DTT+compound]</sub> – OD<sub>T0[PDI+DTT+compound]</sub>) – (OD<sub>T80[DTT]</sub> – OD<sub>T0[DTT]</sub>)]/[(OD<sub>T80[PDI+DTT]</sub> – OD<sub>T0[PDI+DTT]</sub>) – (OD<sub>T80[DTT]</sub> – OD<sub>T0[DTT]</sub>)] × 100 (OD<sub>T0</sub> and OD<sub>T80</sub> were the absorbance values at 0 and 80 min after the reduction reaction, respectively).</div><div class="NLM_p last">To assess the effect of NAC on compound activity, compounds were pretreated with NAC for 30 min at 37 °C. The compound:NAC complexes were added to the PDI reductase assay as described above to a final concentration of 40 μM and 0, 1, 2, or 5 mM NAC.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> Thermal Shift Assay</h3><div class="NLM_p">Thermal shift of purified PDI (0.5 mg/mL in 50 mM Tris, pH 7.0) in the presence or absence of 100 μM compound was determined as described.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Briefly, 5 μL of PBS, 2 μL of PDI, 1 μL of ligand in 100% DMSO, 2.5 μL of 8× ROX dye (from Protein Thermal Shift Dye Kit, Thermo Fisher Scientific) and water to 20 μL were dispensed in each well of a 384-well microplate. DMSO (5% in buffer) was used as control. The plate was heated at a temperature range from 25 to 99 °C at 1 °C/min in the QuantStudio 6 Flex Real-Time PCR System (Thermo Fisher Scientific), and melt curves were analyzed with the Protein Thermal Shift software (Thermo Fisher Scientific).</div><div class="NLM_p last">Binding affinity was determined under similar conditions with 8.4 μM PDI and a range of inhibitor concentrations. <i>K</i><sub>d</sub> was calculated in GraphPad Prism with the reported equation.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> Growth Inhibition Assay</h3><div class="NLM_p last">Cell growth inhibition was assessed by MTT assay as previously described.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Cells were seeded in 96-well plates at 4000 cells/well (A172, NU04) or 5000 cells/well (U87MG). After overnight incubation at 37 °C and 5% CO<sub>2</sub>, cells were treated with indicated compounds. The plates were incubated with drug or vehicle control for 72 h at 37 °C and 5% CO<sub>2</sub>. MTT solution (20 μL, 3 mg/mL) was added to the wells, and the cells were incubated for 4 h at 37 °C. Supernatant was removed, and DMSO (100 μL) was added to each well. The plates were shaken for 15 min at room temperature, and absorbance of the formazan crystals was measured at 570 nm. Cell growth inhibition was assessed by the cell viability rate as [1 – (<i>A</i><sub>t</sub> – <i>A</i><sub>b</sub>)/(<i>A</i><sub>c</sub> – <i>A</i><sub>b</sub>)] × 100 (<i>A</i><sub>t</sub>, <i>A</i><sub>c</sub>, and <i>A</i><sub>b</sub> are the absorbance values from cells which were treated with compound, cells which were not treated with compound, and blank, respectively).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> Giemsa Staining</h3><div class="NLM_p last">A172 cells were seeded in 6-well plates at 0.5 × 10<sup>6</sup> cells/well. After overnight incubation at 37 °C and 5% CO<sub>2</sub>, cells were treated with compounds (DMSO, 40 μM <b>8</b>, 0.5 μM <b>PACMA31</b>, 17 μM <b>BAP2</b>, 20 μM <b>46</b>, and 11 μM <b>59</b>) for 6, 24, or 48 h. Media was removed, and cells were stained with Giemsa stain (Sigma-Aldrich, St. Louis, MO) for 5 min at room temperature, washed with water, and imaged with the Olympus IX83 inverted microscope at 20× magnification.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> Colony Formation Assay</h3><div class="NLM_p last">U87MG cells were seeded in 96-well plates at 200 cells/well. After overnight incubation at 37 °C and 5% CO<sub>2</sub>, cells were treated with indicated compounds for 24 h. The media was removed and replaced with fresh media, and the cells were incubated 10 days at 37 °C and 5% CO<sub>2</sub>. Media was then removed, and crystal violet solution was added (50 μL) for 30 min. Crystal violet was removed, and cells were washed twice with water and imaged with the Odyssey imaging system (LI-COR Biosciences).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> Western Blot Analysis</h3><div class="NLM_p last">For ER stress analysis, 0.5 × 10<sup>6</sup> U87MG cells/well in 6-well plates were treated with 20 μM chalcone analogues, 1 μM <b>PACMA31</b>, or DMSO for 24 h to assess changes in GRP78 expression. As a positive control, cells were treated with 10 μg/mL tunicamycin for 2 or 24 h before cells were harvested. For EIF2α phosphorylation analysis, cells were treated with 1 μM <b>PACMA31</b> or 20 μM <b>6</b>, <b>18</b>, <b>46</b>, <b>59</b>, <b>68</b>, or <b>69</b> for 2 h. Cells were harvested with a lysis buffer (25 mM tris(hydroxymethyl)aminomethane, 150 mM NaCl, 17 mM Triton X-100, 3.5 mM SDS, pH 7.4), lysed via sonication, and spun in a centrifuge at 13500<i>g</i> at 4 °C for 10 min. Supernatant was collected, and protein concentration determined with the BCA assay (Thermo Fisher Scientific, Waltham, MO). Samples were prepared with 30 μg of protein and loaded onto 10% acrylamide (Bio-Rad, Hercules, CA) gels. Protein was electrotransferred to methanol-activated immobilon-FL PVDF membranes (EMD Millipore, La Jolla, CA). Membranes were blocked for 1 h with Odyssey blocking buffer (LI-COR Biosciences). Membranes were probed for proteins using primary antibodies (PDI, Cell Signaling, Danvers, MA, 1:4000; GRP78, Cell Signaling, Danvers, MA, 1:2000; pEIF2α, Cell Signaling, 1:200; EIF2α, Cell Signaling, 1:200; actin, Santa Cruz, 1:3000; MMP2, Cell Signaling, 1:1000; MMP9, Cell Signaling, 1:1000; p-FAK, Cell Signaling, 1:1000; FAK, Cell Signaling, 1:1000) overnight at 4 °C. Membranes were incubated with secondary antibodies (antirabbit, Cell Signaling, 1:7500, or anti-mouse, Cell Signaling, 1:5000), and fluorescence was imaged with the Odyssey imaging system (LI-COR Biosciences).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> Gelatin Zymography</h3><div class="NLM_p last">U87MG cells were seeded at 0.5 × 10<sup>6</sup> cells/well in 6-well plates and allowed to attach overnight. Cells were serum-starved for 12 h prior to designated treatment with chalcone analogues for 24 h. Conditioned media was collected, cleared, and mixed with 5× SDS loading buffer, and 5 μg of protein was subjected to electrophoresis on a 10% SDS-PAGE gel containing 0.1% gelatin. After electrophoresis, the gels were washed in washing buffer (50 mM Tris HCl, 5 mM CaCl<sub>2</sub>, 1 μM ZnCl<sub>2</sub>, 2.5% Triton X-100) twice for 30 min each time, then washed for 5 min in incubation buffer (50 mM Tris HCl, 5 mM CaCl<sub>2</sub>, 1 μM ZnCl<sub>2</sub>, 1.0% Triton X-100). Incubation buffer was replaced, and the gels were incubated overnight at 37 °C to allow for digestion of the gelatin. The gelatinolytic activity of MMPs was visualized by staining the gels with 0.5% Coomassie blue R-250 in 45% methanol and 10% acetic acid for 1 h. The gels were destained with 45% methanol and 10% acetic acid until clear bands appeared. Gels were imaged with the Odyssey imaging system (LI-COR Biosciences).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> Wound Healing Assay</h3><div class="NLM_p last">A172 cells were seeded in 12-well plates at 50000 cells/well. After overnight incubation at 37 °C and 5% CO<sub>2</sub>, media was replaced with serum-free DMEM and the cells were incubated another 24 h. A scratch was made in each well, and compounds were added at indicated concentrations in media containing 10% FBS. Cells were allowed to grow for 24 h until the scratch in the negative control wells containing DMSO closed. Cells were stained with Giemsa stain (Sigma-Aldrich) and imaged with the Olympus IX83 inverted microscope at 10× magnification.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i126" class="anchor-spacer"></div><h3 class="article-section__title" id="_i126"> Transwell Migration Assay</h3><div class="NLM_p last">The transwell migration assay was performed with BioCoat Control Inserts with 8.0 μm of PET membrane (Corning, Corning, NY). Then 1 × 10<sup>5</sup> A172 cells were treated with indicated compounds and seeded into inserts containing serum-free medium. Then 500 μL of DMEM with 10% FBS was added to the bottom of each well. The cells were incubated for 4 h and stained with the Giemsa stain. The stained cells were imaged with the Olympus IX83 inverted microscope at 10× magnification.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i127" class="anchor-spacer"></div><h3 class="article-section__title" id="_i127"> Bromouridine RNA Sequencing (Bru-seq)</h3><div class="NLM_p">Bru-seq was performed as previously described.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> U87MG cells were treated with DMSO, <b>18</b> (10 μM), or <b>46</b> (16 μM) for 4 h. Then 2 mM Bru was added in the last 30 min of treatment. Cells were collected, and total RNA was isolated with TRIzol reagent. Bru-labeled RNA was captured from total RNA by incubation with anti-BrdU antibodies (BD Biosciences) conjugated to magnetic beads (Dynabeads, goat anti-mouse IgG; Invitrogen). The Bru-containing RNA population was isolated and sequenced. Sequencing reads were mapped to the hg19 reference genome. Preranked gene lists were generated for each treatment ranking genes by fold change in transcription compared to control. Sequencing results were filtered using cutoff value of gene size >300 bp and mean RPKM >0.5.</div><div class="NLM_p">The data sets were interrogated with Gene Set Enrichment Analysis (GSEA).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> A preranked gene list of 7749 genes (cutoff values: gene size >300 bp and mean RPKM >0.5) was analyzed for gene enrichment using GSEA gene sets based on the Kolmogorov–Smirnov statistic. For each gene set, an enrichment score (ES) was normalized to account for the difference in gene set size, and a false discovery rate (FDR) was calculated based on the normalized enrichment score (NES) values.</div><div class="NLM_p last">The data sets were also interrogated with Connectivity Map (CMap, <a href="https://www.broadinstitute.org/connectivity-map-cmap" class="extLink">https://www.broadinstitute.org/connectivity-map-cmap</a>). Bru-seq gene sets were used with a cut off of ≥2-fold change in transcription. Some genes were omitted from analysis because they had no connection in CMap (see Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_006.xlsx" class="ext-link">File 5</a> for gene lists used; structures are listed in Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_007.xlsx" class="ext-link">File 6</a>).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i128" class="anchor-spacer"></div><h3 class="article-section__title" id="_i128"> Proteomics with Tandem Mass Tag Multiplexing</h3><div class="NLM_p last">U87MG cells were seeded and allowed to attach overnight. Cells were treated with DMSO, 20 μM <b>BAP2</b>, or 20 μM <b>18</b>. Cells were washed three times in DPBS and suspended in RIPA buffer. Proteomics experiment and analysis was performed by the Mass Spectrometry-Based Proteomics Resource Facility in the Department of Pathology at the University of Michigan with the TMTsixplex Isobaric Label Reagent Set (Thermo Fisher). The abundance ratio data sets were transformed to log2(fold change) values and interrogated with GSEA.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i129" class="anchor-spacer"></div><h3 class="article-section__title" id="_i129"> Protein Identification and Relative Quantitation by TMT labeling and LC-Tandem MS</h3><div class="NLM_p">Tandem Mass Tag (TMT) labeling was performed using the TMT-6plex isobaric labeling kit (ThermoFisher Scientific, catalogue no. 90061) according to the manufacturer’s protocol with minor modifications. Briefly, 75 μg of protein from each sample was reduced with DTT (5 mM) at 45 °C for 1 h followed by alkylation with 2-chloroacetamide (15 mM) at room temperature for 30 min. Proteins were precipitated by adding 6 volumes of ice-cold acetone and incubating overnight at −20 °C. Precipitated proteins were pelleted by centrifuging at 8000<i>g</i> for 10 min at 4 °C, and supernatant was discarded. The pellet was resuspended in 100 μL of 100 mM TEAB and digested overnight at 37 °C by adding 1.5 μg of sequencing grade, modified porcine trypsin (Promega, V5113). TMT reagents were reconstituted in 41 μL of anhydrous acetonitrile, and digested peptides were transferred to the TMT reagent vial and incubated at room temperature for 1 h. The reaction was quenched by adding 8 μL of 5% hydroxylamine and incubating it for 15 min. The samples were combined and dried.</div><div class="NLM_p last">Prior to MS analysis, two-dimensional separation of the samples was performed. For the first dimension, an offline fractionation of an aliquot of each sample mix (200 μg) using high pH reverse phase fractionation kit into 10 fractions was performed following the manufacturer’s protocol (Pierce, catalogue. no. 84868). Fractions were dried and reconstituted in 12 μL of loading buffer (0.1% formic acid and 2% acetonitrile).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i130" class="anchor-spacer"></div><h3 class="article-section__title" id="_i130"> Liquid Chromatography–Mass Spectrometry Analysis (LC-MultiNotch MS3)</h3><div class="NLM_p">The MultiNotch-MS3 method was employed.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Orbitrap Fusion (Thermo Fisher Scientific) and RSLC Ultimate 3000 Nano-UPLC (Dionex) were used to acquire the data. Two μM of each fraction was resolved in the second dimension on a nanocapillary reverse phase column (Acclaim PepMap C18, 2 μm, 75 μm i.d. × 50 cm, ThermoScientific) using a 0.1% formic/acetonitrile gradient at 300 nL/min (2–22% acetonitrile in 150 min; 22–32% acetonitrile in 40 min; 20 min wash at 90% followed by 50 min re-equilibration) and directly sprayed onto Orbitrap Fusion using EasySpray source (ThermoFisher Scientific). Mass spectrometer was set to collect one MS1 scan (Orbitrap; 120 K resolution; AGC target 2 × 10<sup>5</sup>; max IT 100 ms) followed by data-dependent, “Top Speed” (3 s) MS2 scans (collision induced dissociation; ion trap; NCD 35; AGC 5 × 10<sup>3</sup>; max IT 100 ms). For multinotch-MS3, top 10 precursors from each MS2 were fragmented by HCD followed by Orbitrap analysis (NCE 55; 60K resolution; AGC 5 × 10<sup>4</sup>; max IT 120 ms, 100–500 <i>m</i>/<i>z</i> scan range).</div><div class="NLM_p last">Proteome Discoverer (v2.1; Thermo Fisher) was used for data analysis. MS2 spectra were searched against SwissProt human protein database (release 2015-11-11; 42084 sequences) using the following search parameters: MS1 and MS2 tolerance were set to 10 ppm and 0.6 Da, respectively, carbamidomethylation of cysteines (57.02146 Da) and TMT labeling of lysine and N-termini of peptides (229.16293 Da) were considered static modifications, and oxidation of methionine (15.9949 Da) and deamidation of asparagine and glutamine (0.98401 Da) were considered variable. Identified proteins and peptides were filtered to retain only those that passed ≤1% FDR threshold. Quantitation was performed using high-quality MS3 spectra (average signal-to-noise ratio of 6 and <40% isolation interference).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i131" class="anchor-spacer"></div><h3 class="article-section__title" id="_i131"> 1-Anilinonaphthalene-8-sulfonic Acid (ANS) Spectral Scan</h3><div class="NLM_p last">The ANS spectral scan was performed as previously described.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Briefly, 5 μM PDI was incubated in the presence 100 μM compounds or equivalent DMSO concentration in 50 μL of TBS at 37 °C for 1 h. Subsequently, 50 μM ANS was added and the mixture was incubated in the dark at 25 °C for 20 min. Fluorescence spectrum (Ex, 370 nm, Em, 400–700 nm) was measured in a 384-well plate.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i132" class="anchor-spacer"></div><h3 class="article-section__title" id="_i132"> Clonogenic Assay</h3><div class="NLM_p last">D54 cells were irradiated with 0, 1, 2, 4, or 6 Gy and immediately plated in 6-well plates at 200, 200, 400, 600, and 1000 cells/well, respectively. Cells were treated with DMSO, 0.05 μM <b>PACMA31</b>, 1 μM <b>BAP2</b>, 1 μM <b>59</b>, or 1 μM <b>68</b> and incubated for 10–12 days before colonies were stained using 0.1% crystal violet solution.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> Molecular Docking</h3><div class="NLM_p">Molecular docking of <b>BAP2</b> derivatives on PDI was performed in the two catalytic sites and the hydrophobic binding site using a crystal structure of PDI (Protein Data Bank <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a>). In three separate docking studies, all analogues were docked into the three binding sites using Autodock Vina.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The structures of the <b>BAP2</b> derivatives were optimized using steepest descent geometry optimization with the MMFF94 force field and PyRx tool.</div><div class="NLM_p last">AutoDock (version 1.5.6; Molecular Graphics Laboratory, La Jolla, CA, USA) was used to prepare the input pdbqt file by merging nonpolar hydrogen atoms of PDI and calculating Gasteiger charges. Docking was conducted by defining the SG atom in Cys56 and Cys397 and NE1 in His256 as the center of the grid box for the catalytic and hydrophobic sites, respectively. The grid cavity size was set to 15 × 15 × 15 in the dimensions of <i>x</i>, <i>y</i>, and <i>z</i> using 0.375 Å spacing. The 2D and 3D diagrams for receptor–ligand interactions were plotted using Discovery Studio Visualizer v17.2.0.16349.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i134" class="anchor-spacer"></div><h3 class="article-section__title" id="_i134"> Statistics</h3><div class="NLM_p last">The 50% inhibitory concentration values (IC<sub>50</sub>) were determined by analyzing the log of the concentration–response curves by nonlinear regression analysis using GraphPad Prism (version 5). Biochemical and cell culture experiments were performed at least three separate times unless otherwise noted. Bru-seq and proteomics experiments were performed once.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i135"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01951" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40453" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40453" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01951" class="ext-link">10.1021/acs.jmedchem.8b01951</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional computational analysis, biochemical data, and structures; Supporting Figures and Tables (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Bru-seq-<b>18</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_002.xls" class="ext-link">XLS</a>)</p></li><li><p class="inline">Bru-seq-<b>46</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_003.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">Proteomics results (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_004.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">Proteomics GSEA (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_005.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">CMap (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_006.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">CMap structures (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_007.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">Docked <b>18</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_008.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docked <b>35</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_009.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docked <b>46</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_010.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docked <b>47</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_011.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docked <b>49</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_012.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docked <b>50</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_013.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docked <b>67</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_014.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docked <b>68</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_015.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docked <b>69</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_016.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Docked <b>70</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_017.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_018.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf">jm8b01951_si_001.pdf (1.29 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_002.xls">jm8b01951_si_002.xls (32.55 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_003.xlsx">jm8b01951_si_003.xlsx (14.62 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_004.xlsx">jm8b01951_si_004.xlsx (777.41 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_005.xlsx">jm8b01951_si_005.xlsx (318.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_006.xlsx">jm8b01951_si_006.xlsx (1.57 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_007.xlsx">jm8b01951_si_007.xlsx (670.05 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_008.pdb">jm8b01951_si_008.pdb (597.85 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_009.pdb">jm8b01951_si_009.pdb (596.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_010.pdb">jm8b01951_si_010.pdb (596.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_011.pdb">jm8b01951_si_011.pdb (596.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_012.pdb">jm8b01951_si_012.pdb (597.13 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_013.pdb">jm8b01951_si_013.pdb (597.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_014.pdb">jm8b01951_si_014.pdb (596.41 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_015.pdb">jm8b01951_si_015.pdb (596.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_016.pdb">jm8b01951_si_016.pdb (596.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_017.pdb">jm8b01951_si_017.pdb (597.25 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_018.csv">jm8b01951_si_018.csv (4.96 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01951" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nouri Neamati</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal
Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3291-7131" title="Orcid link">http://orcid.org/0000-0003-3291-7131</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4d23282c202c39240d3820242e2563282938"><span class="__cf_email__" data-cfemail="503e35313d31243910253d3933387e353425">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suhui Yang</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal
Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span>; 
    <span>Present Address:
                        S.Y.: Department of Pharmaceutical Sciences, School of Pharmacy, American University of Health Sciences, 1600 East Hill Street, Signal Hill, CA 90755; Email, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="90e3e9f1fef7d0f1e5f8e3bef5f4e5">[email protected]</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Shergalis</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal
Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1155-1583" title="Orcid link">http://orcid.org/0000-0002-1155-1583</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Lu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal
Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anahita Kyani</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal
Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ziwei Liu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal
Chemistry, College of Pharmacy, Rogel Cancer Center, University of Michigan, North Campus Research Complex, 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mats Ljungman</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiation Oncology Rogel Cancer Center, University of Michigan Medical School and Rogel Cancer
Center, School of Public Health, Ann Arbor, Michigan 48109, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.Y. and A.S. contributed equally to this work. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i139">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Kirin Cromer, Kelly Torolski, Amina Tanweer, Fah Koranant, Pantira Khonlumb, Jean Denphaetcharangkul, Vichanee Meethavorn, Trey Feldeisen, Hannah Driks, Michelle Paulsen, and Ding Xue for their help and contributions to the project. The expression vector of recombinant human PDI was a generous gift from Dr. Lloyd W. Ruddock (University of Oulu, Oulu, Finland). We are grateful for the University of Michigan Proteomics Resource Facility at the Department of Pathology for performing the proteomics experiments and analyzing the results. We are also grateful to Krishnapriya Chinnaswamy at the Center for Structural Biology at the University of Michigan for running the ITC experiments. We also thank the University of Michigan DNA Sequencing Core. This work was supported by a grant from the NIH (CA193690).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ATCC</td><td class="NLM_def"><p class="first last">American Type Culture Collection</p></td></tr><tr><td class="NLM_term">CN</td><td class="NLM_def"><p class="first last">nitrile</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle Medium</p></td></tr><tr><td class="NLM_term">EIF2α</td><td class="NLM_def"><p class="first last">eukaryotic translation initiation factor 2α</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">GBM</td><td class="NLM_def"><p class="first last">glioblastoma</p></td></tr><tr><td class="NLM_term">GRP78</td><td class="NLM_def"><p class="first last">glucose-regulated protein, 78 kDa</p></td></tr><tr><td class="NLM_term">HFF</td><td class="NLM_def"><p class="first last">human foreskin fibroblasts</p></td></tr><tr><td class="NLM_term">Keap1</td><td class="NLM_def"><p class="first last">Kelch-like ECH-associated protein 1</p></td></tr><tr><td class="NLM_term">LB</td><td class="NLM_def"><p class="first last">lysogeny broth</p></td></tr><tr><td class="NLM_term">MMFF</td><td class="NLM_def"><p class="first last">Merck Molecular Force Field</p></td></tr><tr><td class="NLM_term">MMP9</td><td class="NLM_def"><p class="first last">matrix metalloprotein 9</p></td></tr><tr><td class="NLM_term">MMP2</td><td class="NLM_def"><p class="first last">matrix metalloprotein 2</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">NCI</td><td class="NLM_def"><p class="first last">National Cancer Institute</p></td></tr><tr><td class="NLM_term">NF-kB</td><td class="NLM_def"><p class="first last">nuclear factor- kB</p></td></tr><tr><td class="NLM_term">PDI</td><td class="NLM_def"><p class="first last">protein disulfide isomerase</p></td></tr><tr><td class="NLM_term">PERK</td><td class="NLM_def"><p class="first last">protein kinase RNA-like endoplasmic reticulum kinase</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">polyethylene terephthalate</p></td></tr><tr><td class="NLM_term">p-FAK</td><td class="NLM_def"><p class="first last">phosphorylated focal adhesion kinase</p></td></tr><tr><td class="NLM_term">PVDF</td><td class="NLM_def"><p class="first last">polyvinylidene difluoride</p></td></tr><tr><td class="NLM_term">RPMI</td><td class="NLM_def"><p class="first last">Roswell Park Memorial Institute</p></td></tr><tr><td class="NLM_term">STR</td><td class="NLM_def"><p class="first last">short tandem repeats</p></td></tr><tr><td class="NLM_term">UPR</td><td class="NLM_def"><p class="first last">unfolded protein response</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i141">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shergalis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankhead, A.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesakul, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muangsin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Current challenges and opportunities in treating glioblastoma</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">445</span>, <span class="refDoi"> DOI: 10.1124/pr.117.014944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1124%2Fpr.117.014944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=29669750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=412-445&author=A.+Shergalisauthor=A.+Bankheadauthor=U.+Luesakulauthor=N.+Muangsinauthor=N.+Neamati&title=Current+challenges+and+opportunities+in+treating+glioblastoma&doi=10.1124%2Fpr.117.014944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current challenges and opportunities in treating glioblastoma</span></div><div class="casAuthors">Shergalis, Andrea; Bankhead, Armand; Luesakul, Urarika; Muangsin, Nongnuj; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">412-445</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Glioblastoma multiforme (GBM), the most common and aggressive primary brain tumor, has a high mortality rate despite extensive efforts to develop new treatments.  GBM exhibits both intra- and intertumor heterogeneity, lending to resistance and eventual tumor recurrence.  Large-scale genomic and proteomic anal. of GBM tumors has uncovered potential drug targets.  Effective and "druggable" targets must be validated to embark on a robust medicinal chem. campaign culminating in the discovery of clin. candidates.  Here, we review recent developments in GBM drug discovery and delivery.  To identify GBM drug targets, we performed extensive bioinformatics anal. using data from The Cancer Genome Atlas project.  We discovered 20 genes, BOC, CLEC4GP1, ELOVL6, EREG, ESR2, FDCSP, FURIN, FUT8-AS1, GZMB, IRX3, LITAF, NDEL1, NKX3-1, PODNL1, PTPRN, QSOX1, SEMA4F, TH, VEGFC, and C20orf166AS1 that are overexpressed in a subpopulation of GBM patients and correlate with poor survival outcomes.  Importantly, nine of these genes exhibit higher expression in GBM vs. low-grade glioma and may be involved in disease progression.  In this review, we discuss these proteins in the context of GBM disease progression.  We also conducted computational multi-parameter optimization to assess the blood-brain barrier (BBB) permeability of small mols. in clin. trials for GBM treatment.  Drug delivery in the context of GBM is particularly challenging because the BBB hinders small mol. transport.  Therefore, we discuss novel drug delivery methods, including nanoparticles and prodrugs.  Given the aggressive nature of GBM and the complexity of targeting the central nervous system, effective treatment options are a major unmet medical need.  Identification and validation of biomarkers and drug targets assocd. with GBM disease progression present an exciting opportunity to improve treatment of this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKoQ_eLuZhn7Vg90H21EOLACvtfcHk0lh-aaHUZ0ouNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsb8%253D&md5=80fb3912ca8df56db7b1c146ef45ffef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.117.014944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.117.014944%26sid%3Dliteratum%253Aachs%26aulast%3DShergalis%26aufirst%3DA.%26aulast%3DBankhead%26aufirst%3DA.%26aulast%3DLuesakul%26aufirst%3DU.%26aulast%3DMuangsin%26aufirst%3DN.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DCurrent%2520challenges%2520and%2520opportunities%2520in%2520treating%2520glioblastoma%26jtitle%3DPharmacol.%2520Rev.%26date%3D2018%26volume%3D70%26spage%3D412%26epage%3D445%26doi%3D10.1124%2Fpr.117.014944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preusser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Ribaupierre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohrer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erridge, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupp, R.</span></span> <span> </span><span class="NLM_article-title">Current concepts and management of glioblastoma</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1002/ana.22425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1002%2Fana.22425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=21786296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A280%3ADC%252BC3Mjgslylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=9-21&author=M.+Preusserauthor=S.+de+Ribaupierreauthor=A.+Wohrerauthor=S.+C.+Erridgeauthor=M.+Hegiauthor=M.+Wellerauthor=R.+Stupp&title=Current+concepts+and+management+of+glioblastoma&doi=10.1002%2Fana.22425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Current concepts and management of glioblastoma</span></div><div class="casAuthors">Preusser Matthias; de Ribaupierre Sandrine; Wohrer Adelheid; Erridge Sara C; Hegi Monika; Weller Michael; Stupp Roger</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma is the most common malignant primary brain tumor in adults.  Its often rapid clinical course, with many medical and psychosocial challenges, requires a multidisciplinary management.  Modern multimodality treatment and care improve patients' life expectancy and quality of life.  This review covers major aspects of care of glioblastoma patients with a focus on the management of common symptoms and complications.  We aim to provide a guide for clinicians confronted with glioblastoma patients in their everyday practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbRy_XNJVr7bFU0A1HOshhfW6udTcc2eZGEUg2_yI1Gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mjgslylug%253D%253D&md5=28831a878bcf73d212c011e2c9363e60</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fana.22425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22425%26sid%3Dliteratum%253Aachs%26aulast%3DPreusser%26aufirst%3DM.%26aulast%3Dde%2BRibaupierre%26aufirst%3DS.%26aulast%3DWohrer%26aufirst%3DA.%26aulast%3DErridge%26aufirst%3DS.%2BC.%26aulast%3DHegi%26aufirst%3DM.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DStupp%26aufirst%3DR.%26atitle%3DCurrent%2520concepts%2520and%2520management%2520of%2520glioblastoma%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D70%26spage%3D9%26epage%3D21%26doi%3D10.1002%2Fana.22425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallego, O.</span></span> <span> </span><span class="NLM_article-title">Nonsurgical treatment of recurrent glioblastoma</span>. <i>Curr. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">e273</span>– <span class="NLM_lpage">e281</span>, <span class="refDoi"> DOI: 10.3747/co.22.2436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3747%2Fco.22.2436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26300678" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=e273-e281&author=O.+Gallego&title=Nonsurgical+treatment+of+recurrent+glioblastoma&doi=10.3747%2Fco.22.2436"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3747%2Fco.22.2436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3747%252Fco.22.2436%26sid%3Dliteratum%253Aachs%26aulast%3DGallego%26aufirst%3DO.%26atitle%3DNonsurgical%2520treatment%2520of%2520recurrent%2520glioblastoma%26jtitle%3DCurr.%2520Oncol.%26date%3D2015%26volume%3D22%26spage%3De273%26epage%3De281%26doi%3D10.3747%2Fco.22.2436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahiri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, J.</span></span> <span> </span><span class="NLM_article-title">Recurrent glioblastoma: Where we stand</span>. <i>South Asian J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.4103/2278-330X.175953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.4103%2F2278-330X.175953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26981507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A280%3ADC%252BC28fgvVWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=163-173&author=S.+Royauthor=D.+Lahiriauthor=T.+Majiauthor=J.+Biswas&title=Recurrent+glioblastoma%3A+Where+we+stand&doi=10.4103%2F2278-330X.175953"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Recurrent Glioblastoma: Where we stand</span></div><div class="casAuthors">Roy Sanjoy; Lahiri Debarshi; Maji Tapas; Biswas Jaydip</div><div class="citationInfo"><span class="NLM_cas:title">South Asian journal of cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">163-73</span>
        ISSN:<span class="NLM_cas:issn">2278-330X</span>.
    </div><div class="casAbstract">Current first-line treatment regimens combine surgical resection and chemoradiation for Glioblastoma that provides a slight increase in overall survival.  Age on its own should not be used as an exclusion criterion of glioblastoma multiforme (GBM) treatment, but performance should be factored heavily into the decision-making process for treatment planning.  Despite aggressive initial treatment, most patients develop recurrent diseases which can be treated with re-resection, systemic treatment with targeted agents or cytotoxic chemotherapy, reirradiation, or radiosurgery.  Research into novel therapies is investigating alternative temozolomide regimens, convection-enhanced delivery, immunotherapy, gene therapy, antiangiogenic agents, poly ADP ribose polymerase inhibitors, or cancer stem cell signaling pathways.  Given the aggressive and resilient nature of GBM, continued efforts to better understand GBM pathophysiology are required to discover novel targets for future therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyHsYASlwm3xOk4JA3soTqfW6udTcc2eYiWfWtkn-nlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fgvVWntw%253D%253D&md5=fa8c4228fa1e349a37b8957c216f18b7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4103%2F2278-330X.175953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2278-330X.175953%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DLahiri%26aufirst%3DD.%26aulast%3DMaji%26aufirst%3DT.%26aulast%3DBiswas%26aufirst%3DJ.%26atitle%3DRecurrent%2520glioblastoma%253A%2520Where%2520we%2520stand%26jtitle%3DSouth%2520Asian%2520J.%2520Cancer%26date%3D2015%26volume%3D4%26spage%3D163%26epage%3D173%26doi%3D10.4103%2F2278-330X.175953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrlinger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyerbrock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldbrunner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronellenfitsch, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciaczyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krex, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajkoczy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortmann, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehdorn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer-Steinacker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fietkau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brehmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuplich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kebir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunkl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leutgeb, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proescholdt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbach, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stummer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glas, M.</span></span> <span> </span><span class="NLM_article-title">Bevacizumab plus irinotecan versus Temozolomide in newly diagnosed O6-methylguanine-DNA methyltransferase nonmethylated glioblastoma: The randomized GLARIUS trial</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1611</span>– <span class="NLM_lpage">1619</span>, <span class="refDoi"> DOI: 10.1200/JCO.2015.63.4691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1200%2FJCO.2015.63.4691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26976423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFClsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=1611-1619&author=U.+Herrlingerauthor=N.+Schaferauthor=J.+P.+Steinbachauthor=A.+Weyerbrockauthor=P.+Hauauthor=R.+Goldbrunnerauthor=F.+Friedrichauthor=V.+Rohdeauthor=F.+Ringelauthor=U.+Schlegelauthor=M.+Sabelauthor=M.+W.+Ronellenfitschauthor=M.+Uhlauthor=J.+Maciaczykauthor=S.+Grauauthor=O.+Schnellauthor=M.+Hanelauthor=D.+Krexauthor=P.+Vajkoczyauthor=R.+Gerlachauthor=R.+D.+Kortmannauthor=M.+Mehdornauthor=J.+Tuttenbergauthor=R.+Mayer-Steinackerauthor=R.+Fietkauauthor=S.+Brehmerauthor=F.+Mackauthor=M.+Stuplichauthor=S.+Kebirauthor=R.+Kohnenauthor=E.+Dunklauthor=B.+Leutgebauthor=M.+Proescholdtauthor=T.+Pietschauthor=H.+Urbachauthor=C.+Belkaauthor=W.+Stummerauthor=M.+Glas&title=Bevacizumab+plus+irinotecan+versus+Temozolomide+in+newly+diagnosed+O6-methylguanine-DNA+methyltransferase+nonmethylated+glioblastoma%3A+The+randomized+GLARIUS+trial&doi=10.1200%2FJCO.2015.63.4691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab plus irinotecan versus temozolomide in newly diagnosed O6-methylguanine-DNA methyltransferase nonmethylated glioblastoma: the randomized GLARIUS trial</span></div><div class="casAuthors">Herrlinger, Ulrich; Schaefer, Niklas; Steinbach, Joachim P.; Weyerbrock, Astrid; Hau, Peter; Goldbrunner, Roland; Friedrich, Franziska; Rohde, Veit; Ringel, Florian; Schlegel, Uwe; Sabel, Michael; Ronellenfitsch, Michael W.; Uhl, Martin; Maciaczyk, Jaroslaw; Grau, Stefan; Schnell, Oliver; Haenel, Mathias; Krex, Dietmar; Vajkoczy, Peter; Gerlach, Ruediger; Kortmann, Rolf-Dieter; Mehdorn, Maximilian; Tuettenberg, Jochen; Mayer-Steinacker, Regine; Fietkau, Rainer; Brehmer, Stefanie; Mack, Frederic; Stuplich, Moritz; Kebir, Sied; Kohnen, Ralf; Dunkl, Elmar; Leutgeb, Barbara; Proescholdt, Martin; Pietsch, Torsten; Urbach, Horst; Belka, Claus; Stummer, Walter; Glas, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1611-1619</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">1527-7755</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose In patients with newly diagnosed glioblastoma that harbors a nonmethylated O6-methylguanine- DNA methyltransferase promotor, std. temozolomide (TMZ) has, at best, limited efficacy.  The GLARIUS trial thus explored bevacizumab plus irinotecan (BEV+IRI) as an alternative to TMZ.  Patients and Methods In this phase II, unblinded trial 182 patients in 22 centers were randomly assigned 2:1 to BEV (10mg/kg every 2 wk) during radiotherapy (RT) followed by maintenance BEV (10mg/kg every 2 wk) plus IRI(125 mg/m2 every 2 wk) or to daily TMZ (75 mg/m2) during RT followed by six courses of TMZ (150-200 mg/m2/d for 5 days every 4 wk).  The primary end point was the progression-free survival rate after 6 mo (PFS-6).  Results In the modified intention-to-treat (ITT) population, PFS-6 was increased from 42.6% with TMZ(95% CI, 29.4% to 55.8% ) to 79.3% with BEV+IRI (95% CI, 71.9% to 86.7% ; P <.001).  PFS was prolonged from a median of 5.99 mo (95% CI, 2.7 to 7.3 mo) to 9.7months (95% CI, 8.7 to 10.8months; P,.001).  At progression, crossover BEV therapy was given to 81.8% of all patients who received any sort of second-line therapy in the TMZ arm.  Overall survival (OS) was not different in the two arms: the median OSwas 16.6months (95% CI, 15.4 to 18.4 mo)with BEV+IRI and was 17.5months (95% CI, 15.1 to 20.5 mo) with TMZ.  The time course of quality of life (QOL) in six selected domains of the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire (QLQ) -C30 and QLQ-BN20 (which included cognitive functioning), of the Karnofsky performance score, and of the Mini Mental State Examn. score was not different between the treatment arms.  Conclusion BEV+IRI resulted in a superior PFS-6 rate and median PFS compared with TMZ.  However, BEV+IRI did not improve OS, potentially because of the high crossover rate.BEV+IRI did not alter QOL compared with TMZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph7PLBxQZ_fLVg90H21EOLACvtfcHk0ljwUhRK1N57kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFClsbk%253D&md5=e500df1c5e62d33ac56b9b2057552d82</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1200%2FJCO.2015.63.4691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2015.63.4691%26sid%3Dliteratum%253Aachs%26aulast%3DHerrlinger%26aufirst%3DU.%26aulast%3DSchafer%26aufirst%3DN.%26aulast%3DSteinbach%26aufirst%3DJ.%2BP.%26aulast%3DWeyerbrock%26aufirst%3DA.%26aulast%3DHau%26aufirst%3DP.%26aulast%3DGoldbrunner%26aufirst%3DR.%26aulast%3DFriedrich%26aufirst%3DF.%26aulast%3DRohde%26aufirst%3DV.%26aulast%3DRingel%26aufirst%3DF.%26aulast%3DSchlegel%26aufirst%3DU.%26aulast%3DSabel%26aufirst%3DM.%26aulast%3DRonellenfitsch%26aufirst%3DM.%2BW.%26aulast%3DUhl%26aufirst%3DM.%26aulast%3DMaciaczyk%26aufirst%3DJ.%26aulast%3DGrau%26aufirst%3DS.%26aulast%3DSchnell%26aufirst%3DO.%26aulast%3DHanel%26aufirst%3DM.%26aulast%3DKrex%26aufirst%3DD.%26aulast%3DVajkoczy%26aufirst%3DP.%26aulast%3DGerlach%26aufirst%3DR.%26aulast%3DKortmann%26aufirst%3DR.%2BD.%26aulast%3DMehdorn%26aufirst%3DM.%26aulast%3DTuttenberg%26aufirst%3DJ.%26aulast%3DMayer-Steinacker%26aufirst%3DR.%26aulast%3DFietkau%26aufirst%3DR.%26aulast%3DBrehmer%26aufirst%3DS.%26aulast%3DMack%26aufirst%3DF.%26aulast%3DStuplich%26aufirst%3DM.%26aulast%3DKebir%26aufirst%3DS.%26aulast%3DKohnen%26aufirst%3DR.%26aulast%3DDunkl%26aufirst%3DE.%26aulast%3DLeutgeb%26aufirst%3DB.%26aulast%3DProescholdt%26aufirst%3DM.%26aulast%3DPietsch%26aufirst%3DT.%26aulast%3DUrbach%26aufirst%3DH.%26aulast%3DBelka%26aufirst%3DC.%26aulast%3DStummer%26aufirst%3DW.%26aulast%3DGlas%26aufirst%3DM.%26atitle%3DBevacizumab%2520plus%2520irinotecan%2520versus%2520Temozolomide%2520in%2520newly%2520diagnosed%2520O6-methylguanine-DNA%2520methyltransferase%2520nonmethylated%2520glioblastoma%253A%2520The%2520randomized%2520GLARIUS%2520trial%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D34%26spage%3D1611%26epage%3D1619%26doi%3D10.1200%2FJCO.2015.63.4691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zetterberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, W.</span></span> <span> </span><span class="NLM_article-title">Cell-cycle-specific induction of quiescence achieved by limited inhibition of protein synthesis: Counteractive effect of addition of purified growth factors</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=3894388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADyaL2MXksVyktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1985&pages=375-387&author=O.+Larssonauthor=A.+Zetterbergauthor=W.+Engstrom&title=Cell-cycle-specific+induction+of+quiescence+achieved+by+limited+inhibition+of+protein+synthesis%3A+Counteractive+effect+of+addition+of+purified+growth+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cycle-specific induction of quiescence achieved by limited inhibition of protein synthesis:  counteractive effect of addition of purified growth factors</span></div><div class="casAuthors">Larsson, Olle; Zetterberg, Anders; Engstroem, Wilhelm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">375-87</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    </div><div class="casAbstract">Swiss 3T3 cells located in the 1st part of G1 (post-mitotic G1 cells younger than 4.0 h or G1pm cells) were arrested after 9-10 h in the cell cycle by a short (1-8 h) exposure to serum-free medium or by a short (2-4 h) exposure to low doses of the protein synthesis inhibitor cycloheximide (CH).  Cells older than 4 h, i.e. cells in mid or late G1 are already committed to DNA synthesis (presynthesis or G1ps cells).  These cells as well as S and G2 cells were consequently unaffected by the brief serum starvation or the brief treatment with cycloheximide.  The 10-h intermitotic delay that follows a 1-2 h exposure to serum-free medium was completely counteracted by the presence of any one of the purified growth factors, epidermal growth factor (EGF)  [62229-50-9], insulin  [9004-10-8], or platelet-derived growth factor (PDGF).  In contrast, the intermitotic delay following a longer exposure (8 h) to serum-free medium could no longer be counteracted by EGF or insulin.  However, a PDGF was still active in this respect.  Most interestingly, the 12 h gross intermitotic delay introduced by a 4 h exposure to CH was efficiently counteracted by EGF, PDGF, or insulin.  However, this effect on CH-treated cells was counteracted by the growth factor only in the presence of 10% serum.  This indicates the existence of a cooperative effect between PDGF, EGF, or insulin and an unidentified serum factor.  The effects on the cell cycle time of brief serum starvation and exposure to CH were compared with the effects on rate of protein synthesis and degrdn.  Although the effects of serum starvation on protein synthesis and degrdn. were partially normalized by growth factors, growth factors probably prevent cells from leaving the cell cycle by another mechanism and not merely by affecting the level of overall protein accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEKO88jVTP0LVg90H21EOLACvtfcHk0ljwUhRK1N57kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXksVyktLc%253D&md5=a37e59a7043060bfb986326719172fbb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarsson%26aufirst%3DO.%26aulast%3DZetterberg%26aufirst%3DA.%26aulast%3DEngstrom%26aufirst%3DW.%26atitle%3DCell-cycle-specific%2520induction%2520of%2520quiescence%2520achieved%2520by%2520limited%2520inhibition%2520of%2520protein%2520synthesis%253A%2520Counteractive%2520effect%2520of%2520addition%2520of%2520purified%2520growth%2520factors%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D1985%26volume%3D73%26spage%3D375%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">Cell death and endoplasmic reticulum stress: Disease relevance and therapeutic opportunities</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1013</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1038/nrd2755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fnrd2755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=19043451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVenu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1013-1030&author=I.+Kimauthor=W.+Xuauthor=J.+C.+Reed&title=Cell+death+and+endoplasmic+reticulum+stress%3A+Disease+relevance+and+therapeutic+opportunities&doi=10.1038%2Fnrd2755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities</span></div><div class="casAuthors">Kim, Inki; Xu, Wenjie; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1013-1030</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The accumulation of unfolded proteins in the endoplasmic reticulum (ER) represents a cellular stress induced by multiple stimuli and pathol. conditions.  These include hypoxia, oxidative injury, high-fat diet, hypoglycemia, protein inclusion bodies and viral infection.  ER stress triggers an evolutionarily conserved series of signal-transduction events, which constitutes the unfolded protein response.  These signaling events aim to ameliorate the accumulation of unfolded proteins in the ER; however, when these events are severe or protracted they can induce cell death.  With the increasing recognition of an assocn. between ER stress and human diseases, and with the improved understanding of the diverse underlying mol. mechanisms, novel targets for drug discovery and new strategies for therapeutic intervention are beginning to emerge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0c9ZXf8xcx7Vg90H21EOLACvtfcHk0lgIQ_fu8moRGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVenu7%252FM&md5=aee7d77ad27a21f82ea36a3854bbd449</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd2755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2755%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DCell%2520death%2520and%2520endoplasmic%2520reticulum%2520stress%253A%2520Disease%2520relevance%2520and%2520therapeutic%2520opportunities%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D1013%26epage%3D1030%26doi%3D10.1038%2Fnrd2755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. S.</span></span> <span> </span><span class="NLM_article-title">The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">818</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fonc.2012.130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22508478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls1Wns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=805-818&author=B.+Luoauthor=A.+S.+Lee&title=The+critical+roles+of+endoplasmic+reticulum+chaperones+and+unfolded+protein+response+in+tumorigenesis+and+anticancer+therapies&doi=10.1038%2Fonc.2012.130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies</span></div><div class="casAuthors">Luo, B.; Lee, A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">805-818</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer progression is characterized by rapidly proliferating cancer cells that are in need of increased protein synthesis.  Therefore, enhanced endoplasmic reticulum (ER) activity is required to facilitate the folding, assembly and transportation of membrane and secretory proteins.  These functions are carried out by ER chaperones.  It is now becoming clear that the ER chaperones have crit. functions outside of simply facilitating protein folding.  For example, cancer progression requires glucose regulated protein (GRP) 78 for cancer cell survival and proliferation, as well as angiogenesis in the microenvironment.  GRP78 can translocate to the cell surface acting as a receptor regulating oncogenic signaling and cell viability.  Calreticulin, another ER chaperone, can translocate to the cell surface of apoptotic cancer cells and induce immunogenic cancer cell death and antitumor responses in vivo.  Tumor-secreted GRP94 has been shown to elicit antitumor immune responses when used as antitumor vaccines.  Protein disulfide isomerase is another ER chaperone that demonstrates pro-oncogenic and pro-survival functions.  Because of intrinsic alterations of cellular metab. and extrinsic factors in the tumor microenvironment, cancer cells are under ER stress, and they respond to this stress by activating the unfolded protein response (UPR).  Depending on the severity and duration of ER stress, the signaling branches of the UPR can activate adaptive and pro-survival signals, or induce apoptotic cell death.  The protein kinase RNA-like ER kinase signaling branch of the UPR has a dual role in cancer proliferation and survival, and is also required for ER stress-induced autophagy.  The activation of the inositol-requiring kinase 1α branch promotes tumorigenesis, cancer cell survival and regulates tumor invasion.  In summary, perturbance of ER homeostasis has crit. roles in tumorigenesis, and therapeutic modulation of ER chaperones and/or UPR components presents potential antitumor treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUbqbHLgiJgLVg90H21EOLACvtfcHk0lgIQ_fu8moRGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls1Wns70%253D&md5=4893de5f108947c67708ac87c4d4392e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.130%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DA.%2BS.%26atitle%3DThe%2520critical%2520roles%2520of%2520endoplasmic%2520reticulum%2520chaperones%2520and%2520unfolded%2520protein%2520response%2520in%2520tumorigenesis%2520and%2520anticancer%2520therapies%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D805%26epage%3D818%26doi%3D10.1038%2Fonc.2012.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Protein disulfide isomerase: A promising target for cancer therapy</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.drudis.2013.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=24184531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvValsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=222-240&author=S.+L.+Xuauthor=S.+Sankarauthor=N.+Neamati&title=Protein+disulfide+isomerase%3A+A+promising+target+for+cancer+therapy&doi=10.1016%2Fj.drudis.2013.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Protein disulfide isomerase: a promising target for cancer therapy</span></div><div class="casAuthors">Xu, Shili; Sankar, Saranya; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-240</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein disulfide isomerase (PDI) has a key role in maintaining cellular homeostasis by mediating oxidative protein folding.  It catalyzes disulfide bond formation, breakage and rearrangement in the endoplasmic reticulum and has chaperone protein activity.  Increasing evidence suggests that PDI supports the survival and progression of several cancers.  During the past decade, robust PDI activity assays have been developed and several PDI inhibitors identified, but none has been approved for clin. use.  Herein, we review current knowledge of the role of PDI in cancer and discuss various assays for measuring the activities of PDI, highlighting their sensitivities and usefulness for high-throughput screening.  The previously reported PDI inhibitors require further validation to serve as bona fide leads and addnl. optimization to generate novel drug candidates for clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquANbcuJ6Bv7Vg90H21EOLACvtfcHk0lgIQ_fu8moRGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvValsbrM&md5=cab1d37a444bf32f1974567b7622f7e0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%2BL.%26aulast%3DSankar%26aufirst%3DS.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DProtein%2520disulfide%2520isomerase%253A%2520A%2520promising%2520target%2520for%2520cancer%2520therapy%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D222%26epage%3D240%26doi%3D10.1016%2Fj.drudis.2013.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shergalis, A.</span>; <span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Protein Disulfide Isomerase</span>. In  <i>Encyclopedia of Signaling Molecules</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>. <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">4200</span>– <span class="NLM_lpage">4211</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1007%2F978-1-4614-6438-9_101768-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=4200-4211&author=A.+Shergalis&author=N.+Neamatiauthor=S.+Choi&title=Encyclopedia+of+Signaling+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-6438-9_101768-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-6438-9_101768-1%26sid%3Dliteratum%253Aachs%26aulast%3DShergalis%26aufirst%3DA.%26atitle%3DProtein%2520Disulfide%2520Isomerase%26btitle%3DEncyclopedia%2520of%2520Signaling%2520Molecules%26aulast%3DChoi%26aufirst%3DS.%26pub%3DSpringer%26date%3D2016%26spage%3D4200%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. C.</span></span> <span> </span><span class="NLM_article-title">Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1089/ars.2012.4630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1089%2Fars.2012.4630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22657537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A280%3ADC%252BC38not1Cnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=36-45&author=C.+Wangauthor=W.+Liauthor=J.+Renauthor=J.+Fangauthor=H.+Keauthor=W.+Gongauthor=W.+Fengauthor=C.+C.+Wang&title=Structural+insights+into+the+redox-regulated+dynamic+conformations+of+human+protein+disulfide+isomerase&doi=10.1089%2Fars.2012.4630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase</span></div><div class="casAuthors">Wang Chao; Li Wei; Ren Jinqi; Fang Jingqi; Ke Huimin; Gong Weimin; Feng Wei; Wang Chih-Chen</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & redox signaling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIM:  Human protein disulfide isomerase (hPDI) is a key enzyme and a redox-regulated chaperone responsible for oxidative protein folding in the endoplasmic reticulum.  This work aims to reveal the molecular mechanism underlying the redox-regulated functions of hPDI by determining the crystal structures of hPDI in different redox states.  RESULTS:  The structures of hPDI (abb'xa') in both the reduced and oxidized states showed that the four thioredoxin domains of a, b, b', and a' are arranged as a horseshoe shape with two CGHC active sites, respectively, in domains a and a' facing each other at the two ends.  In reduced hPDI, domains a, b, and b' line up in the same plane, whereas domain a' twists ∼45° out.  The two active sites are 27.6 ÅA apart.  In oxidized hPDI, the four domains are differently organized to stay in the same plane, and the distance between the active sites increases to 40.3 ÅA.  In contrast to the closed conformation of reduced hPDI, oxidized hPDI exists in an open state with more exposed hydrophobic areas and a larger cleft with potential for substrate binding.  INNOVATION:  This is the first report of the high-resolution structures of hPDI containing all four domains in both the reduced and the oxidized states.  It reveals the redox-regulated structural dynamic properties of the protein.  CONCLUSION:  The redox-regulated open/closed conformational switch of hPDI endows the protein with versatile target-binding capacities for its enzymatic and chaperone functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWKKds5MV7mi86Js-BCLiifW6udTcc2eZN2NgjaOMpVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38not1Cnug%253D%253D&md5=ff87e33dc426c3d2a8ad7c76d8a27635</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.4630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.4630%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DC.%2BC.%26atitle%3DStructural%2520insights%2520into%2520the%2520redox-regulated%2520dynamic%2520conformations%2520of%2520human%2520protein%2520disulfide%2520isomerase%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2013%26volume%3D19%26spage%3D36%26epage%3D45%26doi%3D10.1089%2Fars.2012.4630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, R. Q.</span></span> <span> </span><span class="NLM_article-title">The acidic C-terminal domain stabilizes the chaperone function of protein disulfide isomerase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">48830</span>– <span class="NLM_lpage">48835</span>, <span class="refDoi"> DOI: 10.1074/jbc.M407076200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1074%2Fjbc.M407076200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=48830-48835&author=R.+Tianauthor=S.+J.+Liauthor=D.+L.+Wangauthor=Z.+Zhaoauthor=Y.+Liuauthor=R.+Q.+He&title=The+acidic+C-terminal+domain+stabilizes+the+chaperone+function+of+protein+disulfide+isomerase&doi=10.1074%2Fjbc.M407076200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M407076200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M407076200%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DD.%2BL.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DR.%2BQ.%26atitle%3DThe%2520acidic%2520C-terminal%2520domain%2520stabilizes%2520the%2520chaperone%2520function%2520of%2520protein%2520disulfide%2520isomerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D48830%26epage%3D48835%26doi%3D10.1074%2Fjbc.M407076200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, G. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways</span>. <i>Neuro. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.1093/neuonc/not005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1093%2Fneuonc%2Fnot005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=23444257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVOqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=562-577&author=S.+Sunauthor=D.+Leeauthor=A.+S.+Hoauthor=J.+K.+Puauthor=X.+Q.+Zhangauthor=N.+P.+Leeauthor=P.+J.+Dayauthor=W.+M.+Luiauthor=C.+F.+Fungauthor=G.+K.+Leung&title=Inhibition+of+prolyl+4-hydroxylase%2C+beta+polypeptide+%28P4HB%29+attenuates+temozolomide+resistance+in+malignant+glioma+via+the+endoplasmic+reticulum+stress+response+%28ERSR%29+pathways&doi=10.1093%2Fneuonc%2Fnot005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways</span></div><div class="casAuthors">Sun, Stella; Lee, Derek; Ho, Amy S. W.; Pu, Jenny K. S.; Zhang, X. Q.; Lee, Nikki P.; Day, Philip J. R.; Lui, W. M.; Fung, C. F.; Leung, Gilberto K. K.</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">562-577</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Glioblastoma multiforme (GBM), the most aggressive malignant primary brain tumor of the central nervous system, is characterized by a relentless disease recurrence despite continued advancement in surgery, radiotherapy, and chemotherapy.  Resistance to temozolomide (TMZ), a std. chemotherapeutic agent for GBM, remains a major challenge.  Understanding the mechanisms behind TMZ resistance can direct the development of novel strategies for the prevention, monitoring, and treatment of tumor relapse.  Methods and results Our research platform, based on the establishment of 2 pairs of TMZ-sensitive/resistant GBM cells (D54-S and D54-R; U87-S and U87-R), has successfully identified prolyl 4-hydroxylase, beta polypeptide (P4HB) over-expression to be assocd. with an increased IC50 of TMZ.  Elevated P4HB expression was verified using in vivo xenografts developed from U87-R cells.  Clin., we found that P4HB was relatively up-regulated in the recurrent GBM specimens that were initially responsive to TMZ but later developed acquired resistance, when compared with treatment-naive tumors.  Functionally, P4HB inhibition by RNAi knockdown and bacitracin inhibition could sensitize D54-R and U87-R cells to TMZ in vitro and in vivo, whereas over-expression of P4HB in vitro conferred resistance to TMZ in both D54-S and U87-S cells.  Moreover, targeting P4HB blocked its protective function and sensitized glioma cells to TMZ through the PERK arm of the endoplasmic reticulum stress response.  Conclusions Our study identified a novel target together with its functional pathway in the development of TMZ resistance.  P4HB inhibition may be used alone or in combination with TMZ for the treatment of TMZ-resistant GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAlJXnH663frVg90H21EOLACvtfcHk0lgSbFR5cyOmrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVOqt7c%253D&md5=6a1aba8d7c72c22bd594623f84d64267</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnot005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnot005%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DA.%2BS.%26aulast%3DPu%26aufirst%3DJ.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BQ.%26aulast%3DLee%26aufirst%3DN.%2BP.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DLui%26aufirst%3DW.%2BM.%26aulast%3DFung%26aufirst%3DC.%2BF.%26aulast%3DLeung%26aufirst%3DG.%2BK.%26atitle%3DInhibition%2520of%2520prolyl%25204-hydroxylase%252C%2520beta%2520polypeptide%2520%2528P4HB%2529%2520attenuates%2520temozolomide%2520resistance%2520in%2520malignant%2520glioma%2520via%2520the%2520endoplasmic%2520reticulum%2520stress%2520response%2520%2528ERSR%2529%2520pathways%26jtitle%3DNeuro.%2520Oncol.%26date%3D2013%26volume%3D15%26spage%3D562%26epage%3D577%26doi%3D10.1093%2Fneuonc%2Fnot005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eirich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schyschka, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servatius, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antes, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmaier, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vollmar, A. M.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibits protein disulfide isomerase and triggers the chemosensitization of cancer cells</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">12960</span>– <span class="NLM_lpage">12965</span>, <span class="refDoi"> DOI: 10.1002/anie.201406577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1002%2Fanie.201406577" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=12960-12965&author=J.+Eirichauthor=S.+Braigauthor=L.+Schyschkaauthor=P.+Servatiusauthor=J.+Hoffmannauthor=S.+Hechtauthor=S.+Fuldaauthor=S.+Zahlerauthor=I.+Antesauthor=U.+Kazmaierauthor=S.+A.+Sieberauthor=A.+M.+Vollmar&title=A+small+molecule+inhibits+protein+disulfide+isomerase+and+triggers+the+chemosensitization+of+cancer+cells&doi=10.1002%2Fanie.201406577"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fanie.201406577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201406577%26sid%3Dliteratum%253Aachs%26aulast%3DEirich%26aufirst%3DJ.%26aulast%3DBraig%26aufirst%3DS.%26aulast%3DSchyschka%26aufirst%3DL.%26aulast%3DServatius%26aufirst%3DP.%26aulast%3DHoffmann%26aufirst%3DJ.%26aulast%3DHecht%26aufirst%3DS.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DZahler%26aufirst%3DS.%26aulast%3DAntes%26aufirst%3DI.%26aulast%3DKazmaier%26aufirst%3DU.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26aulast%3DVollmar%26aufirst%3DA.%2BM.%26atitle%3DA%2520small%2520molecule%2520inhibits%2520protein%2520disulfide%2520isomerase%2520and%2520triggers%2520the%2520chemosensitization%2520of%2520cancer%2520cells%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D12960%26epage%3D12965%26doi%3D10.1002%2Fanie.201406577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovat, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corazzari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliarini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piacentini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birch-Machin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redfern, C. P.</span></span> <span> </span><span class="NLM_article-title">Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">5363</span>– <span class="NLM_lpage">5369</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-0035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1158%2F0008-5472.CAN-08-0035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=5363-5369&author=P.+E.+Lovatauthor=M.+Corazzariauthor=J.+L.+Armstrongauthor=S.+Martinauthor=V.+Pagliariniauthor=D.+Hillauthor=A.+M.+Brownauthor=M.+Piacentiniauthor=M.+A.+Birch-Machinauthor=C.+P.+Redfern&title=Increasing+melanoma+cell+death+using+inhibitors+of+protein+disulfide+isomerases+to+abrogate+survival+responses+to+endoplasmic+reticulum+stress&doi=10.1158%2F0008-5472.CAN-08-0035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-0035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-0035%26sid%3Dliteratum%253Aachs%26aulast%3DLovat%26aufirst%3DP.%2BE.%26aulast%3DCorazzari%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPagliarini%26aufirst%3DV.%26aulast%3DHill%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DPiacentini%26aufirst%3DM.%26aulast%3DBirch-Machin%26aufirst%3DM.%2BA.%26aulast%3DRedfern%26aufirst%3DC.%2BP.%26atitle%3DIncreasing%2520melanoma%2520cell%2520death%2520using%2520inhibitors%2520of%2520protein%2520disulfide%2520isomerases%2520to%2520abrogate%2520survival%2520responses%2520to%2520endoplasmic%2520reticulum%2520stress%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D5363%26epage%3D5369%26doi%3D10.1158%2F0008-5472.CAN-08-0035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vatolin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindgari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distelhorst, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilakala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reu, F. J.</span></span> <span> </span><span class="NLM_article-title">Novel protein disulfide isomerase inhibitor with anticancer activity in multiple myeloma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">3340</span>– <span class="NLM_lpage">3350</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-3099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1158%2F0008-5472.CAN-15-3099" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=3340-3350&author=S.+Vatolinauthor=J.+G.+Phillipsauthor=B.+K.+Jhaauthor=S.+Govindgariauthor=J.+Huauthor=D.+Grabowskiauthor=Y.+Parkerauthor=D.+J.+Lindnerauthor=F.+Zhongauthor=C.+W.+Distelhorstauthor=M.+R.+Smithauthor=C.+Cottaauthor=Y.+Xuauthor=S.+Chilakalaauthor=R.+R.+Kuangauthor=S.+Tallauthor=F.+J.+Reu&title=Novel+protein+disulfide+isomerase+inhibitor+with+anticancer+activity+in+multiple+myeloma&doi=10.1158%2F0008-5472.CAN-15-3099"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-3099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-3099%26sid%3Dliteratum%253Aachs%26aulast%3DVatolin%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DJ.%2BG.%26aulast%3DJha%26aufirst%3DB.%2BK.%26aulast%3DGovindgari%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DGrabowski%26aufirst%3DD.%26aulast%3DParker%26aufirst%3DY.%26aulast%3DLindner%26aufirst%3DD.%2BJ.%26aulast%3DZhong%26aufirst%3DF.%26aulast%3DDistelhorst%26aufirst%3DC.%2BW.%26aulast%3DSmith%26aufirst%3DM.%2BR.%26aulast%3DCotta%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChilakala%26aufirst%3DS.%26aulast%3DKuang%26aufirst%3DR.%2BR.%26aulast%3DTall%26aufirst%3DS.%26aulast%3DReu%26aufirst%3DF.%2BJ.%26atitle%3DNovel%2520protein%2520disulfide%2520isomerase%2520inhibitor%2520with%2520anticancer%2520activity%2520in%2520multiple%2520myeloma%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D3340%26epage%3D3350%26doi%3D10.1158%2F0008-5472.CAN-15-3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goplen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enger, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tysnes, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terzis, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laerum, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjerkvig, R.</span></span> <span> </span><span class="NLM_article-title">Protein disulfide isomerase expression is related to the invasive properties of malignant glioma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">9895</span>– <span class="NLM_lpage">9902</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-4589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1158%2F0008-5472.CAN-05-4589" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=9895-9902&author=D.+Goplenauthor=J.+Wangauthor=P.+O.+Engerauthor=B.+B.+Tysnesauthor=A.+J.+Terzisauthor=O.+D.+Laerumauthor=R.+Bjerkvig&title=Protein+disulfide+isomerase+expression+is+related+to+the+invasive+properties+of+malignant+glioma&doi=10.1158%2F0008-5472.CAN-05-4589"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-4589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-4589%26sid%3Dliteratum%253Aachs%26aulast%3DGoplen%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DEnger%26aufirst%3DP.%2BO.%26aulast%3DTysnes%26aufirst%3DB.%2BB.%26aulast%3DTerzis%26aufirst%3DA.%2BJ.%26aulast%3DLaerum%26aufirst%3DO.%2BD.%26aulast%3DBjerkvig%26aufirst%3DR.%26atitle%3DProtein%2520disulfide%2520isomerase%2520expression%2520is%2520related%2520to%2520the%2520invasive%2520properties%2520of%2520malignant%2520glioma%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D9895%26epage%3D9902%26doi%3D10.1158%2F0008-5472.CAN-05-4589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.</span></span> <span> </span><span class="NLM_article-title">Bacitracin inhibits the migration of U87-MG glioma cells via interferences of the integrin outside-in signaling pathway</span>. <i>J. Korean Neurosurg. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.3340/jkns.2016.59.2.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3340%2Fjkns.2016.59.2.106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26962415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslamsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=106-116&author=S.+Liauthor=C.+Liauthor=H.+H.+Ryuauthor=S.+H.+Limauthor=W.+Y.+Jangauthor=S.+Jung&title=Bacitracin+inhibits+the+migration+of+U87-MG+glioma+cells+via+interferences+of+the+integrin+outside-in+signaling+pathway&doi=10.3340%2Fjkns.2016.59.2.106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Bacitracin inhibits the migration of U87-MG glioma cells via interferences of the integrin outside-in signaling pathway</span></div><div class="casAuthors">Li, Songyuan; Li, Chunhao; Ryu, Hyang-Hwa; Lim, Sa-Hoe; Jang, Woo-Youl; Jung, Shin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Korean Neurosurgical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-116</span>CODEN:
                <span class="NLM_cas:coden">JKNSAI</span>;
        ISSN:<span class="NLM_cas:issn">1598-7876</span>.
    
            (<span class="NLM_cas:orgname">Korean Neurosurgical Society</span>)
        </div><div class="casAbstract">Objective : Protein disulfide isomerase (PDI) acts as a chaperone on the cell surface, and it has been reported that PDI is assocd. with the tumor cell migration and invasion.  The aims of this study are to investigate the anti-migration effect of bacitracin, which is an inhibitor of PDI, and the assocd. factor in this process.  Methods : U87-MG glioma cells were treated with bacitracin in 1.25, 2.5, 3.75, and 5.0 mM concns.  Western blot with caspase-3 was applied to evaluate the cytotoxicity of bacitracin.  Adhesion, morphol., migration assays, and organotypic brain-slice culture were performed to evaluate the effect of bacitracin to the tumor cell.  Western blot, PCR, and gelatin zymog. were performed to investigate the assocd. factors.  Thirty glioma tissues were collected following immunohistochem. and Western blot.  Results : Bacitracin showed a cytotoxicity in 3rd (p <0.05) and 4th (p <0.001) days, in 5.0 Mm concn.  The cell adhesion significantly decreased and the cells became a round shape after treated with bacitracin.  The migration ability, the expression of phosphorylated focal adhesion kinase (p-FAK) and matrix metalloproteinase-2 (MMP-2) decreased in a bacitracin dose- and time-dependent manner.  The U87-MG cells exhibited low-invasiveness in the 2.5 mM, compared with the untreated in organotypic brain-slice culture.  PDI was expressed in the tumor margin, and significantly increased with histol. glioma grades (p <0.001).  Conclusion : Bacitracin, as a functional inhibitor of PDI, decreased the phosphorylated FAK and the secreted MMP-2, which are the downstream of integrin and play a major role in cell migration and invasion, might become one of the feasible therapeutic strategies for glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIU4aZqDW09bVg90H21EOLACvtfcHk0lgQtI5kD7mOtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslamsLo%253D&md5=d04da5bc6727eb06e0afbd2810b98ee7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3340%2Fjkns.2016.59.2.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3340%252Fjkns.2016.59.2.106%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DRyu%26aufirst%3DH.%2BH.%26aulast%3DLim%26aufirst%3DS.%2BH.%26aulast%3DJang%26aufirst%3DW.%2BY.%26aulast%3DJung%26aufirst%3DS.%26atitle%3DBacitracin%2520inhibits%2520the%2520migration%2520of%2520U87-MG%2520glioma%2520cells%2520via%2520interferences%2520of%2520the%2520integrin%2520outside-in%2520signaling%2520pathway%26jtitle%3DJ.%2520Korean%2520Neurosurg.%2520Soc.%26date%3D2016%26volume%3D59%26spage%3D106%26epage%3D116%26doi%3D10.3340%2Fjkns.2016.59.2.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span> <span> </span><span class="NLM_article-title">Chalcone: A privileged structure in medicinal chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">7762</span>– <span class="NLM_lpage">7810</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnt1GkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=7762-7810&author=C.+Zhuangauthor=W.+Zhangauthor=C.+Shengauthor=W.+Zhangauthor=C.+Xingauthor=Z.+Miao&title=Chalcone%3A+A+privileged+structure+in+medicinal+chemistry&doi=10.1021%2Facs.chemrev.7b00020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone: A Privileged Structure in Medicinal Chemistry</span></div><div class="casAuthors">Zhuang, Chunlin; Zhang, Wen; Sheng, Chunquan; Zhang, Wannian; Xing, Chengguo; Miao, Zhenyuan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7762-7810</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Privileged structures have been widely used as an effective template in medicinal chem. for drug discovery.  Chalcone is a common simple scaffold found in many naturally occurring compds.  Many chalcone derivs. have also been prepd. due to their convenient synthesis.  These natural products and synthetic compds. have shown numerous interesting biol. activities with clin. potentials against various diseases.  This review aims to highlight the recent evidence of chalcone as a privileged scaffold in medicinal chem.  Multiple aspects of chalcone will be summarized herein, including the isolation of novel chalcone derivs., the development of new synthetic methodologies, the evaluation of their biol. properties, and the exploration of the mechanisms of action as well as target identification.  This review is expected to be a comprehensive, authoritative, and crit. review of the chalcone template to the chem. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4bv1ODSSNG7Vg90H21EOLACvtfcHk0lgQtI5kD7mOtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnt1GkurY%253D&md5=7cdb47c11721ca75c6f0f77a3ad2ee98</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00020%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26atitle%3DChalcone%253A%2520A%2520privileged%2520structure%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D7762%26epage%3D7810%26doi%3D10.1021%2Facs.chemrev.7b00020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanigawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, T.</span></span> <span> </span><span class="NLM_article-title">Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: A randomized controlled comparative trial with cimetidine, an H2-receptor antagonist</span>. <i>J. Gastroenterol. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">S155</span>– <span class="NLM_lpage">S160</span>, <span class="refDoi"> DOI: 10.1111/j.1440-1746.2010.06232.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1111%2Fj.1440-1746.2010.06232.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=20586860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFKgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=S155-S160&author=K.+Higuchiauthor=T.+Watanabeauthor=T.+Tanigawaauthor=K.+Tominagaauthor=Y.+Fujiwaraauthor=T.+Arakawa&title=Sofalcone%2C+a+gastroprotective+drug%2C+promotes+gastric+ulcer+healing+following+eradication+therapy+for+Helicobacter+pylori%3A+A+randomized+controlled+comparative+trial+with+cimetidine%2C+an+H2-receptor+antagonist&doi=10.1111%2Fj.1440-1746.2010.06232.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist</span></div><div class="casAuthors">Higuchi, Kazuhide; Watanabe, Toshio; Tanigawa, Tetsuya; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S155-S160</span>CODEN:
                <span class="NLM_cas:coden">JGHEEO</span>;
        ISSN:<span class="NLM_cas:issn">0815-9319</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">According to reports in Japanese patients, 1 wk of Helicobacter pylori eradication therapy alone is not adequate for healing of gastric ulcers; 7-8 wk of anti-ulcer therapy are subsequently required.  We compared a gastroprotective drug, sofalcone, and an H2-receptor antagonist, cimetidine, in terms of promoting ulcer healing after 7 wk of administration following 1 wk of eradication therapy.  Eradication therapy was administered to 64 patients with H. pylori-pos. active gastric ulcer at least 10 mm in diam., after which 32 patients each received 7 wk of ulcer treatment with sofalcone (300 mg/day) or cimetidine (800 mg/day).  The H. pylori eradication rate was 81.3% (intention-to-treat: ITT) and 81.3% (per protocol: PP) in the sofalcone group, and 62.5% (ITT) and 64.5% (PP) in the cimetidine group.  The ulcer healing rate after 8 wk was 71.9% (ITT) and 71.9% (PP) in the sofalcone group, and 71.9% (ITT) and 71.0% (PP) in the cimetidine group.  The rate of a flat pattern of scarred mucosa was 43.5% (ITT) and 43.5% (PP) in the sofalcone group, and 47.8% (ITT) and 50.0% (PP) in the cimetidine group.  No significant differences were seen between the two groups in terms of H. pylori eradication rate, ulcer healing rate and flat pattern rate.  Sofalcone promoted gastric ulcer healing during 7 wk of treatment following 1 wk of eradication therapy, and the healing rate was equiv. to that of cimetidine.  Symptom disappearance rates were significantly better in the sofalcone group than in the cimetidine group.  This may be a useful way of using a gastroprotective drug in the H. pylori era.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolkbHapLNAcLVg90H21EOLACvtfcHk0lgT1YNFw2tZMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFKgtLk%253D&md5=0c5957d8d7d42a7a6393ddaca1d99b48</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1746.2010.06232.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1746.2010.06232.x%26sid%3Dliteratum%253Aachs%26aulast%3DHiguchi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DTanigawa%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DK.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DArakawa%26aufirst%3DT.%26atitle%3DSofalcone%252C%2520a%2520gastroprotective%2520drug%252C%2520promotes%2520gastric%2520ulcer%2520healing%2520following%2520eradication%2520therapy%2520for%2520Helicobacter%2520pylori%253A%2520A%2520randomized%2520controlled%2520comparative%2520trial%2520with%2520cimetidine%252C%2520an%2520H2-receptor%2520antagonist%26jtitle%3DJ.%2520Gastroenterol.%2520Hepatol.%26date%3D2010%26volume%3D25%26spage%3DS155%26epage%3DS160%26doi%3D10.1111%2Fj.1440-1746.2010.06232.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawahara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, T.</span></span> <span> </span><span class="NLM_article-title">Sofalcone, a gastric mucosa protective agent, increases vascular endothelial growth factor via the Nrf2-heme-oxygenase-1 dependent pathway in gastric epithelial cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>398</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2010.06.124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.bbrc.2010.06.124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=2010&pages=581-584&author=A.+Shibuyaauthor=K.+Ondaauthor=H.+Kawaharaauthor=Y.+Uchiyamaauthor=H.+Nakayamaauthor=T.+Omiauthor=M.+Nagaokaauthor=H.+Matsuiauthor=T.+Hirano&title=Sofalcone%2C+a+gastric+mucosa+protective+agent%2C+increases+vascular+endothelial+growth+factor+via+the+Nrf2-heme-oxygenase-1+dependent+pathway+in+gastric+epithelial+cells&doi=10.1016%2Fj.bbrc.2010.06.124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2010.06.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2010.06.124%26sid%3Dliteratum%253Aachs%26aulast%3DShibuya%26aufirst%3DA.%26aulast%3DOnda%26aufirst%3DK.%26aulast%3DKawahara%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DH.%26aulast%3DOmi%26aufirst%3DT.%26aulast%3DNagaoka%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DHirano%26aufirst%3DT.%26atitle%3DSofalcone%252C%2520a%2520gastric%2520mucosa%2520protective%2520agent%252C%2520increases%2520vascular%2520endothelial%2520growth%2520factor%2520via%2520the%2520Nrf2-heme-oxygenase-1%2520dependent%2520pathway%2520in%2520gastric%2520epithelial%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D398%26spage%3D581%26epage%3D584%26doi%3D10.1016%2Fj.bbrc.2010.06.124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, A.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic properties of hydroxysafflor yellow A in healthy Chinese female volunteers</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2009.02.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.jep.2009.02.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2009&pages=635-638&author=Z.+Yangauthor=J.+Yangauthor=Y.+Jiaauthor=Y.+Tianauthor=A.+Wen&title=Pharmacokinetic+properties+of+hydroxysafflor+yellow+A+in+healthy+Chinese+female+volunteers&doi=10.1016%2Fj.jep.2009.02.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2009.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2009.02.026%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DA.%26atitle%3DPharmacokinetic%2520properties%2520of%2520hydroxysafflor%2520yellow%2520A%2520in%2520healthy%2520Chinese%2520female%2520volunteers%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2009%26volume%3D124%26spage%3D635%26epage%3D638%26doi%3D10.1016%2Fj.jep.2009.02.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Syam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelwahab, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Mamary, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of chalcones with anticancer activities</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6179</span>– <span class="NLM_lpage">6195</span>, <span class="refDoi"> DOI: 10.3390/molecules17066179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3390%2Fmolecules17066179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22634834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=6179-6195&author=S.+Syamauthor=S.+I.+Abdelwahabauthor=M.+A.+Al-Mamaryauthor=S.+Mohan&title=Synthesis+of+chalcones+with+anticancer+activities&doi=10.3390%2Fmolecules17066179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of chalcones with anticancer activities</span></div><div class="casAuthors">Syam, Suvitha; Abdelwahab, Siddig Ibrahim; Al-Mamary, Mohammed Ali; Mohan, Syam</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6179-6195</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Several chalcones were synthesized and their in vitro cytotoxicity against various human cell lines, including human breast adenocarcinoma cell line MCF-7, human lung adenocarcinoma cell line A549, human prostate cancer cell line PC3, human adenocarcinoma cell line HT-29 (colorectal cancer) and human normal liver cell line WRL-68 was evaluated.  Most of the compds. being active cytotoxic agents, four of them with minimal IC50 values were chosen and studied in detail with MCF-7 cells.  The compds. 1, 5, 23, and 25 were capable in eliciting apoptosis in MCF-7 cells as shown by multiparameter cytotoxicity assay and caspase-3/7, -8, and -9 activities (p < 0.05).  The ROS level showed 1.3-fold increase (p < 0.05) at the low concns. used and thus it was concluded that the compds. increased the ROS level eventually leading to apoptosis in MCF-7 cells through intrinsic as well as extrinsic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC67Q8637e47Vg90H21EOLACvtfcHk0lgT1YNFw2tZMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVektb4%253D&md5=be8bbccce7e74f468960765691cd42fc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3390%2Fmolecules17066179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules17066179%26sid%3Dliteratum%253Aachs%26aulast%3DSyam%26aufirst%3DS.%26aulast%3DAbdelwahab%26aufirst%3DS.%2BI.%26aulast%3DAl-Mamary%26aufirst%3DM.%2BA.%26aulast%3DMohan%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520chalcones%2520with%2520anticancer%2520activities%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26spage%3D6179%26epage%3D6195%26doi%3D10.3390%2Fmolecules17066179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharazmi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liljefors, T.</span></span> <span> </span><span class="NLM_article-title">Antileishmanial chalcones: Statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">4819</span>– <span class="NLM_lpage">4832</span>, <span class="refDoi"> DOI: 10.1021/jm980410m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980410m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4819-4832&author=S.+F.+Nielsenauthor=S.+B.+Christensenauthor=G.+Crucianiauthor=A.+Kharazmiauthor=T.+Liljefors&title=Antileishmanial+chalcones%3A+Statistical+design%2C+synthesis%2C+and+three-dimensional+quantitative+structure-activity+relationship+analysis&doi=10.1021%2Fjm980410m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm980410m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980410m%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DS.%2BF.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DKharazmi%26aufirst%3DA.%26aulast%3DLiljefors%26aufirst%3DT.%26atitle%3DAntileishmanial%2520chalcones%253A%2520Statistical%2520design%252C%2520synthesis%252C%2520and%2520three-dimensional%2520quantitative%2520structure-activity%2520relationship%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4819%26epage%3D4832%26doi%3D10.1021%2Fjm980410m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis of exiguaflavanone K and (±)-leachianone G</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">968</span>– <span class="NLM_lpage">969</span>, <span class="refDoi"> DOI: 10.1021/np960169j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np960169j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1996&pages=968-969&author=X.+Y.+Buauthor=Y.+L.+Li&title=Synthesis+of+exiguaflavanone+K+and+%28%C2%B1%29-leachianone+G&doi=10.1021%2Fnp960169j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fnp960169j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp960169j%26sid%3Dliteratum%253Aachs%26aulast%3DBu%26aufirst%3DX.%2BY.%26aulast%3DLi%26aufirst%3DY.%2BL.%26atitle%3DSynthesis%2520of%2520exiguaflavanone%2520K%2520and%2520%2528%25C2%25B1%2529-leachianone%2520G%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1996%26volume%3D59%26spage%3D968%26epage%3D969%26doi%3D10.1021%2Fnp960169j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeon, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6486</span>– <span class="NLM_lpage">6496</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.bmc.2015.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26337020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOmtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6486-6496&author=J.+W.+Choiauthor=B.+K.+Jangauthor=N.+C.+Choauthor=J.+H.+Parkauthor=S.+K.+Yeonauthor=E.+J.+Juauthor=Y.+S.+Leeauthor=G.+Hanauthor=A.+N.+Paeauthor=D.+J.+Kimauthor=K.+D.+Park&title=Synthesis+of+a+series+of+unsaturated+ketone+derivatives+as+selective+and+reversible+monoamine+oxidase+inhibitors&doi=10.1016%2Fj.bmc.2015.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors</span></div><div class="casAuthors">Choi, Ji Won; Jang, Bo Ko; Cho, Nam-chul; Park, Jong-Hyun; Yeon, Seul Ki; Ju, Eun Ji; Lee, Yong Sup; Han, Gyoonhee; Pae, Ae Nim; Kim, Dong Jin; Park, Ki Duk</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6486-6496</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors have synthesized three categories of α,β-unsatd. carbonyl derivs. and evaluated their MAO-A and MAO-B inhibitory activities.  Among them, compd. I including α,β-unsatd. ketone group showed the most potent and selective MAO-B inhibitory activity (IC50 human MAO-B 16 nM, >6000-fold selective vs. MAO-A) and compd. I exhibited good reversibility compared with selegiline, a well-known irreversible MAO-B inhibitor.  However, both α,β-unsatd. amide and ester derivs. exhibited weaker MAO-B inhibition potencies.  The docking studies provided insights into the possible binding modes and the key interaction sites of the synthesized MAO-B inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotgFdyaai9JrVg90H21EOLACvtfcHk0lj7pJLQqh14Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOmtL3E&md5=57992ecedb10268c48fd9cfac29d15a7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DJang%26aufirst%3DB.%2BK.%26aulast%3DCho%26aufirst%3DN.%2BC.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DYeon%26aufirst%3DS.%2BK.%26aulast%3DJu%26aufirst%3DE.%2BJ.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BD.%26atitle%3DSynthesis%2520of%2520a%2520series%2520of%2520unsaturated%2520ketone%2520derivatives%2520as%2520selective%2520and%2520reversible%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6486%26epage%3D6496%26doi%3D10.1016%2Fj.bmc.2015.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palleros, D. R.</span></span> <span> </span><span class="NLM_article-title">Solvent-free synthesis of chalcones</span>. <i>J. Chem. Educ.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1347</span>, <span class="refDoi"> DOI: 10.1021/ed081p1345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ed081p1345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsFSmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2004&pages=1345-1347&author=D.+R.+Palleros&title=Solvent-free+synthesis+of+chalcones&doi=10.1021%2Fed081p1345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Solvent-free synthesis of chalcones</span></div><div class="casAuthors">Palleros, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Education</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1347</span>CODEN:
                <span class="NLM_cas:coden">JCEDA8</span>;
        ISSN:<span class="NLM_cas:issn">0021-9584</span>.
    
            (<span class="NLM_cas:orgname">Journal of Chemical Education, Dept. of Chemistry</span>)
        </div><div class="casAbstract">The synthesis of chalcones is a typical prepn. included in introductory org. chem. labs.  It illustrates an emblematic reaction that proceeds with high atom economy and is relatively easy to perform in teaching labs.  The synthesis of 20 different chalcones in the absence of solvent is described.  Overall, it was found that the reactions proceed rapidly and afford very good yields of product.  Of the 20 chalcones investigated, 17 can be obtained in a matter of minutes by mixing the corresponding benzaldehyde and acetophenone in the presence of solid NaOH in a mortar with pestle; the yields of crude product were in the range of 81-94%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprWgmVMOQV4LVg90H21EOLACvtfcHk0lj7pJLQqh14Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsFSmsb0%253D&md5=c12b1a64e80b155cdd66dc742bd33fa1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fed081p1345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fed081p1345%26sid%3Dliteratum%253Aachs%26aulast%3DPalleros%26aufirst%3DD.%2BR.%26atitle%3DSolvent-free%2520synthesis%2520of%2520chalcones%26jtitle%3DJ.%2520Chem.%2520Educ.%26date%3D2004%26volume%3D81%26spage%3D1345%26epage%3D1347%26doi%3D10.1021%2Fed081p1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calloway, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, L. D.</span></span> <span> </span><span class="NLM_article-title">Reactions in the presence of metallic halides I beta-unsaturated ketone formation as a side reaction in Friedel-Crafts acylations</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1937</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.1021/ja01284a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01284a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1937&pages=809-811&author=N.+O.+Callowayauthor=L.+D.+Green&title=Reactions+in+the+presence+of+metallic+halides+I+beta-unsaturated+ketone+formation+as+a+side+reaction+in+Friedel-Crafts+acylations&doi=10.1021%2Fja01284a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja01284a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01284a011%26sid%3Dliteratum%253Aachs%26aulast%3DCalloway%26aufirst%3DN.%2BO.%26aulast%3DGreen%26aufirst%3DL.%2BD.%26atitle%3DReactions%2520in%2520the%2520presence%2520of%2520metallic%2520halides%2520I%2520beta-unsaturated%2520ketone%2520formation%2520as%2520a%2520side%2520reaction%2520in%2520Friedel-Crafts%2520acylations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1937%26volume%3D59%26spage%3D809%26epage%3D811%26doi%3D10.1021%2Fja01284a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sipos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirokman, F.</span></span> <span> </span><span class="NLM_article-title">Chalcon formation of different substituted acetophenones + rho-hydroxy-benzaldehyde</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">489</span>, <span class="refDoi"> DOI: 10.1038/202489a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2F202489a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=14167831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADyaF2cXktFOmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=1964&pages=489&author=G.+Siposauthor=F.+Sirokman&title=Chalcon+formation+of+different+substituted+acetophenones+%2B+rho-hydroxy-benzaldehyde&doi=10.1038%2F202489a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone formation by substituted acetophenones and p-hydroxybenzaldehyde</span></div><div class="casAuthors">Sipos, Gy.; Sirokman, F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">4931</span>),
    <span class="NLM_cas:pages">489</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">In abs. EtOH satd. with HCl, p-HOC6H4CHO reacts at room temp. with 4-hydroxy-3-nitro-, 2-hydroxy-4-nitro-, 3-hydroxy-4-nitro-, and 3-hydroxy-6-nitroacetophenone, and at high temps. with 2-hydroxy-5-nitroacetophenone as well as with 4-hydroxyacetophenone.  Only 4-hydroxy-3-nitroacetophenone, however, reacts in the presence of NaOH.  This greater reactivity in acidic medium is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZDQKKtqeqo7Vg90H21EOLACvtfcHk0li7iM3qWofOMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXktFOmu7o%253D&md5=db1f0b5312d87f83c50a144a472aa904</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F202489a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F202489a0%26sid%3Dliteratum%253Aachs%26aulast%3DSipos%26aufirst%3DG.%26aulast%3DSirokman%26aufirst%3DF.%26atitle%3DChalcon%2520formation%2520of%2520different%2520substituted%2520acetophenones%2520%252B%2520rho-hydroxy-benzaldehyde%26jtitle%3DNature%26date%3D1964%26volume%3D202%26spage%3D489%26doi%3D10.1038%2F202489a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narender, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. P.</span></span> <span> </span><span class="NLM_article-title">A simple and highly efficient method for the synthesis of chalcones by using borontrifluoride-etherate</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3177</span>– <span class="NLM_lpage">3180</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2007.03.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.tetlet.2007.03.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=3177-3180&author=T.+Narenderauthor=K.+P.+Reddy&title=A+simple+and+highly+efficient+method+for+the+synthesis+of+chalcones+by+using+borontrifluoride-etherate&doi=10.1016%2Fj.tetlet.2007.03.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.03.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.03.054%26sid%3Dliteratum%253Aachs%26aulast%3DNarender%26aufirst%3DT.%26aulast%3DReddy%26aufirst%3DK.%2BP.%26atitle%3DA%2520simple%2520and%2520highly%2520efficient%2520method%2520for%2520the%2520synthesis%2520of%2520chalcones%2520by%2520using%2520borontrifluoride-etherate%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D3177%26epage%3D3180%26doi%3D10.1016%2Fj.tetlet.2007.03.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koketsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span> <span> </span><span class="NLM_article-title">Newly synthesized ’hidabeni’ chalcone derivatives potently suppress LPS-induced NO production via inhibition of STAT1, but not NF-kappaB, JNK, and p38, pathways in microglia</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1042</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1248/bpb.b14-00116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1248%2Fbpb.b14-00116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=24882415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKnu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=1042-1049&author=H.+Haraauthor=R.+Ikedaauthor=M.+Ninomiyaauthor=T.+Kamiyaauthor=M.+Koketsuauthor=T.+Adachi&title=Newly+synthesized+%E2%80%99hidabeni%E2%80%99+chalcone+derivatives+potently+suppress+LPS-induced+NO+production+via+inhibition+of+STAT1%2C+but+not+NF-kappaB%2C+JNK%2C+and+p38%2C+pathways+in+microglia&doi=10.1248%2Fbpb.b14-00116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Newly synthesized 'Hidabeni' chalcone derivatives potently suppress LPS-induced NO production via inhibition of STAT1, but not NF-κB, JNK, and p38, pathways in microglia</span></div><div class="casAuthors">Hara, Hirokazu; Ikeda, Ryoko; Ninomiya, Masayuki; Kamiya, Tetsuro; Koketsu, Mamoru; Adachi, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1042-1049</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A series of chalcone derivs. I [R1 = R2 = H, OH, MeO; R3 = R4 = H, MeO; R5 = H,HO] were synthesized and explored for their potent NO inhibitory activity.  The compds. were synthesized based on 'hidabeni' chalcone and examd. for their effects on LPS-triggered inducible NO synthase (iNOS) expression and NO prodn.  Compds. I [R1 = R2 = R3 = R4 = MeO; R5 = H, HO] potently inhibited NO prodn. (IC50: 4.19, 2.88μM, resp.).  Compds. I [R1 = R2 = R3 = R4 = MeO; R5 = H, HO] suppressed LPS-induced iNOS expression via the inhibition of the signal transduction and activator of transcription 1 (STAT1), but not nuclear factor-kappa B (NF-κB), c-Jun N terminal kinase (JNK) and p38 pathways.  Compd. I [R1 = R2 = R3 = R4 = MeO; R5 = H], but not [R1 = R2 = R3 = R4 = MeO; R5 = OH], inhibited activation of the MEK/extracellular signal-regulated kinase (ERK) pathway.  Compds. I [R1 = R2 = R3 = R4 = MeO; R5 = H, OH] also suppressed LPS-induced expression of interferon regulatory factor 1 (IRF-1), which is an important transcription factor involved in iNOS expression.  Our findings indicate that these chalcone derivs. I were candidate compds. for preventing microglia-mediated neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwmsq0o1Fs-LVg90H21EOLACvtfcHk0li7iM3qWofOMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKnu7jE&md5=df19eaf1cde96581417531e3637dc288</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b14-00116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b14-00116%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DR.%26aulast%3DNinomiya%26aufirst%3DM.%26aulast%3DKamiya%26aufirst%3DT.%26aulast%3DKoketsu%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DT.%26atitle%3DNewly%2520synthesized%2520%25E2%2580%2599hidabeni%25E2%2580%2599%2520chalcone%2520derivatives%2520potently%2520suppress%2520LPS-induced%2520NO%2520production%2520via%2520inhibition%2520of%2520STAT1%252C%2520but%2520not%2520NF-kappaB%252C%2520JNK%252C%2520and%2520p38%252C%2520pathways%2520in%2520microglia%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2014%26volume%3D37%26spage%3D1042%26epage%3D1049%26doi%3D10.1248%2Fbpb.b14-00116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochizuki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koketsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effects of chalcone glycosides isolated from Brassica rapa L. ’hidabeni’ and their synthetic derivatives on LPS-induced NO production in microglia</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5559</span>– <span class="NLM_lpage">5568</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.bmc.2011.07.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=5559-5568&author=H.+Haraauthor=Y.+Nakamuraauthor=M.+Ninomiyaauthor=R.+Mochizukiauthor=T.+Kamiyaauthor=E.+Aizenmanauthor=M.+Koketsuauthor=T.+Adachi&title=Inhibitory+effects+of+chalcone+glycosides+isolated+from+Brassica+rapa+L.+%E2%80%99hidabeni%E2%80%99+and+their+synthetic+derivatives+on+LPS-induced+NO+production+in+microglia&doi=10.1016%2Fj.bmc.2011.07.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNinomiya%26aufirst%3DM.%26aulast%3DMochizuki%26aufirst%3DR.%26aulast%3DKamiya%26aufirst%3DT.%26aulast%3DAizenman%26aufirst%3DE.%26aulast%3DKoketsu%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DT.%26atitle%3DInhibitory%2520effects%2520of%2520chalcone%2520glycosides%2520isolated%2520from%2520Brassica%2520rapa%2520L.%2520%25E2%2580%2599hidabeni%25E2%2580%2599%2520and%2520their%2520synthetic%2520derivatives%2520on%2520LPS-induced%2520NO%2520production%2520in%2520microglia%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D5559%26epage%3D5568%26doi%3D10.1016%2Fj.bmc.2011.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narender, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkateswarlu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayak, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span> <span> </span><span class="NLM_article-title">A new chemical access for 3 ’-acetyl-4 ’ hydroxychalcones using borontrifluoride-etherate via a regioselective Cilaisen-Schmidt condensation and its application in the synthesis of chalcone hybrids</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5794</span>– <span class="NLM_lpage">5798</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.08.120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.tetlet.2011.08.120" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=5794-5798&author=T.+Narenderauthor=K.+Venkateswarluauthor=B.+V.+Nayakauthor=S.+Sarkar&title=A+new+chemical+access+for+3+%E2%80%99-acetyl-4+%E2%80%99+hydroxychalcones+using+borontrifluoride-etherate+via+a+regioselective+Cilaisen-Schmidt+condensation+and+its+application+in+the+synthesis+of+chalcone+hybrids&doi=10.1016%2Fj.tetlet.2011.08.120"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.08.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.08.120%26sid%3Dliteratum%253Aachs%26aulast%3DNarender%26aufirst%3DT.%26aulast%3DVenkateswarlu%26aufirst%3DK.%26aulast%3DNayak%26aufirst%3DB.%2BV.%26aulast%3DSarkar%26aufirst%3DS.%26atitle%3DA%2520new%2520chemical%2520access%2520for%25203%2520%25E2%2580%2599-acetyl-4%2520%25E2%2580%2599%2520hydroxychalcones%2520using%2520borontrifluoride-etherate%2520via%2520a%2520regioselective%2520Cilaisen-Schmidt%2520condensation%2520and%2520its%2520application%2520in%2520the%2520synthesis%2520of%2520chalcone%2520hybrids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D5794%26epage%3D5798%26doi%3D10.1016%2Fj.tetlet.2011.08.120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meltzer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madras, B. K.</span></span> <span> </span><span class="NLM_article-title">1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: A promising class of monoamine uptake inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1420</span>– <span class="NLM_lpage">1432</span>, <span class="refDoi"> DOI: 10.1021/jm050797a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050797a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1420-1432&author=P.+C.+Meltzerauthor=D.+Butlerauthor=J.+R.+Deschampsauthor=B.+K.+Madras&title=1-%284-Methylphenyl%29-2-pyrrolidin-1-yl-pentan-1-one+%28pyrovalerone%29+analogues%3A+A+promising+class+of+monoamine+uptake+inhibitors&doi=10.1021%2Fjm050797a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">1-(4-Methylphenyl)-2-pyrrolidin-1-ylpentan-1-one (Pyrovalerone) Analogs: A Promising Class of Monoamine Uptake Inhibitors</span></div><div class="casAuthors">Meltzer, Peter C.; Butler, David; Deschamps, Jeffrey R.; Madras, Bertha K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1420-1432</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dopamine, serotonin, and norepinephrine are essential for neurotransmission in the mammalian system.  These three neurotransmitters have been the focus of considerable research because the modulation of their prodn. and their interaction at monoamine receptors has profound effects upon a multitude of pharmacol. outcomes.  Our interest has focused on neurotransmitter reuptake mechanisms in a search for medications for cocaine abuse.  Herein we describe the synthesis and biol. evaluation of an array of 2-aminopentanophenones.  This array has yielded selective inhibitors of the dopamine and norepinephrine transporters with little effect upon serotonin trafficking.  A subset of compds. had no significant affinity at 5HT1A, 5HT1B, 5HT1C, D1, D2, or D3 receptors.  The lead compd., racemic 1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one, was resolved into its enantiomers and the S isomer was found to be the most biol. active enantiomer.  Among the most potent of these DAT/NET selective compds. are the 1-(3,4-dichlorophenyl)- and the 1-naphthyl-2-pyrrolidin-1-ylpentan-1-one analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo5tyfBb2fyLVg90H21EOLACvtfcHk0lic2T1fcqv7GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWnsA%253D%253D&md5=36d96d6d50901467657e649d8bc0e9d3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm050797a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050797a%26sid%3Dliteratum%253Aachs%26aulast%3DMeltzer%26aufirst%3DP.%2BC.%26aulast%3DButler%26aufirst%3DD.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DMadras%26aufirst%3DB.%2BK.%26atitle%3D1-%25284-Methylphenyl%2529-2-pyrrolidin-1-yl-pentan-1-one%2520%2528pyrovalerone%2529%2520analogues%253A%2520A%2520promising%2520class%2520of%2520monoamine%2520uptake%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1420%26epage%3D1432%26doi%3D10.1021%2Fjm050797a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T. J. J.</span></span> <span> </span><span class="NLM_article-title">Sequential coupling-isomerization-coupling reactions - A novel three-component synthesis of aryl chalcones</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2006</i></span>,  <span class="NLM_fpage">3469</span>– <span class="NLM_lpage">3473</span>, <span class="refDoi"> DOI: 10.1055/s-2006-956480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1055%2Fs-2006-956480" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=3469-3473&author=W.+W.+Liaoauthor=T.+J.+J.+Muller&title=Sequential+coupling-isomerization-coupling+reactions+-+A+novel+three-component+synthesis+of+aryl+chalcones&doi=10.1055%2Fs-2006-956480"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-956480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-956480%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DW.%2BW.%26aulast%3DMuller%26aufirst%3DT.%2BJ.%2BJ.%26atitle%3DSequential%2520coupling-isomerization-coupling%2520reactions%2520-%2520A%2520novel%2520three-component%2520synthesis%2520of%2520aryl%2520chalcones%26jtitle%3DSynlett%26date%3D2006%26volume%3D2006%26spage%3D3469%26epage%3D3473%26doi%3D10.1055%2Fs-2006-956480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazzotti, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Palladium(III)-catalyzed fluorination of arylboronic acid derivatives</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">14012</span>– <span class="NLM_lpage">14015</span>, <span class="refDoi"> DOI: 10.1021/ja405919z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja405919z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVGjtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=14012-14015&author=A.+R.+Mazzottiauthor=M.+G.+Campbellauthor=P.+Tangauthor=J.+M.+Murphyauthor=T.+Ritter&title=Palladium%28III%29-catalyzed+fluorination+of+arylboronic+acid+derivatives&doi=10.1021%2Fja405919z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(III)-Catalyzed Fluorination of Arylboronic Acid Derivatives</span></div><div class="casAuthors">Mazzotti, Anthony R.; Campbell, Michael G.; Tang, Pingping; Murphy, Jennifer M.; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">14012-14015</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical, palladium-catalyzed synthesis of aryl fluorides from arylboronic acid derivs. is presented.  The reaction is operationally simple and amenable to multigram-scale synthesis.  Evaluation of the reaction mechanism suggests a single-electron-transfer pathway, involving a Pd-(III) intermediate that has been isolated and characterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4K_B4IfFEArVg90H21EOLACvtfcHk0lic2T1fcqv7GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVGjtLrL&md5=354937ee43479f7daaa0b0f9c51e3d01</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja405919z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja405919z%26sid%3Dliteratum%253Aachs%26aulast%3DMazzotti%26aufirst%3DA.%2BR.%26aulast%3DCampbell%26aufirst%3DM.%2BG.%26aulast%3DTang%26aufirst%3DP.%26aulast%3DMurphy%26aufirst%3DJ.%2BM.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DPalladium%2528III%2529-catalyzed%2520fluorination%2520of%2520arylboronic%2520acid%2520derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D14012%26epage%3D14015%26doi%3D10.1021%2Fja405919z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkevich, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zandi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petasis, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">16348</span>– <span class="NLM_lpage">16353</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205226109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1073%2Fpnas.1205226109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22988091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGktLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=16348-16353&author=S.+Xuauthor=A.+N.+Butkevichauthor=R.+Yamadaauthor=Y.+Zhouauthor=B.+Debnathauthor=R.+Duncanauthor=E.+Zandiauthor=N.+A.+Petasisauthor=N.+Neamati&title=Discovery+of+an+orally+active+small-molecule+irreversible+inhibitor+of+protein+disulfide+isomerase+for+ovarian+cancer+treatment&doi=10.1073%2Fpnas.1205226109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment</span></div><div class="casAuthors">Xu, Shili; Butkevich, Alexey N.; Yamada, Roppei; Zhou, Yu; Debnath, Bikash; Duncan, Roger; Zandi, Ebrahim; Petasis, Nicos A.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">16348-16353, S16348/1-S16348/18</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Protein disulfide isomerase (PDI), an endoplasmic reticulum chaper-one protein, catalyzes disulfide bond breakage, formation, and rearrangement.  The effect of PDI inhibition on ovarian cancer progression is not yet clear, and there is a need for potent selective, and safe small-mol. inhibitors of PDI.  Here, we report a class of propynoic acid carbamoyl Me amides (PACMAs) that are active against a panel of human ovarian cancer cell lines.  Using fluorescent derivs., 2D gel electrophoresis, and MS, we established that one of the most active analogs, acts as an irreversible small-mol. inhibitor of PDI, forming a covalent bond with the active site cysteines of PDI.  We also showed that PDI activity is essential for the survival and proliferation of human ovarian cancer cells.  In vivo that compd. showed tumor targeting ability and significantly suppressed ovarian tumor growth without causing toxicity to normal tissues.  These irreversible small-mol. PDI inhibitors represent an important approach for the development of targeted anticancer agents for ovarian cancer therapy, and they can also serve as useful probes for investigating the biol. of PDI-implicated pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozZP4n4am-hLVg90H21EOLACvtfcHk0lhHTYzyQCAQXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGktLzE&md5=26801591b73d67710e06ef184ee9ddde</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205226109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205226109%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%26aulast%3DButkevich%26aufirst%3DA.%2BN.%26aulast%3DYamada%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDebnath%26aufirst%3DB.%26aulast%3DDuncan%26aufirst%3DR.%26aulast%3DZandi%26aufirst%3DE.%26aulast%3DPetasis%26aufirst%3DN.%2BA.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520active%2520small-molecule%2520irreversible%2520inhibitor%2520of%2520protein%2520disulfide%2520isomerase%2520for%2520ovarian%2520cancer%2520treatment%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D16348%26epage%3D16353%26doi%3D10.1073%2Fpnas.1205226109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simizu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawatani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osada, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.1021/cb100387r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100387r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=245-251&author=M.+M.+Khanauthor=S.+Simizuauthor=N.+S.+Laiauthor=M.+Kawataniauthor=T.+Shimizuauthor=H.+Osada&title=Discovery+of+a+small+molecule+PDI+inhibitor+that+inhibits+reduction+of+HIV-1+envelope+glycoprotein+gp120&doi=10.1021%2Fcb100387r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fcb100387r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100387r%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DM.%2BM.%26aulast%3DSimizu%26aufirst%3DS.%26aulast%3DLai%26aufirst%3DN.%2BS.%26aulast%3DKawatani%26aufirst%3DM.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DOsada%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520a%2520small%2520molecule%2520PDI%2520inhibitor%2520that%2520inhibits%2520reduction%2520of%2520HIV-1%2520envelope%2520glycoprotein%2520gp120%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D245%26epage%3D251%26doi%3D10.1021%2Fcb100387r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B. T.</span></span> <span> </span><span class="NLM_article-title">Characterization of the estradiol-binding site structure of human pancreas-specific protein disulfide isomerase: Indispensable role of the hydrogen bond between His278 and the estradiol 3-hydroxyl group</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1021/bi101451g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi101451g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGmsrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=106-115&author=X.+M.+Fuauthor=P.+Wangauthor=B.+T.+Zhu&title=Characterization+of+the+estradiol-binding+site+structure+of+human+pancreas-specific+protein+disulfide+isomerase%3A+Indispensable+role+of+the+hydrogen+bond+between+His278+and+the+estradiol+3-hydroxyl+group&doi=10.1021%2Fbi101451g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Estradiol-Binding Site Structure of Human Pancreas-Specific Protein Disulfide Isomerase: Indispensable Role of the Hydrogen Bond between His278 and the Estradiol 3-Hydroxyl Group</span></div><div class="casAuthors">Fu, Xin-Miao; Wang, Pan; Zhu, Bao Ting</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-115</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Estradiol (E2), a female sex hormone, has important biol. functions.  Human pancreas-specific protein disulfide isomerase (PDIp), a protein folding catalyst, was recently found to be able to bind E2.  Here we report the characterization of its E2-binding site by using biochem. methods coupled with mol. modeling tools.  Anal. of various truncated PDIp proteins showed that the b-b' fragment contains an intact E2-binding site that has the same binding affinity as the full-length PDIp protein, with apparent Kd values of approx. 170 nM.  Computational modeling and docking analyses revealed that the E2-binding site in the b-b' fragment is located in a hydrophobic pocket composed mainly of the b' domain and partially of the b domain.  The hydrogen bond, formed between the 3-hydroxyl group of E2 (donor) and PDIp's His278 (acceptor), is indispensable for its binding.  By contrast, the 17β-hydroxyl group of E2 is of negligible importance for E2 binding.  This binding model was jointly confirmed by a series of expts., such as selective mutation of the binding site amino acid residues and selective modification of the ligand structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphkGNCUq_vDLVg90H21EOLACvtfcHk0lhHTYzyQCAQXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGmsrfM&md5=451cb61264566e553c4b5906d28dc38b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi101451g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi101451g%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%2BM.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DB.%2BT.%26atitle%3DCharacterization%2520of%2520the%2520estradiol-binding%2520site%2520structure%2520of%2520human%2520pancreas-specific%2520protein%2520disulfide%2520isomerase%253A%2520Indispensable%2520role%2520of%2520the%2520hydrogen%2520bond%2520between%2520His278%2520and%2520the%2520estradiol%25203-hydroxyl%2520group%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D106%26epage%3D115%26doi%3D10.1021%2Fbi101451g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowley, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stopa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furie, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaumenhaft, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furie, B.</span></span> <span> </span><span class="NLM_article-title">Quercetin-3-rutinoside inhibits protein disulfide isomerase by binding to its b′x domain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">23543</span>– <span class="NLM_lpage">23552</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.666180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1074%2Fjbc.M115.666180" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=23543-23552&author=L.+Linauthor=S.+Gopalauthor=A.+Shardaauthor=F.+Passamauthor=S.+R.+Bowleyauthor=J.+Stopaauthor=G.+Xueauthor=C.+Yuanauthor=B.+C.+Furieauthor=R.+Flaumenhaftauthor=M.+Huangauthor=B.+Furie&title=Quercetin-3-rutinoside+inhibits+protein+disulfide+isomerase+by+binding+to+its+b%E2%80%B2x+domain&doi=10.1074%2Fjbc.M115.666180"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.666180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.666180%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DGopal%26aufirst%3DS.%26aulast%3DSharda%26aufirst%3DA.%26aulast%3DPassam%26aufirst%3DF.%26aulast%3DBowley%26aufirst%3DS.%2BR.%26aulast%3DStopa%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DG.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DFurie%26aufirst%3DB.%2BC.%26aulast%3DFlaumenhaft%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DFurie%26aufirst%3DB.%26atitle%3DQuercetin-3-rutinoside%2520inhibits%2520protein%2520disulfide%2520isomerase%2520by%2520binding%2520to%2520its%2520b%25E2%2580%25B2x%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D23543%26epage%3D23552%26doi%3D10.1074%2Fjbc.M115.666180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hetz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, H. P.</span></span> <span> </span><span class="NLM_article-title">Targeting the unfolded protein response in disease</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1038/nrd3976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fnrd3976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=23989796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCgt7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=703-719&author=C.+Hetzauthor=E.+Chevetauthor=H.+P.+Harding&title=Targeting+the+unfolded+protein+response+in+disease&doi=10.1038%2Fnrd3976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the unfolded protein response in disease</span></div><div class="casAuthors">Hetz, Claudio; Chevet, Eric; Harding, Heather P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">703-719</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Stress induced by the accumulation of unfolded proteins in the endoplasmic reticulum (ER) is a feature of specialized secretory cells and is also obsd. in many diseases, including cancer, diabetes, autoimmune conditions, liver disorders, obesity and neurodegenerative disorders.  Cellular adaptation to ER stress is achieved by the activation of the unfolded protein response, which is an integrated signal transduction pathway that modulates many aspects of ER physiol.  When these mechanisms of adaptation are insufficient to handle the unfolded protein load, cells undergo apoptosis.  Here, we discuss recent advances in the design of novel compds. and therapeutic strategies to manipulate levels of ER stress in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFF-GKfocCubVg90H21EOLACvtfcHk0lgkc7ZaBU14Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCgt7jL&md5=9d6b6ca5e39f55efc81ebb4deda0157b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrd3976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3976%26sid%3Dliteratum%253Aachs%26aulast%3DHetz%26aufirst%3DC.%26aulast%3DChevet%26aufirst%3DE.%26aulast%3DHarding%26aufirst%3DH.%2BP.%26atitle%3DTargeting%2520the%2520unfolded%2520protein%2520response%2520in%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D703%26epage%3D719%26doi%3D10.1038%2Fnrd3976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martianov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramadass, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra Barros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akoulitchev, A.</span></span> <span> </span><span class="NLM_article-title">Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>445</i></span>,  <span class="NLM_fpage">666</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1038/nature05519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fnature05519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=17237763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=445&publication_year=2007&pages=666-670&author=I.+Martianovauthor=A.+Ramadassauthor=A.+Serra+Barrosauthor=N.+Chowauthor=A.+Akoulitchev&title=Repression+of+the+human+dihydrofolate+reductase+gene+by+a+non-coding+interfering+transcript&doi=10.1038%2Fnature05519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript</span></div><div class="casAuthors">Martianov, Igor; Ramadass, Aroul; Serra Barros, Ana; Chow, Natalie; Akoulitchev, Alexandre</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">445</span>
        (<span class="NLM_cas:issue">7128</span>),
    <span class="NLM_cas:pages">666-670</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alternative promoters within the same gene are a general phenomenon in gene expression.  Mechanisms of their selective regulation vary from one gene to another and are still poorly understood.  Here we show that in quiescent cells the mechanism of transcriptional repression of the major promoter of the gene encoding dihydrofolate reductase depends on a non-coding transcript initiated from the upstream minor promoter and involves both the direct interaction of the RNA and promoter-specific interference.  The specificity and efficiency of repression is ensured by the formation of a stable complex between non-coding RNA and the major promoter, direct interaction of the non-coding RNA with the general transcription factor IIB and dissocn. of the preinitiation complex from the major promoter.  By using in vivo and in vitro assays such as inducible and reconstituted transcription, RNA bandshifts, RNA interference, chromatin immunopptn. and RNA immunopptn., it has been shown that the regulatory transcript produced from the minor promoter has a crit. function in an epigenetic mechanism of promoter-specific transcriptional repression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtJY89lCAgJ7Vg90H21EOLACvtfcHk0lgkc7ZaBU14Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOrtbw%253D&md5=c29ddf95256f2a6c3d71c9491640ee90</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnature05519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05519%26sid%3Dliteratum%253Aachs%26aulast%3DMartianov%26aufirst%3DI.%26aulast%3DRamadass%26aufirst%3DA.%26aulast%3DSerra%2BBarros%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DN.%26aulast%3DAkoulitchev%26aufirst%3DA.%26atitle%3DRepression%2520of%2520the%2520human%2520dihydrofolate%2520reductase%2520gene%2520by%2520a%2520non-coding%2520interfering%2520transcript%26jtitle%3DNature%26date%3D2007%26volume%3D445%26spage%3D666%26epage%3D670%26doi%3D10.1038%2Fnature05519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eischen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span> <span> </span><span class="NLM_article-title">The potential roles of long noncoding RNAs (lncRNA) in glioblastoma development</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2977</span>– <span class="NLM_lpage">2986</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1158%2F1535-7163.MCT-16-0320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=27784795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFynt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=2977-2986&author=S.+Liuauthor=R.+Mitraauthor=M.+M.+Zhaoauthor=W.+Fanauthor=C.+M.+Eischenauthor=F.+Yinauthor=Z.+Zhao&title=The+potential+roles+of+long+noncoding+RNAs+%28lncRNA%29+in+glioblastoma+development&doi=10.1158%2F1535-7163.MCT-16-0320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Potential Roles of Long Noncoding RNAs (lncRNA) in Glioblastoma Development</span></div><div class="casAuthors">Liu, Shuang; Mitra, Ramkrishna; Zhao, Ming-Ming; Fan, Wenhong; Eischen, Christine M.; Yin, Feng; Zhao, Zhongming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2977-2986</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Long noncoding RNA (lncRNA) may contribute to the initiation and progression of tumor.  In this study, we first systematically compared lncRNA and mRNA expression between glioblastoma and paired normal brain tissues using microarray data.  We found 27 lncRNA and 82 mRNA significantly upregulated in glioblastoma, as well as 198 lncRNA and 285 mRNA significantly downregulated in glioblastoma.  We identified 138 coexpressed lncRNA-mRNA pairs from these differentially expressed lncRNA and genes.  Subsequent pathway anal. of the lncRNA-paired genes indicated that EphrinB-EPHB, p75-mediated signaling, TNFα/NF-κB, and ErbB2/ErbB3 signaling pathways might be altered in glioblastoma.  Specifically, lncRNA RAMP2-AS1 had significant decrease of expression in glioblastoma tissues and showed coexpressional relationship with NOTCH3, an important tumor promoter in many neoplastic diseases.  Our follow up expt. indicated that (i) an overexpression of RAMP2-AS1 reduced glioblastoma cell proliferation in vitro and also reduced glioblastoma xenograft tumors in vivo; (ii) NOTCH3 and RAMP2-AS1 coexpression rescued the inhibitory action of RAMP2-AS1 in glioblastoma cells; and (iii) RNA pull-down assay revealed a direct interaction of RAMP2-AS1 with DHC10, which may consequently inhibit, as we hypothesize, the expression of NOTCH3 and its downstream signaling mol. HES1 in glioblastoma.  Taken together, our data revealed that lncRNA expression profile in glioblastoma tissue was significantly altered; and RAMP2-AS1 might play a tumor suppressive role in glioblastoma through an indirect inhibition of NOTCH3.  Our results provided some insights into understanding the key roles of lncRNA-mRNA coregulation in human glioblastoma and the mechanisms responsible for glioblastoma progression and pathogenesis.  Mol Cancer Ther; 15(12); 2977-86. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-b-bEcD1nbrVg90H21EOLACvtfcHk0lgkc7ZaBU14Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFynt73J&md5=78b769c8d7abfb53c1bfbb9ceca32b64</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0320%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMitra%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DM.%2BM.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DEischen%26aufirst%3DC.%2BM.%26aulast%3DYin%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DThe%2520potential%2520roles%2520of%2520long%2520noncoding%2520RNAs%2520%2528lncRNA%2529%2520in%2520glioblastoma%2520development%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D2977%26epage%3D2986%26doi%3D10.1158%2F1535-7163.MCT-16-0320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaver, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dashwood, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajendran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dashwood, R. H.</span></span> <span> </span><span class="NLM_article-title">A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1600769</span>, <span class="refDoi"> DOI: 10.1002/mnfr.201600769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1002%2Fmnfr.201600769" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=1600769&author=G.+S.+Johnsonauthor=J.+Liauthor=L.+M.+Beaverauthor=W.+M.+Dashwoodauthor=D.+Sunauthor=P.+Rajendranauthor=D.+E.+Williamsauthor=E.+Hoauthor=R.+H.+Dashwood&title=A+functional+pseudogene%2C+NMRAL2P%2C+is+regulated+by+Nrf2+and+serves+as+a+coactivator+of+NQO1+in+sulforaphane-treated+colon+cancer+cells&doi=10.1002%2Fmnfr.201600769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.201600769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.201600769%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DG.%2BS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBeaver%26aufirst%3DL.%2BM.%26aulast%3DDashwood%26aufirst%3DW.%2BM.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DRajendran%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26aulast%3DHo%26aufirst%3DE.%26aulast%3DDashwood%26aufirst%3DR.%2BH.%26atitle%3DA%2520functional%2520pseudogene%252C%2520NMRAL2P%252C%2520is%2520regulated%2520by%2520Nrf2%2520and%2520serves%2520as%2520a%2520coactivator%2520of%2520NQO1%2520in%2520sulforaphane-treated%2520colon%2520cancer%2520cells%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2017%26volume%3D61%26spage%3D1600769%26doi%3D10.1002%2Fmnfr.201600769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span> <span> </span><span class="NLM_article-title">Protein disulphide isomerase is required for signal peptide peptidase-mediated protein degradation</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1038/emboj.2009.359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Femboj.2009.359" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=363-375&author=S.+O.+Leeauthor=K.+Choauthor=S.+Choauthor=I.+Kimauthor=C.+Ohauthor=K.+Ahn&title=Protein+disulphide+isomerase+is+required+for+signal+peptide+peptidase-mediated+protein+degradation&doi=10.1038%2Femboj.2009.359"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Femboj.2009.359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2009.359%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BO.%26aulast%3DCho%26aufirst%3DK.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DOh%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DProtein%2520disulphide%2520isomerase%2520is%2520required%2520for%2520signal%2520peptide%2520peptidase-mediated%2520protein%2520degradation%26jtitle%3DEMBO%2520J.%26date%3D2010%26volume%3D29%26spage%3D363%26epage%3D375%26doi%3D10.1038%2Femboj.2009.359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryoo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of M + HC class I-antigen processing: Redox considerations</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">907</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1089/ars.2008.2316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1089%2Fars.2008.2316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=19178136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlWiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=907-936&author=Y.+Kimauthor=K.+Kangauthor=I.+Kimauthor=Y.+J.+Leeauthor=C.+Ohauthor=J.+Ryooauthor=E.+Jeongauthor=K.+Ahn&title=Molecular+mechanisms+of+M+%2B+HC+class+I-antigen+processing%3A+Redox+considerations&doi=10.1089%2Fars.2008.2316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanisms of MHC Class I-Antigen Processing: Redox Considerations</span></div><div class="casAuthors">Kim, Youngkyun; Kang, Kwonyoon; Kim, Ilkwon; Lee, Yoon Jeong; Oh, Changhoon; Ryoo, Jeongmin; Jeong, Eunae; Ahn, Kwangseog; Benham, Adam; Jensen, Peter; Pinkoski, Michael J.; Powis, Simon; Rubartelli, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">907-936</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Major histocompatibility complex (MHC) class I mols. present antigenic peptides to the cell surface for screening by CD8+ T cells.  A no. of ER-resident chaperones assist the assembly of peptides onto MHC class I mols., a process that can be divided into several steps.  Early folding of the MHC class I heavy chain is followed by its assocn. with β2-microglobulin (β2m).  The MHC class I heavy chain-β2m heterodimer is incorporated into the peptide-loading complex, leading to peptide loading, release of the peptide-filled MHC class I mols. from the peptide-loading complex, and exit of the complete MHC class I complex from the ER.  Because proper antigen presentation is vital for normal immune responses, the assembly of MHC class I mols. requires tight regulation.  Emerging evidence indicates that thiol-based redox regulation plays crit. roles in MHC class I-restricted antigen processing and presentation, establishing an unexpected link between redox biol. and antigen processing.  The authors review the influences of redox regulation on antigen processing and presentation.  Because redox signaling pathways are a rich source of validated drug targets, newly discovered redox biol.-mediated mechanisms of antigen processing may facilitate the development of more selective and therapeutic drugs or vaccines against immune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhXP7pkSMwyLVg90H21EOLACvtfcHk0liDUR2zdvU9Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlWiurs%253D&md5=d6cd8eab68a811248b57fbaf3d1e2fb9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1089%2Fars.2008.2316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2008.2316%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26aulast%3DOh%26aufirst%3DC.%26aulast%3DRyoo%26aufirst%3DJ.%26aulast%3DJeong%26aufirst%3DE.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DMolecular%2520mechanisms%2520of%2520M%2520%252B%2520HC%2520class%2520I-antigen%2520processing%253A%2520Redox%2520considerations%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2009%26volume%3D11%26spage%3D907%26epage%3D936%26doi%3D10.1089%2Fars.2008.2316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span> <span> </span><span class="NLM_article-title">Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.08.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.cell.2006.08.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=17055437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=369-382&author=B.+Parkauthor=S.+Leeauthor=E.+Kimauthor=K.+Choauthor=S.+R.+Riddellauthor=S.+Choauthor=K.+Ahn&title=Redox+regulation+facilitates+optimal+peptide+selection+by+MHC+class+I+during+antigen+processing&doi=10.1016%2Fj.cell.2006.08.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing</span></div><div class="casAuthors">Park, Boyoun; Lee, Sungwook; Kim, Eunkyung; Cho, Kwangmin; Riddell, Stanley R.; Cho, Sunglim; Ahn, Kwangseog</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">369-382</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activated CD8+ T cells discriminate infected and tumor cells from normal self by recognizing MHC class I-bound peptides on the surface of antigen-presenting cells.  The mechanism by which MHC class I mols. select optimal peptides against a background of prevailing suboptimal peptides and in a considerably proteolytic ER environment remained unknown.  Here, we identify protein disulfide isomerase (PDI), an enzyme crit. to the formation of correct disulfide bonds in proteins, as a component of the peptide-loading complex.  We show that PDI stabilizes a peptide-receptive site by regulating the oxidn. state of the disulfide bond in the MHC peptide-binding groove, a function that is essential for selecting optimal peptides.  Furthermore, we demonstrate that human cytomegalovirus US3 protein inhibits CD8+ T cell recognition by mediating PDI degrdn., verifying the functional relevance of PDI-catalyzed peptide editing in controlling intracellular pathogens.  These results establish a link between thiol-based redox regulation and antigen processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMvtRndL8w2bVg90H21EOLACvtfcHk0ljQTANfT_-t6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73E&md5=59e3005680937376b1a7e735542648d7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.08.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.08.041%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DCho%26aufirst%3DK.%26aulast%3DRiddell%26aufirst%3DS.%2BR.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DRedox%2520regulation%2520facilitates%2520optimal%2520peptide%2520selection%2520by%2520MHC%2520class%2520I%2520during%2520antigen%2520processing%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D369%26epage%3D382%26doi%3D10.1016%2Fj.cell.2006.08.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farmery, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulleid, N. J.</span></span> <span> </span><span class="NLM_article-title">The role of ERp57 in disulfide bond formation during the assembly of major histocompatibility complex class I in a synchronized semipermeabilized cell translation system</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">14933</span>– <span class="NLM_lpage">14938</span>, <span class="refDoi"> DOI: 10.1074/jbc.275.20.14933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1074%2Fjbc.275.20.14933" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=14933-14938&author=M.+R.+Farmeryauthor=S.+Allenauthor=A.+J.+Allenauthor=N.+J.+Bulleid&title=The+role+of+ERp57+in+disulfide+bond+formation+during+the+assembly+of+major+histocompatibility+complex+class+I+in+a+synchronized+semipermeabilized+cell+translation+system&doi=10.1074%2Fjbc.275.20.14933"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.20.14933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.20.14933%26sid%3Dliteratum%253Aachs%26aulast%3DFarmery%26aufirst%3DM.%2BR.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DAllen%26aufirst%3DA.%2BJ.%26aulast%3DBulleid%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520role%2520of%2520ERp57%2520in%2520disulfide%2520bond%2520formation%2520during%2520the%2520assembly%2520of%2520major%2520histocompatibility%2520complex%2520class%2520I%2520in%2520a%2520synchronized%2520semipermeabilized%2520cell%2520translation%2520system%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D14933%26epage%3D14938%26doi%3D10.1074%2Fjbc.275.20.14933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blat, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrobel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunet, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hieronymus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span> <span> </span><span class="NLM_article-title">The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">1929</span>– <span class="NLM_lpage">1935</span>, <span class="refDoi"> DOI: 10.1126/science.1132939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1126%2Fscience.1132939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=17008526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSnsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2006&pages=1929-1935&author=J.+Lambauthor=E.+D.+Crawfordauthor=D.+Peckauthor=J.+W.+Modellauthor=I.+C.+Blatauthor=M.+J.+Wrobelauthor=J.+Lernerauthor=J.+P.+Brunetauthor=A.+Subramanianauthor=K.+N.+Rossauthor=M.+Reichauthor=H.+Hieronymusauthor=G.+Weiauthor=S.+A.+Armstrongauthor=S.+J.+Haggartyauthor=P.+A.+Clemonsauthor=R.+Weiauthor=S.+A.+Carrauthor=E.+S.+Landerauthor=T.+R.+Golub&title=The+Connectivity+Map%3A+Using+gene-expression+signatures+to+connect+small+molecules%2C+genes%2C+and+disease&doi=10.1126%2Fscience.1132939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease</span></div><div class="casAuthors">Lamb, Justin; Crawford, Emily D.; Peck, David; Modell, Joshua W.; Blat, Irene C.; Wrobel, Matthew J.; Lerner, Jim; Brunet, Jean-Philippe; Subramanian, Aravind; Ross, Kenneth N.; Reich, Michael; Hieronymus, Haley; Wei, Guo; Armstrong, Scott A.; Haggarty, Stephen J.; Clemons, Paul A.; Wei, Ru; Carr, Steven A.; Lander, Eric S.; Golub, Todd R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">5795</span>),
    <span class="NLM_cas:pages">1929-1935</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a ref. collection of gene-expression profiles from cultured human cells treated with bioactive small mols., together with pattern-matching software to mine these data.  We demonstrate that this "Connectivity Map" resource can be used to find connections among small mols. sharing a mechanism of action, chems. and physiol. processes, and diseases and drugs.  These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtu0M2BUO2w7Vg90H21EOLACvtfcHk0ljQTANfT_-t6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSnsrbN&md5=1fad887ad515ffdd8064e526ff25a4db</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132939%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DJ.%26aulast%3DCrawford%26aufirst%3DE.%2BD.%26aulast%3DPeck%26aufirst%3DD.%26aulast%3DModell%26aufirst%3DJ.%2BW.%26aulast%3DBlat%26aufirst%3DI.%2BC.%26aulast%3DWrobel%26aufirst%3DM.%2BJ.%26aulast%3DLerner%26aufirst%3DJ.%26aulast%3DBrunet%26aufirst%3DJ.%2BP.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DRoss%26aufirst%3DK.%2BN.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DHieronymus%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DArmstrong%26aufirst%3DS.%2BA.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DWei%26aufirst%3DR.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DThe%2520Connectivity%2520Map%253A%2520Using%2520gene-expression%2520signatures%2520to%2520connect%2520small%2520molecules%252C%2520genes%252C%2520and%2520disease%26jtitle%3DScience%26date%3D2006%26volume%3D313%26spage%3D1929%26epage%3D1935%26doi%3D10.1126%2Fscience.1132939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuong, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, B. S.</span></span> <span> </span><span class="NLM_article-title">Phenolic compounds from Caesalpinia sappan heartwood and their anti-inflammatory activity</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">2069</span>– <span class="NLM_lpage">2075</span>, <span class="refDoi"> DOI: 10.1021/np3003673</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np3003673" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=2069-2075&author=T.+D.+Cuongauthor=T.+M.+Hungauthor=J.+C.+Kimauthor=E.+H.+Kimauthor=M.+H.+Wooauthor=J.+S.+Choiauthor=J.+H.+Leeauthor=B.+S.+Min&title=Phenolic+compounds+from+Caesalpinia+sappan+heartwood+and+their+anti-inflammatory+activity&doi=10.1021%2Fnp3003673"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fnp3003673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp3003673%26sid%3Dliteratum%253Aachs%26aulast%3DCuong%26aufirst%3DT.%2BD.%26aulast%3DHung%26aufirst%3DT.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DE.%2BH.%26aulast%3DWoo%26aufirst%3DM.%2BH.%26aulast%3DChoi%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMin%26aufirst%3DB.%2BS.%26atitle%3DPhenolic%2520compounds%2520from%2520Caesalpinia%2520sappan%2520heartwood%2520and%2520their%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D2069%26epage%3D2075%26doi%3D10.1021%2Fnp3003673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. H.</span></span> <span> </span><span class="NLM_article-title">Brazilin inhibits growth and induces apoptosis in human glioblastoma cells</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2449</span>– <span class="NLM_lpage">2457</span>, <span class="refDoi"> DOI: 10.3390/molecules18022449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3390%2Fmolecules18022449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=23429418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFKjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=2449-2457&author=D.+Y.+Leeauthor=M.+K.+Leeauthor=G.+S.+Kimauthor=H.+J.+Nohauthor=M.+H.+Lee&title=Brazilin+inhibits+growth+and+induces+apoptosis+in+human+glioblastoma+cells&doi=10.3390%2Fmolecules18022449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Brazilin inhibits growth and induces apoptosis in human glioblastoma cells</span></div><div class="casAuthors">Lee, Dae-Young; Lee, Mi-Kyoung; Kim, Geum-Soog; Noh, Hyung-Jun; Lee, Min-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2449-2457</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Brazilin, isolated from the methanol ext. of the heart wood of Caesalpinia sappan, sensitizes cancer cells to apoptosis.  Glioblastoma multiforme (GBM), which accounts for most cases of central nervous system malignancy, has a very poor prognosis and lacks effective therapeutic interventions.  We, therefore, investigated the effects of different concns. of and different periods of exposure to brazilin on cell proliferation and apoptosis in the glioma U87 cell line.  Cell proliferation was investigated by MTT assays and growth curve anal., apoptosis was assessed by FACS anal. and western blot studies.  Brazilin showed dose-dependent inhibition of cell proliferation and induction of apoptosis in glioma cells.  It also increased the ratio of cleaved poly-(ADP)-ribose polymerase and decreased the expression of caspase-3 and caspase-7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa7F44Zk2DVbVg90H21EOLACvtfcHk0lgsBJ93b9UHwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFKjsbg%253D&md5=fcfff8320509e677f4f30809b69e42dd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18022449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18022449%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BY.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DG.%2BS.%26aulast%3DNoh%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BH.%26atitle%3DBrazilin%2520inhibits%2520growth%2520and%2520induces%2520apoptosis%2520in%2520human%2520glioblastoma%2520cells%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D2449%26epage%3D2457%26doi%3D10.3390%2Fmolecules18022449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handayani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susidarti, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenie, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiyanto, E.</span></span> <span> </span><span class="NLM_article-title">Two active compounds from caesalpinia sappan L. in combination with cisplatin synergistically induce apoptosis and cell cycle arrest on WiDr cells</span>. <i>Adv. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.15171/apb.2017.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.15171%2Fapb.2017.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=29071219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFCnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=375-380&author=S.+Handayaniauthor=R.+A.+Susidartiauthor=R.+I.+Jenieauthor=E.+Meiyanto&title=Two+active+compounds+from+caesalpinia+sappan+L.+in+combination+with+cisplatin+synergistically+induce+apoptosis+and+cell+cycle+arrest+on+WiDr+cells&doi=10.15171%2Fapb.2017.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Two active compounds from Caesalpinia sappan L. in combination with cisplatin synergistically induce apoptosis and cell cycle arrest on WiDr cells</span></div><div class="casAuthors">Handayani, Sri; Susidarti, Ratna Asmah; Jenie, Riris Istighfari; Meiyanto, Edy</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">375-380</span>CODEN:
                <span class="NLM_cas:coden">APBDCL</span>;
        ISSN:<span class="NLM_cas:issn">2251-7308</span>.
    
            (<span class="NLM_cas:orgname">Tabriz University of Medical Sciences</span>)
        </div><div class="casAbstract">Purpose: The aim of this study is to observe the synergistic effect of two active compds. of secang, brazilin and brazilein, combined with cisplatin on WiDr colon cancer cells.  Methods: Cytotoxic activities of brazilin (Bi) and brazilein (Be) in single and in combination with cisplatin (Cisp) were examd. by MTT assay.  Synergistic effect was analyzed by combination index (CI) parameter.  Apoptosis and cell cycle profiles were obsd. by using flow cytometry.  Results: The result of MTT assay showed that IC50 value of brazilin and brazilein on WiDr cancer cells were 41 μM and 52 μM resp.  The combination of 1/2 IC50 of Bi-Cisp reduced cells viability up to 64% and showed synergistic effect with CI value less than 1 (CI = 0.8).  The combinations of 1/2 IC50 of Be-Cisp also reduced cells viability up to 78% and showed synergistic effect (CI=0.65).  Combination of Bi-Cisp and Be-Cisp induced apoptosis higher than the single treatments.  Further anal. on the cell cycle progression showed that single treatment of 1/2 IC50 of Be and Bi induced S-phase and G2/M-phase accumulation, while combination of Be-Cisp and Bi-Cisp enhanced S-phase accumulation.  Conclusion: Both combination of Bi-Cisp and Be-Cisp showed synergistic effect on WiDr cells through induction of apoptosis and halted the cell cycle progression, thus, WiDr cells growth were significantly reduced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNnSnQO-YuKLVg90H21EOLACvtfcHk0lgsBJ93b9UHwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFCnur4%253D&md5=19ab3b57762c6881cf492c2f2085829e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.15171%2Fapb.2017.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15171%252Fapb.2017.045%26sid%3Dliteratum%253Aachs%26aulast%3DHandayani%26aufirst%3DS.%26aulast%3DSusidarti%26aufirst%3DR.%2BA.%26aulast%3DJenie%26aufirst%3DR.%2BI.%26aulast%3DMeiyanto%26aufirst%3DE.%26atitle%3DTwo%2520active%2520compounds%2520from%2520caesalpinia%2520sappan%2520L.%2520in%2520combination%2520with%2520cisplatin%2520synergistically%2520induce%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520on%2520WiDr%2520cells%26jtitle%3DAdv.%2520Pharm.%2520Bull.%26date%3D2017%26volume%3D7%26spage%3D375%26epage%3D380%26doi%3D10.15171%2Fapb.2017.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larochette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decaudin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacotot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamzami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>249</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1006/excr.1999.4519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1006%2Fexcr.1999.4519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10366441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADyaK1MXjslSlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=1999&pages=413-421&author=N.+Larochetteauthor=D.+Decaudinauthor=E.+Jacototauthor=C.+Brennerauthor=I.+Marzoauthor=S.+A.+Susinauthor=N.+Zamzamiauthor=Z.+H.+Xieauthor=J.+Reedauthor=G.+Kroemer&title=Arsenite+induces+apoptosis+via+a+direct+effect+on+the+mitochondrial+permeability+transition+pore&doi=10.1006%2Fexcr.1999.4519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenite Induces Apoptosis via a Direct Effect on the Mitochondrial Permeability Transition Pore</span></div><div class="casAuthors">Larochette, Nathanael; Decaudin, Didier; Jacotot, Etienne; Brenner, Catherine; Marzo, Isabel; Susin, Santos A.; Zamzami, Naoufal; Xie, Zhihua; Reed, John; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">249</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">413-421</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The mol. mode of action of arsenic, a therapeutic agent employed in the treatment of acute promyelocytic leukemia, has been elusive.  Here we provide evidence that arsenic compds. may act on mitochondria to induce apoptosis.  Arsenite induces apoptosis accompanied by a loss of the mitochondrial transmembrane potential (Δ[Psi]m).  Inhibition of caspases prevents the arsenite-induced nuclear DNA loss, but has no effect on the Δ[Psi]m dissipation and cytolysis induced by arsenite.  In contrast, Bcl-2 expression induced by gene transfer prevents all hallmarks of arsenite-induced cell death, including the Δ[Psi]m collapse.  PK11195, a ligand of the mitochondrial benzodiazepine receptor, neutralizes this Bcl-2 effect.  Mitochondria are required in a cell-free system to mediate arsenite-induced nuclear apoptosis.  Arsenite causes the release of an apoptosis-inducing factor (AIF) from the mitochondrial intermembrane space.  This effect is prevented by the permeability transition (PT) pore inhibitor cyclosporin A, as well as by Bcl-2, which is known to function as an endogenous PT pore antagonist.  Arsenite also opens the purified, reconstituted PT pore in vitro in a cyclosporin A- and Bcl-2-inhibitable fashion.  Altogether these data suggest that arsenite can induce apoptosis via a direct effect on the mitochondrial PT pore.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLhuzqFvNz57Vg90H21EOLACvtfcHk0lit9b2LK33r5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslSlsLo%253D&md5=c17f89aacc1a4d6cfdac266966840fb6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1999.4519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1999.4519%26sid%3Dliteratum%253Aachs%26aulast%3DLarochette%26aufirst%3DN.%26aulast%3DDecaudin%26aufirst%3DD.%26aulast%3DJacotot%26aufirst%3DE.%26aulast%3DBrenner%26aufirst%3DC.%26aulast%3DMarzo%26aufirst%3DI.%26aulast%3DSusin%26aufirst%3DS.%2BA.%26aulast%3DZamzami%26aufirst%3DN.%26aulast%3DXie%26aufirst%3DZ.%2BH.%26aulast%3DReed%26aufirst%3DJ.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DArsenite%2520induces%2520apoptosis%2520via%2520a%2520direct%2520effect%2520on%2520the%2520mitochondrial%2520permeability%2520transition%2520pore%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D249%26spage%3D413%26epage%3D421%26doi%3D10.1006%2Fexcr.1999.4519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuh, H. J.</span></span> <span> </span><span class="NLM_article-title">Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1669</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.3892/ijo_00000298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3892%2Fijo_00000298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=19424586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVCiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=1669-1679&author=W.+H.+Chungauthor=B.+H.+Sungauthor=S.+S.+Kimauthor=H.+Rhimauthor=H.+J.+Kuh&title=Synergistic+interaction+between+tetra-arsenic+oxide+and+paclitaxel+in+human+cancer+cells+in+vitro&doi=10.3892%2Fijo_00000298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro</span></div><div class="casAuthors">Chung, Won-Heui; Sung, Bong Hwan; Kim, Sang-Soo; Rhim, Hyangshuk; Kuh, Hyo-Jeong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1669-1679</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Similar to arsenic trioxide (As2O3), tetra-arsenic oxide (As4O6, TAO) has shown anti-proliferative and apoptosis-inducing effects against human leukemic and solid tumor cells.  In order to assess the increase in efficacy, we evaluated the combinatory interaction of TAO combined with paclitaxel, 5-FU or cisplatin and studied its mechanism of action in the cell lines of human gastric, cervix and head and neck tumors.  Two agents were combined at equitoxic ratios based on the IC50 of each drug.  Efficacy improvement was evaluated using a combination index and isobologram at 50% inhibition level.  Apoptosis induction and expression of apoptosis-related proteins was detd. and the effect on microtubule polymn. was monitored.  TAO combined with paclitaxel showed synergistic interaction in all three of gastric, cervix and head and neck cancer cell lines.  On the other hand, TAO when combined with 5-FU or cisplatin showed an antagonistic interaction in head and neck or cervix cancer cell lines, resp.  Simultaneous treatment with TAO with paclitaxel resulted in an increased percentage of apoptotic cells and a significant increase in PARP cleavage and caspase-3 activation in the gastric and cervix cancer cells compared to TAO alone as well as the antagonistic groups (TAO with 5-FU or cisplatin).  TAO suppressed the tubulin polymn. in the presence and absence of paclitaxel in a concn.-dependent manner, suggesting mitotic catastrophe as a potential mechanism of the synergism with paclitaxel.  Overall, the present study suggests that TAO may have a greater potential as an anti-cancer agent against human gastric, cervix and head and neck tumors, in combination with paclitaxel.  The synergistic interaction with paclitaxel may be assocd. with increased apoptosis via inhibition of paclitaxel- induced tubulin polymn.  Further detailed studies of combinatory mechanisms and evaluation using in vivo models are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoSuhITvD48LVg90H21EOLACvtfcHk0lit9b2LK33r5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVCiuro%253D&md5=1dcfbc7da2636395e330f51a125b8069</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.3892%2Fijo_00000298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo_00000298%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DW.%2BH.%26aulast%3DSung%26aufirst%3DB.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BS.%26aulast%3DRhim%26aufirst%3DH.%26aulast%3DKuh%26aufirst%3DH.%2BJ.%26atitle%3DSynergistic%2520interaction%2520between%2520tetra-arsenic%2520oxide%2520and%2520paclitaxel%2520in%2520human%2520cancer%2520cells%2520in%2520vitro%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2009%26volume%3D34%26spage%3D1669%26epage%3D1679%26doi%3D10.3892%2Fijo_00000298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, J. C.</span></span> <span> </span><span class="NLM_article-title">Drug combination studies and their synergy quantification using the Chou-Talalay method-Letter</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">2400</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-3763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1158%2F0008-5472.CAN-14-3763" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=2400&author=J.+C.+Ashton&title=Drug+combination+studies+and+their+synergy+quantification+using+the+Chou-Talalay+method-Letter&doi=10.1158%2F0008-5472.CAN-14-3763"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-3763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-3763%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DJ.%2BC.%26atitle%3DDrug%2520combination%2520studies%2520and%2520their%2520synergy%2520quantification%2520using%2520the%2520Chou-Talalay%2520method-Letter%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D2400%26doi%3D10.1158%2F0008-5472.CAN-14-3763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bekendam, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendapudi, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nag, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldenzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaumenhaft, R.</span></span> <span> </span><span class="NLM_article-title">A substrate-driven allosteric switch that enhances PDI catalytic activity</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12579</span>, <span class="refDoi"> DOI: 10.1038/ncomms12579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fncomms12579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=27573496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKjsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12579&author=R.+H.+Bekendamauthor=P.+K.+Bendapudiauthor=L.+Linauthor=P.+P.+Nagauthor=J.+Puauthor=D.+R.+Kennedyauthor=A.+Feldenzerauthor=J.+Chiuauthor=K.+M.+Cookauthor=B.+Furieauthor=M.+Huangauthor=P.+J.+Hoggauthor=R.+Flaumenhaft&title=A+substrate-driven+allosteric+switch+that+enhances+PDI+catalytic+activity&doi=10.1038%2Fncomms12579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A substrate-driven allosteric switch that enhances PDI catalytic activity</span></div><div class="casAuthors">Bekendam, Roelof H.; Bendapudi, Pavan K.; Lin, Lin; Nag, Partha P.; Pu, Jun; Kennedy, Daniel R.; Feldenzer, Alexandra; Chiu, Joyce; Cook, Kristina M.; Furie, Bruce; Huang, Mingdong; Hogg, Philip J.; Flaumenhaft, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12579</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein disulfide isomerase (PDI) is an oxidoreductase essential for folding proteins in the endoplasmic reticulum.  The domain structure of PDI is a-b-b'-x-a', wherein the thioredoxin-like a and a' domains mediate disulfide bond shuffling and b and b' domains are substrate binding.  The b' and a' domains are connected via the x-linker, a 19-amino-acid flexible peptide.  Here we identify a class of compds., termed bepristats, that target the substrate-binding pocket of b'.  Bepristats reversibly block substrate binding and inhibit platelet aggregation and thrombus formation in vivo.  Ligation of the substrate-binding pocket by bepristats paradoxically enhances catalytic activity of a and a' by displacing the x-linker, which acts as an allosteric switch to augment reductase activity in the catalytic domains.  This substrate-driven allosteric switch is also activated by peptides and proteins and is present in other thiol isomerases.  Our results demonstrate a mechanism whereby binding of a substrate to thiol isomerases enhances catalytic activity of remote domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkUYTT5B9w97Vg90H21EOLACvtfcHk0ligMRZuwIC49A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKjsbjL&md5=a138a269279f7bf35c2adc80332facad</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fncomms12579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12579%26sid%3Dliteratum%253Aachs%26aulast%3DBekendam%26aufirst%3DR.%2BH.%26aulast%3DBendapudi%26aufirst%3DP.%2BK.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DNag%26aufirst%3DP.%2BP.%26aulast%3DPu%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DD.%2BR.%26aulast%3DFeldenzer%26aufirst%3DA.%26aulast%3DChiu%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DK.%2BM.%26aulast%3DFurie%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DHogg%26aufirst%3DP.%2BJ.%26aulast%3DFlaumenhaft%26aufirst%3DR.%26atitle%3DA%2520substrate-driven%2520allosteric%2520switch%2520that%2520enhances%2520PDI%2520catalytic%2520activity%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12579%26doi%3D10.1038%2Fncomms12579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span> <span> </span><span class="NLM_article-title">Reversible covalent inhibition of a protein target</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">8699</span>– <span class="NLM_lpage">8700</span>, <span class="refDoi"> DOI: 10.1002/anie.201203341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1002%2Fanie.201203341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVehtLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8699-8700&author=C.+U.+Leeauthor=T.+N.+Grossmann&title=Reversible+covalent+inhibition+of+a+protein+target&doi=10.1002%2Fanie.201203341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible covalent inhibition of a protein target</span></div><div class="casAuthors">Lee, Chang-Uk; Grossmann, Tom N.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">8699-8700</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Electron-deficient Michael acceptors can be used in reversible addn./elimination reactions with thiols.  These electrophiles have been used by J. Taunton and colleagues [M. S. Cohen et al. (2005)] to convert a known irreversible protein kinase inhibitor into a covalent reversible inhibitor.  Such an approach might provide high-affinity binders with increased selectivity without the toxicol. risks assocd. with irreversible protein modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8c9MUbShnWLVg90H21EOLACvtfcHk0ligMRZuwIC49A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVehtLrM&md5=af55c6ca399146709faaaf23532b784a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fanie.201203341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201203341%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BU.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26atitle%3DReversible%2520covalent%2520inhibition%2520of%2520a%2520protein%2520target%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D8699%26epage%3D8700%26doi%3D10.1002%2Fanie.201203341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gersch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreuzer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span> <span> </span><span class="NLM_article-title">Electrophilic natural products and their biological targets</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.1039/c2np20012k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1039%2Fc2np20012k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22504336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVehsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=659-682&author=M.+Gerschauthor=J.+Kreuzerauthor=S.+A.+Sieber&title=Electrophilic+natural+products+and+their+biological+targets&doi=10.1039%2Fc2np20012k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Electrophilic natural products and their biological targets</span></div><div class="casAuthors">Gersch, Malte; Kreuzer, Johannes; Sieber, Stephan A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">659-682</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The study of biol. active natural products has resulted in seminal contributions to the understanding of living systems.  In the case of electrophilic natural products, the covalent nature of their interaction has largely facilitated the identification of their biol. binding partners.  In this review, we provide a comprehensive compilation of electrophilic natural products from all major chem. classes together with their biol. targets.  Covering Michael acceptor systems, ring-strained compds. and other electrophiles, such as esters or carbamates, we highlight representative and instructive examples for over 20 electrophilic moieties.  The fruitful cooperation of natural product chem., medicinal chem. and chem. biol. has produced a collection of well-studied examples for how electrophilic natural products exert their biol. functions that range from antibiotic to antitumor effects.  Special emphasis is put on the elucidation of their resp. biol. targets via activity-based protein profiling, which together with the recent advancements in mass spectrometry has been crucial to the success of the field.  The wealth of naturally occurring electrophilic moieties and their chem. complexity enables binding of a large variety of biol. targets, such as enzymes of all classes, nonenzymic proteins, DNA and other cellular compds.  With approx. 30 000 genes in the human genome but only 266 confirmed protein drug targets, the study of biol. active, electrophilic natural products has the potential to provide insights into fundamental biol. processes and to greatly aid the discovery of new drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHI4qnF7oSNbVg90H21EOLACvtfcHk0ligMRZuwIC49A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVehsb0%253D&md5=560cb6a084f0905741109551530ed02c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2Fc2np20012k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2np20012k%26sid%3Dliteratum%253Aachs%26aulast%3DGersch%26aufirst%3DM.%26aulast%3DKreuzer%26aufirst%3DJ.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26atitle%3DElectrophilic%2520natural%2520products%2520and%2520their%2520biological%2520targets%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2012%26volume%3D29%26spage%3D659%26epage%3D682%26doi%3D10.1039%2Fc2np20012k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yagi-Utsumi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span> <span> </span><span class="NLM_article-title">Structural basis of redox-dependent substrate binding of protein disulfide isomerase</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13909</span>, <span class="refDoi"> DOI: 10.1038/srep13909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fsrep13909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26350503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A280%3ADC%252BC283gs1emsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13909&author=M.+Yagi-Utsumiauthor=T.+Satohauthor=K.+Kato&title=Structural+basis+of+redox-dependent+substrate+binding+of+protein+disulfide+isomerase&doi=10.1038%2Fsrep13909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of redox-dependent substrate binding of protein disulfide isomerase</span></div><div class="casAuthors">Yagi-Utsumi Maho; Kato Koichi; Yagi-Utsumi Maho; Satoh Tadashi; Kato Koichi; Satoh Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13909</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Protein disulfide isomerase (PDI) is a multidomain enzyme, operating as an essential folding catalyst, in which the b' and a' domains provide substrate binding sites and undergo an open-closed domain rearrangement depending on the redox states of the a' domain.  Despite the long research history of this enzyme, three-dimensional structural data remain unavailable for its ligand-binding mode.  Here we characterize PDI substrate recognition using α-synuclein (αSN) as the model ligand.  Our nuclear magnetic resonance (NMR) data revealed that the substrate-binding domains of PDI captured the αSN segment Val37-Val40 only in the oxidized form.  Furthermore, we determined the crystal structure of an oxidized form of the b'-a' domains in complex with an undecapeptide corresponding to this segment.  The peptide-binding mode observed in the crystal structure with NMR validation, was characterized by hydrophobic interactions on the b' domain in an open conformation.  Comparison with the previously reported crystal structure indicates that the a' domain partially masks the binding surface of the b' domain, causing steric hindrance against the peptide in the reduced form of the b'-a' domains that exhibits a closed conformation.  These findings provide a structural basis for the mechanism underlying the redox-dependent substrate binding of PDI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpfk-Ws4uTwQHqQV89nF-2fW6udTcc2eZZENajujwC37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283gs1emsA%253D%253D&md5=7692447dbe4ba0ff097098536ba0c645</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fsrep13909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13909%26sid%3Dliteratum%253Aachs%26aulast%3DYagi-Utsumi%26aufirst%3DM.%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DK.%26atitle%3DStructural%2520basis%2520of%2520redox-dependent%2520substrate%2520binding%2520of%2520protein%2520disulfide%2520isomerase%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13909%26doi%3D10.1038%2Fsrep13909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rucker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Rifai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rascle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottfried, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodziak-Jarosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhauser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amslinger, S.</span></span> <span> </span><span class="NLM_article-title">Enhancing the anti-inflammatory activity of chalcones by tuning the Michael acceptor site</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">3040</span>– <span class="NLM_lpage">3047</span>, <span class="refDoi"> DOI: 10.1039/C4OB02301C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1039%2FC4OB02301C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=3040-3047&author=H.+Ruckerauthor=N.+Al-Rifaiauthor=A.+Rascleauthor=E.+Gottfriedauthor=L.+Brodziak-Jaroszauthor=C.+Gerhauserauthor=T.+P.+Dickauthor=S.+Amslinger&title=Enhancing+the+anti-inflammatory+activity+of+chalcones+by+tuning+the+Michael+acceptor+site&doi=10.1039%2FC4OB02301C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1039%2FC4OB02301C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB02301C%26sid%3Dliteratum%253Aachs%26aulast%3DRucker%26aufirst%3DH.%26aulast%3DAl-Rifai%26aufirst%3DN.%26aulast%3DRascle%26aufirst%3DA.%26aulast%3DGottfried%26aufirst%3DE.%26aulast%3DBrodziak-Jarosz%26aufirst%3DL.%26aulast%3DGerhauser%26aufirst%3DC.%26aulast%3DDick%26aufirst%3DT.%2BP.%26aulast%3DAmslinger%26aufirst%3DS.%26atitle%3DEnhancing%2520the%2520anti-inflammatory%2520activity%2520of%2520chalcones%2520by%2520tuning%2520the%2520Michael%2520acceptor%2520site%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D3040%26epage%3D3047%26doi%3D10.1039%2FC4OB02301C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. Y.</span></span> <span> </span><span class="NLM_article-title">A synthetic chalcone, 2 ’-hydroxy-2,3,5 ’-trimethoxychalcone triggers unfolded protein response-mediated apoptosis in breast cancer cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.canlet.2015.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26742460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2016&pages=1-9&author=D.+H.+Leeauthor=Y.+J.+Jungauthor=D.+Kohauthor=Y.+Limauthor=Y.+H.+Leeauthor=S.+Y.+Shin&title=A+synthetic+chalcone%2C+2+%E2%80%99-hydroxy-2%2C3%2C5+%E2%80%99-trimethoxychalcone+triggers+unfolded+protein+response-mediated+apoptosis+in+breast+cancer+cells&doi=10.1016%2Fj.canlet.2015.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">A synthetic chalcone, 2'-hydroxy-2,3,5'-trimethoxychalcone triggers unfolded protein response-mediated apoptosis in breast cancer cells</span></div><div class="casAuthors">Lee, Da Hyun; Jung Jung, You; Koh, Dongsoo; Lim, Yoongho; Lee, Young Han; Shin, Soon Young</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The primary aim of this study was to find novel chemopreventive agents effective against breast cancer.  Endoplasmic reticulum (ER) stress can induce apoptosis through the unfolded protein response (UPR). 2'-Hydroxy-2,3,5'-trimethoxychalcone (DK143) is a synthetic flavonoid deriv.  The present study provides evidence supporting the role of the UPR in mediating the apoptotic effect of DK143.  Treatment with DK143 triggered apoptosis through the activation of the caspase pathway in MDA-MB-231 breast cancer cells without affecting viability of MCF10A non-transformed breast epithelial cells.  Further anal. revealed that DK143 produced reactive oxygen species (ROS) in MDA-MB-231 cells, but not in MCF10A cells, and upregulated the expression of ER stress sensors, including GRP78/BiP, IRE1α, CHOP, and Bim in MDA-MB-231 cells.  In addn., UPR-related transcription factors, XBP-1 and CHOP, were activated by DK143.  Moreover, silencing of IRE1α or CHOP by corresponding siRNA mols. attenuated DK143-induced apoptosis.  Furthermore, DK143 suppressed mouse tumor growth in vivo.  These results demonstrate that promoting ER stress in breast cancer cells via UPR induction might be a promising strategy for developing new chemotherapeutic or chemopreventive agents for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Q8MKDKIiJLVg90H21EOLACvtfcHk0lh2vDGbZ616MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCksA%253D%253D&md5=262986f0ae7b3aec9f61f00effc57124</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DJung%26aufirst%3DY.%2BJ.%26aulast%3DKoh%26aufirst%3DD.%26aulast%3DLim%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DShin%26aufirst%3DS.%2BY.%26atitle%3DA%2520synthetic%2520chalcone%252C%25202%2520%25E2%2580%2599-hydroxy-2%252C3%252C5%2520%25E2%2580%2599-trimethoxychalcone%2520triggers%2520unfolded%2520protein%2520response-mediated%2520apoptosis%2520in%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D372%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.canlet.2015.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sklar, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogelj, S.</span></span> <span> </span><span class="NLM_article-title">Sulfhydryl regulation of L-selectin shedding: Phenylarsine oxide promotes activation-independent L-selectin shedding from leukocytes</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">4120</span>– <span class="NLM_lpage">4129</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.164.8.4120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.4049%2Fjimmunol.164.8.4120" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2000&pages=4120-4129&author=T.+A.+Bennettauthor=B.+S.+Edwardsauthor=L.+A.+Sklarauthor=S.+Rogelj&title=Sulfhydryl+regulation+of+L-selectin+shedding%3A+Phenylarsine+oxide+promotes+activation-independent+L-selectin+shedding+from+leukocytes&doi=10.4049%2Fjimmunol.164.8.4120"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.164.8.4120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.164.8.4120%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DT.%2BA.%26aulast%3DEdwards%26aufirst%3DB.%2BS.%26aulast%3DSklar%26aufirst%3DL.%2BA.%26aulast%3DRogelj%26aufirst%3DS.%26atitle%3DSulfhydryl%2520regulation%2520of%2520L-selectin%2520shedding%253A%2520Phenylarsine%2520oxide%2520promotes%2520activation-independent%2520L-selectin%2520shedding%2520from%2520leukocytes%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D164%26spage%3D4120%26epage%3D4129%26doi%3D10.4049%2Fjimmunol.164.8.4120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soiffer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanneman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jinushi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dranoff, G.</span></span> <span> </span><span class="NLM_article-title">Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1681</span>– <span class="NLM_lpage">1688</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-09-114157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1182%2Fblood-2007-09-114157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=19008459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisV2iu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=1681-1688&author=C.+Fonsecaauthor=R.+Soifferauthor=V.+Hoauthor=M.+Vannemanauthor=M.+Jinushiauthor=J.+Ritzauthor=D.+Neubergauthor=R.+Stoneauthor=D.+DeAngeloauthor=G.+Dranoff&title=Protein+disulfide+isomerases+are+antibody+targets+during+immune-mediated+tumor+destruction&doi=10.1182%2Fblood-2007-09-114157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction</span></div><div class="casAuthors">Fonseca, Catia; Soiffer, Robert; Ho, Vincent; Vanneman, Matthew; Jinushi, Masahisa; Ritz, Jerome; Neuberg, Donna; Stone, Richard; DeAngelo, Dan; Dranoff, Glenn</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">tumor1681-1688</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The identification of cancer antigens that contribute to transformation and are linked with immune-mediated tumor destruction is an important goal for immunotherapy.  Toward this end, we screened a murine renal cell carcinoma cDNA expression library with sera from mice vaccinated with irradiated tumor cells engineered to secrete granulocyte macrophage colony-stimulating factor (GM-CSF).  Multiple nonmutated, overexpressed proteins that function in tumor cell migration, protein/nucleic acid homeostasis, metab., and stress responses were detected.  Among these, the most frequently recognized clone was protein disulfide isomerase (PDI).  High titer antibodies to human PDI were similarly induced in an acute myeloid leukemia patient who achieved a complete response after vaccination with irradiated, autologous GM-CSF-secreting tumor cells in the setting of nonmyeloablative allogeneic bone marrow transplantation.  Moreover, ERp5, a closely related disulfide isomerase involved in major histocompatibility complex (MHC) class I chain-related protein A (MICA) shedding, also evoked potent humoral reactions in diverse solid and hematol. malignancy patients who responded to GM-CSF-secreting tumor cell vaccines or antibody blockade of cytotoxic T lymphocyte-assocd. antigen 4 (CTLA-4).  Together, these findings reveal the unexpected immunogenicity of PDIs and raise the possibility that these gene products might serve as targets for therapeutic monoclonal antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrlNWaN21uc7Vg90H21EOLACvtfcHk0lgEa_gECvNgLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisV2iu74%253D&md5=feb061eae29212f24b495cbb31506005</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-09-114157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-09-114157%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DC.%26aulast%3DSoiffer%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DV.%26aulast%3DVanneman%26aufirst%3DM.%26aulast%3DJinushi%26aufirst%3DM.%26aulast%3DRitz%26aufirst%3DJ.%26aulast%3DNeuberg%26aufirst%3DD.%26aulast%3DStone%26aufirst%3DR.%26aulast%3DDeAngelo%26aufirst%3DD.%26aulast%3DDranoff%26aufirst%3DG.%26atitle%3DProtein%2520disulfide%2520isomerases%2520are%2520antibody%2520targets%2520during%2520immune-mediated%2520tumor%2520destruction%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D1681%26epage%3D1688%26doi%3D10.1182%2Fblood-2007-09-114157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spies, T.</span></span> <span> </span><span class="NLM_article-title">Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>447</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nature05768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fnature05768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=17495932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFOhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2007&pages=482-486&author=B.+K.+Kaiserauthor=D.+Yimauthor=I.+T.+Chowauthor=S.+Gonzalezauthor=Z.+Daiauthor=H.+H.+Mannauthor=R.+K.+Strongauthor=V.+Grohauthor=T.+Spies&title=Disulphide-isomerase-enabled+shedding+of+tumour-associated+NKG2D+ligands&doi=10.1038%2Fnature05768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands</span></div><div class="casAuthors">Kaiser, Brett K.; Yim, Daesong; Chow, I.-Ting; Gonzalez, Segundo; Dai, Zhenpeng; Mann, Henning H.; Strong, Roland K.; Groh, Veronika; Spies, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">7143</span>),
    <span class="NLM_cas:pages">482-486</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor-assocd. ligands of the activating NKG2D (natural killer group 2, member D; also called KLRK1) receptor, which are induced by genotoxic or cellular stress, trigger activation of natural killer cells and co-stimulation of effector T cells, and may thus promote resistance to cancer.  However, many progressing tumors in humans counter this antitumor activity by shedding the sol. MHC class-I-related ligand MICA, which induces internalization and degrdn. of NKG2D and stimulates population expansions of normally rare NKG2D+CD4+ T cells with neg. regulatory functions.  Here the authors show that on the surface of tumor cells, MICA assocs. with endoplasmic reticulum protein 5 (ERp5; also called PDIA6 or P5), which, similar to protein disulfide isomerase, usually assists in the folding of nascent proteins inside cells.  Pharmacol. inhibition of thioreductase activity and ERp5 gene silencing revealed that cell-surface ERp5 function is required for MICA shedding.  ERp5 and membrane-anchored MICA form transitory mixed disulfide complexes from which sol. MICA is released after proteolytic cleavage near the cell membrane.  Redn. of the seemingly inaccessible disulfide bond in the membrane-proximal α3 domain of MICA must involve a large conformational change that enables proteolytic cleavage.  These results uncover a mol. mechanism whereby domain-specific deconstruction regulates MICA protein shedding, thereby promoting tumor immune evasion, and identify surface ERp5 as a strategic target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZS-YLUQKYp7Vg90H21EOLACvtfcHk0lgEa_gECvNgLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFOhu7g%253D&md5=6ce54edfb4ac1d8916be6924129d4173</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnature05768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05768%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DB.%2BK.%26aulast%3DYim%26aufirst%3DD.%26aulast%3DChow%26aufirst%3DI.%2BT.%26aulast%3DGonzalez%26aufirst%3DS.%26aulast%3DDai%26aufirst%3DZ.%26aulast%3DMann%26aufirst%3DH.%2BH.%26aulast%3DStrong%26aufirst%3DR.%2BK.%26aulast%3DGroh%26aufirst%3DV.%26aulast%3DSpies%26aufirst%3DT.%26atitle%3DDisulphide-isomerase-enabled%2520shedding%2520of%2520tumour-associated%2520NKG2D%2520ligands%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D482%26epage%3D486%26doi%3D10.1038%2Fnature05768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zocchi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catellani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevali, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garuti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villaggio, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraternali-Orcioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunkl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravetti, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poggi, A.</span></span> <span> </span><span class="NLM_article-title">High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1479</span>– <span class="NLM_lpage">1489</span>, <span class="refDoi"> DOI: 10.1182/blood-2011-07-370841</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1182%2Fblood-2011-07-370841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22167753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=1479-1489&author=M.+R.+Zocchiauthor=S.+Catellaniauthor=P.+Canevaliauthor=S.+Tavellaauthor=A.+Garutiauthor=B.+Villaggioauthor=A.+Zuninoauthor=M.+Gobbiauthor=G.+Fraternali-Orcioniauthor=A.+Kunklauthor=J.+L.+Ravettiauthor=S.+Boeroauthor=A.+Mussoauthor=A.+Poggi&title=High+ERp5%2FADAM10+expression+in+lymph+node+microenvironment+and+impaired+NKG2D+ligands+recognition+in+Hodgkin+lymphomas&doi=10.1182%2Fblood-2011-07-370841"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas</span></div><div class="casAuthors">Zocchi, Maria Raffaella; Catellani, Silvia; Canevali, Paolo; Tavella, Sara; Garuti, Anna; Villaggio, Barbara; Zunino, Annalisa; Gobbi, Marco; Fraternali-Orcioni, Giulio; Kunkl, Annalisa; Ravetti, Jean-Louis; Boero, Silvia; Musso, Alessandra; Poggi, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1479-1489</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Herein we describe that in classic Hodgkin lymphomas (cHL, n = 25) the lymph node (LN) stroma displayed in situ high levels of transcription and expression of the disulfide-isomerase ERp5 and of the disintegrin-metalloproteinase ADAM10, able to shed the ligands for NKG2D (NKG2D-L) from the cell membrane.  These enzymes were detected both in LN mesenchymal stromal cells (MSCs) and in Reed-Sternberg (RS) cells; in addn., MIC-A and ULBP3 were present in culture supernatants of LN MSCs or RS cells.  NKG2D-L-neg. RS cells could not be killed by CD8+αβT or γδT cells; tumor cell killing was partially restored by treating RS cells with valproic acid, which enhanced NKG2D-L surface expression.  Upon coculture with LN MSCs, CD8+αβT and γδT cells strongly reduced their cytolytic activity against NKG2D-L+ targets; this seems to be the result of TGF-β, present at the tumor site, produced in vitro by LN MSCs and able to down-regulate the expression of NKG2D on T lymphocytes.  In addn., CD8+αβT and γδT cells from the lymph nodes of cHL patients, cocultured in vitro with LN MSCs, underwent TGF-β-mediated down regulation of NKG2D.  Thus, in cHL the tumor microenvironment is prone to inhibit the development of an efficient antitumor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm0PmPCupbnLVg90H21EOLACvtfcHk0lgB6uTO5sbCag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSrs7g%253D&md5=9998199b08e0113f6472fb719282b001</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-07-370841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-07-370841%26sid%3Dliteratum%253Aachs%26aulast%3DZocchi%26aufirst%3DM.%2BR.%26aulast%3DCatellani%26aufirst%3DS.%26aulast%3DCanevali%26aufirst%3DP.%26aulast%3DTavella%26aufirst%3DS.%26aulast%3DGaruti%26aufirst%3DA.%26aulast%3DVillaggio%26aufirst%3DB.%26aulast%3DZunino%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DFraternali-Orcioni%26aufirst%3DG.%26aulast%3DKunkl%26aufirst%3DA.%26aulast%3DRavetti%26aufirst%3DJ.%2BL.%26aulast%3DBoero%26aufirst%3DS.%26aulast%3DMusso%26aufirst%3DA.%26aulast%3DPoggi%26aufirst%3DA.%26atitle%3DHigh%2520ERp5%252FADAM10%2520expression%2520in%2520lymph%2520node%2520microenvironment%2520and%2520impaired%2520NKG2D%2520ligands%2520recognition%2520in%2520Hodgkin%2520lymphomas%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D1479%26epage%3D1489%26doi%3D10.1182%2Fblood-2011-07-370841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vivoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlechild, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span> <span> </span><span class="NLM_article-title">Determination of protein-ligand interactions using differential scanning fluorimetry</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">e51809</span>, <span class="refDoi"> DOI: 10.3791/51809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3791%2F51809" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2014&pages=e51809&author=M.+Vivoliauthor=H.+R.+Novakauthor=J.+A.+Littlechildauthor=N.+J.+Harmer&title=Determination+of+protein-ligand+interactions+using+differential+scanning+fluorimetry&doi=10.3791%2F51809"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3791%2F51809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F51809%26sid%3Dliteratum%253Aachs%26aulast%3DVivoli%26aufirst%3DM.%26aulast%3DNovak%26aufirst%3DH.%2BR.%26aulast%3DLittlechild%26aufirst%3DJ.%2BA.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26atitle%3DDetermination%2520of%2520protein-ligand%2520interactions%2520using%2520differential%2520scanning%2520fluorimetry%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2014%26volume%3D91%26spage%3De51809%26doi%3D10.3791%2F51809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, M.
T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veloso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar-Sinha, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, M.</span></span> <span> </span><span class="NLM_article-title">Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">2240</span>– <span class="NLM_lpage">2245</span>, <span class="refDoi"> DOI: 10.1073/pnas.1219192110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1073%2Fpnas.1219192110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=23345452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVersLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=2240-2245&author=M.%0AT.+Paulsenauthor=A.+Velosoauthor=J.+Prasadauthor=K.+Bediauthor=E.+A.+Ljungmanauthor=Y.+C.+Tsanauthor=C.+W.+Changauthor=B.+Tarrierauthor=J.+G.+Washburnauthor=R.+Lyonsauthor=D.+R.+Robinsonauthor=C.+Kumar-Sinhaauthor=T.+E.+Wilsonauthor=M.+Ljungman&title=Coordinated+regulation+of+synthesis+and+stability+of+RNA+during+the+acute+TNF-induced+proinflammatory+response&doi=10.1073%2Fpnas.1219192110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response</span></div><div class="casAuthors">Paulsen, Michelle T.; Veloso, Artur; Prasad, Jayendra; Bedi, Karan; Ljungman, Emily A.; Tsan, Ya-Chun; Chang, Ching-Wei; Tarrier, Brendan; Washburn, Joseph G.; Lyons, Robert; Robinson, Daniel R.; Kumar-Sinha, Chandan; Wilson, Thomas E.; Ljungman, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2240-2245, S2240/1-S2240/347</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Steady-state gene expression is a coordination of synthesis and decay of RNA through epigenetic regulation, transcription factors, micro RNAs (miRNAs), and RNA-binding proteins.  Here, we present bromouride labeling and sequencing (Bru-Seq) and bromouridine pulse-chase and sequencing (BruChase-Seq) to assess genome-wide changes to RNA synthesis and stability in human fibroblasts at homeostasis and after exposure to the proinflammatory tumor necrosis factor (TNF).  The inflammatory response in human cells involves rapid and dramatic changes in gene expression, and the Bru-Seq and BruChase-Seq techniques revealed a coordinated and complex regulation of gene expression both at the transcriptional and posttranscriptional levels.  The combinatory anal. of both RNA synthesis and stability using Bru-Seq and BruChase-Seq allows for a much deeper understanding of mechanisms of gene regulation than afforded by the anal. of steady-state total RNA and should be useful in many biol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfuRwriMUd77Vg90H21EOLACvtfcHk0lgB6uTO5sbCag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVersLY%253D&md5=74e41864b9379692b3265cb7a806e7ca</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1219192110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1219192110%26sid%3Dliteratum%253Aachs%26aulast%3DPaulsen%26aufirst%3DM.%2BT.%26aulast%3DVeloso%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DK.%26aulast%3DLjungman%26aufirst%3DE.%2BA.%26aulast%3DTsan%26aufirst%3DY.%2BC.%26aulast%3DChang%26aufirst%3DC.%2BW.%26aulast%3DTarrier%26aufirst%3DB.%26aulast%3DWashburn%26aufirst%3DJ.%2BG.%26aulast%3DLyons%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DKumar-Sinha%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DT.%2BE.%26aulast%3DLjungman%26aufirst%3DM.%26atitle%3DCoordinated%2520regulation%2520of%2520synthesis%2520and%2520stability%2520of%2520RNA%2520during%2520the%2520acute%2520TNF-induced%2520proinflammatory%2520response%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D2240%26epage%3D2245%26doi%3D10.1073%2Fpnas.1219192110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mootha, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillette, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomeroy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span> <span> </span><span class="NLM_article-title">Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">15545</span>– <span class="NLM_lpage">15550</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506580102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1073%2Fpnas.0506580102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=16199517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=15545-15550&author=A.+Subramanianauthor=P.+Tamayoauthor=V.+K.+Moothaauthor=S.+Mukherjeeauthor=B.+L.+Ebertauthor=M.+A.+Gilletteauthor=A.+Paulovichauthor=S.+L.+Pomeroyauthor=T.+R.+Golubauthor=E.+S.+Landerauthor=J.+P.+Mesirov&title=Gene+set+enrichment+analysis%3A+A+knowledge-based+approach+for+interpreting+genome-wide+expression+profiles&doi=10.1073%2Fpnas.0506580102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</span></div><div class="casAuthors">Subramanian, Aravind; Tamayo, Pablo; Mootha, Vamsi K.; Mukherjee, Sayan; Ebert, Benjamin L.; Gillette, Michael A.; Paulovich, Amanda; Pomeroy, Scott L.; Golub, Todd R.; Lander, Eric S.; Mesirov, Jill P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15545-15550</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although genomewide RNA expression anal. has become a routine tool in biomedical research, extg. biol. insight from such information remains a major challenge.  Here, we describe a powerful anal. method called Gene Set Enrichment Anal. (GSEA) for interpreting gene expression data.  The method derives its power by focusing on gene sets, i.e., groups of genes that share common biol. function, chromosomal location, or regulation.  We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer.  Notably, where single-gene anal. finds little similarity between two independent studies of patients survival in lung cancer, GSEA reveals many biol. pathways in common.  The GSEA method is embodied in a freely available software package, together with an initial database of 1,325 biol. defined gene sets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH2_E6gWd0yrVg90H21EOLACvtfcHk0lilrhLUWeUC3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO&md5=ca2eb221010f20379199e6442c65fc2e</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506580102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506580102%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DMootha%26aufirst%3DV.%2BK.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGillette%26aufirst%3DM.%2BA.%26aulast%3DPaulovich%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26atitle%3DGene%2520set%2520enrichment%2520analysis%253A%2520A%2520knowledge-based%2520approach%2520for%2520interpreting%2520genome-wide%2520expression%2520profiles%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D15545%26epage%3D15550%26doi%3D10.1073%2Fpnas.0506580102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAlister, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusinow, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jedrychowski, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuhr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttlin, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gygi, S. P.</span></span> <span> </span><span class="NLM_article-title">MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">7150</span>– <span class="NLM_lpage">7158</span>, <span class="refDoi"> DOI: 10.1021/ac502040v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac502040v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1Kmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=7150-7158&author=G.+C.+McAlisterauthor=D.+P.+Nusinowauthor=M.+P.+Jedrychowskiauthor=M.+Wuhrauthor=E.+L.+Huttlinauthor=B.+K.+Ericksonauthor=R.+Radauthor=W.+Haasauthor=S.+P.+Gygi&title=MultiNotch+MS3+enables+accurate%2C+sensitive%2C+and+multiplexed+detection+of+differential+expression+across+cancer+cell+line+proteomes&doi=10.1021%2Fac502040v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes</span></div><div class="casAuthors">McAlister, Graeme C.; Nusinow, David P.; Jedrychowski, Mark P.; Wuhr, Martin; Huttlin, Edward L.; Erickson, Brian K.; Rad, Ramin; Haas, Wilhelm; Gygi, Steven P.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7150-7158</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multiplexed quantitation via isobaric chem. tags (e.g., tandem mass tags (TMT) and isobaric tags for relative and abs. quantitation (iTRAQ)) has the potential to revolutionize quant. proteomics.  However, until recently the utility of these tags was questionable due to reporter ion ratio distortion resulting from fragmentation of coisolated interfering species.  These interfering signals can be negated through addnl. gas-phase manipulations (e.g., MS/MS/MS (MS3) and proton-transfer reactions (PTR)).  These methods, however, have a significant sensitivity penalty.  Using isolation waveforms with multiple frequency notches (i.e., synchronous precursor selection, SPS), the authors coisolated and cofragmented multiple MS2 fragment ions, thereby increasing the no. of reporter ions in the MS3 spectrum 10-fold over the std. MS3 method (i.e., MultiNotch MS3).  By increasing the reporter ion signals, this method improves the dynamic range of reporter ion quantitation, reduces reporter ion signal variance, and ultimately produces more high-quality quant. measurements.  To demonstrate utility, the authors analyzed biol. triplicates of eight colon cancer cell lines using the MultiNotch MS3 method.  Across all the replicates the authors quantified 8378 proteins in union and 6168 proteins in common.  Taking into account that each of these quantified proteins contains eight distinct cell-line measurements, this data set encompasses 174,704 quant. ratios each measured in triplicate across the biol. replicates.  Herein, the MultiNotch MS3 method uniquely combines multiplexing capacity with quant. sensitivity and accuracy, drastically increasing the informational value obtainable from proteomic expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonIBGSGUtKzbVg90H21EOLACvtfcHk0lilrhLUWeUC3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1Kmur8%253D&md5=bda847612d4a16030b7921bc8ae6f5c6</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fac502040v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac502040v%26sid%3Dliteratum%253Aachs%26aulast%3DMcAlister%26aufirst%3DG.%2BC.%26aulast%3DNusinow%26aufirst%3DD.%2BP.%26aulast%3DJedrychowski%26aufirst%3DM.%2BP.%26aulast%3DWuhr%26aufirst%3DM.%26aulast%3DHuttlin%26aufirst%3DE.%2BL.%26aulast%3DErickson%26aufirst%3DB.%2BK.%26aulast%3DRad%26aufirst%3DR.%26aulast%3DHaas%26aufirst%3DW.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26atitle%3DMultiNotch%2520MS3%2520enables%2520accurate%252C%2520sensitive%252C%2520and%2520multiplexed%2520detection%2520of%2520differential%2520expression%2520across%2520cancer%2520cell%2520line%2520proteomes%26jtitle%3DAnal.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D7150%26epage%3D7158%26doi%3D10.1021%2Fac502040v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2009&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+Improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520Improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Dennis Özcelik</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of Neuroblastoma Cells with Inhibitors of Protein Disulfide Isomerase Upregulates NQO1 Activity. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2020,</strong> <em>33 </em>
                                    (8)
                                     , 2099-2107. <a href="https://doi.org/10.1021/acs.chemrestox.0c00101" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.0c00101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.0c00101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.0c00101%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DTreatment%252Bof%252BNeuroblastoma%252BCells%252Bwith%252BInhibitors%252Bof%252BProtein%252BDisulfide%252BIsomerase%252BUpregulates%252BNQO1%252BActivity%26aulast%3D%25C3%2596zcelik%26aufirst%3DDennis%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19032020%26date%3D14072020%26volume%3D33%26issue%3D8%26spage%3D2099%26epage%3D2107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xulin  Xu</span>, <span class="hlFld-ContribAuthor ">Joyce  Chiu</span>, <span class="hlFld-ContribAuthor ">Shuai  Chen</span>, <span class="hlFld-ContribAuthor ">Chao  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Pathophysiological roles of cell surface and extracellular protein disulfide isomerase and their molecular mechanisms. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2021,</strong> <em>178 </em>
                                    (15)
                                     , 2911-2930. <a href="https://doi.org/10.1111/bph.15493" title="DOI URL">https://doi.org/10.1111/bph.15493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15493%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DPathophysiological%252Broles%252Bof%252Bcell%252Bsurface%252Band%252Bextracellular%252Bprotein%252Bdisulfide%252Bisomerase%252Band%252Btheir%252Bmolecular%252Bmechanisms%26aulast%3DXu%26aufirst%3DXulin%26date%3D2021%26date%3D2021%26volume%3D178%26issue%3D15%26spage%3D2911%26epage%3D2930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monalisa  Kundu</span>, <span class="hlFld-ContribAuthor ">Anup Kumar  Misra</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of glycosyl disulfides and sulfides via the formation of glycosyl Bunte salts as thiol surrogates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2021,</strong> <em>294 </em>, 132242. <a href="https://doi.org/10.1016/j.tet.2021.132242" title="DOI URL">https://doi.org/10.1016/j.tet.2021.132242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2021.132242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2021.132242%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DPreparation%252Bof%252Bglycosyl%252Bdisulfides%252Band%252Bsulfides%252Bvia%252Bthe%252Bformation%252Bof%252Bglycosyl%252BBunte%252Bsalts%252Bas%252Bthiol%252Bsurrogates%26aulast%3DKundu%26aufirst%3DMonalisa%26date%3D2021%26volume%3D294%26spage%3D132242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauren E.  Powell</span>, <span class="hlFld-ContribAuthor ">Paul A.  Foster</span>. </span><span class="cited-content_cbyCitation_article-title">Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy. </span><span class="cited-content_cbyCitation_journal-name">Cancer Medicine</span><span> <strong>2021,</strong> <em>10 </em>
                                    (8)
                                     , 2812-2825. <a href="https://doi.org/10.1002/cam4.3836" title="DOI URL">https://doi.org/10.1002/cam4.3836</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cam4.3836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcam4.3836%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Medicine%26atitle%3DProtein%252Bdisulphide%252Bisomerase%252Binhibition%252Bas%252Ba%252Bpotential%252Bcancer%252Btherapeutic%252Bstrategy%26aulast%3DPowell%26aufirst%3DLauren%2BE.%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D8%26spage%3D2812%26epage%3D2825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Jiaojiao  Yu</span>, <span class="hlFld-ContribAuthor ">Chih‐chen  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Protein disulfide isomerase is regulated in multiple ways: Consequences for conformation, activities, and pathophysiological functions. </span><span class="cited-content_cbyCitation_journal-name">BioEssays</span><span> <strong>2021,</strong> <em>43 </em>
                                    (3)
                                     , 2000147. <a href="https://doi.org/10.1002/bies.202000147" title="DOI URL">https://doi.org/10.1002/bies.202000147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bies.202000147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbies.202000147%26sid%3Dliteratum%253Aachs%26jtitle%3DBioEssays%26atitle%3DProtein%252Bdisulfide%252Bisomerase%252Bis%252Bregulated%252Bin%252Bmultiple%252Bways%25253A%252BConsequences%252Bfor%252Bconformation%25252C%252Bactivities%25252C%252Band%252Bpathophysiological%252Bfunctions%26aulast%3DWang%26aufirst%3DLei%26date%3D2021%26date%3D2020%26volume%3D43%26issue%3D3%26spage%3D2000147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa‐Marie  Holbrook</span>, <span class="hlFld-ContribAuthor ">Shirley J.  Keeton</span>, <span class="hlFld-ContribAuthor ">Parvathy  Sasikumar</span>, <span class="hlFld-ContribAuthor ">Sophie  Nock</span>, <span class="hlFld-ContribAuthor ">Justine  Gelzinis</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Brunt</span>, <span class="hlFld-ContribAuthor ">Sarah  Ryan</span>, <span class="hlFld-ContribAuthor ">Megan M.  Pantos</span>, <span class="hlFld-ContribAuthor ">Christina A.  Verbetsky</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Gibbins</span>, <span class="hlFld-ContribAuthor ">Daniel R.  Kennedy</span>. </span><span class="cited-content_cbyCitation_article-title">Zafirlukast is a broad‐spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2021,</strong> <em>178 </em>
                                    (3)
                                     , 550-563. <a href="https://doi.org/10.1111/bph.15291" title="DOI URL">https://doi.org/10.1111/bph.15291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15291%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DZafirlukast%252Bis%252Ba%252Bbroad%2525E2%252580%252590spectrum%252Bthiol%252Bisomerase%252Binhibitor%252Bthat%252Binhibits%252Bthrombosis%252Bwithout%252Baltering%252Bbleeding%252Btimes%26aulast%3DHolbrook%26aufirst%3DLisa%25E2%2580%2590Marie%26date%3D2021%26date%3D2021%26volume%3D178%26issue%3D3%26spage%3D550%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiahui  Fu</span>, <span class="hlFld-ContribAuthor ">Jihui  Gao</span>, <span class="hlFld-ContribAuthor ">Zhongxin  Liang</span>, <span class="hlFld-ContribAuthor ">Dong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">PDI-Regulated Disulfide Bond Formation in Protein Folding and Biomolecular Assembly. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (1)
                                     , 171. <a href="https://doi.org/10.3390/molecules26010171" title="DOI URL">https://doi.org/10.3390/molecules26010171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26010171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26010171%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPDI-Regulated%252BDisulfide%252BBond%252BFormation%252Bin%252BProtein%252BFolding%252Band%252BBiomolecular%252BAssembly%26aulast%3DFu%26aufirst%3DJiahui%26date%3D2021%26date%3D2020%26volume%3D26%26issue%3D1%26spage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea G.  Shergalis</span>, <span class="hlFld-ContribAuthor ">Shuai  Hu</span>, <span class="hlFld-ContribAuthor ">Armand  Bankhead</span>, <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">Role of the ERO1-PDI interaction in oxidative protein folding and disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>210 </em>, 107525. <a href="https://doi.org/10.1016/j.pharmthera.2020.107525" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107525</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107525%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DRole%252Bof%252Bthe%252BERO1-PDI%252Binteraction%252Bin%252Boxidative%252Bprotein%252Bfolding%252Band%252Bdisease%26aulast%3DShergalis%26aufirst%3DAndrea%2BG.%26date%3D2020%26volume%3D210%26spage%3D107525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Kabakov</span>, <span class="hlFld-ContribAuthor ">Anna  Yakimova</span>, <span class="hlFld-ContribAuthor ">Olga  Matchuk</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (4)
                                     , 892. <a href="https://doi.org/10.3390/cells9040892" title="DOI URL">https://doi.org/10.3390/cells9040892</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9040892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9040892%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DMolecular%252BChaperones%252Bin%252BCancer%252BStem%252BCells%25253A%252BDeterminants%252Bof%252BStemness%252Band%252BPotential%252BTargets%252Bfor%252BAntitumor%252BTherapy%26aulast%3DKabakov%26aufirst%3DAlexander%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D4%26spage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed A.A.  Radwan</span>, <span class="hlFld-ContribAuthor ">Maha A.  Alshubramy</span>, <span class="hlFld-ContribAuthor ">Marwa  Abdel-Motaal</span>, <span class="hlFld-ContribAuthor ">Bahaa A.  Hemdan</span>, <span class="hlFld-ContribAuthor ">Dina S.  El-Kady</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, molecular docking and antimicrobial activity of new fused pyrimidine and pyridine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>96 </em>, 103516. <a href="https://doi.org/10.1016/j.bioorg.2019.103516" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103516%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bmolecular%252Bdocking%252Band%252Bantimicrobial%252Bactivity%252Bof%252Bnew%252Bfused%252Bpyrimidine%252Band%252Bpyridine%252Bderivatives%26aulast%3DRadwan%26aufirst%3DMohamed%2BA.A.%26date%3D2020%26volume%3D96%26spage%3D103516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhigang  Peng</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Hui  Cao</span>, <span class="hlFld-ContribAuthor ">Hecun  Zou</span>, <span class="hlFld-ContribAuthor ">Xin  Wan</span>, <span class="hlFld-ContribAuthor ">Wenjing  Zeng</span>, <span class="hlFld-ContribAuthor ">Yanling  Liu</span>, <span class="hlFld-ContribAuthor ">Jiaqing  Hu</span>, <span class="hlFld-ContribAuthor ">Nan  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Xia</span>, <span class="hlFld-ContribAuthor ">Zhixiong  Liu</span>, <span class="hlFld-ContribAuthor ">Quan  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients. </span><span class="cited-content_cbyCitation_journal-name">Aging</span><span> <strong>2020,</strong> <em>12 </em>
                                    (3)
                                     , 2347-2372. <a href="https://doi.org/10.18632/aging.102748" title="DOI URL">https://doi.org/10.18632/aging.102748</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/aging.102748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Faging.102748%26sid%3Dliteratum%253Aachs%26jtitle%3DAging%26atitle%3DProtein%252Bdisulfide%252Bisomerases%252Bare%252Bpromising%252Btargets%252Bfor%252Bpredicting%252Bthe%252Bsurvival%252Band%252Btumor%252Bprogression%252Bin%252Bglioma%252Bpatients%26aulast%3DPeng%26aufirst%3DZhigang%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D3%26spage%3D2347%26epage%3D2372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reeder M.  Robinson</span>, <span class="hlFld-ContribAuthor ">Leticia  Reyes</span>, <span class="hlFld-ContribAuthor ">Ravyn M.  Duncan</span>, <span class="hlFld-ContribAuthor ">Haiyan  Bian</span>, <span class="hlFld-ContribAuthor ">Eric D.  Strobel</span>, <span class="hlFld-ContribAuthor ">Sarah L.  Hyman</span>, <span class="hlFld-ContribAuthor ">Allen B.  Reitz</span>, <span class="hlFld-ContribAuthor ">Nathan G.  Dolloff</span>. </span><span class="cited-content_cbyCitation_article-title">Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111906. <a href="https://doi.org/10.1016/j.ejmech.2019.111906" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111906%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTuning%252Bisoform%252Bselectivity%252Band%252Bbortezomib%252Bsensitivity%252Bwith%252Ba%252Bnew%252Bclass%252Bof%252Balkenyl%252Bindene%252BPDI%252Binhibitor%26aulast%3DRobinson%26aufirst%3DReeder%2BM.%26date%3D2020%26volume%3D186%26spage%3D111906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of chalcones that have been marketed or clinically tested and the hit compound <b>BAP2</b> as a PDI inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-Substituted Acetophenones (<b>3a</b>–<b>n</b>) and Benzaldehydes (<b>4a</b>–<b>b</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <b>3a</b>, K<sub>2</sub>CO<sub>3</sub>, MeI, acetone, reflux. (ii) <b>3b</b>, THF, rt; <b>3c</b>–<b>i</b>, Et<sub>3</sub>N, anhyd THF, rt. (iii) <b>3j</b> (1) pyridine, anhyd DCM, rt; (2) 1 N HCl, <b>3k</b>–<b>m</b>; (1) SOCl<sub>2</sub>, rt; (2) pyridine, DCM. (iv) <b>3n</b> (1) NBS, AIBN, MeCN, reflux; (2) CaCO<sub>3</sub>, dioxane, H<sub>2</sub>O, reflux. (v) (1) Cs<sub>2</sub>CO<sub>3</sub>, MeOH/H<sub>2</sub>O (10:1), rt; (2) MeI, DMF, rt. (vi) benzimidazole, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>BAP2</b> Analogues <b>5</b>–<b>72</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <b>5</b>, <b>10</b>–<b>26</b>, <b>28</b>, <b>30</b>–<b>38</b>, <b>40</b>–<b>44</b>, <b>47</b>–<b>55</b>, <b>57</b>–<b>67</b>, <b>70</b>: BF<sub>3</sub>·Et<sub>2</sub>O, 1,4-dioxane, 80 °C. <b>8</b>–<b>9</b>, <b>39</b>: 60% NaOH, EtOH, 0 °C → rt. <b>29</b>, <b>56</b>: (1) Et<sub>2</sub>NH, pyridine, 80–120 °C; (2) acetic acid. (ii) <b>71</b>: DBU, PPh<sub>3</sub>, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, THF, MW 120 °C, 40 min. (iii) <b>6</b>: (1) Py·HCl, 210 °C; (2) NaHCO<sub>3</sub>, pH 7–8. (iv) <b>7</b>, <b>27</b>: K<sub>2</sub>CO<sub>3</sub>, MeI, acetone, reflux. (v) <b>31</b>: (1) Bis(pinacolato)diboron, PdCl<sub>2</sub>(dppf), KOAc, dioxane, reflux; (2) NaIO<sub>4</sub>, THF, H<sub>2</sub>O, rt; (3) HCl, H<sub>2</sub>O, rt. (vi) <b>45</b>: (1) NaOH, H<sub>2</sub>O, THF, rt; (2) HCl, H<sub>2</sub>O. (vii) <b>46</b>: cat. H<sub>2</sub>SO<sub>4</sub>, anhyd MeOH, reflux. (viii) <b>68</b>: pyridine-3-boronic acid, 10 mol % Pd(OAc)<sub>2</sub>, KF, PEG/EtOH, MW 110 °C, 30 min. (ix) <b>69</b>: Cs<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, MW 130 °C, 20 min. (x) <b>72</b>: (1) NaIO<sub>4</sub>, H<sub>2</sub>O, THF, rt; (2) HCl, H<sub>2</sub>O, rt.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Summarized SAR of synthesized <b>BAP2</b> analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Optimized <b>BAP2</b> analogues inhibit colony formation and PDI activity. (a) Chemical structures of five optimized <b>BAP2</b> (<b>6</b>) analogues. (b) PDI reductase inhibition activity of <b>PACMA31</b>, <b>6</b>, <b>18</b>, <b>46</b>, <b>59</b>, <b>68</b>, and <b>69</b>. Recombinant PDI at 400 nM was incubated at 42 °C for 1 h in the presence or absence of indicated compounds. Reduction of insulin was followed by an increase in absorbance at 620 nm for 120 min. IC<sub>50</sub> values were calculated at 80 min. (c) Colony formation ability of U87MG cells was determine in the presence of DMSO or PDI inhibitors. Normalized well intensity from three independent experiments is shown in the right panel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Optimized <b>BAP2</b> analogues stabilize PDI. (a) Boltzmann melting temperatures calculated for PDI (0.5 μg/μL) in the presence of 100 μM <b>PACMA31</b>, <b>6</b>, <b>8</b>, <b>18</b>, <b>46</b>, <b>59</b>, <b>68</b>, <b>69</b>, or DMSO. The change in melting temperature compared to DMSO is reported above each bar. (b) Dose–response effects of estradiol, <b>6</b>, <b>46</b>, <b>59</b>, and <b>68</b> in the presence of PDI. Results are reported as the change in the melting temperature of the curve compared to the vehicle control. (c) Change in melting temperature of 0.5 μg/μL wild-type, C53S/C397S, and H256A PDI in the presence of indicated compounds at 100 μM (DMSO used as vehicle control). P, <b>PACMA31</b>; E2, estradiol. Results are reported as mean ± standard deviation of three experiments. *, <i>p</i> < 0.05; **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001, compared to wild-type PDI values. Statistical significance was measured using 2-way analysis of variance (ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>BAP2</b> analogues inhibit protein synthesis via EIF2α pathway (a) U87MG cells were treated with tunicamycin (10 μg/mL), 1.0 μM <b>PACMA31</b>, or 20 μM <b>6</b>, <b>46</b>, <b>18</b>, <b>68</b>, <b>69</b>, or <b>59</b> for 2 h, and Western blots were performed as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. (b) U87MG cells treated with tunicamycin (10 μg/mL), 1.0 μM <b>PACMA31</b>, or indicated compounds at 20 μM for 24 h. Abbreviations: P, <b>PACMA31</b>; TM, tunicamycin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>BAP2</b> analogues inhibit cell migration in a dose-dependent manner. (a) Compounds tested in the wound healing assay for 24 h. Cells were stained with Giemsa stain, and images were taken at 10× magnification. (b) A172 cells migrated through an 8.0 μm membrane in the transwell migration assay, in the presence of <b>6</b>, <b>18</b>, <b>45</b>, and <b>PACMA31</b>, at indicated concentrations, or DMSO as a vehicle control. Wells without FBS were used as a control. Images are representative of five fields per well. (c) U87 cells were treated for 48 h with 10 μM <b>BAP2</b> analogues (or 0.25 μM <b>PACMA31</b>). The activity of MMP-2 was assessed by gelatin zymography. (d) Western blot was performed on the conditioned media of the chalcone-treated cells to determine the expression of cleaved MMP2. (e) Western blot was performed on the cell lysates of the chalcone-treated U87MG cells to determine expression of MMP2 and MMP9. (f) Western blot was performed on chalcone-treated U87MG cells to assess changes in the phosphorylation of FAK.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>BAP2</b> analogues induce transcription of ER stress genes and downregulate DNA damage response genes <i>RAD51</i> and <i>E2F1</i>. Traces of RNA transcripts derived from (a) ER stress genes, (b) <i>RAD51</i>, or (c) <i>E2F1</i> loci in U87MG cells treated with 10 μM <b>18</b> or 16 μM <b>46</b> for 4 h. Traces represent RNA abundance following treatment. RPKM: reads/kilobase of transcript/million mapped reads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>18</b> treatment (10 μM in U87MG cells) positively correlates with enrichment of (a) HALLMARK_TNFA_SIGNALING_VIA_NFKB, (b) HALLMARK_MTORC1_SIGNALING, (c) HALLMARK_UNFOLDED_PROTEIN_RESPONSE, (d) KEGG_PROTEASOME, (e) TTCNRGNNNNTTC_HSF_Q6, and (f) CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP. NES, normalized enrichment score; FDR q-val, false discovery rate <i>q</i>-value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compound <b>18</b> treatment (10 μM in U87MG cells) negatively correlates with enrichment of (a) HALLMARK_E2F_TARGETS, (b) HALLMARK_G2M_CHECKPOINT, and (c) E2F1_Q6. NES, normalized enrichment score; FDR q-val, false discovery rate <i>q</i>-value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Compound <b>46</b> treatment (16 μM in U87MG cells) positively correlates with enrichment of (a) HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY, (b) HALLMARK_MTORC1_SIGNALING, (c) HALLMARK_XENOBIOTIC_METABOLISM, (d) HALLMARK_UNFOLDED_PROTEIN_RESPONSE, (e) KEGG_PROTEASOME, and (f) TTCNRGNNNNTTC_HSF_Q6. NES, normalized enrichment score; FDR q-val, false discovery rate <i>q</i>-value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compound <b>46</b> treatment (16 μM in U87MG cells) negatively correlates with enrichment of (a) HALLMARK_E2F_TARGETS, (b) HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION, (c) HALLMARK_TNFA_SIGNALING_VIA_NFKB, (d) HALLMARK_KRAS_SIGNALING_UP, (e) KEGG_RIBOSOME, and (f) BMI1_DN.V1_UP. NES: normalized enrichment score; FDR q-val: false discovery rate <i>q</i>-value.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. GSEA analysis of proteome perturbation by <b>BAP2</b> and <b>18</b> reveals increased expression of G2M checkpoint and arsenic trioxide response and reduced expression of proteins involved in ribosome and DNA replication. Gene set enrichment analysis was used to assess the effect of PDI inhibitors <b>BAP2</b> and <b>18</b> on the proteome of U87MG cells. GSEA plots of (a) upregulated and (b) downregulated pathways upon 20 μM <b>BAP2</b> treatment: G2M checkpoint and ribosome, respectively. GSEA plots of (c) upregulated and (d) downregulated pathways upon 20 μM <b>18</b> treatment: Response to arsenic trioxide and DNA replication, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. <b>BAP2</b> analogues interact with the b′ domain of PDI. (a) Activity of PDI inhibitors at 10 μM (<b>PACMA31</b> tested at 30 μM) against wild-type and H256A PDI, measured with the PDI reductase assay. Results are reported as mean ± standard deviation of three independent experiments. (b) ANS spectral scan with 5 μM PDI and 100 μM PDI inhibitors (estradiol, <b>BAP2</b>, <b>PACMA31</b>, <b>46</b>, <b>68</b>, and <b>59</b>) or inactive <b>BAP2</b> analogues (<b>8</b> and <b>29</b>). (c) Activity of PDI inhibitors at 40 μM in the presence of indicated concentrations of <i>N</i>-acetyl cysteine (NAC). P: <b>PACMA31</b>. DMSO used as a negative control. **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001 compared to wild-type PDI result in the same treatment group. Statistical significance was measured using two-way analysis of variance (ANOVA).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. <b>BAP2</b> analogues interact with the b′ domain of PDI. (a) Molecular docking of 68 <b>BAP2</b> derivatives into three binding sites of PDIA1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a>): Cys56 (Top right), His256 (middle), and Cys397 (top left). (b) Heat map plot for binding affinities of <b>BAP2</b> derivatives in three potential binding pockets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/medium/jm-2018-01951y_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. <b>BAP2</b> analogues docked in the b′ domain. Docking pose and protein–ligand interactions of PDI inhibitors (a) <b>49</b> and (b) <b>68</b> in the b′ domain of PDI (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-7/acs.jmedchem.8b01951/20190404/images/large/jm-2018-01951y_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01951&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i141">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shergalis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankhead, A.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luesakul, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muangsin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Current challenges and opportunities in treating glioblastoma</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">445</span>, <span class="refDoi"> DOI: 10.1124/pr.117.014944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1124%2Fpr.117.014944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=29669750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=412-445&author=A.+Shergalisauthor=A.+Bankheadauthor=U.+Luesakulauthor=N.+Muangsinauthor=N.+Neamati&title=Current+challenges+and+opportunities+in+treating+glioblastoma&doi=10.1124%2Fpr.117.014944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Current challenges and opportunities in treating glioblastoma</span></div><div class="casAuthors">Shergalis, Andrea; Bankhead, Armand; Luesakul, Urarika; Muangsin, Nongnuj; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">412-445</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Glioblastoma multiforme (GBM), the most common and aggressive primary brain tumor, has a high mortality rate despite extensive efforts to develop new treatments.  GBM exhibits both intra- and intertumor heterogeneity, lending to resistance and eventual tumor recurrence.  Large-scale genomic and proteomic anal. of GBM tumors has uncovered potential drug targets.  Effective and "druggable" targets must be validated to embark on a robust medicinal chem. campaign culminating in the discovery of clin. candidates.  Here, we review recent developments in GBM drug discovery and delivery.  To identify GBM drug targets, we performed extensive bioinformatics anal. using data from The Cancer Genome Atlas project.  We discovered 20 genes, BOC, CLEC4GP1, ELOVL6, EREG, ESR2, FDCSP, FURIN, FUT8-AS1, GZMB, IRX3, LITAF, NDEL1, NKX3-1, PODNL1, PTPRN, QSOX1, SEMA4F, TH, VEGFC, and C20orf166AS1 that are overexpressed in a subpopulation of GBM patients and correlate with poor survival outcomes.  Importantly, nine of these genes exhibit higher expression in GBM vs. low-grade glioma and may be involved in disease progression.  In this review, we discuss these proteins in the context of GBM disease progression.  We also conducted computational multi-parameter optimization to assess the blood-brain barrier (BBB) permeability of small mols. in clin. trials for GBM treatment.  Drug delivery in the context of GBM is particularly challenging because the BBB hinders small mol. transport.  Therefore, we discuss novel drug delivery methods, including nanoparticles and prodrugs.  Given the aggressive nature of GBM and the complexity of targeting the central nervous system, effective treatment options are a major unmet medical need.  Identification and validation of biomarkers and drug targets assocd. with GBM disease progression present an exciting opportunity to improve treatment of this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKoQ_eLuZhn7Vg90H21EOLACvtfcHk0lg5rerdPsdfqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVKnsb8%253D&md5=80fb3912ca8df56db7b1c146ef45ffef</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.117.014944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.117.014944%26sid%3Dliteratum%253Aachs%26aulast%3DShergalis%26aufirst%3DA.%26aulast%3DBankhead%26aufirst%3DA.%26aulast%3DLuesakul%26aufirst%3DU.%26aulast%3DMuangsin%26aufirst%3DN.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DCurrent%2520challenges%2520and%2520opportunities%2520in%2520treating%2520glioblastoma%26jtitle%3DPharmacol.%2520Rev.%26date%3D2018%26volume%3D70%26spage%3D412%26epage%3D445%26doi%3D10.1124%2Fpr.117.014944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preusser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Ribaupierre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohrer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erridge, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupp, R.</span></span> <span> </span><span class="NLM_article-title">Current concepts and management of glioblastoma</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1002/ana.22425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1002%2Fana.22425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=21786296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A280%3ADC%252BC3Mjgslylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=9-21&author=M.+Preusserauthor=S.+de+Ribaupierreauthor=A.+Wohrerauthor=S.+C.+Erridgeauthor=M.+Hegiauthor=M.+Wellerauthor=R.+Stupp&title=Current+concepts+and+management+of+glioblastoma&doi=10.1002%2Fana.22425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Current concepts and management of glioblastoma</span></div><div class="casAuthors">Preusser Matthias; de Ribaupierre Sandrine; Wohrer Adelheid; Erridge Sara C; Hegi Monika; Weller Michael; Stupp Roger</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma is the most common malignant primary brain tumor in adults.  Its often rapid clinical course, with many medical and psychosocial challenges, requires a multidisciplinary management.  Modern multimodality treatment and care improve patients' life expectancy and quality of life.  This review covers major aspects of care of glioblastoma patients with a focus on the management of common symptoms and complications.  We aim to provide a guide for clinicians confronted with glioblastoma patients in their everyday practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbRy_XNJVr7bFU0A1HOshhfW6udTcc2eY5bIqcw1pOObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mjgslylug%253D%253D&md5=28831a878bcf73d212c011e2c9363e60</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fana.22425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22425%26sid%3Dliteratum%253Aachs%26aulast%3DPreusser%26aufirst%3DM.%26aulast%3Dde%2BRibaupierre%26aufirst%3DS.%26aulast%3DWohrer%26aufirst%3DA.%26aulast%3DErridge%26aufirst%3DS.%2BC.%26aulast%3DHegi%26aufirst%3DM.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DStupp%26aufirst%3DR.%26atitle%3DCurrent%2520concepts%2520and%2520management%2520of%2520glioblastoma%26jtitle%3DAnn.%2520Neurol.%26date%3D2011%26volume%3D70%26spage%3D9%26epage%3D21%26doi%3D10.1002%2Fana.22425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallego, O.</span></span> <span> </span><span class="NLM_article-title">Nonsurgical treatment of recurrent glioblastoma</span>. <i>Curr. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">e273</span>– <span class="NLM_lpage">e281</span>, <span class="refDoi"> DOI: 10.3747/co.22.2436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3747%2Fco.22.2436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26300678" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=e273-e281&author=O.+Gallego&title=Nonsurgical+treatment+of+recurrent+glioblastoma&doi=10.3747%2Fco.22.2436"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3747%2Fco.22.2436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3747%252Fco.22.2436%26sid%3Dliteratum%253Aachs%26aulast%3DGallego%26aufirst%3DO.%26atitle%3DNonsurgical%2520treatment%2520of%2520recurrent%2520glioblastoma%26jtitle%3DCurr.%2520Oncol.%26date%3D2015%26volume%3D22%26spage%3De273%26epage%3De281%26doi%3D10.3747%2Fco.22.2436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahiri, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, J.</span></span> <span> </span><span class="NLM_article-title">Recurrent glioblastoma: Where we stand</span>. <i>South Asian J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">173</span>, <span class="refDoi"> DOI: 10.4103/2278-330X.175953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.4103%2F2278-330X.175953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26981507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A280%3ADC%252BC28fgvVWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=163-173&author=S.+Royauthor=D.+Lahiriauthor=T.+Majiauthor=J.+Biswas&title=Recurrent+glioblastoma%3A+Where+we+stand&doi=10.4103%2F2278-330X.175953"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Recurrent Glioblastoma: Where we stand</span></div><div class="casAuthors">Roy Sanjoy; Lahiri Debarshi; Maji Tapas; Biswas Jaydip</div><div class="citationInfo"><span class="NLM_cas:title">South Asian journal of cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">163-73</span>
        ISSN:<span class="NLM_cas:issn">2278-330X</span>.
    </div><div class="casAbstract">Current first-line treatment regimens combine surgical resection and chemoradiation for Glioblastoma that provides a slight increase in overall survival.  Age on its own should not be used as an exclusion criterion of glioblastoma multiforme (GBM) treatment, but performance should be factored heavily into the decision-making process for treatment planning.  Despite aggressive initial treatment, most patients develop recurrent diseases which can be treated with re-resection, systemic treatment with targeted agents or cytotoxic chemotherapy, reirradiation, or radiosurgery.  Research into novel therapies is investigating alternative temozolomide regimens, convection-enhanced delivery, immunotherapy, gene therapy, antiangiogenic agents, poly ADP ribose polymerase inhibitors, or cancer stem cell signaling pathways.  Given the aggressive and resilient nature of GBM, continued efforts to better understand GBM pathophysiology are required to discover novel targets for future therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyHsYASlwm3xOk4JA3soTqfW6udTcc2eYqmL-Mll7L-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28fgvVWntw%253D%253D&md5=fa8c4228fa1e349a37b8957c216f18b7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4103%2F2278-330X.175953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2278-330X.175953%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DLahiri%26aufirst%3DD.%26aulast%3DMaji%26aufirst%3DT.%26aulast%3DBiswas%26aufirst%3DJ.%26atitle%3DRecurrent%2520glioblastoma%253A%2520Where%2520we%2520stand%26jtitle%3DSouth%2520Asian%2520J.%2520Cancer%26date%3D2015%26volume%3D4%26spage%3D163%26epage%3D173%26doi%3D10.4103%2F2278-330X.175953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrlinger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schafer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyerbrock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldbrunner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronellenfitsch, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uhl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maciaczyk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnell, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krex, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajkoczy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortmann, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehdorn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuttenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer-Steinacker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fietkau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brehmer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuplich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kebir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunkl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leutgeb, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proescholdt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietsch, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbach, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stummer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glas, M.</span></span> <span> </span><span class="NLM_article-title">Bevacizumab plus irinotecan versus Temozolomide in newly diagnosed O6-methylguanine-DNA methyltransferase nonmethylated glioblastoma: The randomized GLARIUS trial</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1611</span>– <span class="NLM_lpage">1619</span>, <span class="refDoi"> DOI: 10.1200/JCO.2015.63.4691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1200%2FJCO.2015.63.4691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26976423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFClsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=1611-1619&author=U.+Herrlingerauthor=N.+Schaferauthor=J.+P.+Steinbachauthor=A.+Weyerbrockauthor=P.+Hauauthor=R.+Goldbrunnerauthor=F.+Friedrichauthor=V.+Rohdeauthor=F.+Ringelauthor=U.+Schlegelauthor=M.+Sabelauthor=M.+W.+Ronellenfitschauthor=M.+Uhlauthor=J.+Maciaczykauthor=S.+Grauauthor=O.+Schnellauthor=M.+Hanelauthor=D.+Krexauthor=P.+Vajkoczyauthor=R.+Gerlachauthor=R.+D.+Kortmannauthor=M.+Mehdornauthor=J.+Tuttenbergauthor=R.+Mayer-Steinackerauthor=R.+Fietkauauthor=S.+Brehmerauthor=F.+Mackauthor=M.+Stuplichauthor=S.+Kebirauthor=R.+Kohnenauthor=E.+Dunklauthor=B.+Leutgebauthor=M.+Proescholdtauthor=T.+Pietschauthor=H.+Urbachauthor=C.+Belkaauthor=W.+Stummerauthor=M.+Glas&title=Bevacizumab+plus+irinotecan+versus+Temozolomide+in+newly+diagnosed+O6-methylguanine-DNA+methyltransferase+nonmethylated+glioblastoma%3A+The+randomized+GLARIUS+trial&doi=10.1200%2FJCO.2015.63.4691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Bevacizumab plus irinotecan versus temozolomide in newly diagnosed O6-methylguanine-DNA methyltransferase nonmethylated glioblastoma: the randomized GLARIUS trial</span></div><div class="casAuthors">Herrlinger, Ulrich; Schaefer, Niklas; Steinbach, Joachim P.; Weyerbrock, Astrid; Hau, Peter; Goldbrunner, Roland; Friedrich, Franziska; Rohde, Veit; Ringel, Florian; Schlegel, Uwe; Sabel, Michael; Ronellenfitsch, Michael W.; Uhl, Martin; Maciaczyk, Jaroslaw; Grau, Stefan; Schnell, Oliver; Haenel, Mathias; Krex, Dietmar; Vajkoczy, Peter; Gerlach, Ruediger; Kortmann, Rolf-Dieter; Mehdorn, Maximilian; Tuettenberg, Jochen; Mayer-Steinacker, Regine; Fietkau, Rainer; Brehmer, Stefanie; Mack, Frederic; Stuplich, Moritz; Kebir, Sied; Kohnen, Ralf; Dunkl, Elmar; Leutgeb, Barbara; Proescholdt, Martin; Pietsch, Torsten; Urbach, Horst; Belka, Claus; Stummer, Walter; Glas, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1611-1619</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">1527-7755</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose In patients with newly diagnosed glioblastoma that harbors a nonmethylated O6-methylguanine- DNA methyltransferase promotor, std. temozolomide (TMZ) has, at best, limited efficacy.  The GLARIUS trial thus explored bevacizumab plus irinotecan (BEV+IRI) as an alternative to TMZ.  Patients and Methods In this phase II, unblinded trial 182 patients in 22 centers were randomly assigned 2:1 to BEV (10mg/kg every 2 wk) during radiotherapy (RT) followed by maintenance BEV (10mg/kg every 2 wk) plus IRI(125 mg/m2 every 2 wk) or to daily TMZ (75 mg/m2) during RT followed by six courses of TMZ (150-200 mg/m2/d for 5 days every 4 wk).  The primary end point was the progression-free survival rate after 6 mo (PFS-6).  Results In the modified intention-to-treat (ITT) population, PFS-6 was increased from 42.6% with TMZ(95% CI, 29.4% to 55.8% ) to 79.3% with BEV+IRI (95% CI, 71.9% to 86.7% ; P <.001).  PFS was prolonged from a median of 5.99 mo (95% CI, 2.7 to 7.3 mo) to 9.7months (95% CI, 8.7 to 10.8months; P,.001).  At progression, crossover BEV therapy was given to 81.8% of all patients who received any sort of second-line therapy in the TMZ arm.  Overall survival (OS) was not different in the two arms: the median OSwas 16.6months (95% CI, 15.4 to 18.4 mo)with BEV+IRI and was 17.5months (95% CI, 15.1 to 20.5 mo) with TMZ.  The time course of quality of life (QOL) in six selected domains of the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire (QLQ) -C30 and QLQ-BN20 (which included cognitive functioning), of the Karnofsky performance score, and of the Mini Mental State Examn. score was not different between the treatment arms.  Conclusion BEV+IRI resulted in a superior PFS-6 rate and median PFS compared with TMZ.  However, BEV+IRI did not improve OS, potentially because of the high crossover rate.BEV+IRI did not alter QOL compared with TMZ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph7PLBxQZ_fLVg90H21EOLACvtfcHk0lhzqWfMFCD6aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFClsbk%253D&md5=e500df1c5e62d33ac56b9b2057552d82</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1200%2FJCO.2015.63.4691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2015.63.4691%26sid%3Dliteratum%253Aachs%26aulast%3DHerrlinger%26aufirst%3DU.%26aulast%3DSchafer%26aufirst%3DN.%26aulast%3DSteinbach%26aufirst%3DJ.%2BP.%26aulast%3DWeyerbrock%26aufirst%3DA.%26aulast%3DHau%26aufirst%3DP.%26aulast%3DGoldbrunner%26aufirst%3DR.%26aulast%3DFriedrich%26aufirst%3DF.%26aulast%3DRohde%26aufirst%3DV.%26aulast%3DRingel%26aufirst%3DF.%26aulast%3DSchlegel%26aufirst%3DU.%26aulast%3DSabel%26aufirst%3DM.%26aulast%3DRonellenfitsch%26aufirst%3DM.%2BW.%26aulast%3DUhl%26aufirst%3DM.%26aulast%3DMaciaczyk%26aufirst%3DJ.%26aulast%3DGrau%26aufirst%3DS.%26aulast%3DSchnell%26aufirst%3DO.%26aulast%3DHanel%26aufirst%3DM.%26aulast%3DKrex%26aufirst%3DD.%26aulast%3DVajkoczy%26aufirst%3DP.%26aulast%3DGerlach%26aufirst%3DR.%26aulast%3DKortmann%26aufirst%3DR.%2BD.%26aulast%3DMehdorn%26aufirst%3DM.%26aulast%3DTuttenberg%26aufirst%3DJ.%26aulast%3DMayer-Steinacker%26aufirst%3DR.%26aulast%3DFietkau%26aufirst%3DR.%26aulast%3DBrehmer%26aufirst%3DS.%26aulast%3DMack%26aufirst%3DF.%26aulast%3DStuplich%26aufirst%3DM.%26aulast%3DKebir%26aufirst%3DS.%26aulast%3DKohnen%26aufirst%3DR.%26aulast%3DDunkl%26aufirst%3DE.%26aulast%3DLeutgeb%26aufirst%3DB.%26aulast%3DProescholdt%26aufirst%3DM.%26aulast%3DPietsch%26aufirst%3DT.%26aulast%3DUrbach%26aufirst%3DH.%26aulast%3DBelka%26aufirst%3DC.%26aulast%3DStummer%26aufirst%3DW.%26aulast%3DGlas%26aufirst%3DM.%26atitle%3DBevacizumab%2520plus%2520irinotecan%2520versus%2520Temozolomide%2520in%2520newly%2520diagnosed%2520O6-methylguanine-DNA%2520methyltransferase%2520nonmethylated%2520glioblastoma%253A%2520The%2520randomized%2520GLARIUS%2520trial%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D34%26spage%3D1611%26epage%3D1619%26doi%3D10.1200%2FJCO.2015.63.4691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zetterberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, W.</span></span> <span> </span><span class="NLM_article-title">Cell-cycle-specific induction of quiescence achieved by limited inhibition of protein synthesis: Counteractive effect of addition of purified growth factors</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=3894388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADyaL2MXksVyktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1985&pages=375-387&author=O.+Larssonauthor=A.+Zetterbergauthor=W.+Engstrom&title=Cell-cycle-specific+induction+of+quiescence+achieved+by+limited+inhibition+of+protein+synthesis%3A+Counteractive+effect+of+addition+of+purified+growth+factors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cycle-specific induction of quiescence achieved by limited inhibition of protein synthesis:  counteractive effect of addition of purified growth factors</span></div><div class="casAuthors">Larsson, Olle; Zetterberg, Anders; Engstroem, Wilhelm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">375-87</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    </div><div class="casAbstract">Swiss 3T3 cells located in the 1st part of G1 (post-mitotic G1 cells younger than 4.0 h or G1pm cells) were arrested after 9-10 h in the cell cycle by a short (1-8 h) exposure to serum-free medium or by a short (2-4 h) exposure to low doses of the protein synthesis inhibitor cycloheximide (CH).  Cells older than 4 h, i.e. cells in mid or late G1 are already committed to DNA synthesis (presynthesis or G1ps cells).  These cells as well as S and G2 cells were consequently unaffected by the brief serum starvation or the brief treatment with cycloheximide.  The 10-h intermitotic delay that follows a 1-2 h exposure to serum-free medium was completely counteracted by the presence of any one of the purified growth factors, epidermal growth factor (EGF)  [62229-50-9], insulin  [9004-10-8], or platelet-derived growth factor (PDGF).  In contrast, the intermitotic delay following a longer exposure (8 h) to serum-free medium could no longer be counteracted by EGF or insulin.  However, a PDGF was still active in this respect.  Most interestingly, the 12 h gross intermitotic delay introduced by a 4 h exposure to CH was efficiently counteracted by EGF, PDGF, or insulin.  However, this effect on CH-treated cells was counteracted by the growth factor only in the presence of 10% serum.  This indicates the existence of a cooperative effect between PDGF, EGF, or insulin and an unidentified serum factor.  The effects on the cell cycle time of brief serum starvation and exposure to CH were compared with the effects on rate of protein synthesis and degrdn.  Although the effects of serum starvation on protein synthesis and degrdn. were partially normalized by growth factors, growth factors probably prevent cells from leaving the cell cycle by another mechanism and not merely by affecting the level of overall protein accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEKO88jVTP0LVg90H21EOLACvtfcHk0lhzqWfMFCD6aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXksVyktLc%253D&md5=a37e59a7043060bfb986326719172fbb</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarsson%26aufirst%3DO.%26aulast%3DZetterberg%26aufirst%3DA.%26aulast%3DEngstrom%26aufirst%3DW.%26atitle%3DCell-cycle-specific%2520induction%2520of%2520quiescence%2520achieved%2520by%2520limited%2520inhibition%2520of%2520protein%2520synthesis%253A%2520Counteractive%2520effect%2520of%2520addition%2520of%2520purified%2520growth%2520factors%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D1985%26volume%3D73%26spage%3D375%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J. C.</span></span> <span> </span><span class="NLM_article-title">Cell death and endoplasmic reticulum stress: Disease relevance and therapeutic opportunities</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1013</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1038/nrd2755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fnrd2755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=19043451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVenu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1013-1030&author=I.+Kimauthor=W.+Xuauthor=J.+C.+Reed&title=Cell+death+and+endoplasmic+reticulum+stress%3A+Disease+relevance+and+therapeutic+opportunities&doi=10.1038%2Fnrd2755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities</span></div><div class="casAuthors">Kim, Inki; Xu, Wenjie; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1013-1030</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The accumulation of unfolded proteins in the endoplasmic reticulum (ER) represents a cellular stress induced by multiple stimuli and pathol. conditions.  These include hypoxia, oxidative injury, high-fat diet, hypoglycemia, protein inclusion bodies and viral infection.  ER stress triggers an evolutionarily conserved series of signal-transduction events, which constitutes the unfolded protein response.  These signaling events aim to ameliorate the accumulation of unfolded proteins in the ER; however, when these events are severe or protracted they can induce cell death.  With the increasing recognition of an assocn. between ER stress and human diseases, and with the improved understanding of the diverse underlying mol. mechanisms, novel targets for drug discovery and new strategies for therapeutic intervention are beginning to emerge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0c9ZXf8xcx7Vg90H21EOLACvtfcHk0lgj-FdJOs1mDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVenu7%252FM&md5=aee7d77ad27a21f82ea36a3854bbd449</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd2755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2755%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DI.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DCell%2520death%2520and%2520endoplasmic%2520reticulum%2520stress%253A%2520Disease%2520relevance%2520and%2520therapeutic%2520opportunities%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D1013%26epage%3D1030%26doi%3D10.1038%2Fnrd2755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. S.</span></span> <span> </span><span class="NLM_article-title">The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">805</span>– <span class="NLM_lpage">818</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fonc.2012.130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22508478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38Xls1Wns70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=805-818&author=B.+Luoauthor=A.+S.+Lee&title=The+critical+roles+of+endoplasmic+reticulum+chaperones+and+unfolded+protein+response+in+tumorigenesis+and+anticancer+therapies&doi=10.1038%2Fonc.2012.130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies</span></div><div class="casAuthors">Luo, B.; Lee, A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">805-818</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer progression is characterized by rapidly proliferating cancer cells that are in need of increased protein synthesis.  Therefore, enhanced endoplasmic reticulum (ER) activity is required to facilitate the folding, assembly and transportation of membrane and secretory proteins.  These functions are carried out by ER chaperones.  It is now becoming clear that the ER chaperones have crit. functions outside of simply facilitating protein folding.  For example, cancer progression requires glucose regulated protein (GRP) 78 for cancer cell survival and proliferation, as well as angiogenesis in the microenvironment.  GRP78 can translocate to the cell surface acting as a receptor regulating oncogenic signaling and cell viability.  Calreticulin, another ER chaperone, can translocate to the cell surface of apoptotic cancer cells and induce immunogenic cancer cell death and antitumor responses in vivo.  Tumor-secreted GRP94 has been shown to elicit antitumor immune responses when used as antitumor vaccines.  Protein disulfide isomerase is another ER chaperone that demonstrates pro-oncogenic and pro-survival functions.  Because of intrinsic alterations of cellular metab. and extrinsic factors in the tumor microenvironment, cancer cells are under ER stress, and they respond to this stress by activating the unfolded protein response (UPR).  Depending on the severity and duration of ER stress, the signaling branches of the UPR can activate adaptive and pro-survival signals, or induce apoptotic cell death.  The protein kinase RNA-like ER kinase signaling branch of the UPR has a dual role in cancer proliferation and survival, and is also required for ER stress-induced autophagy.  The activation of the inositol-requiring kinase 1α branch promotes tumorigenesis, cancer cell survival and regulates tumor invasion.  In summary, perturbance of ER homeostasis has crit. roles in tumorigenesis, and therapeutic modulation of ER chaperones and/or UPR components presents potential antitumor treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUbqbHLgiJgLVg90H21EOLACvtfcHk0lgj-FdJOs1mDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xls1Wns70%253D&md5=4893de5f108947c67708ac87c4d4392e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.130%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DA.%2BS.%26atitle%3DThe%2520critical%2520roles%2520of%2520endoplasmic%2520reticulum%2520chaperones%2520and%2520unfolded%2520protein%2520response%2520in%2520tumorigenesis%2520and%2520anticancer%2520therapies%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D805%26epage%3D818%26doi%3D10.1038%2Fonc.2012.130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Protein disulfide isomerase: A promising target for cancer therapy</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2013.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.drudis.2013.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=24184531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvValsbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=222-240&author=S.+L.+Xuauthor=S.+Sankarauthor=N.+Neamati&title=Protein+disulfide+isomerase%3A+A+promising+target+for+cancer+therapy&doi=10.1016%2Fj.drudis.2013.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Protein disulfide isomerase: a promising target for cancer therapy</span></div><div class="casAuthors">Xu, Shili; Sankar, Saranya; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">222-240</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein disulfide isomerase (PDI) has a key role in maintaining cellular homeostasis by mediating oxidative protein folding.  It catalyzes disulfide bond formation, breakage and rearrangement in the endoplasmic reticulum and has chaperone protein activity.  Increasing evidence suggests that PDI supports the survival and progression of several cancers.  During the past decade, robust PDI activity assays have been developed and several PDI inhibitors identified, but none has been approved for clin. use.  Herein, we review current knowledge of the role of PDI in cancer and discuss various assays for measuring the activities of PDI, highlighting their sensitivities and usefulness for high-throughput screening.  The previously reported PDI inhibitors require further validation to serve as bona fide leads and addnl. optimization to generate novel drug candidates for clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquANbcuJ6Bv7Vg90H21EOLACvtfcHk0lhqVde3_D1m4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvValsbrM&md5=cab1d37a444bf32f1974567b7622f7e0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2013.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2013.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%2BL.%26aulast%3DSankar%26aufirst%3DS.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DProtein%2520disulfide%2520isomerase%253A%2520A%2520promising%2520target%2520for%2520cancer%2520therapy%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D222%26epage%3D240%26doi%3D10.1016%2Fj.drudis.2013.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shergalis, A.</span>; <span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Protein Disulfide Isomerase</span>. In  <i>Encyclopedia of Signaling Molecules</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>. <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">4200</span>– <span class="NLM_lpage">4211</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1007%2F978-1-4614-6438-9_101768-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=4200-4211&author=A.+Shergalis&author=N.+Neamatiauthor=S.+Choi&title=Encyclopedia+of+Signaling+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-6438-9_101768-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-6438-9_101768-1%26sid%3Dliteratum%253Aachs%26aulast%3DShergalis%26aufirst%3DA.%26atitle%3DProtein%2520Disulfide%2520Isomerase%26btitle%3DEncyclopedia%2520of%2520Signaling%2520Molecules%26aulast%3DChoi%26aufirst%3DS.%26pub%3DSpringer%26date%3D2016%26spage%3D4200%26epage%3D4211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. C.</span></span> <span> </span><span class="NLM_article-title">Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1089/ars.2012.4630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1089%2Fars.2012.4630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22657537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A280%3ADC%252BC38not1Cnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=36-45&author=C.+Wangauthor=W.+Liauthor=J.+Renauthor=J.+Fangauthor=H.+Keauthor=W.+Gongauthor=W.+Fengauthor=C.+C.+Wang&title=Structural+insights+into+the+redox-regulated+dynamic+conformations+of+human+protein+disulfide+isomerase&doi=10.1089%2Fars.2012.4630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase</span></div><div class="casAuthors">Wang Chao; Li Wei; Ren Jinqi; Fang Jingqi; Ke Huimin; Gong Weimin; Feng Wei; Wang Chih-Chen</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & redox signaling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-45</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIM:  Human protein disulfide isomerase (hPDI) is a key enzyme and a redox-regulated chaperone responsible for oxidative protein folding in the endoplasmic reticulum.  This work aims to reveal the molecular mechanism underlying the redox-regulated functions of hPDI by determining the crystal structures of hPDI in different redox states.  RESULTS:  The structures of hPDI (abb'xa') in both the reduced and oxidized states showed that the four thioredoxin domains of a, b, b', and a' are arranged as a horseshoe shape with two CGHC active sites, respectively, in domains a and a' facing each other at the two ends.  In reduced hPDI, domains a, b, and b' line up in the same plane, whereas domain a' twists ∼45° out.  The two active sites are 27.6 ÅA apart.  In oxidized hPDI, the four domains are differently organized to stay in the same plane, and the distance between the active sites increases to 40.3 ÅA.  In contrast to the closed conformation of reduced hPDI, oxidized hPDI exists in an open state with more exposed hydrophobic areas and a larger cleft with potential for substrate binding.  INNOVATION:  This is the first report of the high-resolution structures of hPDI containing all four domains in both the reduced and the oxidized states.  It reveals the redox-regulated structural dynamic properties of the protein.  CONCLUSION:  The redox-regulated open/closed conformational switch of hPDI endows the protein with versatile target-binding capacities for its enzymatic and chaperone functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWKKds5MV7mi86Js-BCLiifW6udTcc2eY0dnnxdv967rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38not1Cnug%253D%253D&md5=ff87e33dc426c3d2a8ad7c76d8a27635</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.4630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.4630%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DGong%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DC.%2BC.%26atitle%3DStructural%2520insights%2520into%2520the%2520redox-regulated%2520dynamic%2520conformations%2520of%2520human%2520protein%2520disulfide%2520isomerase%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2013%26volume%3D19%26spage%3D36%26epage%3D45%26doi%3D10.1089%2Fars.2012.4630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, R. Q.</span></span> <span> </span><span class="NLM_article-title">The acidic C-terminal domain stabilizes the chaperone function of protein disulfide isomerase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">48830</span>– <span class="NLM_lpage">48835</span>, <span class="refDoi"> DOI: 10.1074/jbc.M407076200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1074%2Fjbc.M407076200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=48830-48835&author=R.+Tianauthor=S.+J.+Liauthor=D.+L.+Wangauthor=Z.+Zhaoauthor=Y.+Liuauthor=R.+Q.+He&title=The+acidic+C-terminal+domain+stabilizes+the+chaperone+function+of+protein+disulfide+isomerase&doi=10.1074%2Fjbc.M407076200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M407076200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M407076200%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DS.%2BJ.%26aulast%3DWang%26aufirst%3DD.%2BL.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DR.%2BQ.%26atitle%3DThe%2520acidic%2520C-terminal%2520domain%2520stabilizes%2520the%2520chaperone%2520function%2520of%2520protein%2520disulfide%2520isomerase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D48830%26epage%3D48835%26doi%3D10.1074%2Fjbc.M407076200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, G. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways</span>. <i>Neuro. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">577</span>, <span class="refDoi"> DOI: 10.1093/neuonc/not005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1093%2Fneuonc%2Fnot005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=23444257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVOqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=562-577&author=S.+Sunauthor=D.+Leeauthor=A.+S.+Hoauthor=J.+K.+Puauthor=X.+Q.+Zhangauthor=N.+P.+Leeauthor=P.+J.+Dayauthor=W.+M.+Luiauthor=C.+F.+Fungauthor=G.+K.+Leung&title=Inhibition+of+prolyl+4-hydroxylase%2C+beta+polypeptide+%28P4HB%29+attenuates+temozolomide+resistance+in+malignant+glioma+via+the+endoplasmic+reticulum+stress+response+%28ERSR%29+pathways&doi=10.1093%2Fneuonc%2Fnot005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways</span></div><div class="casAuthors">Sun, Stella; Lee, Derek; Ho, Amy S. W.; Pu, Jenny K. S.; Zhang, X. Q.; Lee, Nikki P.; Day, Philip J. R.; Lui, W. M.; Fung, C. F.; Leung, Gilberto K. K.</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">562-577</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background Glioblastoma multiforme (GBM), the most aggressive malignant primary brain tumor of the central nervous system, is characterized by a relentless disease recurrence despite continued advancement in surgery, radiotherapy, and chemotherapy.  Resistance to temozolomide (TMZ), a std. chemotherapeutic agent for GBM, remains a major challenge.  Understanding the mechanisms behind TMZ resistance can direct the development of novel strategies for the prevention, monitoring, and treatment of tumor relapse.  Methods and results Our research platform, based on the establishment of 2 pairs of TMZ-sensitive/resistant GBM cells (D54-S and D54-R; U87-S and U87-R), has successfully identified prolyl 4-hydroxylase, beta polypeptide (P4HB) over-expression to be assocd. with an increased IC50 of TMZ.  Elevated P4HB expression was verified using in vivo xenografts developed from U87-R cells.  Clin., we found that P4HB was relatively up-regulated in the recurrent GBM specimens that were initially responsive to TMZ but later developed acquired resistance, when compared with treatment-naive tumors.  Functionally, P4HB inhibition by RNAi knockdown and bacitracin inhibition could sensitize D54-R and U87-R cells to TMZ in vitro and in vivo, whereas over-expression of P4HB in vitro conferred resistance to TMZ in both D54-S and U87-S cells.  Moreover, targeting P4HB blocked its protective function and sensitized glioma cells to TMZ through the PERK arm of the endoplasmic reticulum stress response.  Conclusions Our study identified a novel target together with its functional pathway in the development of TMZ resistance.  P4HB inhibition may be used alone or in combination with TMZ for the treatment of TMZ-resistant GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAlJXnH663frVg90H21EOLACvtfcHk0lhb3cfELx8sqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVOqt7c%253D&md5=6a1aba8d7c72c22bd594623f84d64267</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnot005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnot005%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DA.%2BS.%26aulast%3DPu%26aufirst%3DJ.%2BK.%26aulast%3DZhang%26aufirst%3DX.%2BQ.%26aulast%3DLee%26aufirst%3DN.%2BP.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DLui%26aufirst%3DW.%2BM.%26aulast%3DFung%26aufirst%3DC.%2BF.%26aulast%3DLeung%26aufirst%3DG.%2BK.%26atitle%3DInhibition%2520of%2520prolyl%25204-hydroxylase%252C%2520beta%2520polypeptide%2520%2528P4HB%2529%2520attenuates%2520temozolomide%2520resistance%2520in%2520malignant%2520glioma%2520via%2520the%2520endoplasmic%2520reticulum%2520stress%2520response%2520%2528ERSR%2529%2520pathways%26jtitle%3DNeuro.%2520Oncol.%26date%3D2013%26volume%3D15%26spage%3D562%26epage%3D577%26doi%3D10.1093%2Fneuonc%2Fnot005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eirich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schyschka, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servatius, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antes, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazmaier, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vollmar, A. M.</span></span> <span> </span><span class="NLM_article-title">A small molecule inhibits protein disulfide isomerase and triggers the chemosensitization of cancer cells</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">12960</span>– <span class="NLM_lpage">12965</span>, <span class="refDoi"> DOI: 10.1002/anie.201406577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1002%2Fanie.201406577" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=12960-12965&author=J.+Eirichauthor=S.+Braigauthor=L.+Schyschkaauthor=P.+Servatiusauthor=J.+Hoffmannauthor=S.+Hechtauthor=S.+Fuldaauthor=S.+Zahlerauthor=I.+Antesauthor=U.+Kazmaierauthor=S.+A.+Sieberauthor=A.+M.+Vollmar&title=A+small+molecule+inhibits+protein+disulfide+isomerase+and+triggers+the+chemosensitization+of+cancer+cells&doi=10.1002%2Fanie.201406577"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fanie.201406577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201406577%26sid%3Dliteratum%253Aachs%26aulast%3DEirich%26aufirst%3DJ.%26aulast%3DBraig%26aufirst%3DS.%26aulast%3DSchyschka%26aufirst%3DL.%26aulast%3DServatius%26aufirst%3DP.%26aulast%3DHoffmann%26aufirst%3DJ.%26aulast%3DHecht%26aufirst%3DS.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DZahler%26aufirst%3DS.%26aulast%3DAntes%26aufirst%3DI.%26aulast%3DKazmaier%26aufirst%3DU.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26aulast%3DVollmar%26aufirst%3DA.%2BM.%26atitle%3DA%2520small%2520molecule%2520inhibits%2520protein%2520disulfide%2520isomerase%2520and%2520triggers%2520the%2520chemosensitization%2520of%2520cancer%2520cells%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D12960%26epage%3D12965%26doi%3D10.1002%2Fanie.201406577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovat, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corazzari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagliarini, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piacentini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birch-Machin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redfern, C. P.</span></span> <span> </span><span class="NLM_article-title">Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">5363</span>– <span class="NLM_lpage">5369</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-0035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1158%2F0008-5472.CAN-08-0035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=5363-5369&author=P.+E.+Lovatauthor=M.+Corazzariauthor=J.+L.+Armstrongauthor=S.+Martinauthor=V.+Pagliariniauthor=D.+Hillauthor=A.+M.+Brownauthor=M.+Piacentiniauthor=M.+A.+Birch-Machinauthor=C.+P.+Redfern&title=Increasing+melanoma+cell+death+using+inhibitors+of+protein+disulfide+isomerases+to+abrogate+survival+responses+to+endoplasmic+reticulum+stress&doi=10.1158%2F0008-5472.CAN-08-0035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-0035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-0035%26sid%3Dliteratum%253Aachs%26aulast%3DLovat%26aufirst%3DP.%2BE.%26aulast%3DCorazzari%26aufirst%3DM.%26aulast%3DArmstrong%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPagliarini%26aufirst%3DV.%26aulast%3DHill%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DA.%2BM.%26aulast%3DPiacentini%26aufirst%3DM.%26aulast%3DBirch-Machin%26aufirst%3DM.%2BA.%26aulast%3DRedfern%26aufirst%3DC.%2BP.%26atitle%3DIncreasing%2520melanoma%2520cell%2520death%2520using%2520inhibitors%2520of%2520protein%2520disulfide%2520isomerases%2520to%2520abrogate%2520survival%2520responses%2520to%2520endoplasmic%2520reticulum%2520stress%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D5363%26epage%3D5369%26doi%3D10.1158%2F0008-5472.CAN-08-0035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vatolin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jha, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindgari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Distelhorst, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilakala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reu, F. J.</span></span> <span> </span><span class="NLM_article-title">Novel protein disulfide isomerase inhibitor with anticancer activity in multiple myeloma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">3340</span>– <span class="NLM_lpage">3350</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-3099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1158%2F0008-5472.CAN-15-3099" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=3340-3350&author=S.+Vatolinauthor=J.+G.+Phillipsauthor=B.+K.+Jhaauthor=S.+Govindgariauthor=J.+Huauthor=D.+Grabowskiauthor=Y.+Parkerauthor=D.+J.+Lindnerauthor=F.+Zhongauthor=C.+W.+Distelhorstauthor=M.+R.+Smithauthor=C.+Cottaauthor=Y.+Xuauthor=S.+Chilakalaauthor=R.+R.+Kuangauthor=S.+Tallauthor=F.+J.+Reu&title=Novel+protein+disulfide+isomerase+inhibitor+with+anticancer+activity+in+multiple+myeloma&doi=10.1158%2F0008-5472.CAN-15-3099"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-3099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-3099%26sid%3Dliteratum%253Aachs%26aulast%3DVatolin%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DJ.%2BG.%26aulast%3DJha%26aufirst%3DB.%2BK.%26aulast%3DGovindgari%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DGrabowski%26aufirst%3DD.%26aulast%3DParker%26aufirst%3DY.%26aulast%3DLindner%26aufirst%3DD.%2BJ.%26aulast%3DZhong%26aufirst%3DF.%26aulast%3DDistelhorst%26aufirst%3DC.%2BW.%26aulast%3DSmith%26aufirst%3DM.%2BR.%26aulast%3DCotta%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChilakala%26aufirst%3DS.%26aulast%3DKuang%26aufirst%3DR.%2BR.%26aulast%3DTall%26aufirst%3DS.%26aulast%3DReu%26aufirst%3DF.%2BJ.%26atitle%3DNovel%2520protein%2520disulfide%2520isomerase%2520inhibitor%2520with%2520anticancer%2520activity%2520in%2520multiple%2520myeloma%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26spage%3D3340%26epage%3D3350%26doi%3D10.1158%2F0008-5472.CAN-15-3099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goplen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enger, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tysnes, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terzis, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laerum, O. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjerkvig, R.</span></span> <span> </span><span class="NLM_article-title">Protein disulfide isomerase expression is related to the invasive properties of malignant glioma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">9895</span>– <span class="NLM_lpage">9902</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-4589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1158%2F0008-5472.CAN-05-4589" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=9895-9902&author=D.+Goplenauthor=J.+Wangauthor=P.+O.+Engerauthor=B.+B.+Tysnesauthor=A.+J.+Terzisauthor=O.+D.+Laerumauthor=R.+Bjerkvig&title=Protein+disulfide+isomerase+expression+is+related+to+the+invasive+properties+of+malignant+glioma&doi=10.1158%2F0008-5472.CAN-05-4589"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-4589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-4589%26sid%3Dliteratum%253Aachs%26aulast%3DGoplen%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DEnger%26aufirst%3DP.%2BO.%26aulast%3DTysnes%26aufirst%3DB.%2BB.%26aulast%3DTerzis%26aufirst%3DA.%2BJ.%26aulast%3DLaerum%26aufirst%3DO.%2BD.%26aulast%3DBjerkvig%26aufirst%3DR.%26atitle%3DProtein%2520disulfide%2520isomerase%2520expression%2520is%2520related%2520to%2520the%2520invasive%2520properties%2520of%2520malignant%2520glioma%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D9895%26epage%3D9902%26doi%3D10.1158%2F0008-5472.CAN-05-4589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, W. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.</span></span> <span> </span><span class="NLM_article-title">Bacitracin inhibits the migration of U87-MG glioma cells via interferences of the integrin outside-in signaling pathway</span>. <i>J. Korean Neurosurg. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.3340/jkns.2016.59.2.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3340%2Fjkns.2016.59.2.106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26962415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmslamsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=106-116&author=S.+Liauthor=C.+Liauthor=H.+H.+Ryuauthor=S.+H.+Limauthor=W.+Y.+Jangauthor=S.+Jung&title=Bacitracin+inhibits+the+migration+of+U87-MG+glioma+cells+via+interferences+of+the+integrin+outside-in+signaling+pathway&doi=10.3340%2Fjkns.2016.59.2.106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Bacitracin inhibits the migration of U87-MG glioma cells via interferences of the integrin outside-in signaling pathway</span></div><div class="casAuthors">Li, Songyuan; Li, Chunhao; Ryu, Hyang-Hwa; Lim, Sa-Hoe; Jang, Woo-Youl; Jung, Shin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Korean Neurosurgical Society</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-116</span>CODEN:
                <span class="NLM_cas:coden">JKNSAI</span>;
        ISSN:<span class="NLM_cas:issn">1598-7876</span>.
    
            (<span class="NLM_cas:orgname">Korean Neurosurgical Society</span>)
        </div><div class="casAbstract">Objective : Protein disulfide isomerase (PDI) acts as a chaperone on the cell surface, and it has been reported that PDI is assocd. with the tumor cell migration and invasion.  The aims of this study are to investigate the anti-migration effect of bacitracin, which is an inhibitor of PDI, and the assocd. factor in this process.  Methods : U87-MG glioma cells were treated with bacitracin in 1.25, 2.5, 3.75, and 5.0 mM concns.  Western blot with caspase-3 was applied to evaluate the cytotoxicity of bacitracin.  Adhesion, morphol., migration assays, and organotypic brain-slice culture were performed to evaluate the effect of bacitracin to the tumor cell.  Western blot, PCR, and gelatin zymog. were performed to investigate the assocd. factors.  Thirty glioma tissues were collected following immunohistochem. and Western blot.  Results : Bacitracin showed a cytotoxicity in 3rd (p <0.05) and 4th (p <0.001) days, in 5.0 Mm concn.  The cell adhesion significantly decreased and the cells became a round shape after treated with bacitracin.  The migration ability, the expression of phosphorylated focal adhesion kinase (p-FAK) and matrix metalloproteinase-2 (MMP-2) decreased in a bacitracin dose- and time-dependent manner.  The U87-MG cells exhibited low-invasiveness in the 2.5 mM, compared with the untreated in organotypic brain-slice culture.  PDI was expressed in the tumor margin, and significantly increased with histol. glioma grades (p <0.001).  Conclusion : Bacitracin, as a functional inhibitor of PDI, decreased the phosphorylated FAK and the secreted MMP-2, which are the downstream of integrin and play a major role in cell migration and invasion, might become one of the feasible therapeutic strategies for glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIU4aZqDW09bVg90H21EOLACvtfcHk0lj_5JDnbeI-TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmslamsLo%253D&md5=d04da5bc6727eb06e0afbd2810b98ee7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3340%2Fjkns.2016.59.2.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3340%252Fjkns.2016.59.2.106%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DRyu%26aufirst%3DH.%2BH.%26aulast%3DLim%26aufirst%3DS.%2BH.%26aulast%3DJang%26aufirst%3DW.%2BY.%26aulast%3DJung%26aufirst%3DS.%26atitle%3DBacitracin%2520inhibits%2520the%2520migration%2520of%2520U87-MG%2520glioma%2520cells%2520via%2520interferences%2520of%2520the%2520integrin%2520outside-in%2520signaling%2520pathway%26jtitle%3DJ.%2520Korean%2520Neurosurg.%2520Soc.%26date%3D2016%26volume%3D59%26spage%3D106%26epage%3D116%26doi%3D10.3340%2Fjkns.2016.59.2.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span> <span> </span><span class="NLM_article-title">Chalcone: A privileged structure in medicinal chemistry</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">7762</span>– <span class="NLM_lpage">7810</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.7b00020</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.7b00020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnt1GkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=7762-7810&author=C.+Zhuangauthor=W.+Zhangauthor=C.+Shengauthor=W.+Zhangauthor=C.+Xingauthor=Z.+Miao&title=Chalcone%3A+A+privileged+structure+in+medicinal+chemistry&doi=10.1021%2Facs.chemrev.7b00020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone: A Privileged Structure in Medicinal Chemistry</span></div><div class="casAuthors">Zhuang, Chunlin; Zhang, Wen; Sheng, Chunquan; Zhang, Wannian; Xing, Chengguo; Miao, Zhenyuan</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7762-7810</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Privileged structures have been widely used as an effective template in medicinal chem. for drug discovery.  Chalcone is a common simple scaffold found in many naturally occurring compds.  Many chalcone derivs. have also been prepd. due to their convenient synthesis.  These natural products and synthetic compds. have shown numerous interesting biol. activities with clin. potentials against various diseases.  This review aims to highlight the recent evidence of chalcone as a privileged scaffold in medicinal chem.  Multiple aspects of chalcone will be summarized herein, including the isolation of novel chalcone derivs., the development of new synthetic methodologies, the evaluation of their biol. properties, and the exploration of the mechanisms of action as well as target identification.  This review is expected to be a comprehensive, authoritative, and crit. review of the chalcone template to the chem. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4bv1ODSSNG7Vg90H21EOLACvtfcHk0lhh-y0CL2NLTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnt1GkurY%253D&md5=7cdb47c11721ca75c6f0f77a3ad2ee98</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.7b00020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.7b00020%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DZ.%26atitle%3DChalcone%253A%2520A%2520privileged%2520structure%2520in%2520medicinal%2520chemistry%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D7762%26epage%3D7810%26doi%3D10.1021%2Facs.chemrev.7b00020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanigawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, T.</span></span> <span> </span><span class="NLM_article-title">Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: A randomized controlled comparative trial with cimetidine, an H2-receptor antagonist</span>. <i>J. Gastroenterol. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">S155</span>– <span class="NLM_lpage">S160</span>, <span class="refDoi"> DOI: 10.1111/j.1440-1746.2010.06232.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1111%2Fj.1440-1746.2010.06232.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=20586860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFKgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=S155-S160&author=K.+Higuchiauthor=T.+Watanabeauthor=T.+Tanigawaauthor=K.+Tominagaauthor=Y.+Fujiwaraauthor=T.+Arakawa&title=Sofalcone%2C+a+gastroprotective+drug%2C+promotes+gastric+ulcer+healing+following+eradication+therapy+for+Helicobacter+pylori%3A+A+randomized+controlled+comparative+trial+with+cimetidine%2C+an+H2-receptor+antagonist&doi=10.1111%2Fj.1440-1746.2010.06232.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist</span></div><div class="casAuthors">Higuchi, Kazuhide; Watanabe, Toshio; Tanigawa, Tetsuya; Tominaga, Kazunari; Fujiwara, Yasuhiro; Arakawa, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology and Hepatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S155-S160</span>CODEN:
                <span class="NLM_cas:coden">JGHEEO</span>;
        ISSN:<span class="NLM_cas:issn">0815-9319</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">According to reports in Japanese patients, 1 wk of Helicobacter pylori eradication therapy alone is not adequate for healing of gastric ulcers; 7-8 wk of anti-ulcer therapy are subsequently required.  We compared a gastroprotective drug, sofalcone, and an H2-receptor antagonist, cimetidine, in terms of promoting ulcer healing after 7 wk of administration following 1 wk of eradication therapy.  Eradication therapy was administered to 64 patients with H. pylori-pos. active gastric ulcer at least 10 mm in diam., after which 32 patients each received 7 wk of ulcer treatment with sofalcone (300 mg/day) or cimetidine (800 mg/day).  The H. pylori eradication rate was 81.3% (intention-to-treat: ITT) and 81.3% (per protocol: PP) in the sofalcone group, and 62.5% (ITT) and 64.5% (PP) in the cimetidine group.  The ulcer healing rate after 8 wk was 71.9% (ITT) and 71.9% (PP) in the sofalcone group, and 71.9% (ITT) and 71.0% (PP) in the cimetidine group.  The rate of a flat pattern of scarred mucosa was 43.5% (ITT) and 43.5% (PP) in the sofalcone group, and 47.8% (ITT) and 50.0% (PP) in the cimetidine group.  No significant differences were seen between the two groups in terms of H. pylori eradication rate, ulcer healing rate and flat pattern rate.  Sofalcone promoted gastric ulcer healing during 7 wk of treatment following 1 wk of eradication therapy, and the healing rate was equiv. to that of cimetidine.  Symptom disappearance rates were significantly better in the sofalcone group than in the cimetidine group.  This may be a useful way of using a gastroprotective drug in the H. pylori era.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolkbHapLNAcLVg90H21EOLACvtfcHk0lhh-y0CL2NLTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFKgtLk%253D&md5=0c5957d8d7d42a7a6393ddaca1d99b48</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1746.2010.06232.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1746.2010.06232.x%26sid%3Dliteratum%253Aachs%26aulast%3DHiguchi%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DTanigawa%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DK.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DArakawa%26aufirst%3DT.%26atitle%3DSofalcone%252C%2520a%2520gastroprotective%2520drug%252C%2520promotes%2520gastric%2520ulcer%2520healing%2520following%2520eradication%2520therapy%2520for%2520Helicobacter%2520pylori%253A%2520A%2520randomized%2520controlled%2520comparative%2520trial%2520with%2520cimetidine%252C%2520an%2520H2-receptor%2520antagonist%26jtitle%3DJ.%2520Gastroenterol.%2520Hepatol.%26date%3D2010%26volume%3D25%26spage%3DS155%26epage%3DS160%26doi%3D10.1111%2Fj.1440-1746.2010.06232.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawahara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, T.</span></span> <span> </span><span class="NLM_article-title">Sofalcone, a gastric mucosa protective agent, increases vascular endothelial growth factor via the Nrf2-heme-oxygenase-1 dependent pathway in gastric epithelial cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>398</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2010.06.124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.bbrc.2010.06.124" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=398&publication_year=2010&pages=581-584&author=A.+Shibuyaauthor=K.+Ondaauthor=H.+Kawaharaauthor=Y.+Uchiyamaauthor=H.+Nakayamaauthor=T.+Omiauthor=M.+Nagaokaauthor=H.+Matsuiauthor=T.+Hirano&title=Sofalcone%2C+a+gastric+mucosa+protective+agent%2C+increases+vascular+endothelial+growth+factor+via+the+Nrf2-heme-oxygenase-1+dependent+pathway+in+gastric+epithelial+cells&doi=10.1016%2Fj.bbrc.2010.06.124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2010.06.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2010.06.124%26sid%3Dliteratum%253Aachs%26aulast%3DShibuya%26aufirst%3DA.%26aulast%3DOnda%26aufirst%3DK.%26aulast%3DKawahara%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DH.%26aulast%3DOmi%26aufirst%3DT.%26aulast%3DNagaoka%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DH.%26aulast%3DHirano%26aufirst%3DT.%26atitle%3DSofalcone%252C%2520a%2520gastric%2520mucosa%2520protective%2520agent%252C%2520increases%2520vascular%2520endothelial%2520growth%2520factor%2520via%2520the%2520Nrf2-heme-oxygenase-1%2520dependent%2520pathway%2520in%2520gastric%2520epithelial%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D398%26spage%3D581%26epage%3D584%26doi%3D10.1016%2Fj.bbrc.2010.06.124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, A.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic properties of hydroxysafflor yellow A in healthy Chinese female volunteers</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2009.02.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.jep.2009.02.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2009&pages=635-638&author=Z.+Yangauthor=J.+Yangauthor=Y.+Jiaauthor=Y.+Tianauthor=A.+Wen&title=Pharmacokinetic+properties+of+hydroxysafflor+yellow+A+in+healthy+Chinese+female+volunteers&doi=10.1016%2Fj.jep.2009.02.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2009.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2009.02.026%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DA.%26atitle%3DPharmacokinetic%2520properties%2520of%2520hydroxysafflor%2520yellow%2520A%2520in%2520healthy%2520Chinese%2520female%2520volunteers%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2009%26volume%3D124%26spage%3D635%26epage%3D638%26doi%3D10.1016%2Fj.jep.2009.02.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Syam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelwahab, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Mamary, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis of chalcones with anticancer activities</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">6179</span>– <span class="NLM_lpage">6195</span>, <span class="refDoi"> DOI: 10.3390/molecules17066179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3390%2Fmolecules17066179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22634834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38XosVektb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=6179-6195&author=S.+Syamauthor=S.+I.+Abdelwahabauthor=M.+A.+Al-Mamaryauthor=S.+Mohan&title=Synthesis+of+chalcones+with+anticancer+activities&doi=10.3390%2Fmolecules17066179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of chalcones with anticancer activities</span></div><div class="casAuthors">Syam, Suvitha; Abdelwahab, Siddig Ibrahim; Al-Mamary, Mohammed Ali; Mohan, Syam</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6179-6195</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Several chalcones were synthesized and their in vitro cytotoxicity against various human cell lines, including human breast adenocarcinoma cell line MCF-7, human lung adenocarcinoma cell line A549, human prostate cancer cell line PC3, human adenocarcinoma cell line HT-29 (colorectal cancer) and human normal liver cell line WRL-68 was evaluated.  Most of the compds. being active cytotoxic agents, four of them with minimal IC50 values were chosen and studied in detail with MCF-7 cells.  The compds. 1, 5, 23, and 25 were capable in eliciting apoptosis in MCF-7 cells as shown by multiparameter cytotoxicity assay and caspase-3/7, -8, and -9 activities (p < 0.05).  The ROS level showed 1.3-fold increase (p < 0.05) at the low concns. used and thus it was concluded that the compds. increased the ROS level eventually leading to apoptosis in MCF-7 cells through intrinsic as well as extrinsic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC67Q8637e47Vg90H21EOLACvtfcHk0lg0Na4BGhRxBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosVektb4%253D&md5=be8bbccce7e74f468960765691cd42fc</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3390%2Fmolecules17066179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules17066179%26sid%3Dliteratum%253Aachs%26aulast%3DSyam%26aufirst%3DS.%26aulast%3DAbdelwahab%26aufirst%3DS.%2BI.%26aulast%3DAl-Mamary%26aufirst%3DM.%2BA.%26aulast%3DMohan%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520chalcones%2520with%2520anticancer%2520activities%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26spage%3D6179%26epage%3D6195%26doi%3D10.3390%2Fmolecules17066179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruciani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharazmi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liljefors, T.</span></span> <span> </span><span class="NLM_article-title">Antileishmanial chalcones: Statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">4819</span>– <span class="NLM_lpage">4832</span>, <span class="refDoi"> DOI: 10.1021/jm980410m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980410m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4819-4832&author=S.+F.+Nielsenauthor=S.+B.+Christensenauthor=G.+Crucianiauthor=A.+Kharazmiauthor=T.+Liljefors&title=Antileishmanial+chalcones%3A+Statistical+design%2C+synthesis%2C+and+three-dimensional+quantitative+structure-activity+relationship+analysis&doi=10.1021%2Fjm980410m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm980410m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980410m%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DS.%2BF.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DCruciani%26aufirst%3DG.%26aulast%3DKharazmi%26aufirst%3DA.%26aulast%3DLiljefors%26aufirst%3DT.%26atitle%3DAntileishmanial%2520chalcones%253A%2520Statistical%2520design%252C%2520synthesis%252C%2520and%2520three-dimensional%2520quantitative%2520structure-activity%2520relationship%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4819%26epage%3D4832%26doi%3D10.1021%2Fjm980410m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bu, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis of exiguaflavanone K and (±)-leachianone G</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">968</span>– <span class="NLM_lpage">969</span>, <span class="refDoi"> DOI: 10.1021/np960169j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np960169j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1996&pages=968-969&author=X.+Y.+Buauthor=Y.+L.+Li&title=Synthesis+of+exiguaflavanone+K+and+%28%C2%B1%29-leachianone+G&doi=10.1021%2Fnp960169j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fnp960169j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp960169j%26sid%3Dliteratum%253Aachs%26aulast%3DBu%26aufirst%3DX.%2BY.%26aulast%3DLi%26aufirst%3DY.%2BL.%26atitle%3DSynthesis%2520of%2520exiguaflavanone%2520K%2520and%2520%2528%25C2%25B1%2529-leachianone%2520G%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1996%26volume%3D59%26spage%3D968%26epage%3D969%26doi%3D10.1021%2Fnp960169j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeon, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6486</span>– <span class="NLM_lpage">6496</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.bmc.2015.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26337020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOmtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=6486-6496&author=J.+W.+Choiauthor=B.+K.+Jangauthor=N.+C.+Choauthor=J.+H.+Parkauthor=S.+K.+Yeonauthor=E.+J.+Juauthor=Y.+S.+Leeauthor=G.+Hanauthor=A.+N.+Paeauthor=D.+J.+Kimauthor=K.+D.+Park&title=Synthesis+of+a+series+of+unsaturated+ketone+derivatives+as+selective+and+reversible+monoamine+oxidase+inhibitors&doi=10.1016%2Fj.bmc.2015.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors</span></div><div class="casAuthors">Choi, Ji Won; Jang, Bo Ko; Cho, Nam-chul; Park, Jong-Hyun; Yeon, Seul Ki; Ju, Eun Ji; Lee, Yong Sup; Han, Gyoonhee; Pae, Ae Nim; Kim, Dong Jin; Park, Ki Duk</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6486-6496</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors have synthesized three categories of α,β-unsatd. carbonyl derivs. and evaluated their MAO-A and MAO-B inhibitory activities.  Among them, compd. I including α,β-unsatd. ketone group showed the most potent and selective MAO-B inhibitory activity (IC50 human MAO-B 16 nM, >6000-fold selective vs. MAO-A) and compd. I exhibited good reversibility compared with selegiline, a well-known irreversible MAO-B inhibitor.  However, both α,β-unsatd. amide and ester derivs. exhibited weaker MAO-B inhibition potencies.  The docking studies provided insights into the possible binding modes and the key interaction sites of the synthesized MAO-B inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotgFdyaai9JrVg90H21EOLACvtfcHk0ljpj5AvhSuWMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOmtL3E&md5=57992ecedb10268c48fd9cfac29d15a7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DJang%26aufirst%3DB.%2BK.%26aulast%3DCho%26aufirst%3DN.%2BC.%26aulast%3DPark%26aufirst%3DJ.%2BH.%26aulast%3DYeon%26aufirst%3DS.%2BK.%26aulast%3DJu%26aufirst%3DE.%2BJ.%26aulast%3DLee%26aufirst%3DY.%2BS.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DPae%26aufirst%3DA.%2BN.%26aulast%3DKim%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DK.%2BD.%26atitle%3DSynthesis%2520of%2520a%2520series%2520of%2520unsaturated%2520ketone%2520derivatives%2520as%2520selective%2520and%2520reversible%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D6486%26epage%3D6496%26doi%3D10.1016%2Fj.bmc.2015.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palleros, D. R.</span></span> <span> </span><span class="NLM_article-title">Solvent-free synthesis of chalcones</span>. <i>J. Chem. Educ.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1347</span>, <span class="refDoi"> DOI: 10.1021/ed081p1345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ed081p1345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsFSmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2004&pages=1345-1347&author=D.+R.+Palleros&title=Solvent-free+synthesis+of+chalcones&doi=10.1021%2Fed081p1345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Solvent-free synthesis of chalcones</span></div><div class="casAuthors">Palleros, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Education</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1345-1347</span>CODEN:
                <span class="NLM_cas:coden">JCEDA8</span>;
        ISSN:<span class="NLM_cas:issn">0021-9584</span>.
    
            (<span class="NLM_cas:orgname">Journal of Chemical Education, Dept. of Chemistry</span>)
        </div><div class="casAbstract">The synthesis of chalcones is a typical prepn. included in introductory org. chem. labs.  It illustrates an emblematic reaction that proceeds with high atom economy and is relatively easy to perform in teaching labs.  The synthesis of 20 different chalcones in the absence of solvent is described.  Overall, it was found that the reactions proceed rapidly and afford very good yields of product.  Of the 20 chalcones investigated, 17 can be obtained in a matter of minutes by mixing the corresponding benzaldehyde and acetophenone in the presence of solid NaOH in a mortar with pestle; the yields of crude product were in the range of 81-94%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprWgmVMOQV4LVg90H21EOLACvtfcHk0li-NVMXnXxAsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsFSmsb0%253D&md5=c12b1a64e80b155cdd66dc742bd33fa1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fed081p1345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fed081p1345%26sid%3Dliteratum%253Aachs%26aulast%3DPalleros%26aufirst%3DD.%2BR.%26atitle%3DSolvent-free%2520synthesis%2520of%2520chalcones%26jtitle%3DJ.%2520Chem.%2520Educ.%26date%3D2004%26volume%3D81%26spage%3D1345%26epage%3D1347%26doi%3D10.1021%2Fed081p1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calloway, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, L. D.</span></span> <span> </span><span class="NLM_article-title">Reactions in the presence of metallic halides I beta-unsaturated ketone formation as a side reaction in Friedel-Crafts acylations</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1937</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">811</span>, <span class="refDoi"> DOI: 10.1021/ja01284a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01284a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1937&pages=809-811&author=N.+O.+Callowayauthor=L.+D.+Green&title=Reactions+in+the+presence+of+metallic+halides+I+beta-unsaturated+ketone+formation+as+a+side+reaction+in+Friedel-Crafts+acylations&doi=10.1021%2Fja01284a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja01284a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01284a011%26sid%3Dliteratum%253Aachs%26aulast%3DCalloway%26aufirst%3DN.%2BO.%26aulast%3DGreen%26aufirst%3DL.%2BD.%26atitle%3DReactions%2520in%2520the%2520presence%2520of%2520metallic%2520halides%2520I%2520beta-unsaturated%2520ketone%2520formation%2520as%2520a%2520side%2520reaction%2520in%2520Friedel-Crafts%2520acylations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1937%26volume%3D59%26spage%3D809%26epage%3D811%26doi%3D10.1021%2Fja01284a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sipos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirokman, F.</span></span> <span> </span><span class="NLM_article-title">Chalcon formation of different substituted acetophenones + rho-hydroxy-benzaldehyde</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1964</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">489</span>, <span class="refDoi"> DOI: 10.1038/202489a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2F202489a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=14167831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADyaF2cXktFOmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=1964&pages=489&author=G.+Siposauthor=F.+Sirokman&title=Chalcon+formation+of+different+substituted+acetophenones+%2B+rho-hydroxy-benzaldehyde&doi=10.1038%2F202489a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone formation by substituted acetophenones and p-hydroxybenzaldehyde</span></div><div class="casAuthors">Sipos, Gy.; Sirokman, F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">4931</span>),
    <span class="NLM_cas:pages">489</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">In abs. EtOH satd. with HCl, p-HOC6H4CHO reacts at room temp. with 4-hydroxy-3-nitro-, 2-hydroxy-4-nitro-, 3-hydroxy-4-nitro-, and 3-hydroxy-6-nitroacetophenone, and at high temps. with 2-hydroxy-5-nitroacetophenone as well as with 4-hydroxyacetophenone.  Only 4-hydroxy-3-nitroacetophenone, however, reacts in the presence of NaOH.  This greater reactivity in acidic medium is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZDQKKtqeqo7Vg90H21EOLACvtfcHk0li-NVMXnXxAsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXktFOmu7o%253D&md5=db1f0b5312d87f83c50a144a472aa904</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F202489a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F202489a0%26sid%3Dliteratum%253Aachs%26aulast%3DSipos%26aufirst%3DG.%26aulast%3DSirokman%26aufirst%3DF.%26atitle%3DChalcon%2520formation%2520of%2520different%2520substituted%2520acetophenones%2520%252B%2520rho-hydroxy-benzaldehyde%26jtitle%3DNature%26date%3D1964%26volume%3D202%26spage%3D489%26doi%3D10.1038%2F202489a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narender, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. P.</span></span> <span> </span><span class="NLM_article-title">A simple and highly efficient method for the synthesis of chalcones by using borontrifluoride-etherate</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">3177</span>– <span class="NLM_lpage">3180</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2007.03.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.tetlet.2007.03.054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=3177-3180&author=T.+Narenderauthor=K.+P.+Reddy&title=A+simple+and+highly+efficient+method+for+the+synthesis+of+chalcones+by+using+borontrifluoride-etherate&doi=10.1016%2Fj.tetlet.2007.03.054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2007.03.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2007.03.054%26sid%3Dliteratum%253Aachs%26aulast%3DNarender%26aufirst%3DT.%26aulast%3DReddy%26aufirst%3DK.%2BP.%26atitle%3DA%2520simple%2520and%2520highly%2520efficient%2520method%2520for%2520the%2520synthesis%2520of%2520chalcones%2520by%2520using%2520borontrifluoride-etherate%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D3177%26epage%3D3180%26doi%3D10.1016%2Fj.tetlet.2007.03.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koketsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span> <span> </span><span class="NLM_article-title">Newly synthesized ’hidabeni’ chalcone derivatives potently suppress LPS-induced NO production via inhibition of STAT1, but not NF-kappaB, JNK, and p38, pathways in microglia</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1042</span>– <span class="NLM_lpage">1049</span>, <span class="refDoi"> DOI: 10.1248/bpb.b14-00116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1248%2Fbpb.b14-00116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=24882415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKnu7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=1042-1049&author=H.+Haraauthor=R.+Ikedaauthor=M.+Ninomiyaauthor=T.+Kamiyaauthor=M.+Koketsuauthor=T.+Adachi&title=Newly+synthesized+%E2%80%99hidabeni%E2%80%99+chalcone+derivatives+potently+suppress+LPS-induced+NO+production+via+inhibition+of+STAT1%2C+but+not+NF-kappaB%2C+JNK%2C+and+p38%2C+pathways+in+microglia&doi=10.1248%2Fbpb.b14-00116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Newly synthesized 'Hidabeni' chalcone derivatives potently suppress LPS-induced NO production via inhibition of STAT1, but not NF-κB, JNK, and p38, pathways in microglia</span></div><div class="casAuthors">Hara, Hirokazu; Ikeda, Ryoko; Ninomiya, Masayuki; Kamiya, Tetsuro; Koketsu, Mamoru; Adachi, Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1042-1049</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A series of chalcone derivs. I [R1 = R2 = H, OH, MeO; R3 = R4 = H, MeO; R5 = H,HO] were synthesized and explored for their potent NO inhibitory activity.  The compds. were synthesized based on 'hidabeni' chalcone and examd. for their effects on LPS-triggered inducible NO synthase (iNOS) expression and NO prodn.  Compds. I [R1 = R2 = R3 = R4 = MeO; R5 = H, HO] potently inhibited NO prodn. (IC50: 4.19, 2.88μM, resp.).  Compds. I [R1 = R2 = R3 = R4 = MeO; R5 = H, HO] suppressed LPS-induced iNOS expression via the inhibition of the signal transduction and activator of transcription 1 (STAT1), but not nuclear factor-kappa B (NF-κB), c-Jun N terminal kinase (JNK) and p38 pathways.  Compd. I [R1 = R2 = R3 = R4 = MeO; R5 = H], but not [R1 = R2 = R3 = R4 = MeO; R5 = OH], inhibited activation of the MEK/extracellular signal-regulated kinase (ERK) pathway.  Compds. I [R1 = R2 = R3 = R4 = MeO; R5 = H, OH] also suppressed LPS-induced expression of interferon regulatory factor 1 (IRF-1), which is an important transcription factor involved in iNOS expression.  Our findings indicate that these chalcone derivs. I were candidate compds. for preventing microglia-mediated neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwmsq0o1Fs-LVg90H21EOLACvtfcHk0lhMKfsHlcMUTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKnu7jE&md5=df19eaf1cde96581417531e3637dc288</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b14-00116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b14-00116%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DH.%26aulast%3DIkeda%26aufirst%3DR.%26aulast%3DNinomiya%26aufirst%3DM.%26aulast%3DKamiya%26aufirst%3DT.%26aulast%3DKoketsu%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DT.%26atitle%3DNewly%2520synthesized%2520%25E2%2580%2599hidabeni%25E2%2580%2599%2520chalcone%2520derivatives%2520potently%2520suppress%2520LPS-induced%2520NO%2520production%2520via%2520inhibition%2520of%2520STAT1%252C%2520but%2520not%2520NF-kappaB%252C%2520JNK%252C%2520and%2520p38%252C%2520pathways%2520in%2520microglia%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2014%26volume%3D37%26spage%3D1042%26epage%3D1049%26doi%3D10.1248%2Fbpb.b14-00116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninomiya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochizuki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koketsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span> <span> </span><span class="NLM_article-title">Inhibitory effects of chalcone glycosides isolated from Brassica rapa L. ’hidabeni’ and their synthetic derivatives on LPS-induced NO production in microglia</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5559</span>– <span class="NLM_lpage">5568</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.bmc.2011.07.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=5559-5568&author=H.+Haraauthor=Y.+Nakamuraauthor=M.+Ninomiyaauthor=R.+Mochizukiauthor=T.+Kamiyaauthor=E.+Aizenmanauthor=M.+Koketsuauthor=T.+Adachi&title=Inhibitory+effects+of+chalcone+glycosides+isolated+from+Brassica+rapa+L.+%E2%80%99hidabeni%E2%80%99+and+their+synthetic+derivatives+on+LPS-induced+NO+production+in+microglia&doi=10.1016%2Fj.bmc.2011.07.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNinomiya%26aufirst%3DM.%26aulast%3DMochizuki%26aufirst%3DR.%26aulast%3DKamiya%26aufirst%3DT.%26aulast%3DAizenman%26aufirst%3DE.%26aulast%3DKoketsu%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DT.%26atitle%3DInhibitory%2520effects%2520of%2520chalcone%2520glycosides%2520isolated%2520from%2520Brassica%2520rapa%2520L.%2520%25E2%2580%2599hidabeni%25E2%2580%2599%2520and%2520their%2520synthetic%2520derivatives%2520on%2520LPS-induced%2520NO%2520production%2520in%2520microglia%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D5559%26epage%3D5568%26doi%3D10.1016%2Fj.bmc.2011.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narender, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkateswarlu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayak, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarkar, S.</span></span> <span> </span><span class="NLM_article-title">A new chemical access for 3 ’-acetyl-4 ’ hydroxychalcones using borontrifluoride-etherate via a regioselective Cilaisen-Schmidt condensation and its application in the synthesis of chalcone hybrids</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5794</span>– <span class="NLM_lpage">5798</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2011.08.120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.tetlet.2011.08.120" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=5794-5798&author=T.+Narenderauthor=K.+Venkateswarluauthor=B.+V.+Nayakauthor=S.+Sarkar&title=A+new+chemical+access+for+3+%E2%80%99-acetyl-4+%E2%80%99+hydroxychalcones+using+borontrifluoride-etherate+via+a+regioselective+Cilaisen-Schmidt+condensation+and+its+application+in+the+synthesis+of+chalcone+hybrids&doi=10.1016%2Fj.tetlet.2011.08.120"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2011.08.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2011.08.120%26sid%3Dliteratum%253Aachs%26aulast%3DNarender%26aufirst%3DT.%26aulast%3DVenkateswarlu%26aufirst%3DK.%26aulast%3DNayak%26aufirst%3DB.%2BV.%26aulast%3DSarkar%26aufirst%3DS.%26atitle%3DA%2520new%2520chemical%2520access%2520for%25203%2520%25E2%2580%2599-acetyl-4%2520%25E2%2580%2599%2520hydroxychalcones%2520using%2520borontrifluoride-etherate%2520via%2520a%2520regioselective%2520Cilaisen-Schmidt%2520condensation%2520and%2520its%2520application%2520in%2520the%2520synthesis%2520of%2520chalcone%2520hybrids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D5794%26epage%3D5798%26doi%3D10.1016%2Fj.tetlet.2011.08.120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meltzer, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madras, B. K.</span></span> <span> </span><span class="NLM_article-title">1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: A promising class of monoamine uptake inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1420</span>– <span class="NLM_lpage">1432</span>, <span class="refDoi"> DOI: 10.1021/jm050797a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050797a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlWnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1420-1432&author=P.+C.+Meltzerauthor=D.+Butlerauthor=J.+R.+Deschampsauthor=B.+K.+Madras&title=1-%284-Methylphenyl%29-2-pyrrolidin-1-yl-pentan-1-one+%28pyrovalerone%29+analogues%3A+A+promising+class+of+monoamine+uptake+inhibitors&doi=10.1021%2Fjm050797a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">1-(4-Methylphenyl)-2-pyrrolidin-1-ylpentan-1-one (Pyrovalerone) Analogs: A Promising Class of Monoamine Uptake Inhibitors</span></div><div class="casAuthors">Meltzer, Peter C.; Butler, David; Deschamps, Jeffrey R.; Madras, Bertha K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1420-1432</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dopamine, serotonin, and norepinephrine are essential for neurotransmission in the mammalian system.  These three neurotransmitters have been the focus of considerable research because the modulation of their prodn. and their interaction at monoamine receptors has profound effects upon a multitude of pharmacol. outcomes.  Our interest has focused on neurotransmitter reuptake mechanisms in a search for medications for cocaine abuse.  Herein we describe the synthesis and biol. evaluation of an array of 2-aminopentanophenones.  This array has yielded selective inhibitors of the dopamine and norepinephrine transporters with little effect upon serotonin trafficking.  A subset of compds. had no significant affinity at 5HT1A, 5HT1B, 5HT1C, D1, D2, or D3 receptors.  The lead compd., racemic 1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one, was resolved into its enantiomers and the S isomer was found to be the most biol. active enantiomer.  Among the most potent of these DAT/NET selective compds. are the 1-(3,4-dichlorophenyl)- and the 1-naphthyl-2-pyrrolidin-1-ylpentan-1-one analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo5tyfBb2fyLVg90H21EOLACvtfcHk0lh3JNpPAJtrpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlWnsA%253D%253D&md5=36d96d6d50901467657e649d8bc0e9d3</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm050797a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050797a%26sid%3Dliteratum%253Aachs%26aulast%3DMeltzer%26aufirst%3DP.%2BC.%26aulast%3DButler%26aufirst%3DD.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DMadras%26aufirst%3DB.%2BK.%26atitle%3D1-%25284-Methylphenyl%2529-2-pyrrolidin-1-yl-pentan-1-one%2520%2528pyrovalerone%2529%2520analogues%253A%2520A%2520promising%2520class%2520of%2520monoamine%2520uptake%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1420%26epage%3D1432%26doi%3D10.1021%2Fjm050797a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T. J. J.</span></span> <span> </span><span class="NLM_article-title">Sequential coupling-isomerization-coupling reactions - A novel three-component synthesis of aryl chalcones</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2006</i></span>,  <span class="NLM_fpage">3469</span>– <span class="NLM_lpage">3473</span>, <span class="refDoi"> DOI: 10.1055/s-2006-956480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1055%2Fs-2006-956480" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=3469-3473&author=W.+W.+Liaoauthor=T.+J.+J.+Muller&title=Sequential+coupling-isomerization-coupling+reactions+-+A+novel+three-component+synthesis+of+aryl+chalcones&doi=10.1055%2Fs-2006-956480"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-956480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-956480%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DW.%2BW.%26aulast%3DMuller%26aufirst%3DT.%2BJ.%2BJ.%26atitle%3DSequential%2520coupling-isomerization-coupling%2520reactions%2520-%2520A%2520novel%2520three-component%2520synthesis%2520of%2520aryl%2520chalcones%26jtitle%3DSynlett%26date%3D2006%26volume%3D2006%26spage%3D3469%26epage%3D3473%26doi%3D10.1055%2Fs-2006-956480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazzotti, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, T.</span></span> <span> </span><span class="NLM_article-title">Palladium(III)-catalyzed fluorination of arylboronic acid derivatives</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">14012</span>– <span class="NLM_lpage">14015</span>, <span class="refDoi"> DOI: 10.1021/ja405919z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja405919z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVGjtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=14012-14015&author=A.+R.+Mazzottiauthor=M.+G.+Campbellauthor=P.+Tangauthor=J.+M.+Murphyauthor=T.+Ritter&title=Palladium%28III%29-catalyzed+fluorination+of+arylboronic+acid+derivatives&doi=10.1021%2Fja405919z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(III)-Catalyzed Fluorination of Arylboronic Acid Derivatives</span></div><div class="casAuthors">Mazzotti, Anthony R.; Campbell, Michael G.; Tang, Pingping; Murphy, Jennifer M.; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">14012-14015</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A practical, palladium-catalyzed synthesis of aryl fluorides from arylboronic acid derivs. is presented.  The reaction is operationally simple and amenable to multigram-scale synthesis.  Evaluation of the reaction mechanism suggests a single-electron-transfer pathway, involving a Pd-(III) intermediate that has been isolated and characterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4K_B4IfFEArVg90H21EOLACvtfcHk0li9l7dEEH82nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVGjtLrL&md5=354937ee43479f7daaa0b0f9c51e3d01</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja405919z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja405919z%26sid%3Dliteratum%253Aachs%26aulast%3DMazzotti%26aufirst%3DA.%2BR.%26aulast%3DCampbell%26aufirst%3DM.%2BG.%26aulast%3DTang%26aufirst%3DP.%26aulast%3DMurphy%26aufirst%3DJ.%2BM.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DPalladium%2528III%2529-catalyzed%2520fluorination%2520of%2520arylboronic%2520acid%2520derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D14012%26epage%3D14015%26doi%3D10.1021%2Fja405919z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkevich, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zandi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petasis, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neamati, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">16348</span>– <span class="NLM_lpage">16353</span>, <span class="refDoi"> DOI: 10.1073/pnas.1205226109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1073%2Fpnas.1205226109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22988091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGktLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=16348-16353&author=S.+Xuauthor=A.+N.+Butkevichauthor=R.+Yamadaauthor=Y.+Zhouauthor=B.+Debnathauthor=R.+Duncanauthor=E.+Zandiauthor=N.+A.+Petasisauthor=N.+Neamati&title=Discovery+of+an+orally+active+small-molecule+irreversible+inhibitor+of+protein+disulfide+isomerase+for+ovarian+cancer+treatment&doi=10.1073%2Fpnas.1205226109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment</span></div><div class="casAuthors">Xu, Shili; Butkevich, Alexey N.; Yamada, Roppei; Zhou, Yu; Debnath, Bikash; Duncan, Roger; Zandi, Ebrahim; Petasis, Nicos A.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">16348-16353, S16348/1-S16348/18</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Protein disulfide isomerase (PDI), an endoplasmic reticulum chaper-one protein, catalyzes disulfide bond breakage, formation, and rearrangement.  The effect of PDI inhibition on ovarian cancer progression is not yet clear, and there is a need for potent selective, and safe small-mol. inhibitors of PDI.  Here, we report a class of propynoic acid carbamoyl Me amides (PACMAs) that are active against a panel of human ovarian cancer cell lines.  Using fluorescent derivs., 2D gel electrophoresis, and MS, we established that one of the most active analogs, acts as an irreversible small-mol. inhibitor of PDI, forming a covalent bond with the active site cysteines of PDI.  We also showed that PDI activity is essential for the survival and proliferation of human ovarian cancer cells.  In vivo that compd. showed tumor targeting ability and significantly suppressed ovarian tumor growth without causing toxicity to normal tissues.  These irreversible small-mol. PDI inhibitors represent an important approach for the development of targeted anticancer agents for ovarian cancer therapy, and they can also serve as useful probes for investigating the biol. of PDI-implicated pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozZP4n4am-hLVg90H21EOLACvtfcHk0li9l7dEEH82nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGktLzE&md5=26801591b73d67710e06ef184ee9ddde</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1205226109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1205226109%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%26aulast%3DButkevich%26aufirst%3DA.%2BN.%26aulast%3DYamada%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DDebnath%26aufirst%3DB.%26aulast%3DDuncan%26aufirst%3DR.%26aulast%3DZandi%26aufirst%3DE.%26aulast%3DPetasis%26aufirst%3DN.%2BA.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520active%2520small-molecule%2520irreversible%2520inhibitor%2520of%2520protein%2520disulfide%2520isomerase%2520for%2520ovarian%2520cancer%2520treatment%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D16348%26epage%3D16353%26doi%3D10.1073%2Fpnas.1205226109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simizu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawatani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osada, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.1021/cb100387r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb100387r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=245-251&author=M.+M.+Khanauthor=S.+Simizuauthor=N.+S.+Laiauthor=M.+Kawataniauthor=T.+Shimizuauthor=H.+Osada&title=Discovery+of+a+small+molecule+PDI+inhibitor+that+inhibits+reduction+of+HIV-1+envelope+glycoprotein+gp120&doi=10.1021%2Fcb100387r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fcb100387r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb100387r%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DM.%2BM.%26aulast%3DSimizu%26aufirst%3DS.%26aulast%3DLai%26aufirst%3DN.%2BS.%26aulast%3DKawatani%26aufirst%3DM.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DOsada%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520a%2520small%2520molecule%2520PDI%2520inhibitor%2520that%2520inhibits%2520reduction%2520of%2520HIV-1%2520envelope%2520glycoprotein%2520gp120%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D245%26epage%3D251%26doi%3D10.1021%2Fcb100387r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B. T.</span></span> <span> </span><span class="NLM_article-title">Characterization of the estradiol-binding site structure of human pancreas-specific protein disulfide isomerase: Indispensable role of the hydrogen bond between His278 and the estradiol 3-hydroxyl group</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1021/bi101451g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi101451g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGmsrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=106-115&author=X.+M.+Fuauthor=P.+Wangauthor=B.+T.+Zhu&title=Characterization+of+the+estradiol-binding+site+structure+of+human+pancreas-specific+protein+disulfide+isomerase%3A+Indispensable+role+of+the+hydrogen+bond+between+His278+and+the+estradiol+3-hydroxyl+group&doi=10.1021%2Fbi101451g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Estradiol-Binding Site Structure of Human Pancreas-Specific Protein Disulfide Isomerase: Indispensable Role of the Hydrogen Bond between His278 and the Estradiol 3-Hydroxyl Group</span></div><div class="casAuthors">Fu, Xin-Miao; Wang, Pan; Zhu, Bao Ting</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-115</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Estradiol (E2), a female sex hormone, has important biol. functions.  Human pancreas-specific protein disulfide isomerase (PDIp), a protein folding catalyst, was recently found to be able to bind E2.  Here we report the characterization of its E2-binding site by using biochem. methods coupled with mol. modeling tools.  Anal. of various truncated PDIp proteins showed that the b-b' fragment contains an intact E2-binding site that has the same binding affinity as the full-length PDIp protein, with apparent Kd values of approx. 170 nM.  Computational modeling and docking analyses revealed that the E2-binding site in the b-b' fragment is located in a hydrophobic pocket composed mainly of the b' domain and partially of the b domain.  The hydrogen bond, formed between the 3-hydroxyl group of E2 (donor) and PDIp's His278 (acceptor), is indispensable for its binding.  By contrast, the 17β-hydroxyl group of E2 is of negligible importance for E2 binding.  This binding model was jointly confirmed by a series of expts., such as selective mutation of the binding site amino acid residues and selective modification of the ligand structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphkGNCUq_vDLVg90H21EOLACvtfcHk0liZ3p8NjSm3ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGmsrfM&md5=451cb61264566e553c4b5906d28dc38b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbi101451g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi101451g%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DX.%2BM.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DB.%2BT.%26atitle%3DCharacterization%2520of%2520the%2520estradiol-binding%2520site%2520structure%2520of%2520human%2520pancreas-specific%2520protein%2520disulfide%2520isomerase%253A%2520Indispensable%2520role%2520of%2520the%2520hydrogen%2520bond%2520between%2520His278%2520and%2520the%2520estradiol%25203-hydroxyl%2520group%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D106%26epage%3D115%26doi%3D10.1021%2Fbi101451g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passam, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowley, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stopa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furie, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaumenhaft, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furie, B.</span></span> <span> </span><span class="NLM_article-title">Quercetin-3-rutinoside inhibits protein disulfide isomerase by binding to its b′x domain</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">23543</span>– <span class="NLM_lpage">23552</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.666180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1074%2Fjbc.M115.666180" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=23543-23552&author=L.+Linauthor=S.+Gopalauthor=A.+Shardaauthor=F.+Passamauthor=S.+R.+Bowleyauthor=J.+Stopaauthor=G.+Xueauthor=C.+Yuanauthor=B.+C.+Furieauthor=R.+Flaumenhaftauthor=M.+Huangauthor=B.+Furie&title=Quercetin-3-rutinoside+inhibits+protein+disulfide+isomerase+by+binding+to+its+b%E2%80%B2x+domain&doi=10.1074%2Fjbc.M115.666180"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.666180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.666180%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DGopal%26aufirst%3DS.%26aulast%3DSharda%26aufirst%3DA.%26aulast%3DPassam%26aufirst%3DF.%26aulast%3DBowley%26aufirst%3DS.%2BR.%26aulast%3DStopa%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DG.%26aulast%3DYuan%26aufirst%3DC.%26aulast%3DFurie%26aufirst%3DB.%2BC.%26aulast%3DFlaumenhaft%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DFurie%26aufirst%3DB.%26atitle%3DQuercetin-3-rutinoside%2520inhibits%2520protein%2520disulfide%2520isomerase%2520by%2520binding%2520to%2520its%2520b%25E2%2580%25B2x%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D23543%26epage%3D23552%26doi%3D10.1074%2Fjbc.M115.666180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hetz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harding, H. P.</span></span> <span> </span><span class="NLM_article-title">Targeting the unfolded protein response in disease</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">719</span>, <span class="refDoi"> DOI: 10.1038/nrd3976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fnrd3976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=23989796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCgt7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=703-719&author=C.+Hetzauthor=E.+Chevetauthor=H.+P.+Harding&title=Targeting+the+unfolded+protein+response+in+disease&doi=10.1038%2Fnrd3976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the unfolded protein response in disease</span></div><div class="casAuthors">Hetz, Claudio; Chevet, Eric; Harding, Heather P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">703-719</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Stress induced by the accumulation of unfolded proteins in the endoplasmic reticulum (ER) is a feature of specialized secretory cells and is also obsd. in many diseases, including cancer, diabetes, autoimmune conditions, liver disorders, obesity and neurodegenerative disorders.  Cellular adaptation to ER stress is achieved by the activation of the unfolded protein response, which is an integrated signal transduction pathway that modulates many aspects of ER physiol.  When these mechanisms of adaptation are insufficient to handle the unfolded protein load, cells undergo apoptosis.  Here, we discuss recent advances in the design of novel compds. and therapeutic strategies to manipulate levels of ER stress in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFF-GKfocCubVg90H21EOLACvtfcHk0lh9xY5A6u_Zgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCgt7jL&md5=9d6b6ca5e39f55efc81ebb4deda0157b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnrd3976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3976%26sid%3Dliteratum%253Aachs%26aulast%3DHetz%26aufirst%3DC.%26aulast%3DChevet%26aufirst%3DE.%26aulast%3DHarding%26aufirst%3DH.%2BP.%26atitle%3DTargeting%2520the%2520unfolded%2520protein%2520response%2520in%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D703%26epage%3D719%26doi%3D10.1038%2Fnrd3976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martianov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramadass, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serra Barros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akoulitchev, A.</span></span> <span> </span><span class="NLM_article-title">Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>445</i></span>,  <span class="NLM_fpage">666</span>– <span class="NLM_lpage">670</span>, <span class="refDoi"> DOI: 10.1038/nature05519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fnature05519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=17237763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=445&publication_year=2007&pages=666-670&author=I.+Martianovauthor=A.+Ramadassauthor=A.+Serra+Barrosauthor=N.+Chowauthor=A.+Akoulitchev&title=Repression+of+the+human+dihydrofolate+reductase+gene+by+a+non-coding+interfering+transcript&doi=10.1038%2Fnature05519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript</span></div><div class="casAuthors">Martianov, Igor; Ramadass, Aroul; Serra Barros, Ana; Chow, Natalie; Akoulitchev, Alexandre</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">445</span>
        (<span class="NLM_cas:issue">7128</span>),
    <span class="NLM_cas:pages">666-670</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alternative promoters within the same gene are a general phenomenon in gene expression.  Mechanisms of their selective regulation vary from one gene to another and are still poorly understood.  Here we show that in quiescent cells the mechanism of transcriptional repression of the major promoter of the gene encoding dihydrofolate reductase depends on a non-coding transcript initiated from the upstream minor promoter and involves both the direct interaction of the RNA and promoter-specific interference.  The specificity and efficiency of repression is ensured by the formation of a stable complex between non-coding RNA and the major promoter, direct interaction of the non-coding RNA with the general transcription factor IIB and dissocn. of the preinitiation complex from the major promoter.  By using in vivo and in vitro assays such as inducible and reconstituted transcription, RNA bandshifts, RNA interference, chromatin immunopptn. and RNA immunopptn., it has been shown that the regulatory transcript produced from the minor promoter has a crit. function in an epigenetic mechanism of promoter-specific transcriptional repression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtJY89lCAgJ7Vg90H21EOLACvtfcHk0lh9xY5A6u_Zgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOrtbw%253D&md5=c29ddf95256f2a6c3d71c9491640ee90</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnature05519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05519%26sid%3Dliteratum%253Aachs%26aulast%3DMartianov%26aufirst%3DI.%26aulast%3DRamadass%26aufirst%3DA.%26aulast%3DSerra%2BBarros%26aufirst%3DA.%26aulast%3DChow%26aufirst%3DN.%26aulast%3DAkoulitchev%26aufirst%3DA.%26atitle%3DRepression%2520of%2520the%2520human%2520dihydrofolate%2520reductase%2520gene%2520by%2520a%2520non-coding%2520interfering%2520transcript%26jtitle%3DNature%26date%3D2007%26volume%3D445%26spage%3D666%26epage%3D670%26doi%3D10.1038%2Fnature05519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eischen, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span> <span> </span><span class="NLM_article-title">The potential roles of long noncoding RNAs (lncRNA) in glioblastoma development</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2977</span>– <span class="NLM_lpage">2986</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-16-0320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1158%2F1535-7163.MCT-16-0320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=27784795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFynt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=2977-2986&author=S.+Liuauthor=R.+Mitraauthor=M.+M.+Zhaoauthor=W.+Fanauthor=C.+M.+Eischenauthor=F.+Yinauthor=Z.+Zhao&title=The+potential+roles+of+long+noncoding+RNAs+%28lncRNA%29+in+glioblastoma+development&doi=10.1158%2F1535-7163.MCT-16-0320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Potential Roles of Long Noncoding RNAs (lncRNA) in Glioblastoma Development</span></div><div class="casAuthors">Liu, Shuang; Mitra, Ramkrishna; Zhao, Ming-Ming; Fan, Wenhong; Eischen, Christine M.; Yin, Feng; Zhao, Zhongming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2977-2986</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Long noncoding RNA (lncRNA) may contribute to the initiation and progression of tumor.  In this study, we first systematically compared lncRNA and mRNA expression between glioblastoma and paired normal brain tissues using microarray data.  We found 27 lncRNA and 82 mRNA significantly upregulated in glioblastoma, as well as 198 lncRNA and 285 mRNA significantly downregulated in glioblastoma.  We identified 138 coexpressed lncRNA-mRNA pairs from these differentially expressed lncRNA and genes.  Subsequent pathway anal. of the lncRNA-paired genes indicated that EphrinB-EPHB, p75-mediated signaling, TNFα/NF-κB, and ErbB2/ErbB3 signaling pathways might be altered in glioblastoma.  Specifically, lncRNA RAMP2-AS1 had significant decrease of expression in glioblastoma tissues and showed coexpressional relationship with NOTCH3, an important tumor promoter in many neoplastic diseases.  Our follow up expt. indicated that (i) an overexpression of RAMP2-AS1 reduced glioblastoma cell proliferation in vitro and also reduced glioblastoma xenograft tumors in vivo; (ii) NOTCH3 and RAMP2-AS1 coexpression rescued the inhibitory action of RAMP2-AS1 in glioblastoma cells; and (iii) RNA pull-down assay revealed a direct interaction of RAMP2-AS1 with DHC10, which may consequently inhibit, as we hypothesize, the expression of NOTCH3 and its downstream signaling mol. HES1 in glioblastoma.  Taken together, our data revealed that lncRNA expression profile in glioblastoma tissue was significantly altered; and RAMP2-AS1 might play a tumor suppressive role in glioblastoma through an indirect inhibition of NOTCH3.  Our results provided some insights into understanding the key roles of lncRNA-mRNA coregulation in human glioblastoma and the mechanisms responsible for glioblastoma progression and pathogenesis.  Mol Cancer Ther; 15(12); 2977-86. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-b-bEcD1nbrVg90H21EOLACvtfcHk0lh9xY5A6u_Zgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFynt73J&md5=78b769c8d7abfb53c1bfbb9ceca32b64</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-16-0320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-16-0320%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMitra%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DM.%2BM.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DEischen%26aufirst%3DC.%2BM.%26aulast%3DYin%26aufirst%3DF.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DThe%2520potential%2520roles%2520of%2520long%2520noncoding%2520RNAs%2520%2528lncRNA%2529%2520in%2520glioblastoma%2520development%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D2977%26epage%3D2986%26doi%3D10.1158%2F1535-7163.MCT-16-0320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaver, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dashwood, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajendran, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dashwood, R. H.</span></span> <span> </span><span class="NLM_article-title">A functional pseudogene, NMRAL2P, is regulated by Nrf2 and serves as a coactivator of NQO1 in sulforaphane-treated colon cancer cells</span>. <i>Mol. Nutr. Food Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1600769</span>, <span class="refDoi"> DOI: 10.1002/mnfr.201600769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1002%2Fmnfr.201600769" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=1600769&author=G.+S.+Johnsonauthor=J.+Liauthor=L.+M.+Beaverauthor=W.+M.+Dashwoodauthor=D.+Sunauthor=P.+Rajendranauthor=D.+E.+Williamsauthor=E.+Hoauthor=R.+H.+Dashwood&title=A+functional+pseudogene%2C+NMRAL2P%2C+is+regulated+by+Nrf2+and+serves+as+a+coactivator+of+NQO1+in+sulforaphane-treated+colon+cancer+cells&doi=10.1002%2Fmnfr.201600769"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fmnfr.201600769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmnfr.201600769%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DG.%2BS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBeaver%26aufirst%3DL.%2BM.%26aulast%3DDashwood%26aufirst%3DW.%2BM.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DRajendran%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DD.%2BE.%26aulast%3DHo%26aufirst%3DE.%26aulast%3DDashwood%26aufirst%3DR.%2BH.%26atitle%3DA%2520functional%2520pseudogene%252C%2520NMRAL2P%252C%2520is%2520regulated%2520by%2520Nrf2%2520and%2520serves%2520as%2520a%2520coactivator%2520of%2520NQO1%2520in%2520sulforaphane-treated%2520colon%2520cancer%2520cells%26jtitle%3DMol.%2520Nutr.%2520Food%2520Res.%26date%3D2017%26volume%3D61%26spage%3D1600769%26doi%3D10.1002%2Fmnfr.201600769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span> <span> </span><span class="NLM_article-title">Protein disulphide isomerase is required for signal peptide peptidase-mediated protein degradation</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1038/emboj.2009.359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Femboj.2009.359" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=363-375&author=S.+O.+Leeauthor=K.+Choauthor=S.+Choauthor=I.+Kimauthor=C.+Ohauthor=K.+Ahn&title=Protein+disulphide+isomerase+is+required+for+signal+peptide+peptidase-mediated+protein+degradation&doi=10.1038%2Femboj.2009.359"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Femboj.2009.359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2009.359%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.%2BO.%26aulast%3DCho%26aufirst%3DK.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DOh%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DProtein%2520disulphide%2520isomerase%2520is%2520required%2520for%2520signal%2520peptide%2520peptidase-mediated%2520protein%2520degradation%26jtitle%3DEMBO%2520J.%26date%3D2010%26volume%3D29%26spage%3D363%26epage%3D375%26doi%3D10.1038%2Femboj.2009.359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryoo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span> <span> </span><span class="NLM_article-title">Molecular mechanisms of M + HC class I-antigen processing: Redox considerations</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">907</span>– <span class="NLM_lpage">936</span>, <span class="refDoi"> DOI: 10.1089/ars.2008.2316</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1089%2Fars.2008.2316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=19178136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlWiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=907-936&author=Y.+Kimauthor=K.+Kangauthor=I.+Kimauthor=Y.+J.+Leeauthor=C.+Ohauthor=J.+Ryooauthor=E.+Jeongauthor=K.+Ahn&title=Molecular+mechanisms+of+M+%2B+HC+class+I-antigen+processing%3A+Redox+considerations&doi=10.1089%2Fars.2008.2316"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Mechanisms of MHC Class I-Antigen Processing: Redox Considerations</span></div><div class="casAuthors">Kim, Youngkyun; Kang, Kwonyoon; Kim, Ilkwon; Lee, Yoon Jeong; Oh, Changhoon; Ryoo, Jeongmin; Jeong, Eunae; Ahn, Kwangseog; Benham, Adam; Jensen, Peter; Pinkoski, Michael J.; Powis, Simon; Rubartelli, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">907-936</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Major histocompatibility complex (MHC) class I mols. present antigenic peptides to the cell surface for screening by CD8+ T cells.  A no. of ER-resident chaperones assist the assembly of peptides onto MHC class I mols., a process that can be divided into several steps.  Early folding of the MHC class I heavy chain is followed by its assocn. with β2-microglobulin (β2m).  The MHC class I heavy chain-β2m heterodimer is incorporated into the peptide-loading complex, leading to peptide loading, release of the peptide-filled MHC class I mols. from the peptide-loading complex, and exit of the complete MHC class I complex from the ER.  Because proper antigen presentation is vital for normal immune responses, the assembly of MHC class I mols. requires tight regulation.  Emerging evidence indicates that thiol-based redox regulation plays crit. roles in MHC class I-restricted antigen processing and presentation, establishing an unexpected link between redox biol. and antigen processing.  The authors review the influences of redox regulation on antigen processing and presentation.  Because redox signaling pathways are a rich source of validated drug targets, newly discovered redox biol.-mediated mechanisms of antigen processing may facilitate the development of more selective and therapeutic drugs or vaccines against immune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhXP7pkSMwyLVg90H21EOLACvtfcHk0lgnWdYNKH9cgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlWiurs%253D&md5=d6cd8eab68a811248b57fbaf3d1e2fb9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1089%2Fars.2008.2316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2008.2316%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DY.%2BJ.%26aulast%3DOh%26aufirst%3DC.%26aulast%3DRyoo%26aufirst%3DJ.%26aulast%3DJeong%26aufirst%3DE.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DMolecular%2520mechanisms%2520of%2520M%2520%252B%2520HC%2520class%2520I-antigen%2520processing%253A%2520Redox%2520considerations%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2009%26volume%3D11%26spage%3D907%26epage%3D936%26doi%3D10.1089%2Fars.2008.2316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K.</span></span> <span> </span><span class="NLM_article-title">Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">382</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.08.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.cell.2006.08.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=17055437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2006&pages=369-382&author=B.+Parkauthor=S.+Leeauthor=E.+Kimauthor=K.+Choauthor=S.+R.+Riddellauthor=S.+Choauthor=K.+Ahn&title=Redox+regulation+facilitates+optimal+peptide+selection+by+MHC+class+I+during+antigen+processing&doi=10.1016%2Fj.cell.2006.08.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing</span></div><div class="casAuthors">Park, Boyoun; Lee, Sungwook; Kim, Eunkyung; Cho, Kwangmin; Riddell, Stanley R.; Cho, Sunglim; Ahn, Kwangseog</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">369-382</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Activated CD8+ T cells discriminate infected and tumor cells from normal self by recognizing MHC class I-bound peptides on the surface of antigen-presenting cells.  The mechanism by which MHC class I mols. select optimal peptides against a background of prevailing suboptimal peptides and in a considerably proteolytic ER environment remained unknown.  Here, we identify protein disulfide isomerase (PDI), an enzyme crit. to the formation of correct disulfide bonds in proteins, as a component of the peptide-loading complex.  We show that PDI stabilizes a peptide-receptive site by regulating the oxidn. state of the disulfide bond in the MHC peptide-binding groove, a function that is essential for selecting optimal peptides.  Furthermore, we demonstrate that human cytomegalovirus US3 protein inhibits CD8+ T cell recognition by mediating PDI degrdn., verifying the functional relevance of PDI-catalyzed peptide editing in controlling intracellular pathogens.  These results establish a link between thiol-based redox regulation and antigen processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMvtRndL8w2bVg90H21EOLACvtfcHk0liau_Erq9_OIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOkt73E&md5=59e3005680937376b1a7e735542648d7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.08.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.08.041%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DCho%26aufirst%3DK.%26aulast%3DRiddell%26aufirst%3DS.%2BR.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DRedox%2520regulation%2520facilitates%2520optimal%2520peptide%2520selection%2520by%2520MHC%2520class%2520I%2520during%2520antigen%2520processing%26jtitle%3DCell%26date%3D2006%26volume%3D127%26spage%3D369%26epage%3D382%26doi%3D10.1016%2Fj.cell.2006.08.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farmery, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulleid, N. J.</span></span> <span> </span><span class="NLM_article-title">The role of ERp57 in disulfide bond formation during the assembly of major histocompatibility complex class I in a synchronized semipermeabilized cell translation system</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">14933</span>– <span class="NLM_lpage">14938</span>, <span class="refDoi"> DOI: 10.1074/jbc.275.20.14933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1074%2Fjbc.275.20.14933" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=14933-14938&author=M.+R.+Farmeryauthor=S.+Allenauthor=A.+J.+Allenauthor=N.+J.+Bulleid&title=The+role+of+ERp57+in+disulfide+bond+formation+during+the+assembly+of+major+histocompatibility+complex+class+I+in+a+synchronized+semipermeabilized+cell+translation+system&doi=10.1074%2Fjbc.275.20.14933"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.20.14933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.20.14933%26sid%3Dliteratum%253Aachs%26aulast%3DFarmery%26aufirst%3DM.%2BR.%26aulast%3DAllen%26aufirst%3DS.%26aulast%3DAllen%26aufirst%3DA.%2BJ.%26aulast%3DBulleid%26aufirst%3DN.%2BJ.%26atitle%3DThe%2520role%2520of%2520ERp57%2520in%2520disulfide%2520bond%2520formation%2520during%2520the%2520assembly%2520of%2520major%2520histocompatibility%2520complex%2520class%2520I%2520in%2520a%2520synchronized%2520semipermeabilized%2520cell%2520translation%2520system%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D14933%26epage%3D14938%26doi%3D10.1074%2Fjbc.275.20.14933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blat, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrobel, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunet, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hieronymus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armstrong, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggarty, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span> <span> </span><span class="NLM_article-title">The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">1929</span>– <span class="NLM_lpage">1935</span>, <span class="refDoi"> DOI: 10.1126/science.1132939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1126%2Fscience.1132939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=17008526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSnsrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2006&pages=1929-1935&author=J.+Lambauthor=E.+D.+Crawfordauthor=D.+Peckauthor=J.+W.+Modellauthor=I.+C.+Blatauthor=M.+J.+Wrobelauthor=J.+Lernerauthor=J.+P.+Brunetauthor=A.+Subramanianauthor=K.+N.+Rossauthor=M.+Reichauthor=H.+Hieronymusauthor=G.+Weiauthor=S.+A.+Armstrongauthor=S.+J.+Haggartyauthor=P.+A.+Clemonsauthor=R.+Weiauthor=S.+A.+Carrauthor=E.+S.+Landerauthor=T.+R.+Golub&title=The+Connectivity+Map%3A+Using+gene-expression+signatures+to+connect+small+molecules%2C+genes%2C+and+disease&doi=10.1126%2Fscience.1132939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease</span></div><div class="casAuthors">Lamb, Justin; Crawford, Emily D.; Peck, David; Modell, Joshua W.; Blat, Irene C.; Wrobel, Matthew J.; Lerner, Jim; Brunet, Jean-Philippe; Subramanian, Aravind; Ross, Kenneth N.; Reich, Michael; Hieronymus, Haley; Wei, Guo; Armstrong, Scott A.; Haggarty, Stephen J.; Clemons, Paul A.; Wei, Ru; Carr, Steven A.; Lander, Eric S.; Golub, Todd R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">5795</span>),
    <span class="NLM_cas:pages">1929-1935</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a ref. collection of gene-expression profiles from cultured human cells treated with bioactive small mols., together with pattern-matching software to mine these data.  We demonstrate that this "Connectivity Map" resource can be used to find connections among small mols. sharing a mechanism of action, chems. and physiol. processes, and diseases and drugs.  These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtu0M2BUO2w7Vg90H21EOLACvtfcHk0liau_Erq9_OIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSnsrbN&md5=1fad887ad515ffdd8064e526ff25a4db</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132939%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DJ.%26aulast%3DCrawford%26aufirst%3DE.%2BD.%26aulast%3DPeck%26aufirst%3DD.%26aulast%3DModell%26aufirst%3DJ.%2BW.%26aulast%3DBlat%26aufirst%3DI.%2BC.%26aulast%3DWrobel%26aufirst%3DM.%2BJ.%26aulast%3DLerner%26aufirst%3DJ.%26aulast%3DBrunet%26aufirst%3DJ.%2BP.%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DRoss%26aufirst%3DK.%2BN.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DHieronymus%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DArmstrong%26aufirst%3DS.%2BA.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DWei%26aufirst%3DR.%26aulast%3DCarr%26aufirst%3DS.%2BA.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26atitle%3DThe%2520Connectivity%2520Map%253A%2520Using%2520gene-expression%2520signatures%2520to%2520connect%2520small%2520molecules%252C%2520genes%252C%2520and%2520disease%26jtitle%3DScience%26date%3D2006%26volume%3D313%26spage%3D1929%26epage%3D1935%26doi%3D10.1126%2Fscience.1132939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuong, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, B. S.</span></span> <span> </span><span class="NLM_article-title">Phenolic compounds from Caesalpinia sappan heartwood and their anti-inflammatory activity</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">2069</span>– <span class="NLM_lpage">2075</span>, <span class="refDoi"> DOI: 10.1021/np3003673</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np3003673" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=2069-2075&author=T.+D.+Cuongauthor=T.+M.+Hungauthor=J.+C.+Kimauthor=E.+H.+Kimauthor=M.+H.+Wooauthor=J.+S.+Choiauthor=J.+H.+Leeauthor=B.+S.+Min&title=Phenolic+compounds+from+Caesalpinia+sappan+heartwood+and+their+anti-inflammatory+activity&doi=10.1021%2Fnp3003673"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fnp3003673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp3003673%26sid%3Dliteratum%253Aachs%26aulast%3DCuong%26aufirst%3DT.%2BD.%26aulast%3DHung%26aufirst%3DT.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DE.%2BH.%26aulast%3DWoo%26aufirst%3DM.%2BH.%26aulast%3DChoi%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMin%26aufirst%3DB.%2BS.%26atitle%3DPhenolic%2520compounds%2520from%2520Caesalpinia%2520sappan%2520heartwood%2520and%2520their%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D2069%26epage%3D2075%26doi%3D10.1021%2Fnp3003673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. H.</span></span> <span> </span><span class="NLM_article-title">Brazilin inhibits growth and induces apoptosis in human glioblastoma cells</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2449</span>– <span class="NLM_lpage">2457</span>, <span class="refDoi"> DOI: 10.3390/molecules18022449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3390%2Fmolecules18022449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=23429418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvFKjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=2449-2457&author=D.+Y.+Leeauthor=M.+K.+Leeauthor=G.+S.+Kimauthor=H.+J.+Nohauthor=M.+H.+Lee&title=Brazilin+inhibits+growth+and+induces+apoptosis+in+human+glioblastoma+cells&doi=10.3390%2Fmolecules18022449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Brazilin inhibits growth and induces apoptosis in human glioblastoma cells</span></div><div class="casAuthors">Lee, Dae-Young; Lee, Mi-Kyoung; Kim, Geum-Soog; Noh, Hyung-Jun; Lee, Min-Ho</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">2449-2457</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Brazilin, isolated from the methanol ext. of the heart wood of Caesalpinia sappan, sensitizes cancer cells to apoptosis.  Glioblastoma multiforme (GBM), which accounts for most cases of central nervous system malignancy, has a very poor prognosis and lacks effective therapeutic interventions.  We, therefore, investigated the effects of different concns. of and different periods of exposure to brazilin on cell proliferation and apoptosis in the glioma U87 cell line.  Cell proliferation was investigated by MTT assays and growth curve anal., apoptosis was assessed by FACS anal. and western blot studies.  Brazilin showed dose-dependent inhibition of cell proliferation and induction of apoptosis in glioma cells.  It also increased the ratio of cleaved poly-(ADP)-ribose polymerase and decreased the expression of caspase-3 and caspase-7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa7F44Zk2DVbVg90H21EOLACvtfcHk0lgx7tQKomBCiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvFKjsbg%253D&md5=fcfff8320509e677f4f30809b69e42dd</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18022449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18022449%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BY.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DG.%2BS.%26aulast%3DNoh%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BH.%26atitle%3DBrazilin%2520inhibits%2520growth%2520and%2520induces%2520apoptosis%2520in%2520human%2520glioblastoma%2520cells%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D2449%26epage%3D2457%26doi%3D10.3390%2Fmolecules18022449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handayani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susidarti, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenie, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiyanto, E.</span></span> <span> </span><span class="NLM_article-title">Two active compounds from caesalpinia sappan L. in combination with cisplatin synergistically induce apoptosis and cell cycle arrest on WiDr cells</span>. <i>Adv. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">380</span>, <span class="refDoi"> DOI: 10.15171/apb.2017.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.15171%2Fapb.2017.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=29071219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktFCnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=375-380&author=S.+Handayaniauthor=R.+A.+Susidartiauthor=R.+I.+Jenieauthor=E.+Meiyanto&title=Two+active+compounds+from+caesalpinia+sappan+L.+in+combination+with+cisplatin+synergistically+induce+apoptosis+and+cell+cycle+arrest+on+WiDr+cells&doi=10.15171%2Fapb.2017.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Two active compounds from Caesalpinia sappan L. in combination with cisplatin synergistically induce apoptosis and cell cycle arrest on WiDr cells</span></div><div class="casAuthors">Handayani, Sri; Susidarti, Ratna Asmah; Jenie, Riris Istighfari; Meiyanto, Edy</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">375-380</span>CODEN:
                <span class="NLM_cas:coden">APBDCL</span>;
        ISSN:<span class="NLM_cas:issn">2251-7308</span>.
    
            (<span class="NLM_cas:orgname">Tabriz University of Medical Sciences</span>)
        </div><div class="casAbstract">Purpose: The aim of this study is to observe the synergistic effect of two active compds. of secang, brazilin and brazilein, combined with cisplatin on WiDr colon cancer cells.  Methods: Cytotoxic activities of brazilin (Bi) and brazilein (Be) in single and in combination with cisplatin (Cisp) were examd. by MTT assay.  Synergistic effect was analyzed by combination index (CI) parameter.  Apoptosis and cell cycle profiles were obsd. by using flow cytometry.  Results: The result of MTT assay showed that IC50 value of brazilin and brazilein on WiDr cancer cells were 41 μM and 52 μM resp.  The combination of 1/2 IC50 of Bi-Cisp reduced cells viability up to 64% and showed synergistic effect with CI value less than 1 (CI = 0.8).  The combinations of 1/2 IC50 of Be-Cisp also reduced cells viability up to 78% and showed synergistic effect (CI=0.65).  Combination of Bi-Cisp and Be-Cisp induced apoptosis higher than the single treatments.  Further anal. on the cell cycle progression showed that single treatment of 1/2 IC50 of Be and Bi induced S-phase and G2/M-phase accumulation, while combination of Be-Cisp and Bi-Cisp enhanced S-phase accumulation.  Conclusion: Both combination of Bi-Cisp and Be-Cisp showed synergistic effect on WiDr cells through induction of apoptosis and halted the cell cycle progression, thus, WiDr cells growth were significantly reduced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNnSnQO-YuKLVg90H21EOLACvtfcHk0lj8s16_lF1_eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktFCnur4%253D&md5=19ab3b57762c6881cf492c2f2085829e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.15171%2Fapb.2017.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15171%252Fapb.2017.045%26sid%3Dliteratum%253Aachs%26aulast%3DHandayani%26aufirst%3DS.%26aulast%3DSusidarti%26aufirst%3DR.%2BA.%26aulast%3DJenie%26aufirst%3DR.%2BI.%26aulast%3DMeiyanto%26aufirst%3DE.%26atitle%3DTwo%2520active%2520compounds%2520from%2520caesalpinia%2520sappan%2520L.%2520in%2520combination%2520with%2520cisplatin%2520synergistically%2520induce%2520apoptosis%2520and%2520cell%2520cycle%2520arrest%2520on%2520WiDr%2520cells%26jtitle%3DAdv.%2520Pharm.%2520Bull.%26date%3D2017%26volume%3D7%26spage%3D375%26epage%3D380%26doi%3D10.15171%2Fapb.2017.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larochette, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decaudin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacotot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susin, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamzami, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroemer, G.</span></span> <span> </span><span class="NLM_article-title">Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>249</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1006/excr.1999.4519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1006%2Fexcr.1999.4519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10366441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADyaK1MXjslSlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=1999&pages=413-421&author=N.+Larochetteauthor=D.+Decaudinauthor=E.+Jacototauthor=C.+Brennerauthor=I.+Marzoauthor=S.+A.+Susinauthor=N.+Zamzamiauthor=Z.+H.+Xieauthor=J.+Reedauthor=G.+Kroemer&title=Arsenite+induces+apoptosis+via+a+direct+effect+on+the+mitochondrial+permeability+transition+pore&doi=10.1006%2Fexcr.1999.4519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Arsenite Induces Apoptosis via a Direct Effect on the Mitochondrial Permeability Transition Pore</span></div><div class="casAuthors">Larochette, Nathanael; Decaudin, Didier; Jacotot, Etienne; Brenner, Catherine; Marzo, Isabel; Susin, Santos A.; Zamzami, Naoufal; Xie, Zhihua; Reed, John; Kroemer, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">249</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">413-421</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The mol. mode of action of arsenic, a therapeutic agent employed in the treatment of acute promyelocytic leukemia, has been elusive.  Here we provide evidence that arsenic compds. may act on mitochondria to induce apoptosis.  Arsenite induces apoptosis accompanied by a loss of the mitochondrial transmembrane potential (Δ[Psi]m).  Inhibition of caspases prevents the arsenite-induced nuclear DNA loss, but has no effect on the Δ[Psi]m dissipation and cytolysis induced by arsenite.  In contrast, Bcl-2 expression induced by gene transfer prevents all hallmarks of arsenite-induced cell death, including the Δ[Psi]m collapse.  PK11195, a ligand of the mitochondrial benzodiazepine receptor, neutralizes this Bcl-2 effect.  Mitochondria are required in a cell-free system to mediate arsenite-induced nuclear apoptosis.  Arsenite causes the release of an apoptosis-inducing factor (AIF) from the mitochondrial intermembrane space.  This effect is prevented by the permeability transition (PT) pore inhibitor cyclosporin A, as well as by Bcl-2, which is known to function as an endogenous PT pore antagonist.  Arsenite also opens the purified, reconstituted PT pore in vitro in a cyclosporin A- and Bcl-2-inhibitable fashion.  Altogether these data suggest that arsenite can induce apoptosis via a direct effect on the mitochondrial PT pore.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLhuzqFvNz57Vg90H21EOLACvtfcHk0lj8s16_lF1_eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslSlsLo%253D&md5=c17f89aacc1a4d6cfdac266966840fb6</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1006%2Fexcr.1999.4519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.1999.4519%26sid%3Dliteratum%253Aachs%26aulast%3DLarochette%26aufirst%3DN.%26aulast%3DDecaudin%26aufirst%3DD.%26aulast%3DJacotot%26aufirst%3DE.%26aulast%3DBrenner%26aufirst%3DC.%26aulast%3DMarzo%26aufirst%3DI.%26aulast%3DSusin%26aufirst%3DS.%2BA.%26aulast%3DZamzami%26aufirst%3DN.%26aulast%3DXie%26aufirst%3DZ.%2BH.%26aulast%3DReed%26aufirst%3DJ.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DArsenite%2520induces%2520apoptosis%2520via%2520a%2520direct%2520effect%2520on%2520the%2520mitochondrial%2520permeability%2520transition%2520pore%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D1999%26volume%3D249%26spage%3D413%26epage%3D421%26doi%3D10.1006%2Fexcr.1999.4519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuh, H. J.</span></span> <span> </span><span class="NLM_article-title">Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1669</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.3892/ijo_00000298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3892%2Fijo_00000298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=19424586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmsVCiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=1669-1679&author=W.+H.+Chungauthor=B.+H.+Sungauthor=S.+S.+Kimauthor=H.+Rhimauthor=H.+J.+Kuh&title=Synergistic+interaction+between+tetra-arsenic+oxide+and+paclitaxel+in+human+cancer+cells+in+vitro&doi=10.3892%2Fijo_00000298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro</span></div><div class="casAuthors">Chung, Won-Heui; Sung, Bong Hwan; Kim, Sang-Soo; Rhim, Hyangshuk; Kuh, Hyo-Jeong</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1669-1679</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Similar to arsenic trioxide (As2O3), tetra-arsenic oxide (As4O6, TAO) has shown anti-proliferative and apoptosis-inducing effects against human leukemic and solid tumor cells.  In order to assess the increase in efficacy, we evaluated the combinatory interaction of TAO combined with paclitaxel, 5-FU or cisplatin and studied its mechanism of action in the cell lines of human gastric, cervix and head and neck tumors.  Two agents were combined at equitoxic ratios based on the IC50 of each drug.  Efficacy improvement was evaluated using a combination index and isobologram at 50% inhibition level.  Apoptosis induction and expression of apoptosis-related proteins was detd. and the effect on microtubule polymn. was monitored.  TAO combined with paclitaxel showed synergistic interaction in all three of gastric, cervix and head and neck cancer cell lines.  On the other hand, TAO when combined with 5-FU or cisplatin showed an antagonistic interaction in head and neck or cervix cancer cell lines, resp.  Simultaneous treatment with TAO with paclitaxel resulted in an increased percentage of apoptotic cells and a significant increase in PARP cleavage and caspase-3 activation in the gastric and cervix cancer cells compared to TAO alone as well as the antagonistic groups (TAO with 5-FU or cisplatin).  TAO suppressed the tubulin polymn. in the presence and absence of paclitaxel in a concn.-dependent manner, suggesting mitotic catastrophe as a potential mechanism of the synergism with paclitaxel.  Overall, the present study suggests that TAO may have a greater potential as an anti-cancer agent against human gastric, cervix and head and neck tumors, in combination with paclitaxel.  The synergistic interaction with paclitaxel may be assocd. with increased apoptosis via inhibition of paclitaxel- induced tubulin polymn.  Further detailed studies of combinatory mechanisms and evaluation using in vivo models are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoSuhITvD48LVg90H21EOLACvtfcHk0lj8s16_lF1_eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmsVCiuro%253D&md5=1dcfbc7da2636395e330f51a125b8069</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.3892%2Fijo_00000298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo_00000298%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DW.%2BH.%26aulast%3DSung%26aufirst%3DB.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BS.%26aulast%3DRhim%26aufirst%3DH.%26aulast%3DKuh%26aufirst%3DH.%2BJ.%26atitle%3DSynergistic%2520interaction%2520between%2520tetra-arsenic%2520oxide%2520and%2520paclitaxel%2520in%2520human%2520cancer%2520cells%2520in%2520vitro%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2009%26volume%3D34%26spage%3D1669%26epage%3D1679%26doi%3D10.3892%2Fijo_00000298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, J. C.</span></span> <span> </span><span class="NLM_article-title">Drug combination studies and their synergy quantification using the Chou-Talalay method-Letter</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">2400</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-3763</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1158%2F0008-5472.CAN-14-3763" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=2400&author=J.+C.+Ashton&title=Drug+combination+studies+and+their+synergy+quantification+using+the+Chou-Talalay+method-Letter&doi=10.1158%2F0008-5472.CAN-14-3763"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-3763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-3763%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DJ.%2BC.%26atitle%3DDrug%2520combination%2520studies%2520and%2520their%2520synergy%2520quantification%2520using%2520the%2520Chou-Talalay%2520method-Letter%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D2400%26doi%3D10.1158%2F0008-5472.CAN-14-3763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bekendam, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendapudi, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nag, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldenzer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flaumenhaft, R.</span></span> <span> </span><span class="NLM_article-title">A substrate-driven allosteric switch that enhances PDI catalytic activity</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">12579</span>, <span class="refDoi"> DOI: 10.1038/ncomms12579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fncomms12579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=27573496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKjsbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12579&author=R.+H.+Bekendamauthor=P.+K.+Bendapudiauthor=L.+Linauthor=P.+P.+Nagauthor=J.+Puauthor=D.+R.+Kennedyauthor=A.+Feldenzerauthor=J.+Chiuauthor=K.+M.+Cookauthor=B.+Furieauthor=M.+Huangauthor=P.+J.+Hoggauthor=R.+Flaumenhaft&title=A+substrate-driven+allosteric+switch+that+enhances+PDI+catalytic+activity&doi=10.1038%2Fncomms12579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A substrate-driven allosteric switch that enhances PDI catalytic activity</span></div><div class="casAuthors">Bekendam, Roelof H.; Bendapudi, Pavan K.; Lin, Lin; Nag, Partha P.; Pu, Jun; Kennedy, Daniel R.; Feldenzer, Alexandra; Chiu, Joyce; Cook, Kristina M.; Furie, Bruce; Huang, Mingdong; Hogg, Philip J.; Flaumenhaft, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12579</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein disulfide isomerase (PDI) is an oxidoreductase essential for folding proteins in the endoplasmic reticulum.  The domain structure of PDI is a-b-b'-x-a', wherein the thioredoxin-like a and a' domains mediate disulfide bond shuffling and b and b' domains are substrate binding.  The b' and a' domains are connected via the x-linker, a 19-amino-acid flexible peptide.  Here we identify a class of compds., termed bepristats, that target the substrate-binding pocket of b'.  Bepristats reversibly block substrate binding and inhibit platelet aggregation and thrombus formation in vivo.  Ligation of the substrate-binding pocket by bepristats paradoxically enhances catalytic activity of a and a' by displacing the x-linker, which acts as an allosteric switch to augment reductase activity in the catalytic domains.  This substrate-driven allosteric switch is also activated by peptides and proteins and is present in other thiol isomerases.  Our results demonstrate a mechanism whereby binding of a substrate to thiol isomerases enhances catalytic activity of remote domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkUYTT5B9w97Vg90H21EOLACvtfcHk0ljy_0PJ8Geblw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKjsbjL&md5=a138a269279f7bf35c2adc80332facad</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fncomms12579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12579%26sid%3Dliteratum%253Aachs%26aulast%3DBekendam%26aufirst%3DR.%2BH.%26aulast%3DBendapudi%26aufirst%3DP.%2BK.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DNag%26aufirst%3DP.%2BP.%26aulast%3DPu%26aufirst%3DJ.%26aulast%3DKennedy%26aufirst%3DD.%2BR.%26aulast%3DFeldenzer%26aufirst%3DA.%26aulast%3DChiu%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DK.%2BM.%26aulast%3DFurie%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DHogg%26aufirst%3DP.%2BJ.%26aulast%3DFlaumenhaft%26aufirst%3DR.%26atitle%3DA%2520substrate-driven%2520allosteric%2520switch%2520that%2520enhances%2520PDI%2520catalytic%2520activity%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12579%26doi%3D10.1038%2Fncomms12579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossmann, T. N.</span></span> <span> </span><span class="NLM_article-title">Reversible covalent inhibition of a protein target</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">8699</span>– <span class="NLM_lpage">8700</span>, <span class="refDoi"> DOI: 10.1002/anie.201203341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1002%2Fanie.201203341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVehtLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8699-8700&author=C.+U.+Leeauthor=T.+N.+Grossmann&title=Reversible+covalent+inhibition+of+a+protein+target&doi=10.1002%2Fanie.201203341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible covalent inhibition of a protein target</span></div><div class="casAuthors">Lee, Chang-Uk; Grossmann, Tom N.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">8699-8700</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Electron-deficient Michael acceptors can be used in reversible addn./elimination reactions with thiols.  These electrophiles have been used by J. Taunton and colleagues [M. S. Cohen et al. (2005)] to convert a known irreversible protein kinase inhibitor into a covalent reversible inhibitor.  Such an approach might provide high-affinity binders with increased selectivity without the toxicol. risks assocd. with irreversible protein modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8c9MUbShnWLVg90H21EOLACvtfcHk0ljy_0PJ8Geblw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVehtLrM&md5=af55c6ca399146709faaaf23532b784a</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fanie.201203341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201203341%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BU.%26aulast%3DGrossmann%26aufirst%3DT.%2BN.%26atitle%3DReversible%2520covalent%2520inhibition%2520of%2520a%2520protein%2520target%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D8699%26epage%3D8700%26doi%3D10.1002%2Fanie.201203341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gersch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreuzer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieber, S. A.</span></span> <span> </span><span class="NLM_article-title">Electrophilic natural products and their biological targets</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">682</span>, <span class="refDoi"> DOI: 10.1039/c2np20012k</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1039%2Fc2np20012k" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22504336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVehsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=659-682&author=M.+Gerschauthor=J.+Kreuzerauthor=S.+A.+Sieber&title=Electrophilic+natural+products+and+their+biological+targets&doi=10.1039%2Fc2np20012k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Electrophilic natural products and their biological targets</span></div><div class="casAuthors">Gersch, Malte; Kreuzer, Johannes; Sieber, Stephan A.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">659-682</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The study of biol. active natural products has resulted in seminal contributions to the understanding of living systems.  In the case of electrophilic natural products, the covalent nature of their interaction has largely facilitated the identification of their biol. binding partners.  In this review, we provide a comprehensive compilation of electrophilic natural products from all major chem. classes together with their biol. targets.  Covering Michael acceptor systems, ring-strained compds. and other electrophiles, such as esters or carbamates, we highlight representative and instructive examples for over 20 electrophilic moieties.  The fruitful cooperation of natural product chem., medicinal chem. and chem. biol. has produced a collection of well-studied examples for how electrophilic natural products exert their biol. functions that range from antibiotic to antitumor effects.  Special emphasis is put on the elucidation of their resp. biol. targets via activity-based protein profiling, which together with the recent advancements in mass spectrometry has been crucial to the success of the field.  The wealth of naturally occurring electrophilic moieties and their chem. complexity enables binding of a large variety of biol. targets, such as enzymes of all classes, nonenzymic proteins, DNA and other cellular compds.  With approx. 30 000 genes in the human genome but only 266 confirmed protein drug targets, the study of biol. active, electrophilic natural products has the potential to provide insights into fundamental biol. processes and to greatly aid the discovery of new drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHI4qnF7oSNbVg90H21EOLACvtfcHk0ljnsWlT-ahlhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVehsb0%253D&md5=560cb6a084f0905741109551530ed02c</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1039%2Fc2np20012k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2np20012k%26sid%3Dliteratum%253Aachs%26aulast%3DGersch%26aufirst%3DM.%26aulast%3DKreuzer%26aufirst%3DJ.%26aulast%3DSieber%26aufirst%3DS.%2BA.%26atitle%3DElectrophilic%2520natural%2520products%2520and%2520their%2520biological%2520targets%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2012%26volume%3D29%26spage%3D659%26epage%3D682%26doi%3D10.1039%2Fc2np20012k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yagi-Utsumi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, K.</span></span> <span> </span><span class="NLM_article-title">Structural basis of redox-dependent substrate binding of protein disulfide isomerase</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">13909</span>, <span class="refDoi"> DOI: 10.1038/srep13909</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fsrep13909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26350503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A280%3ADC%252BC283gs1emsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=13909&author=M.+Yagi-Utsumiauthor=T.+Satohauthor=K.+Kato&title=Structural+basis+of+redox-dependent+substrate+binding+of+protein+disulfide+isomerase&doi=10.1038%2Fsrep13909"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of redox-dependent substrate binding of protein disulfide isomerase</span></div><div class="casAuthors">Yagi-Utsumi Maho; Kato Koichi; Yagi-Utsumi Maho; Satoh Tadashi; Kato Koichi; Satoh Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13909</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Protein disulfide isomerase (PDI) is a multidomain enzyme, operating as an essential folding catalyst, in which the b' and a' domains provide substrate binding sites and undergo an open-closed domain rearrangement depending on the redox states of the a' domain.  Despite the long research history of this enzyme, three-dimensional structural data remain unavailable for its ligand-binding mode.  Here we characterize PDI substrate recognition using α-synuclein (αSN) as the model ligand.  Our nuclear magnetic resonance (NMR) data revealed that the substrate-binding domains of PDI captured the αSN segment Val37-Val40 only in the oxidized form.  Furthermore, we determined the crystal structure of an oxidized form of the b'-a' domains in complex with an undecapeptide corresponding to this segment.  The peptide-binding mode observed in the crystal structure with NMR validation, was characterized by hydrophobic interactions on the b' domain in an open conformation.  Comparison with the previously reported crystal structure indicates that the a' domain partially masks the binding surface of the b' domain, causing steric hindrance against the peptide in the reduced form of the b'-a' domains that exhibits a closed conformation.  These findings provide a structural basis for the mechanism underlying the redox-dependent substrate binding of PDI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpfk-Ws4uTwQHqQV89nF-2fW6udTcc2ea-E1gjIqA6kLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283gs1emsA%253D%253D&md5=7692447dbe4ba0ff097098536ba0c645</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fsrep13909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep13909%26sid%3Dliteratum%253Aachs%26aulast%3DYagi-Utsumi%26aufirst%3DM.%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DK.%26atitle%3DStructural%2520basis%2520of%2520redox-dependent%2520substrate%2520binding%2520of%2520protein%2520disulfide%2520isomerase%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D13909%26doi%3D10.1038%2Fsrep13909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rucker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Rifai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rascle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottfried, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodziak-Jarosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhauser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amslinger, S.</span></span> <span> </span><span class="NLM_article-title">Enhancing the anti-inflammatory activity of chalcones by tuning the Michael acceptor site</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">3040</span>– <span class="NLM_lpage">3047</span>, <span class="refDoi"> DOI: 10.1039/C4OB02301C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1039%2FC4OB02301C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=3040-3047&author=H.+Ruckerauthor=N.+Al-Rifaiauthor=A.+Rascleauthor=E.+Gottfriedauthor=L.+Brodziak-Jaroszauthor=C.+Gerhauserauthor=T.+P.+Dickauthor=S.+Amslinger&title=Enhancing+the+anti-inflammatory+activity+of+chalcones+by+tuning+the+Michael+acceptor+site&doi=10.1039%2FC4OB02301C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1039%2FC4OB02301C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB02301C%26sid%3Dliteratum%253Aachs%26aulast%3DRucker%26aufirst%3DH.%26aulast%3DAl-Rifai%26aufirst%3DN.%26aulast%3DRascle%26aufirst%3DA.%26aulast%3DGottfried%26aufirst%3DE.%26aulast%3DBrodziak-Jarosz%26aufirst%3DL.%26aulast%3DGerhauser%26aufirst%3DC.%26aulast%3DDick%26aufirst%3DT.%2BP.%26aulast%3DAmslinger%26aufirst%3DS.%26atitle%3DEnhancing%2520the%2520anti-inflammatory%2520activity%2520of%2520chalcones%2520by%2520tuning%2520the%2520Michael%2520acceptor%2520site%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D3040%26epage%3D3047%26doi%3D10.1039%2FC4OB02301C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, S. Y.</span></span> <span> </span><span class="NLM_article-title">A synthetic chalcone, 2 ’-hydroxy-2,3,5 ’-trimethoxychalcone triggers unfolded protein response-mediated apoptosis in breast cancer cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2015.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1016%2Fj.canlet.2015.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=26742460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlCksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2016&pages=1-9&author=D.+H.+Leeauthor=Y.+J.+Jungauthor=D.+Kohauthor=Y.+Limauthor=Y.+H.+Leeauthor=S.+Y.+Shin&title=A+synthetic+chalcone%2C+2+%E2%80%99-hydroxy-2%2C3%2C5+%E2%80%99-trimethoxychalcone+triggers+unfolded+protein+response-mediated+apoptosis+in+breast+cancer+cells&doi=10.1016%2Fj.canlet.2015.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">A synthetic chalcone, 2'-hydroxy-2,3,5'-trimethoxychalcone triggers unfolded protein response-mediated apoptosis in breast cancer cells</span></div><div class="casAuthors">Lee, Da Hyun; Jung Jung, You; Koh, Dongsoo; Lim, Yoongho; Lee, Young Han; Shin, Soon Young</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The primary aim of this study was to find novel chemopreventive agents effective against breast cancer.  Endoplasmic reticulum (ER) stress can induce apoptosis through the unfolded protein response (UPR). 2'-Hydroxy-2,3,5'-trimethoxychalcone (DK143) is a synthetic flavonoid deriv.  The present study provides evidence supporting the role of the UPR in mediating the apoptotic effect of DK143.  Treatment with DK143 triggered apoptosis through the activation of the caspase pathway in MDA-MB-231 breast cancer cells without affecting viability of MCF10A non-transformed breast epithelial cells.  Further anal. revealed that DK143 produced reactive oxygen species (ROS) in MDA-MB-231 cells, but not in MCF10A cells, and upregulated the expression of ER stress sensors, including GRP78/BiP, IRE1α, CHOP, and Bim in MDA-MB-231 cells.  In addn., UPR-related transcription factors, XBP-1 and CHOP, were activated by DK143.  Moreover, silencing of IRE1α or CHOP by corresponding siRNA mols. attenuated DK143-induced apoptosis.  Furthermore, DK143 suppressed mouse tumor growth in vivo.  These results demonstrate that promoting ER stress in breast cancer cells via UPR induction might be a promising strategy for developing new chemotherapeutic or chemopreventive agents for breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Q8MKDKIiJLVg90H21EOLACvtfcHk0lj7G10r8k0UEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlCksA%253D%253D&md5=262986f0ae7b3aec9f61f00effc57124</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2015.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2015.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DJung%26aufirst%3DY.%2BJ.%26aulast%3DKoh%26aufirst%3DD.%26aulast%3DLim%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DY.%2BH.%26aulast%3DShin%26aufirst%3DS.%2BY.%26atitle%3DA%2520synthetic%2520chalcone%252C%25202%2520%25E2%2580%2599-hydroxy-2%252C3%252C5%2520%25E2%2580%2599-trimethoxychalcone%2520triggers%2520unfolded%2520protein%2520response-mediated%2520apoptosis%2520in%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2016%26volume%3D372%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.canlet.2015.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sklar, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogelj, S.</span></span> <span> </span><span class="NLM_article-title">Sulfhydryl regulation of L-selectin shedding: Phenylarsine oxide promotes activation-independent L-selectin shedding from leukocytes</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">4120</span>– <span class="NLM_lpage">4129</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.164.8.4120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.4049%2Fjimmunol.164.8.4120" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2000&pages=4120-4129&author=T.+A.+Bennettauthor=B.+S.+Edwardsauthor=L.+A.+Sklarauthor=S.+Rogelj&title=Sulfhydryl+regulation+of+L-selectin+shedding%3A+Phenylarsine+oxide+promotes+activation-independent+L-selectin+shedding+from+leukocytes&doi=10.4049%2Fjimmunol.164.8.4120"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.164.8.4120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.164.8.4120%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DT.%2BA.%26aulast%3DEdwards%26aufirst%3DB.%2BS.%26aulast%3DSklar%26aufirst%3DL.%2BA.%26aulast%3DRogelj%26aufirst%3DS.%26atitle%3DSulfhydryl%2520regulation%2520of%2520L-selectin%2520shedding%253A%2520Phenylarsine%2520oxide%2520promotes%2520activation-independent%2520L-selectin%2520shedding%2520from%2520leukocytes%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D164%26spage%3D4120%26epage%3D4129%26doi%3D10.4049%2Fjimmunol.164.8.4120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soiffer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanneman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jinushi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeAngelo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dranoff, G.</span></span> <span> </span><span class="NLM_article-title">Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1681</span>– <span class="NLM_lpage">1688</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-09-114157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1182%2Fblood-2007-09-114157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=19008459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisV2iu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=1681-1688&author=C.+Fonsecaauthor=R.+Soifferauthor=V.+Hoauthor=M.+Vannemanauthor=M.+Jinushiauthor=J.+Ritzauthor=D.+Neubergauthor=R.+Stoneauthor=D.+DeAngeloauthor=G.+Dranoff&title=Protein+disulfide+isomerases+are+antibody+targets+during+immune-mediated+tumor+destruction&doi=10.1182%2Fblood-2007-09-114157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction</span></div><div class="casAuthors">Fonseca, Catia; Soiffer, Robert; Ho, Vincent; Vanneman, Matthew; Jinushi, Masahisa; Ritz, Jerome; Neuberg, Donna; Stone, Richard; DeAngelo, Dan; Dranoff, Glenn</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">tumor1681-1688</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The identification of cancer antigens that contribute to transformation and are linked with immune-mediated tumor destruction is an important goal for immunotherapy.  Toward this end, we screened a murine renal cell carcinoma cDNA expression library with sera from mice vaccinated with irradiated tumor cells engineered to secrete granulocyte macrophage colony-stimulating factor (GM-CSF).  Multiple nonmutated, overexpressed proteins that function in tumor cell migration, protein/nucleic acid homeostasis, metab., and stress responses were detected.  Among these, the most frequently recognized clone was protein disulfide isomerase (PDI).  High titer antibodies to human PDI were similarly induced in an acute myeloid leukemia patient who achieved a complete response after vaccination with irradiated, autologous GM-CSF-secreting tumor cells in the setting of nonmyeloablative allogeneic bone marrow transplantation.  Moreover, ERp5, a closely related disulfide isomerase involved in major histocompatibility complex (MHC) class I chain-related protein A (MICA) shedding, also evoked potent humoral reactions in diverse solid and hematol. malignancy patients who responded to GM-CSF-secreting tumor cell vaccines or antibody blockade of cytotoxic T lymphocyte-assocd. antigen 4 (CTLA-4).  Together, these findings reveal the unexpected immunogenicity of PDIs and raise the possibility that these gene products might serve as targets for therapeutic monoclonal antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrlNWaN21uc7Vg90H21EOLACvtfcHk0lgDgYbR8R14lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisV2iu74%253D&md5=feb061eae29212f24b495cbb31506005</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-09-114157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-09-114157%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DC.%26aulast%3DSoiffer%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DV.%26aulast%3DVanneman%26aufirst%3DM.%26aulast%3DJinushi%26aufirst%3DM.%26aulast%3DRitz%26aufirst%3DJ.%26aulast%3DNeuberg%26aufirst%3DD.%26aulast%3DStone%26aufirst%3DR.%26aulast%3DDeAngelo%26aufirst%3DD.%26aulast%3DDranoff%26aufirst%3DG.%26atitle%3DProtein%2520disulfide%2520isomerases%2520are%2520antibody%2520targets%2520during%2520immune-mediated%2520tumor%2520destruction%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D1681%26epage%3D1688%26doi%3D10.1182%2Fblood-2007-09-114157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strong, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spies, T.</span></span> <span> </span><span class="NLM_article-title">Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>447</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">486</span>, <span class="refDoi"> DOI: 10.1038/nature05768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1038%2Fnature05768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=17495932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFOhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2007&pages=482-486&author=B.+K.+Kaiserauthor=D.+Yimauthor=I.+T.+Chowauthor=S.+Gonzalezauthor=Z.+Daiauthor=H.+H.+Mannauthor=R.+K.+Strongauthor=V.+Grohauthor=T.+Spies&title=Disulphide-isomerase-enabled+shedding+of+tumour-associated+NKG2D+ligands&doi=10.1038%2Fnature05768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands</span></div><div class="casAuthors">Kaiser, Brett K.; Yim, Daesong; Chow, I.-Ting; Gonzalez, Segundo; Dai, Zhenpeng; Mann, Henning H.; Strong, Roland K.; Groh, Veronika; Spies, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">447</span>
        (<span class="NLM_cas:issue">7143</span>),
    <span class="NLM_cas:pages">482-486</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Tumor-assocd. ligands of the activating NKG2D (natural killer group 2, member D; also called KLRK1) receptor, which are induced by genotoxic or cellular stress, trigger activation of natural killer cells and co-stimulation of effector T cells, and may thus promote resistance to cancer.  However, many progressing tumors in humans counter this antitumor activity by shedding the sol. MHC class-I-related ligand MICA, which induces internalization and degrdn. of NKG2D and stimulates population expansions of normally rare NKG2D+CD4+ T cells with neg. regulatory functions.  Here the authors show that on the surface of tumor cells, MICA assocs. with endoplasmic reticulum protein 5 (ERp5; also called PDIA6 or P5), which, similar to protein disulfide isomerase, usually assists in the folding of nascent proteins inside cells.  Pharmacol. inhibition of thioreductase activity and ERp5 gene silencing revealed that cell-surface ERp5 function is required for MICA shedding.  ERp5 and membrane-anchored MICA form transitory mixed disulfide complexes from which sol. MICA is released after proteolytic cleavage near the cell membrane.  Redn. of the seemingly inaccessible disulfide bond in the membrane-proximal α3 domain of MICA must involve a large conformational change that enables proteolytic cleavage.  These results uncover a mol. mechanism whereby domain-specific deconstruction regulates MICA protein shedding, thereby promoting tumor immune evasion, and identify surface ERp5 as a strategic target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZS-YLUQKYp7Vg90H21EOLACvtfcHk0lgDgYbR8R14lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFOhu7g%253D&md5=6ce54edfb4ac1d8916be6924129d4173</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1038%2Fnature05768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05768%26sid%3Dliteratum%253Aachs%26aulast%3DKaiser%26aufirst%3DB.%2BK.%26aulast%3DYim%26aufirst%3DD.%26aulast%3DChow%26aufirst%3DI.%2BT.%26aulast%3DGonzalez%26aufirst%3DS.%26aulast%3DDai%26aufirst%3DZ.%26aulast%3DMann%26aufirst%3DH.%2BH.%26aulast%3DStrong%26aufirst%3DR.%2BK.%26aulast%3DGroh%26aufirst%3DV.%26aulast%3DSpies%26aufirst%3DT.%26atitle%3DDisulphide-isomerase-enabled%2520shedding%2520of%2520tumour-associated%2520NKG2D%2520ligands%26jtitle%3DNature%26date%3D2007%26volume%3D447%26spage%3D482%26epage%3D486%26doi%3D10.1038%2Fnature05768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zocchi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catellani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevali, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garuti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villaggio, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zunino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraternali-Orcioni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunkl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravetti, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boero, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poggi, A.</span></span> <span> </span><span class="NLM_article-title">High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">1479</span>– <span class="NLM_lpage">1489</span>, <span class="refDoi"> DOI: 10.1182/blood-2011-07-370841</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1182%2Fblood-2011-07-370841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=22167753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=1479-1489&author=M.+R.+Zocchiauthor=S.+Catellaniauthor=P.+Canevaliauthor=S.+Tavellaauthor=A.+Garutiauthor=B.+Villaggioauthor=A.+Zuninoauthor=M.+Gobbiauthor=G.+Fraternali-Orcioniauthor=A.+Kunklauthor=J.+L.+Ravettiauthor=S.+Boeroauthor=A.+Mussoauthor=A.+Poggi&title=High+ERp5%2FADAM10+expression+in+lymph+node+microenvironment+and+impaired+NKG2D+ligands+recognition+in+Hodgkin+lymphomas&doi=10.1182%2Fblood-2011-07-370841"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas</span></div><div class="casAuthors">Zocchi, Maria Raffaella; Catellani, Silvia; Canevali, Paolo; Tavella, Sara; Garuti, Anna; Villaggio, Barbara; Zunino, Annalisa; Gobbi, Marco; Fraternali-Orcioni, Giulio; Kunkl, Annalisa; Ravetti, Jean-Louis; Boero, Silvia; Musso, Alessandra; Poggi, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1479-1489</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Herein we describe that in classic Hodgkin lymphomas (cHL, n = 25) the lymph node (LN) stroma displayed in situ high levels of transcription and expression of the disulfide-isomerase ERp5 and of the disintegrin-metalloproteinase ADAM10, able to shed the ligands for NKG2D (NKG2D-L) from the cell membrane.  These enzymes were detected both in LN mesenchymal stromal cells (MSCs) and in Reed-Sternberg (RS) cells; in addn., MIC-A and ULBP3 were present in culture supernatants of LN MSCs or RS cells.  NKG2D-L-neg. RS cells could not be killed by CD8+αβT or γδT cells; tumor cell killing was partially restored by treating RS cells with valproic acid, which enhanced NKG2D-L surface expression.  Upon coculture with LN MSCs, CD8+αβT and γδT cells strongly reduced their cytolytic activity against NKG2D-L+ targets; this seems to be the result of TGF-β, present at the tumor site, produced in vitro by LN MSCs and able to down-regulate the expression of NKG2D on T lymphocytes.  In addn., CD8+αβT and γδT cells from the lymph nodes of cHL patients, cocultured in vitro with LN MSCs, underwent TGF-β-mediated down regulation of NKG2D.  Thus, in cHL the tumor microenvironment is prone to inhibit the development of an efficient antitumor response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm0PmPCupbnLVg90H21EOLACvtfcHk0liYOwKoy1U62g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSrs7g%253D&md5=9998199b08e0113f6472fb719282b001</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-07-370841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-07-370841%26sid%3Dliteratum%253Aachs%26aulast%3DZocchi%26aufirst%3DM.%2BR.%26aulast%3DCatellani%26aufirst%3DS.%26aulast%3DCanevali%26aufirst%3DP.%26aulast%3DTavella%26aufirst%3DS.%26aulast%3DGaruti%26aufirst%3DA.%26aulast%3DVillaggio%26aufirst%3DB.%26aulast%3DZunino%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DM.%26aulast%3DFraternali-Orcioni%26aufirst%3DG.%26aulast%3DKunkl%26aufirst%3DA.%26aulast%3DRavetti%26aufirst%3DJ.%2BL.%26aulast%3DBoero%26aufirst%3DS.%26aulast%3DMusso%26aufirst%3DA.%26aulast%3DPoggi%26aufirst%3DA.%26atitle%3DHigh%2520ERp5%252FADAM10%2520expression%2520in%2520lymph%2520node%2520microenvironment%2520and%2520impaired%2520NKG2D%2520ligands%2520recognition%2520in%2520Hodgkin%2520lymphomas%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D1479%26epage%3D1489%26doi%3D10.1182%2Fblood-2011-07-370841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vivoli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlechild, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmer, N. J.</span></span> <span> </span><span class="NLM_article-title">Determination of protein-ligand interactions using differential scanning fluorimetry</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">e51809</span>, <span class="refDoi"> DOI: 10.3791/51809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.3791%2F51809" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2014&pages=e51809&author=M.+Vivoliauthor=H.+R.+Novakauthor=J.+A.+Littlechildauthor=N.+J.+Harmer&title=Determination+of+protein-ligand+interactions+using+differential+scanning+fluorimetry&doi=10.3791%2F51809"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3791%2F51809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F51809%26sid%3Dliteratum%253Aachs%26aulast%3DVivoli%26aufirst%3DM.%26aulast%3DNovak%26aufirst%3DH.%2BR.%26aulast%3DLittlechild%26aufirst%3DJ.%2BA.%26aulast%3DHarmer%26aufirst%3DN.%2BJ.%26atitle%3DDetermination%2520of%2520protein-ligand%2520interactions%2520using%2520differential%2520scanning%2520fluorimetry%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2014%26volume%3D91%26spage%3De51809%26doi%3D10.3791%2F51809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, M.
T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veloso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Washburn, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar-Sinha, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungman, M.</span></span> <span> </span><span class="NLM_article-title">Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">2240</span>– <span class="NLM_lpage">2245</span>, <span class="refDoi"> DOI: 10.1073/pnas.1219192110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1073%2Fpnas.1219192110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=23345452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVersLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=2240-2245&author=M.%0AT.+Paulsenauthor=A.+Velosoauthor=J.+Prasadauthor=K.+Bediauthor=E.+A.+Ljungmanauthor=Y.+C.+Tsanauthor=C.+W.+Changauthor=B.+Tarrierauthor=J.+G.+Washburnauthor=R.+Lyonsauthor=D.+R.+Robinsonauthor=C.+Kumar-Sinhaauthor=T.+E.+Wilsonauthor=M.+Ljungman&title=Coordinated+regulation+of+synthesis+and+stability+of+RNA+during+the+acute+TNF-induced+proinflammatory+response&doi=10.1073%2Fpnas.1219192110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response</span></div><div class="casAuthors">Paulsen, Michelle T.; Veloso, Artur; Prasad, Jayendra; Bedi, Karan; Ljungman, Emily A.; Tsan, Ya-Chun; Chang, Ching-Wei; Tarrier, Brendan; Washburn, Joseph G.; Lyons, Robert; Robinson, Daniel R.; Kumar-Sinha, Chandan; Wilson, Thomas E.; Ljungman, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2240-2245, S2240/1-S2240/347</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Steady-state gene expression is a coordination of synthesis and decay of RNA through epigenetic regulation, transcription factors, micro RNAs (miRNAs), and RNA-binding proteins.  Here, we present bromouride labeling and sequencing (Bru-Seq) and bromouridine pulse-chase and sequencing (BruChase-Seq) to assess genome-wide changes to RNA synthesis and stability in human fibroblasts at homeostasis and after exposure to the proinflammatory tumor necrosis factor (TNF).  The inflammatory response in human cells involves rapid and dramatic changes in gene expression, and the Bru-Seq and BruChase-Seq techniques revealed a coordinated and complex regulation of gene expression both at the transcriptional and posttranscriptional levels.  The combinatory anal. of both RNA synthesis and stability using Bru-Seq and BruChase-Seq allows for a much deeper understanding of mechanisms of gene regulation than afforded by the anal. of steady-state total RNA and should be useful in many biol. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfuRwriMUd77Vg90H21EOLACvtfcHk0liYOwKoy1U62g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVersLY%253D&md5=74e41864b9379692b3265cb7a806e7ca</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1219192110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1219192110%26sid%3Dliteratum%253Aachs%26aulast%3DPaulsen%26aufirst%3DM.%2BT.%26aulast%3DVeloso%26aufirst%3DA.%26aulast%3DPrasad%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DK.%26aulast%3DLjungman%26aufirst%3DE.%2BA.%26aulast%3DTsan%26aufirst%3DY.%2BC.%26aulast%3DChang%26aufirst%3DC.%2BW.%26aulast%3DTarrier%26aufirst%3DB.%26aulast%3DWashburn%26aufirst%3DJ.%2BG.%26aulast%3DLyons%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DKumar-Sinha%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DT.%2BE.%26aulast%3DLjungman%26aufirst%3DM.%26atitle%3DCoordinated%2520regulation%2520of%2520synthesis%2520and%2520stability%2520of%2520RNA%2520during%2520the%2520acute%2520TNF-induced%2520proinflammatory%2520response%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D2240%26epage%3D2245%26doi%3D10.1073%2Fpnas.1219192110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamayo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mootha, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebert, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillette, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomeroy, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golub, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lander, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesirov, J. P.</span></span> <span> </span><span class="NLM_article-title">Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">15545</span>– <span class="NLM_lpage">15550</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506580102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1073%2Fpnas.0506580102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=16199517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=15545-15550&author=A.+Subramanianauthor=P.+Tamayoauthor=V.+K.+Moothaauthor=S.+Mukherjeeauthor=B.+L.+Ebertauthor=M.+A.+Gilletteauthor=A.+Paulovichauthor=S.+L.+Pomeroyauthor=T.+R.+Golubauthor=E.+S.+Landerauthor=J.+P.+Mesirov&title=Gene+set+enrichment+analysis%3A+A+knowledge-based+approach+for+interpreting+genome-wide+expression+profiles&doi=10.1073%2Fpnas.0506580102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</span></div><div class="casAuthors">Subramanian, Aravind; Tamayo, Pablo; Mootha, Vamsi K.; Mukherjee, Sayan; Ebert, Benjamin L.; Gillette, Michael A.; Paulovich, Amanda; Pomeroy, Scott L.; Golub, Todd R.; Lander, Eric S.; Mesirov, Jill P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15545-15550</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Although genomewide RNA expression anal. has become a routine tool in biomedical research, extg. biol. insight from such information remains a major challenge.  Here, we describe a powerful anal. method called Gene Set Enrichment Anal. (GSEA) for interpreting gene expression data.  The method derives its power by focusing on gene sets, i.e., groups of genes that share common biol. function, chromosomal location, or regulation.  We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer.  Notably, where single-gene anal. finds little similarity between two independent studies of patients survival in lung cancer, GSEA reveals many biol. pathways in common.  The GSEA method is embodied in a freely available software package, together with an initial database of 1,325 biol. defined gene sets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH2_E6gWd0yrVg90H21EOLACvtfcHk0lg59hZCxgij4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShtrnO&md5=ca2eb221010f20379199e6442c65fc2e</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506580102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506580102%26sid%3Dliteratum%253Aachs%26aulast%3DSubramanian%26aufirst%3DA.%26aulast%3DTamayo%26aufirst%3DP.%26aulast%3DMootha%26aufirst%3DV.%2BK.%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGillette%26aufirst%3DM.%2BA.%26aulast%3DPaulovich%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DGolub%26aufirst%3DT.%2BR.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DMesirov%26aufirst%3DJ.%2BP.%26atitle%3DGene%2520set%2520enrichment%2520analysis%253A%2520A%2520knowledge-based%2520approach%2520for%2520interpreting%2520genome-wide%2520expression%2520profiles%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D15545%26epage%3D15550%26doi%3D10.1073%2Fpnas.0506580102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McAlister, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nusinow, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jedrychowski, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuhr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttlin, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gygi, S. P.</span></span> <span> </span><span class="NLM_article-title">MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">7150</span>– <span class="NLM_lpage">7158</span>, <span class="refDoi"> DOI: 10.1021/ac502040v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac502040v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1Kmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=7150-7158&author=G.+C.+McAlisterauthor=D.+P.+Nusinowauthor=M.+P.+Jedrychowskiauthor=M.+Wuhrauthor=E.+L.+Huttlinauthor=B.+K.+Ericksonauthor=R.+Radauthor=W.+Haasauthor=S.+P.+Gygi&title=MultiNotch+MS3+enables+accurate%2C+sensitive%2C+and+multiplexed+detection+of+differential+expression+across+cancer+cell+line+proteomes&doi=10.1021%2Fac502040v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes</span></div><div class="casAuthors">McAlister, Graeme C.; Nusinow, David P.; Jedrychowski, Mark P.; Wuhr, Martin; Huttlin, Edward L.; Erickson, Brian K.; Rad, Ramin; Haas, Wilhelm; Gygi, Steven P.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7150-7158</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Multiplexed quantitation via isobaric chem. tags (e.g., tandem mass tags (TMT) and isobaric tags for relative and abs. quantitation (iTRAQ)) has the potential to revolutionize quant. proteomics.  However, until recently the utility of these tags was questionable due to reporter ion ratio distortion resulting from fragmentation of coisolated interfering species.  These interfering signals can be negated through addnl. gas-phase manipulations (e.g., MS/MS/MS (MS3) and proton-transfer reactions (PTR)).  These methods, however, have a significant sensitivity penalty.  Using isolation waveforms with multiple frequency notches (i.e., synchronous precursor selection, SPS), the authors coisolated and cofragmented multiple MS2 fragment ions, thereby increasing the no. of reporter ions in the MS3 spectrum 10-fold over the std. MS3 method (i.e., MultiNotch MS3).  By increasing the reporter ion signals, this method improves the dynamic range of reporter ion quantitation, reduces reporter ion signal variance, and ultimately produces more high-quality quant. measurements.  To demonstrate utility, the authors analyzed biol. triplicates of eight colon cancer cell lines using the MultiNotch MS3 method.  Across all the replicates the authors quantified 8378 proteins in union and 6168 proteins in common.  Taking into account that each of these quantified proteins contains eight distinct cell-line measurements, this data set encompasses 174,704 quant. ratios each measured in triplicate across the biol. replicates.  Herein, the MultiNotch MS3 method uniquely combines multiplexing capacity with quant. sensitivity and accuracy, drastically increasing the informational value obtainable from proteomic expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonIBGSGUtKzbVg90H21EOLACvtfcHk0lg59hZCxgij4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1Kmur8%253D&md5=bda847612d4a16030b7921bc8ae6f5c6</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fac502040v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac502040v%26sid%3Dliteratum%253Aachs%26aulast%3DMcAlister%26aufirst%3DG.%2BC.%26aulast%3DNusinow%26aufirst%3DD.%2BP.%26aulast%3DJedrychowski%26aufirst%3DM.%2BP.%26aulast%3DWuhr%26aufirst%3DM.%26aulast%3DHuttlin%26aufirst%3DE.%2BL.%26aulast%3DErickson%26aufirst%3DB.%2BK.%26aulast%3DRad%26aufirst%3DR.%26aulast%3DHaas%26aufirst%3DW.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26atitle%3DMultiNotch%2520MS3%2520enables%2520accurate%252C%2520sensitive%252C%2520and%2520multiplexed%2520detection%2520of%2520differential%2520expression%2520across%2520cancer%2520cell%2520line%2520proteomes%26jtitle%3DAnal.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D7150%26epage%3D7158%26doi%3D10.1021%2Fac502040v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2009&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+Improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520Improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ','PDB','4EKZ'); return false;">PDB: 4EKZ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i135"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_66857"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01951">10.1021/acs.jmedchem.8b01951</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional computational analysis, biochemical data, and structures; Supporting Figures and Tables (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Bru-seq-<b>18</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_002.xls">XLS</a>)</p></li><li><p class="inline">Bru-seq-<b>46</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_003.xlsx">XLSX</a>)</p></li><li><p class="inline">Proteomics results (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_004.xlsx">XLSX</a>)</p></li><li><p class="inline">Proteomics GSEA (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_005.xlsx">XLSX</a>)</p></li><li><p class="inline">CMap (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_006.xlsx">XLSX</a>)</p></li><li><p class="inline">CMap structures (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_007.xlsx">XLSX</a>)</p></li><li><p class="inline">Docked <b>18</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_008.pdb">PDB</a>)</p></li><li><p class="inline">Docked <b>35</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_009.pdb">PDB</a>)</p></li><li><p class="inline">Docked <b>46</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_010.pdb">PDB</a>)</p></li><li><p class="inline">Docked <b>47</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_011.pdb">PDB</a>)</p></li><li><p class="inline">Docked <b>49</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_012.pdb">PDB</a>)</p></li><li><p class="inline">Docked <b>50</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_013.pdb">PDB</a>)</p></li><li><p class="inline">Docked <b>67</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_014.pdb">PDB</a>)</p></li><li><p class="inline">Docked <b>68</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_015.pdb">PDB</a>)</p></li><li><p class="inline">Docked <b>69</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_016.pdb">PDB</a>)</p></li><li><p class="inline">Docked <b>70</b> with <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EKZ">4EKZ</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_017.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_018.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_001.pdf">jm8b01951_si_001.pdf (1.29 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_002.xls">jm8b01951_si_002.xls (32.55 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_003.xlsx">jm8b01951_si_003.xlsx (14.62 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_004.xlsx">jm8b01951_si_004.xlsx (777.41 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_005.xlsx">jm8b01951_si_005.xlsx (318.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_006.xlsx">jm8b01951_si_006.xlsx (1.57 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_007.xlsx">jm8b01951_si_007.xlsx (670.05 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_008.pdb">jm8b01951_si_008.pdb (597.85 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_009.pdb">jm8b01951_si_009.pdb (596.62 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_010.pdb">jm8b01951_si_010.pdb (596.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_011.pdb">jm8b01951_si_011.pdb (596.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_012.pdb">jm8b01951_si_012.pdb (597.13 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_013.pdb">jm8b01951_si_013.pdb (597.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_014.pdb">jm8b01951_si_014.pdb (596.41 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_015.pdb">jm8b01951_si_015.pdb (596.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_016.pdb">jm8b01951_si_016.pdb (596.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_017.pdb">jm8b01951_si_017.pdb (597.25 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01951/suppl_file/jm8b01951_si_018.csv">jm8b01951_si_018.csv (4.96 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01951&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01951%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-7%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01951" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                12MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ac064e8aa23e0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
